
<html lang="en"     class="pb-page"  data-request-id="f2cc4ab9-78f2-42c5-adbc-281e109363b2"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.5b00261;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2015.58.issue-17;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Chemical Biology of Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors" /></meta><meta name="dc.Creator" content="Anthony A.  Estrada" /></meta><meta name="dc.Creator" content="Zachary K.  Sweeney" /></meta><meta name="dc.Description" content="There is an urgent need for the development of Parkinson’s disease (PD) treatments that can slow disease progression. The leucine-rich repeat kinase 2 (LRRK2) protein has been genetically and funct..." /></meta><meta name="Description" content="There is an urgent need for the development of Parkinson’s disease (PD) treatments that can slow disease progression. The leucine-rich repeat kinase 2 (LRRK2) protein has been genetically and funct..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 14, 2015" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.5b00261" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2015 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b00261" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.5b00261" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b00261" /></link>
        
    
    

<title>Chemical Biology of Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.5b00261" /></meta><meta property="og:title" content="Chemical Biology of Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00261/20150904/images/large/jm-2015-00261c_0011.jpeg" /></meta><meta property="og:description" content="There is an urgent need for the development of Parkinson’s disease (PD) treatments that can slow disease progression. The leucine-rich repeat kinase 2 (LRRK2) protein has been genetically and functionally linked to PD, and modulation of LRRK2 enzymatic activity has been proposed as a novel therapeutic strategy. In this review, we describe the bioactivity of selected small molecules that have been used to inhibit LRRK2 kinase activity in vitro or in vivo. These compounds are important tools for understanding the cellular biology of LRRK2 and for evaluating the potential of LRRK2 inhibitors as disease-modifying PD therapies." /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta><meta name="twitter:description" content="There is an urgent need for the development of Parkinson’s disease (PD) treatments that can slow disease progression. The leucine-rich repeat kinase 2 (LRRK2) protein has been genetically and functionally linked to PD, and modulation of LRRK2 enzymatic activity has been proposed as a novel therapeutic strategy. In this review, we describe the bioactivity of selected small molecules that have been used to inhibit LRRK2 kinase activity in vitro or in vivo. These compounds are important tools for understanding the cellular biology of LRRK2 and for evaluating the potential of LRRK2 inhibitors as disease-modifying PD therapies." /></meta><meta name="twitter:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00261/20150904/images/large/jm-2015-00261c_0011.jpeg" /></meta><meta name="twitter:title" content="Chemical Biology of Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors" /></meta>
        
            <meta property="og:type" content="Article" /></meta>
        

        
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.5b00261"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/ke1q~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-6ee29527b3d8ff00a106.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.5b00261">
            
        





































    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-12/achre4.2021.54.issue-12/20210615/achre4.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-6/amrcda.2021.2.issue-6/20210625/amrcda.2021.2.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-6/aabmcb.2021.4.issue-6/20210621/aabmcb.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-6/aaembp.2021.3.issue-6/20210622/aaembp.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-6/aaemcq.2021.4.issue-6/20210628/aaemcq.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-25/aamick.2021.13.issue-25/20210630/aamick.2021.13.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-6/aanmf6.2021.4.issue-6/20210625/aanmf6.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-6/aapmcd.2021.3.issue-6/20210611/aapmcd.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-6/abseba.2021.7.issue-6/20210614/abseba.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-12/accacs.2021.11.issue-12/20210618/accacs.2021.11.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-6/acscii.2021.7.issue-6/20210623/acscii.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-6/acbcct.2021.16.issue-6/20210618/acbcct.2021.16.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-3/achsc5.2021.28.issue-3/20210524/achsc5.2021.28.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-12/acncdm.2021.12.issue-12/20210616/acncdm.2021.12.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-6/aesccq.2021.5.issue-6/20210617/aesccq.2021.5.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-6/aelccp.2021.6.issue-6/20210611/aelccp.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-6/aeecco.2021.1.issue-6/20210611/aeecco.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-6/aewcaa.2021.1.issue-6/20210611/aewcaa.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-5/afsthl.2021.1.issue-5/20210618/afsthl.2021.1.issue-5.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-6/aidcbc.2021.7.issue-6/20210611/aidcbc.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-6/amlccd.2021.10.issue-6/20210615/amlccd.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-6/amlcef.2021.3.issue-6/20210607/amlcef.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-6/amclct.2021.12.issue-6/20210610/amclct.2021.12.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-6/ancac3.2021.15.issue-6/20210622/ancac3.2021.15.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-25/acsodf.2021.6.issue-25/20210629/acsodf.2021.6.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-6/apchd5.2021.8.issue-6/20210616/apchd5.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-6/ascefj.2021.6.issue-6/20210625/ascefj.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-25/ascecg.2021.9.issue-25/20210628/ascecg.2021.9.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-6/asbcd6.2021.10.issue-6/20210618/asbcd6.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-25/ancham.2021.93.issue-25/20210629/ancham.2021.93.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-25/bichaw.2021.60.issue-25/20210629/bichaw.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-6/bcches.2021.32.issue-6/20210616/bcches.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-6/bomaf6.2021.22.issue-6/20210614/bomaf6.2021.22.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-24/cgeabj.2021.99.issue-24/20210628-01/cgeabj.2021.99.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-6/crtoec.2021.34.issue-6/20210621/crtoec.2021.34.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-12/chreay.2021.121.issue-12/20210623/chreay.2021.121.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-12/cmatex.2021.33.issue-12/20210622/cmatex.2021.33.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-6/cgdefu.2021.21.issue-6/20210602/cgdefu.2021.21.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-12/enfuem.2021.35.issue-12/20210617/enfuem.2021.35.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-12/esthag.2021.55.issue-12/20210615/esthag.2021.55.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-6/estlcu.2021.8.issue-6/20210608/estlcu.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-25/iecred.2021.60.issue-25/20210630/iecred.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-12/inocaj.2021.60.issue-12/20210621/inocaj.2021.60.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-6/jaaucr.2021.1.issue-6/20210628/jaaucr.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-25/jafcau.2021.69.issue-25/20210630/jafcau.2021.69.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-6/jceaax.2021.66.issue-6/20210610/jceaax.2021.66.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-6/jceda8.2021.98.issue-6/20210608/jceda8.2021.98.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-6/jcisd8.2021.61.issue-6/20210628/jcisd8.2021.61.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-6/jctcce.2021.17.issue-6/20210608/jctcce.2021.17.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/jmcmar.2021.64.issue-12/20210624/jmcmar.2021.64.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-6/jnprdf.2021.84.issue-6/20210625/jnprdf.2021.84.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-12/joceah.2021.86.issue-12/20210618/joceah.2021.86.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-24/jpcafh.2021.125.issue-24/20210624/jpcafh.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-24/jpcbfk.2021.125.issue-24/20210624/jpcbfk.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-24/jpccck.2021.125.issue-24/20210624/jpccck.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-24/jpclcd.2021.12.issue-24/20210624/jpclcd.2021.12.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-6/jprobs.2021.20.issue-6/20210604/jprobs.2021.20.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-25/jacsat.2021.143.issue-25/20210630/jacsat.2021.143.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-6/jamsef.2021.32.issue-6/20210602/jamsef.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-25/langd5.2021.37.issue-25/20210629/langd5.2021.37.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-12/mamobx.2021.54.issue-12/20210622/mamobx.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-6/mpohbp.2021.18.issue-6/20210607/mpohbp.2021.18.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-12/nalefd.2021.21.issue-12/20210623/nalefd.2021.21.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-12/orlef7.2021.23.issue-12/20210618/orlef7.2021.23.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-6/oprdfk.2021.25.issue-6/20210618/oprdfk.2021.25.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-12/orgnd7.2021.40.issue-12/20210628/orgnd7.2021.40.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.5b00261&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.5b00261&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.5b00261&amp;href=/doi/10.1021/acs.jmedchem.5b00261" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2015</span><span class="cit-fg-volume">, 58</span><span class="cit-fg-issue">, 17</span><span class="cit-fg-pageRange">, 6733-6746</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/58/17" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm501690r" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.5b00902" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Chemical Biology of Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors</span></h1><h2 class="article_header-subtitle"><span class="hlFld-SubTitle">Miniperspective</span></h2><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anthony+A.++Estrada">Anthony A. Estrada</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator"> and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zachary+K.++Sweeney">Zachary K. Sweeney</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Department of Discovery Chemistry, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div><div class="corresp-info"><strong>*</strong>A.A.S.: e-mail, <a href="/cdn-cgi/l/email-protection#b1d4c2c5c3d0d5d09fd0dfc5d9dedfc8f1d6d4dfd49fd2dedc"><span class="__cf_email__" data-cfemail="6a0f191e180b0e0b440b041e020504132a0d0f040f44090507">[email protected]</span></a>; phone, 650-225-4934.</div><div class="corresp-info"><strong>*</strong>Z.K.S.: e-mail, <a href="/cdn-cgi/l/email-protection#3b415a58535a494215484c5e5e555e427b425a53545415585456"><span class="__cf_email__" data-cfemail="651f04060d04171c4b161200000b001c251c040d0a0a4b060a08">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b00261&amp;href=/doi/10.1021%2Facs.jmedchem.5b00261" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2015</span></span><span class="cit-volume">, 58</span><span class="cit-issue">, 17</span><span class="cit-pageRange">, 6733–6746</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 27, 2015</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>13 February 2015</li><li><span class="item_label"><b>Published</b> online</span>14 May 2015</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 10 September 2015</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.5b00261" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00261</a></div><div class="article_header-article-copyright"><strong>Copyright © 2015 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6733%26pageCount%3D14%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DAnthony%2BA.%2BEstrada%252C%2BZachary%2BK.%2BSweeney%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D58%26issueNum%3D17%26contentID%3Dacs.jmedchem.5b00261%26title%3DChemical%2BBiology%2Bof%2BLeucine-Rich%2BRepeat%2BKinase%2B2%2B%2528LRRK2%2529%2BInhibitors%26numPages%3D14%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6746%26publicationDate%3DSeptember%2B2015">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.5b00261"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3255</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">22</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.5b00261" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Chemical Biology of Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Anthony&quot;,&quot;last_name&quot;:&quot;A. Estrada&quot;},{&quot;first_name&quot;:&quot;Zachary&quot;,&quot;last_name&quot;:&quot;K. Sweeney&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2015&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;14&quot;,&quot;issue&quot;:&quot;17&quot;,&quot;volume&quot;:&quot;58&quot;,&quot;pages&quot;:&quot;6733-6746&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.5b00261&quot;},&quot;abstract&quot;:&quot;There is an urgent need for the development of Parkinson’s disease (PD) treatments that can slow disease progression. The leucine-rich repeat kinase 2 (LRRK2) protein has been genetically and functionally linked to PD, and modulation of LRRK2 enzymatic activity has been proposed as a novel therapeutic strategy. In this review, we describe the bioactivity of selected small molecules that have been used to inhibit LRRK2 kinase activity in vitro or in vivo. These compounds are important tools for understanding the cellular biology of LRRK2 and for evaluating the potential of LRRK2 inhibitors as disease-modifying PD therapies.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00261&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00261" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00261&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00261" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00261&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00261" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b00261&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00261&amp;href=/doi/10.1021/acs.jmedchem.5b00261" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.5b00261" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.5b00261" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.5b00261%26sid%3Dliteratum%253Aachs%26pmid%3D25915084%26genre%3Darticle%26aulast%3DEstrada%26date%3D2015%26atitle%3DChemical%2BBiology%2Bof%2BLeucine-Rich%2BRepeat%2BKinase%2B2%2B%2528LRRK2%2529%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D58%26issue%3D17%26spage%3D6733%26epage%3D6746%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/58/17" title="Go to Volume 58, Issue 17"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/jmcmar.2015.58.issue-17/20150910/jmcmar.2015.58.issue-17.largecover.jpg" alt="Go to Volume 58, Issue 17"/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00261/20150904/images/medium/jm-2015-00261c_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00261/20150904/images/large/jm-2015-00261c_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00261&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">There is an urgent need for the development of Parkinson’s disease (PD) treatments that can slow disease progression. The leucine-rich repeat kinase 2 (LRRK2) protein has been genetically and functionally linked to PD, and modulation of LRRK2 enzymatic activity has been proposed as a novel therapeutic strategy. In this review, we describe the bioactivity of selected small molecules that have been used to inhibit LRRK2 kinase activity in vitro or in vivo. These compounds are important tools for understanding the cellular biology of LRRK2 and for evaluating the potential of LRRK2 inhibitors as disease-modifying PD therapies.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81580" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81580" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Parkinson’s disease is a neurological disorder defined by a characteristic tremor, rigidity, and slowing of movement in afflicted patients.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> These cardinal symptoms are often accompanied by disabling insomnia, constipation, and depression. Post-mortem examination of the brains of PD patients usually reveals pronounced degeneration of dopaminergic neurons in the substantia nigra and the presence of insoluble protein complexes.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Approved medicines for the treatment of PD, including dopamine agonists and dopamine precursors, help to reduce movement difficulties in the early stages of the disease.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> However, progressive neurodegeneration ultimately reduces the effectiveness of these symptomatic therapies, and there is a significant medical need for medicines that stop the progressive accumulation of disability.</div><div class="NLM_p">Advances in genomics have had a dramatic effect on our understanding of disease origin.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Many human diseases, including neurological disorders that were historically considered to be caused by environmental effects, are now known to have a significant genetic component. Contemporary drug discovery and development efforts can focus on genetically validated targets and well-defined clinical populations, and this approach has contributed to the discovery of several innovative medicines for the treatment of cancer.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a></div><div class="NLM_p last">The application of a genetically based approach to the discovery of new medicines has also been employed by scientists studying PD.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> PD was not considered to have a significant heritable component until disease risk was linked to mutations in the gene encoding the α-synuclein protein.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Subsequent studies identified α-synuclein as a major component of the protein deposits commonly found in the brain of PD patients, and provided one of the first clear genetic links to neurodegenerative disease. Many other genetic variants, including several distinct sequences encoding the LRRK2 protein, have now been linked to an increased risk for PD.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">LRRK2 Discovery, Structure, and Function</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86526" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86526" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The association between LRRK2 and neurodegeneration was first identified in studies of several families that presented with an autosomal dominant, late onset form of PD.<a onclick="showRef(event, 'ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11">(9-11)</a> Since this finding, seven variants (LRRK2[G2019S], LRRK2[I2020T], LRRK2[S1761R], LRRK2[Y1699C], LRRK2[R1441C/G], and LRRK2[N1437H]) have a strong enough association with disease that they are considered to be pathogenic (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> In addition, the G2385R variant increases the risk of developing PD in Asian populations. PD patients with disease-linked LRRK2 mutations have an average age of disease onset, clinical presentation, and pathologies nearly indistinguishable from those of patients with idiopathic disease. Large genome-wide association studies have also identified LRRK2 as a risk factor for the development of PD, suggesting that modification of the normal function of LRRK2 may be a broadly useful approach to the treatment of this disease.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a></div><div class="NLM_p">The LRRK2 gene sequence encodes a large (2527 amino acids) protein that is highly expressed in many tissues, including the brain, the spleen, the lung, the kidney, and immune cells.<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13, 14)</a> This protein sequence contains several protein–protein interaction domains in addition to enzymatically active GTPase and kinase domains (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Most of the pathogenic LRRK2 variants are located in either the enzymatically active serine–threonine kinase domain or the GTPase domain of the protein, potentially indicating that the genomic changes associated with increased disease risk might alter the catalytic properties of the protein. There is no published structure of LRRK2 or any of the individual protein domains. However, studies of related kinases and GTPases indicate that the LRRK2[I2020T] and LRRK2[G2019S] variants likely increase kinase activity by stabilizing the active conformation of the activation loop.<a onclick="showRef(event, 'ref16 ref17 ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref16 ref17 ref18 ref19 ref20">(16-20)</a> GTP-binding in the LRRK2 GTPase domain and protein dimerization also influence LRRK2 kinase activity.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> The LRRK2[R1441C] and LRRK2[Y1699C] pathogenic variants have reduced GTPase activity. These residue changes may impact LRRK2 kinase activity by modulating LRRK2 dimerization kinetics or by altering interactions between the ROC and COR domains. The functional relationship between GTP binding and kinase activity is underscored by the lack of kinase activity of the LRRK2[T1348N] mutant, which is located in the ROC domain and has a greatly reduced ability to bind GTP.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> In total, while the structural biology of LRRK2 is complex, the weight of evidence suggests that LRRK2 pathogenic variants generally increase kinase activity.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Modulation of kinase function with small molecules might be achieved by interfering with ATP-binding in the kinase domain, GTP binding and hydrolysis in the GTPase domain, or the LRRK2 dimerization equilibrium.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00261/20150904/images/medium/jm-2015-00261c_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00261/20150904/images/large/jm-2015-00261c_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Schematic of LRRK2 protein structure with reported PD pathogenic familial mutations (red), risk factors (black), and cellular phosphorylation (blue) and autophosphorylation (green) sites.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00261/20150904/images/large/jm-2015-00261c_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00261&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The development of in vitro LRRK2 kinase assays was important for the identification of selective inhibitors and also provided initial confirmation that disease linked mutations influenced LRRK2 kinase activity.<a onclick="showRef(event, 'ref16 ref24 ref25 ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref16 ref24 ref25 ref26 ref27">(16, 24-27)</a> This finding was consistent with the autosomal dominant inheritance pattern of LRRK2-linked PD and supported the hypothesis that kinase inhibition could serve as a therapeutic intervention.<a onclick="showRef(event, 'ref24 ref28 ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref24 ref28 ref29 ref30">(24, 28-30)</a> Subsequent optimization of systems for LRRK2 expression in bacteria and of conditions for assaying kinase activity in high-throughput assays enabled the identification of LRRK2 inhibitors from large compound collections utilizing biochemical screening assays.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></div><div class="NLM_p">Early cellular studies of LRRK2 function focused on apoptosis or reduction in neurite length end points resulting from overexpression of LRRK2 or pathogenic LRRK2 variants.<a onclick="showRef(event, 'ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref32 ref33">(32, 33)</a> Exhaustive cellular investigations have indicated that LRRK2 may be involved in cell death processes, synaptic vesicle formation, cytoskeleton assembly, and/or autophagy.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Several selective and nonselective kinase inhibitors were found to protect neurons from the consequences of LRRK2 overexpression, but these studies were generally unable to provide a useful biomarker of kinase inhibitor activity or a convincing mechanistic link between LRRK2 cellular function and neurodegeneration.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> As PD has been genetically and pathologically linked to chronic neuroinflammation, LRRK2 in vitro models that interrogate the LRRK2 dependence of inflammatory signaling processes have been developed.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> LRRK2 inhibitors, when incubated at high concentration, have been shown to modulate the reaction of microglial cells to stimulation.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></div><div class="NLM_p">Many studies searching for a cellular biomarker of LRRK2 enzymatic function attempted to identify changes in cellular phosphorylation states that could be associated with differences in LRRK2 kinase activity. The most useful cellular markers of LRRK2 kinase function currently appear to be the phosphorylation status of LRRK2 at S910, S935, or S1292.<a onclick="showRef(event, 'ref23 ref37'); return false;" href="javascript:void(0);" class="ref ref23 ref37">(23, 37)</a> While phosphorylation of S910 and S935 is generally responsive to inhibition of LRRK2 kinase activity, several mutations that increase kinase activity decrease phosphorylation at these sites.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> These findings led to the development of a model in which LRRK2-mediated phosphorylation of an unknown kinase impacts, in turn, phosphorylation of S910 and S935. Alternatively, it has been suggested that binding of ATP-competitive inhibitors to LRRK2 might induce a conformational change that accelerates dephosphorylation at S910 or S935.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></div><div class="NLM_p">Recent studies have also supported the use of the LRRK2[pS1292] phosphorylation status as a biomarker of LRRK2 kinase activity.<a onclick="showRef(event, 'ref23 ref37'); return false;" href="javascript:void(0);" class="ref ref23 ref37">(23, 37)</a> Five LRRK2 variants associated with familial PD and located in either the GTPase domain or the kinase domain (LRRK2[R1441G], LRRK2[Y1699C], LRRK2[G2019S], LRRK2[I2020T], and LRRK2[N1437H]) displayed elevated LRRK2 phosphorylation. LRRK2[T1348N], which does not bind GTP, did not autophosphorylate at S1292 in cells. Studies using transgenic mice have also confirmed that levels of pS1292 were higher in animals expressing LRRK2[G2019S] protein than in transgenic animals expressing equivalent amounts of LRRK2[wild-type] protein. Unfortunately, the LRRK2[pS1292] phosphorylation/dephosphorylation equilibrium heavily favors the dephosphorylated species, and there is only a small amount of LRRK2 phosphorylated at pS1292 present in most cellular and in vivo systems. Therefore, while LRRK2[pS1292] appears to be a direct marker of LRRK2 kinase activity, currently available antibodies are not sensitive enough to permit assessment of LRRK2 kinase activity in wild-type animal tissue using this biomarker. The more easily detected LRRK2[pS910] and LRRK2[pS935] markers are therefore more broadly applicable technologies for confirming LRRK2 inhibition in cellular models or in animal tissue.</div><div class="NLM_p">The historical association between environmental neurotoxin exposure and PD led to the development of animal models that interrogated the degradation of dopaminergic neurons following toxin administration.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> However, these systems do not reflect critical aspects of PD pathophysiology, and several molecules found to be neuroprotective in toxin PD models were not efficacious in clinical studies.<a onclick="showRef(event, 'ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref40 ref41">(40, 41)</a> The discovery of the genetic association between LRRK2 and PD has led to numerous attempts to develop robust, LRRK2-driven in vivo models of PD.<a onclick="showRef(event, 'ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref42 ref43">(42, 43)</a> Demonstration of the ability of an LRRK2 kinase inhibitor to modify PD-related pathology in these animals would provide considerable support for the potential clinical utility of these agents. Unfortunately, although initial reports indicated that LRRK2-transgenic mice had age-dependent movement deficits or exhibited diminished dopamine levels in the striatum, the frequency of these deficits appears to be quite variable, and most reported phenotypes have not been confirmed.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> LRRK2[G2019S] knockin mice and other transgenic animals have a hyperkinetic phenotype starting at a young age, presumably due to differences in dopamine handling in midbrain neurons. This phenotype has been modified through the administration of selective kinase inhibitors.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a></div><div class="NLM_p last">LRRK2 is broadly expressed, and the protein has been associated with several critical cellular pathways. LRRK2-knockout mice and rats have been used to assess the potential safety risks associated with interfering with LRRK2 catalytic function. LRRK2 deficient mice display morphological abnormalities in both kidney and lung tissue. These findings may be associated with impairments in lysosomal regulation or the lysosomal-autophagy pathway.<a onclick="showRef(event, 'ref46 ref47 ref48 ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref46 ref47 ref48 ref49 ref50">(46-50)</a> Changes in the kidney associated with significantly reduced levels of LRRK2 are also observed in mice expressing a LRRK2 kinase-dead protein.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> LRRK2 knockout rats also exhibit an abnormal kidney, lung, and liver phenotype.<a onclick="showRef(event, 'ref51 ref52'); return false;" href="javascript:void(0);" class="ref ref51 ref52">(51, 52)</a> As described in the following section, these findings have stimulated researchers to determine if similar effects are observed following administration of small molecule kinase inhibitors.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">LRRK2 Small Molecule Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78601" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78601" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In the past several years, small molecule inhibitors have emerged as useful tools for interrogating the function of LRRK2. Biochemical assays permit the selectivity of these kinase inhibitors to be estimated, and autophosphorylation biomarkers can be used to assess the ability of these compounds to inhibit LRRK2 kinase activity in vitro and in vivo. Ideally, an LRRK2 kinase inhibitor would demonstrate good selectivity for inhibition of LRRK2 relative to other kinases and be able to inhibit LRRK2 kinase function in the brain and other organs following oral administration to animals. The unbound concentrations of the inhibitor required to inhibit kinase activity in vivo should be proportional to the biochemical potency of the compound. Similarly, the LRRK2 inhibitor should impact cellular processes at levels that can be interpreted in the context of the LRRK2 cellular inhibitory concentrations. Given their inherent promiscuity, these considerations are particularly important for ATP-competitive kinase inhibitors.</div><div class="NLM_p last">Multiple literature<a onclick="showRef(event, 'ref34 ref53 ref54 ref55 ref56 ref57'); return false;" href="javascript:void(0);" class="ref ref34 ref53 ref54 ref55 ref56 ref57">(34, 53-57)</a> and patent reviews<a onclick="showRef(event, 'ref31 ref58 ref59'); return false;" href="javascript:void(0);" class="ref ref31 ref58 ref59">(31, 58, 59)</a> documenting the small molecule LRRK2 inhibitor landscape have been published in the past several years. This review will focus primarily on recently reported kinase inhibitors that are highly selective for LRRK2. These structurally diverse tools should enable “chemical genetic studies” that provide additional understanding of the consequences of LRRK2 kinase inhibition.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">LRRK2-Selective Small Molecule Kinase Inhibitors with Low Brain Penetration</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05828" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05828" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A significant advancement in the LRRK2 small molecule kinase inhibitor field was achieved in 2011 when selective inhibitors CZC25146 (<b>1</b>) [4/184 kinases with a biochemical IC<sub>50</sub> <300 nM using Kinobeads, 286-fold over LRRK2 IC<sub>50</sub>] and LRRK2-IN-1 (<b>2</b>) (12/440 kinases with <10% activity of control, 1667-fold over LRRK2 IC<sub>50</sub>) were disclosed in the literature (see Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> for structures and selected data; all kinase selectivity data are represented as number of kinases identified/total number of kinases tested, and fold selectivity is defined as testing concentration/LRRK2 <i>K</i><sub>i</sub> or IC<sub>50</sub>).<a onclick="showRef(event, 'ref60 ref61'); return false;" href="javascript:void(0);" class="ref ref60 ref61">(60, 61)</a> Prior to these reports, LRRK2 small molecule tool compounds had limited utility for examining LRRK2 biology due to the poor selectivity for LRRK2 inhibition relative to other cellular kinases. Both <b>1</b> and <b>2</b> possess low nanomolar biochemical LRRK2 potency. Using an in vitro rat model of LRRK2[G2019S]-induced neuronal toxicity (as measured by neurite retraction, overt rounding of cells, and DNA fragementation), Ramsden and Hopf et al. demonstrated the attenuation of cell injury in a concentration-dependent fashion using arylsulfonamide <b>1</b> (rat EC<sub>50</sub> ≈ 100 nM). By use of a different quantification method (computerized algorithm assessing neurite length and average branch point count), attenuation of LRRK2[G2019S]-induced neuronal toxicity in primary human cortical neurons was also reported (human EC<sub>50</sub> ≈ 4 nM). Tricyclic diaminopyrimidine <b>2</b> was employed by Alessi and Gray et al. to examine S910 and S935 phosphorylation levels, and 14-3-3 binding in a variety of cell types. Inhibitor <b>2</b> showed a dose-dependent dephosphorylation of both serine biomarkers with significant dephosphorylation achieved at 1–3 μM. Additionally, <b>2</b> demonstrated in vivo inhibition of S910 and S935 phosphorylation in mouse kidney after ip dosing (100 mg kg<sup>–1</sup>). Moehle et al. also used tool compound <b>2</b> to investigate the in vitro amelioration of TLR4-induced proinflammatory signaling in microglia.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></div><div class="NLM_p">While compound <b>2</b> has been utilized by a number of groups in experiments designed to assess the impact of kinase activity on cellular processes,<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> it has been recognized that the promiscuity of <b>2</b> may complicate the interpretation of results generated with this inhibitor. For example, <b>2</b> reduced the induction of LRRK2 expression by IFN-γ, although other LRRK2 kinase inhibitors did not produce this effect. Ultimately it was proposed that inhibition of ERK5 by <b>2</b> mediates the expression of LRRK2 induced by the cytokine.<a onclick="showRef(event, 'ref63 ref64'); return false;" href="javascript:void(0);" class="ref ref63 ref64">(63, 64)</a> Another publication attributes the antiproliferative effects of <b>2</b> in cancer cells to inhibition of DCLK1.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> Finally, an evaluation of the changes in protein phosphorylation caused by <b>2</b> in neuronal cultures from wild-type and LRRK2 knockout mice has demonstrated that this inhibitor can impact a variety of signaling pathways in an LRRK2-independent fashion.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> As these results illustrate, it is nearly impossible to achieve complete specificity for a single kinase target using ATP-competitive compounds. Thus, the use of multiple structurally distinct LRRK2 inhibitors at appropriate concentrations according to their selectivity in biochemical and cellular assays should be strongly encouraged.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Physicochemical Property, Activity, Selectivity, and in Vivo PK Profiles of Reported LRRK2 Inhibitors <b>1</b>–<b>4</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00261/20150904/images/medium/jm-2015-00261c_0006.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">CNS MPO score</th><th class="colsep0 rowsep0" align="center">MW</th><th class="colsep0 rowsep0" align="center">cLogP</th><th class="colsep0 rowsep0" align="center">TPSA (Å<sup>2</sup>)</th><th class="colsep0 rowsep0" align="center">LRRK2 IC<sub>50</sub> <a class="ref internalNav" href="#t1fn1" aria-label="a">a</a> (nM)</th><th class="colsep0 rowsep0" align="center">LLE</th><th class="colsep0 rowsep0" align="center">kinase selectivity</th><th class="colsep0 rowsep0" align="center">mouse Cl (mL min<sup>–1</sup> kg<sup>–1</sup>)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">total <i>B</i>/<i>P</i> <a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b><a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a></td><td class="colsep0 rowsep0" align="left">2.4</td><td class="colsep0 rowsep0" align="left">489</td><td class="colsep0 rowsep0" align="left">3.5</td><td class="colsep0 rowsep0" align="left">117</td><td class="colsep0 rowsep0" align="left">7</td><td class="colsep0 rowsep0" align="left">4.7</td><td class="colsep0 rowsep0" align="left">4/184 < 300 nM<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">2.3</td><td class="colsep0 rowsep0" align="left">Neg<a class="ref internalNav" href="#t1fn9" aria-label="i">i</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b><a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a></td><td class="colsep0 rowsep0" align="left">4.4</td><td class="colsep0 rowsep0" align="left">571</td><td class="colsep0 rowsep0" align="left">2.9</td><td class="colsep0 rowsep0" align="left">97</td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">5.3</td><td class="colsep0 rowsep0" align="left">12/440 < 10% of control<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">5.6</td><td class="colsep0 rowsep0" align="left">Neg<a class="ref internalNav" href="#t1fn9" aria-label="i">i</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b><a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a></td><td class="colsep0 rowsep0" align="left">1.8</td><td class="colsep0 rowsep0" align="left">614</td><td class="colsep0 rowsep0" align="left">5.8</td><td class="colsep0 rowsep0" align="left">102</td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">2.4</td><td class="colsep0 rowsep0" align="left">27/440 < 10% of control<a class="ref internalNav" href="#t1fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left">17</td><td class="colsep0 rowsep0" align="left">1.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b><a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a></td><td class="colsep0 rowsep0" align="left">5.6</td><td class="colsep0 rowsep0" align="left">368</td><td class="colsep0 rowsep0" align="left">2.7</td><td class="colsep0 rowsep0" align="left">79</td><td class="colsep0 rowsep0" align="left">64</td><td class="colsep0 rowsep0" align="left">4.5</td><td class="colsep0 rowsep0" align="left">2/391 < 30% of control<a class="ref internalNav" href="#t1fn7" aria-label="g">g</a></td><td class="colsep0 rowsep0" align="left">nr<a class="ref internalNav" href="#t1fn8" aria-label="h">h</a></td><td class="colsep0 rowsep0" align="left">0.1<a class="ref internalNav" href="#t1fn10" aria-label="j">j</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Biochemical assay; LRRKtide used for compounds <b>1</b> and <b>4</b>, and Nictide used for compounds <b>2</b> and <b>3</b>; G2019S LRRK2 mutant IC<sub>50</sub> at 100 μM ATP for compounds <b>1</b>–<b>3</b> and wild-type LRRK2 IC<sub>50</sub> at 1 mM ATP for compound <b>4</b>.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">Compound <b>1</b> was dosed iv (1 mg kg<sup>–1</sup>) for both systemic and brain PK. Compound <b>2</b> was dosed iv (1 mg kg<sup>–1</sup>). Compound <b>3</b> was dosed iv (1 mg kg<sup>–1</sup>) for both systemic and brain PK.</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">Total brain/plasma AUC ratio.</p></div><div class="footnote" id="t1fn4"><sup>d</sup><p class="last">Kinobeads profiling (2 μM, 286-fold over LRRK2 IC<sub>50</sub>).</p></div><div class="footnote" id="t1fn5"><sup>e</sup><p class="last">KINOMEscan profiling (10 μM, 1667-fold over LRRK2 IC<sub>50</sub>).</p></div><div class="footnote" id="t1fn6"><sup>f</sup><p class="last">KINOMEscan profiling (10 μM, 1667-fold over LRRK2 IC<sub>50</sub>).</p></div><div class="footnote" id="t1fn7"><sup>g</sup><p class="last">KINOMEscan profiling (1 μM, 15-fold over LRRK2 IC<sub>50</sub>).</p></div><div class="footnote" id="t1fn8"><sup>h</sup><p class="last">Not reported.</p></div><div class="footnote" id="t1fn9"><sup>i</sup><p class="last">Negligible brain penetration.</p></div><div class="footnote" id="t1fn10"><sup>j</sup><p class="last">Unbound brain/unbound plasma AUC ratio.</p></div></div></div><div class="NLM_p">Shortly following the disclosure of <b>2</b>, Gray and Alessi et al. published the characterization of TAE684 (<b>3</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). This compound possesses structural features of both <b>1</b> and <b>2</b> and had been previously reported as an ALK inhibitor.<a onclick="showRef(event, 'ref67 ref68'); return false;" href="javascript:void(0);" class="ref ref67 ref68">(67, 68)</a> While sulfone <b>3</b> demonstrated similar biochemical activity as its predecessors (6 nM), it also exhibited a higher level of promiscuity (27/440 kinases with <10% activity of control, 1667-fold over LRRK2 IC<sub>50</sub>).<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> Similar to tool compound <b>2</b>, sulfone <b>3</b> inhibits in vivo phosphorylation of mouse S910 and S935 in the periphery (kidney and spleen) in a dose-dependent fashion after oral administration.</div><div class="NLM_p">Recently, Pfizer has reported a class of triazolopyridazines (i.e. <b>4</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) that are structurally similar to those previously reported by Elan.<a onclick="showRef(event, 'ref70 ref71'); return false;" href="javascript:void(0);" class="ref ref70 ref71">(70, 71)</a> As poor metabolic stability profiles precluded the in vivo assessment of compounds reported by Elan, only triazolopyridazines disclosed by Pfizer will be discussed here. Using TYK2 cocrystal structures, Galatsis et al. were able to confirm a single point contact between the kinase hinge (<i>N</i>-H of Val981) and a nitrogen atom of the triazole moiety. The absence of hydrogen bond donors in <b>4</b> is notable, as hydrogen bond donors increase the probability of P-gp recognition, and reduce CNS penetration.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> Through the application of CNS physicochemical property constraints and by use of TYK2 cocrystal structures to facilitate structure-based drug design, compound <b>4</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) was optimized from an HTS screen. Triazolopyridazine <b>4</b> has a LRRK2 wild-type IC<sub>50</sub> of 64 nM and is reported to be highly selective [2/391 kinases with <30% activity of control (TYK2 and JAK3), 15-fold over LRRK2 IC<sub>50</sub>]. The in vivo tolerability profile of <b>4</b> was assessed in a repeat-dose 14-day PK/PD study in mice at 30 and 300 mg kg<sup>–1</sup> (<i>n</i> = 5 males/dose). No test article-related findings were reported from the examined tissues, which included microscopic examinations of the lung and kidney.</div><div class="NLM_p last">The major drawback of LRRK2 tool compounds <b>1</b>–<b>4</b> is their inability to probe the effects of LRRK2 kinase inhibition in the CNS. The calculated TPSA (117 Å<sup>2</sup>) and CNS MPO score (2.4) for <b>1</b><a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> and TPSA (97 Å<sup>2</sup>) and MW (571) for <b>2</b> are outside desirable CNS physicochemical property space.<a onclick="showRef(event, 'ref72 ref74 ref75 ref76 ref77'); return false;" href="javascript:void(0);" class="ref ref72 ref74 ref75 ref76 ref77">(72, 74-77)</a> Unsurprisingly, mouse pharmacokinetic studies with <b>1</b> exhibited negligible brain penetration (4%) and in vivo PD experiments with <b>2</b> showed no detectable dephosphorylation of S910 or S935 in mouse brain. The overall physicochemical profile of <b>3</b> is also inconsistent with CNS penetration. In vivo mouse PD experiments with <b>3</b> also showed no detectable in vivo LRRK2 kinase inhibition in the brain despite a total brain to plasma (<i>B</i>/<i>P</i>) ratio of 1.7. As compound <b>3</b> is exceedingly lipophilic (cLogP = 5.8), it is likely to be highly bound to brain tissue. The resulting unbound brain concentrations may be negligible, limiting the potential  to induce an in vivo brain PD effect. This underscores the importance of measuring unbound and not total brain concentrations in CNS small molecule drug discovery programs.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> Finally, while inhibitor <b>4</b> possesses an ideal balance of physicochemical properties for CNS penetration (CNS MPO = 5.6) and is not reported as a P-gp substrate, it was shown that the BCRP transporter limited brain penetration (<i>B</i><sub>u</sub>/<i>P</i><sub>u</sub> = 0.14, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). This example emphasizes the importance of assessing both P-gp and BCRP affinity in small molecule CNS campaigns. As a result of the poor free brain levels achieved, LRRK2 PK/PD studies with G2019S transgenic mice and triazolopyridazine <b>4</b> at 300 mg kg<sup>–1</sup> showed only a slight brain PK/PD effect (∼20% pS935 and pS1292 decrease).</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Brain-Penetrant LRRK2-Selective Small Molecule Kinase Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75826" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75826" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Several selective small molecule LRRK2 kinase inhibitors capable of inhibiting LRRK2 kinase activity in the CNS have been reported since 2012.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Physicochemical Property, Activity, and Selectivity Profiles of Reported Aminopyrimidine LRRK2 Inhibitors <b>5</b>–<b>9</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00261/20150904/images/medium/jm-2015-00261c_0007.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">CNS MPO score</th><th class="colsep0 rowsep0" align="center">MW</th><th class="colsep0 rowsep0" align="center">cLogP</th><th class="colsep0 rowsep0" align="center">TPSA (Å<sup>2</sup>)</th><th class="colsep0 rowsep0" align="center">LRRK2 <i>K</i><sub>i</sub> <a class="ref internalNav" href="#t2fn1" aria-label="a">a</a> (nM)</th><th class="colsep0 rowsep0" align="center">LLE</th><th class="colsep0 rowsep0" align="center">kinase selectivity</th><th class="colsep0 rowsep0" align="center">pLRRK2 IC<sub>50</sub> <a class="ref internalNav" href="#t2fn2" aria-label="b">b</a> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b><a onclick="showRef(event, 'ref79 ref80 ref81'); return false;" href="javascript:void(0);" class="ref ref79 ref80 ref81">(79-81)</a></td><td class="colsep0 rowsep0" align="left">5.4</td><td class="colsep0 rowsep0" align="left">378</td><td class="colsep0 rowsep0" align="left">1.9</td><td class="colsep0 rowsep0" align="left">88</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">6.6</td><td class="colsep0 rowsep0" align="left">0/63 >50%<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">29</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b><a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a></td><td class="colsep0 rowsep0" align="left">5.1</td><td class="colsep0 rowsep0" align="left">411</td><td class="colsep0 rowsep0" align="left">2.1</td><td class="colsep0 rowsep0" align="left">88</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">6.6</td><td class="colsep0 rowsep0" align="left">0/178 >50%<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b><a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a></td><td class="colsep0 rowsep0" align="left">4.5</td><td class="colsep0 rowsep0" align="left">443</td><td class="colsep0 rowsep0" align="left">2.8</td><td class="colsep0 rowsep0" align="left">88</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">6.2</td><td class="colsep0 rowsep0" align="left">2/449 < 30% of control<a class="ref internalNav" href="#t2fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b><a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a></td><td class="colsep0 rowsep0" align="left">5.0</td><td class="colsep0 rowsep0" align="left">339</td><td class="colsep0 rowsep0" align="left">3.0</td><td class="colsep0 rowsep0" align="left">91</td><td class="colsep0 rowsep0" align="left">0.7</td><td class="colsep0 rowsep0" align="left">6.2</td><td class="colsep0 rowsep0" align="left">4/188 >50%<a class="ref internalNav" href="#t2fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b><a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a></td><td class="colsep0 rowsep0" align="left">4.5</td><td class="colsep0 rowsep0" align="left">450</td><td class="colsep0 rowsep0" align="left">2.8</td><td class="colsep0 rowsep0" align="left">80</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">5.9</td><td class="colsep0 rowsep0" align="left">1/178 >50%<a class="ref internalNav" href="#t2fn7" aria-label="g">g</a></td><td class="colsep0 rowsep0" align="left">19</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Biochemical assay; LRRKtide and G2019S mutant used for compounds <b>5</b>–<b>9</b>.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">pSer1292 triple mutant (G2019S/R1441G/Y1699C) cellular assay used for compounds <b>5</b>–<b>9</b>.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">Invitrogen profiling (1 μM, 345-fold over LRRK2 <i>K</i><sub>i</sub>).</p></div><div class="footnote" id="t2fn4"><sup>d</sup><p class="last">Invitrogen profiling (0.1 μM, 60-fold over LRRK2 <i>K</i><sub>i</sub>).</p></div><div class="footnote" id="t2fn5"><sup>e</sup><p class="last">KINOMEscan profiling (0.1 μM, 100-fold over LRRK2 <i>K</i><sub>i</sub>).</p></div><div class="footnote" id="t2fn6"><sup>f</sup><p class="last">Invitrogen profiling (0.1 μM, 145-fold over LRRK2 <i>K</i><sub>i</sub>).</p></div><div class="footnote" id="t2fn7"><sup>g</sup><p class="last">Invitrogen profiling (0.1 μM, 50-fold over LRRK2 <i>K</i><sub>i</sub>).</p></div></div></div><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Genentech Diaminopyrimidines</h3><div class="NLM_p">In May of 2012, Genentech published the first of several disclosures highlighting a series of diaminopyrimidine LRRK2 inhibitors.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> Following a high-throughput screening (HTS) campaign, Chen et al. were able to construct a LRRK2 homology model using the JAK2 kinase domain as a structural template. The JAK2-based model proved to be highly robust and successful in assisting hit-to-lead and lead optimization efforts across a range of structurally diverse constructs. G7080 (<b>5</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a> and Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>)<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> was designed from a ligand efficient HTS hit. The methoxy substituent is also found in aminopyrimidine compounds <b>1</b>–<b>3</b>, and is critical for reducing inhibition of many other kinases. This is illustrated in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>, and can be explained by the close proximity of the methoxy substituent of <b>5</b> and Y931 of JAK2 (magenta), which results in a high degree of selectivity against JAK2 and additional kinases (approximately 290 kinases) with large Tyr or Phe residues in this lower hinge region. Conversely, the methoxy substituent is well tolerated in LRRK2 because of the much smaller L1949 residue. Compound <b>5</b> was reported to be highly selective in a kinase profiling study (0/63 kinases with >50% inhibition, 345-fold over LRRK2 <i>K</i><sub>i</sub>).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00261/20150904/images/medium/jm-2015-00261c_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00261/20150904/images/large/jm-2015-00261c_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Docking model of <b>5</b> (cyan) in LRRK2 (green with L1949 in yellow). The side chain of Y931 of JAK2 is also shown (magenta). Intermolecular hydrogen bond interactions are shown as yellow dashed lines. The figure was reproduced from Estrada 2012<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> with permission from Journal of Medicinal Chemistry. Copyright 2012 American Chemical Society.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00261/20150904/images/large/jm-2015-00261c_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00261&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Following the initial disclosure, Choi et al. also described the discovery and activity of <b>5</b> (termed HG-10-102-01 in their publication) and confirmed the high degree of kinase selectivity and biochemical and cellular activity.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> Using <b>2</b> as a benchmark, the authors demonstrated that compound <b>5</b> was able to inhibit phosphorylation of wild-type and G2019S mutant LRRK2 at S910 and S935 in HEK293 cells. Additionally, inhibitor <b>5</b> was able to show dose-dependent inhibition of pS910 and pS935 in endogenously expressed LRRK2 from lymphoblastoid cells (G2019S PD patient sample), mouse Swiss 3T3 cells, and mouse embryonic fibroblast cells with similar or better potency than <b>2</b> [EC<sub>50</sub> ≈ 0.3–1.0 μM].</div><div class="NLM_p">In vivo PK profiling of aminopyrimidine <b>5</b> by Genentech (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) revealed a rat plasma clearance approaching liver blood flow, a short iv half-life (0.5 h), and a modest <i>B</i><sub>u</sub>/<i>P</i><sub>u</sub> ratio (0.17). In an effort to improve upon the pharmacological and pharmacokinetic profile of lead compound <b>5</b>, a thorough lead optimization campaign using structure- and property-based drug design was executed.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> This strategy initially resulted in the identification of G1023 (<b>6</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>),<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> which featured good biochemical lipophilic ligand efficiency (LLE = 6.6),<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> a high degree of kinase selectivity (0/178 kinases with >50% inhibition, 60-fold over LRRK2 <i>K</i><sub>i</sub>), a 3-fold improvement in the pS1292 cellular assay, and an improved in vivo rat PK profile (Cl = 24 mL min<sup>–1</sup> kg<sup>–1</sup>, <i>B</i><sub>u</sub>/<i>P</i><sub>u</sub> = 0.5). Inhibitor <b>6</b> was subsequently used as an in vivo tool to demonstrate the inhibition of in vivo kinase activity in G2019S transgenic mouse brains (pS1292) and the reversal of cellular effects of LRRK2 PD mutations in cultured primary hippocampal neurons. The in vivo unbound brain concentration required to effectively reduce pS1292 autophosphorylation in vivo (IC<sub>50</sub> = 12 nM) was nearly identical to the in vitro cellular IC<sub>50</sub> reported for compound <b>6</b> (9 nM). Additionally, upon treatment of LRRK2[G2019S] mouse embryonic hippocampal neurons with inhibitor <b>6</b> at 100 nM, a statistically significant amelioration of the neurite outgrowth defects associated with the LRRK2[G2019S] transgene was observed.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. In Vitro and in Vivo Rat DMPK Profiles of Reported Aminopyrimidine Brain-Penetrant LRRK2 Inhibitors <b>5</b>–<b>9</b><a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">hep Cl<sub>hep</sub> (mL min<sup>–1</sup> kg<sup>–1</sup>)<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a> h/r<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">% rat PPB</th><th class="colsep0 rowsep0" align="center">Cl (Cl<sub>u</sub>) (mL min<sup>–1</sup> kg<sup>–1</sup>)<a class="ref internalNav" href="#t3fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center">iv <i>t</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center"><i>F</i> (%)</th><th class="colsep0 rowsep0" align="center">MDR1<a class="ref internalNav" href="#t3fn5" aria-label="e">e</a> P-gp ER<a class="ref internalNav" href="#t3fn6" aria-label="f">f</a> (B:A/A:B)<a class="ref internalNav" href="#t3fn7" aria-label="g">g</a></th><th class="colsep0 rowsep0" align="center">total <i>B</i>/<i>P</i> <a class="ref internalNav" href="#t3fn8" aria-label="h">h</a></th><th class="colsep0 rowsep0" align="center"><i>B</i><sub>u</sub>/<i>P</i><sub>u</sub> <a class="ref internalNav" href="#t3fn9" aria-label="i">i</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b><a onclick="showRef(event, 'ref79 ref80 ref81'); return false;" href="javascript:void(0);" class="ref ref79 ref80 ref81">(79-81)</a></td><td class="colsep0 rowsep0" align="left">4.9/24</td><td class="colsep0 rowsep0" align="left">92</td><td class="colsep0 rowsep0" align="left">51 (616)</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">64</td><td class="colsep0 rowsep0" align="left">2.8</td><td class="colsep0 rowsep0" align="left">0.23</td><td class="colsep0 rowsep0" align="left">0.17</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b><a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a></td><td class="colsep0 rowsep0" align="left">1.8/7.6</td><td class="colsep0 rowsep0" align="left">86</td><td class="colsep0 rowsep0" align="left">24 (156)</td><td class="colsep0 rowsep0" align="left">1.2</td><td class="colsep0 rowsep0" align="left">80</td><td class="colsep0 rowsep0" align="left">1.2</td><td class="colsep0 rowsep0" align="left">0.9</td><td class="colsep0 rowsep0" align="left">0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b><a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a></td><td class="colsep0 rowsep0" align="left">3.2/14</td><td class="colsep0 rowsep0" align="left">97</td><td class="colsep0 rowsep0" align="left">8.3 (244)</td><td class="colsep0 rowsep0" align="left">3.1</td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">0.9</td><td class="colsep0 rowsep0" align="left">0.9</td><td class="colsep0 rowsep0" align="left">0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b><a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a></td><td class="colsep0 rowsep0" align="left">3/25</td><td class="colsep0 rowsep0" align="left">79</td><td class="colsep0 rowsep0" align="left">44 (210)</td><td class="colsep0 rowsep0" align="left">1.3</td><td class="colsep0 rowsep0" align="left">90</td><td class="colsep0 rowsep0" align="left">0.8</td><td class="colsep0 rowsep0" align="left">1.2</td><td class="colsep0 rowsep0" align="left">0.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b><a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a></td><td class="colsep0 rowsep0" align="left">1/21</td><td class="colsep0 rowsep0" align="left">79</td><td class="colsep0 rowsep0" align="left">26 (261)</td><td class="colsep0 rowsep0" align="left">1.5</td><td class="colsep0 rowsep0" align="left">90</td><td class="colsep0 rowsep0" align="left">0.8</td><td class="colsep0 rowsep0" align="left">0.7</td><td class="colsep0 rowsep0" align="left">0.5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Compounds <b>5</b>–<b>9</b> were dosed po (1 mg kg<sup>–1</sup>) as an aqueous suspension with 1% methylcellulose, iv (0.5 mg kg<sup>–1</sup>) as a 60% PEG solution or 20–60% NMP solution for systemic PK, and iv (0.5 mg kg<sup>–1</sup>) as a 60% NMP solution for brain PK.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">In vitro stability in cryopreserved hepatocytes.</p></div><div class="footnote" id="t3fn3"><sup>c</sup><p class="last">h/r = human/rat.</p></div><div class="footnote" id="t3fn4"><sup>d</sup><p class="last">Cl<sub>u</sub> = unbound clearance = total clearance/<i>f</i><sub>up</sub>, where <i>f</i><sub>up</sub> is the unbound plasma free fraction.</p></div><div class="footnote" id="t3fn5"><sup>e</sup><p class="last">MDCK-MDR1 human P-gp transfected cell line.</p></div><div class="footnote" id="t3fn6"><sup>f</sup><p class="last">Efflux ratio.</p></div><div class="footnote" id="t3fn7"><sup>g</sup><p class="last">Basolateral-to-apical/apical-to-basolateral.</p></div><div class="footnote" id="t3fn8"><sup>h</sup><p class="last">Total brain/plasma AUC ratio.</p></div><div class="footnote" id="t3fn9"><sup>i</sup><p class="last">Unbound brain/unbound plasma AUC ratio.</p></div></div></div><div class="NLM_p">A targeted subset of kinases (e.g., kinases that shared a similar ATP binding site sequence makeup with LRRK2) that had not been previously evaluated were screened and revealed TTK (MPS1) as a kinase that was also strongly inhibited by pyrimidine <b>6</b> (13-fold TTK selectivity index) and structurally related analogs.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> Structure-based drug design efforts using the JAK2-based homology model and TTK cocrystal structures suggested that substitution on the phenyl ring para to the methoxy substituent would produce a steric clash with Asp608 in TTK and increase the TTK/LRRK2 selectivity window. Thus, a few minor structural modifications, including fluorine substitution at the aforementioned phenyl ring position, resulted in the discovery of GNE-7915 (<b>7</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> Compound <b>7</b> possessed a nearly identical activity and DMPK profile to <b>6</b> but with an improved TTK selectivity index (53-fold) and good kinome selectivity at a concentration (0.1 μM) that satisfied a targeted 100-fold biochemical selectivity window [2/449 kinases with <30% activity of control (TTK and ALK), 100-fold over LRRK2 <i>K</i><sub>i</sub>, DiscoveRx KINOMEscan]. The excellent selectivity profile of optimized inhibitor <b>7</b> at 0.1 μM was further corroborated in an Invitrogen kinase selectivity panel [1/187 kinases with >50% inhibition (TTK), 100-fold over LRRK2 <i>K</i><sub>i</sub>].</div><div class="NLM_p">In an effort to increase the structural diversity and selectivity of the brain-penetrant diaminopyrimidine compounds, aniline bioisosteres were explored. Lead optimization efforts culminated in the identification of aminopyrazoles GNE-0877 and GNE-9605 (<b>8</b> and <b>9</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) as highly potent and specific LRRK2 inhibitors [<b>8</b> = 4/188 kinases with >50% inhibition (Aurora B, RSK2, RSK3, RSK4), 0/188 kinases with >70% inhibition, 145-fold over LRRK2 <i>K</i><sub>i</sub>; <b>9</b> = 1/178 kinases with >50% inhibition (TAK1-TAB1), 0/178 kinases with >60% inhibition, 50-fold over LRRK2 <i>K</i><sub>i</sub>] with excellent DMPK profiles (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>).<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a></div><div class="NLM_p">In vivo non-human primate (NHP) PK profiles of lead aminopyrimidines <b>7</b>, <b>8</b>, and <b>9</b> are summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>. All three compounds demonstrated good in vitro–in vivo correlation, moderate to stable plasma clearance rates, and good iv half-lives. Additionally, CSF/<i>P</i><sub>u</sub> ratios extracted from low-dose PK studies suggested that all three inhibitors possessed approximately equal free brain to free plasma distribution.<a onclick="showRef(event, 'ref84 ref85'); return false;" href="javascript:void(0);" class="ref ref84 ref85">(84, 85)</a> Desirable <i>B</i><sub>u</sub>/<i>P</i><sub>u</sub> ratios were later confirmed for compounds <b>7</b> and <b>8</b> during NHP safety assessments (vide infra).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. In Vivo NHP PK Profiles of LRRK2 Aminopyrimidines <b>7</b>, <b>8</b>, and <b>9</b><a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">hep Cl<sub>hep</sub> (mL min<sup>–1</sup> kg<sup>–1</sup>)<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a> NHP</th><th class="colsep0 rowsep0" align="center">% NHP PPB</th><th class="colsep0 rowsep0" align="center">Cl (Cl<sub>u</sub>) (mL min<sup>–1</sup> kg<sup>–1</sup>)<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">iv <i>t</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center"><i>F</i> (%), 1 mg kg<sup>–1</sup></th><th class="colsep0 rowsep0" align="center">MDR1<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a> P-gp ER<a class="ref internalNav" href="#t4fn5" aria-label="e">e</a> (B:A/A:B)<a class="ref internalNav" href="#t4fn6" aria-label="f">f</a></th><th class="colsep0 rowsep0" align="center"><i>B</i><sub>u</sub>/<i>P</i><sub>u</sub> <a class="ref internalNav" href="#t4fn7" aria-label="g">g</a></th><th class="colsep0 rowsep0" align="center">CSF/<i>P</i><sub>u</sub> <a class="ref internalNav" href="#t4fn8" aria-label="h">h</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b><a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a></td><td class="colsep0 rowsep0" align="left">14</td><td class="colsep0 rowsep0" align="left">95</td><td class="colsep0 rowsep0" align="left">11 (200)</td><td class="colsep0 rowsep0" align="left">7.7</td><td class="colsep0 rowsep0" align="left">17</td><td class="colsep0 rowsep0" align="left">0.9</td><td class="colsep0 rowsep0" align="left">0.6</td><td class="colsep0 rowsep0" align="left">1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b><a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a></td><td class="colsep0 rowsep0" align="left">19</td><td class="colsep0 rowsep0" align="left">80</td><td class="colsep0 rowsep0" align="left">20 (100)</td><td class="colsep0 rowsep0" align="left">2.2</td><td class="colsep0 rowsep0" align="left">35</td><td class="colsep0 rowsep0" align="left">0.8</td><td class="colsep0 rowsep0" align="left">0.7</td><td class="colsep0 rowsep0" align="left">1.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b><a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a></td><td class="colsep0 rowsep0" align="left">13</td><td class="colsep0 rowsep0" align="left">82</td><td class="colsep0 rowsep0" align="left">8 (43)</td><td class="colsep0 rowsep0" align="left">4.0</td><td class="colsep0 rowsep0" align="left">74</td><td class="colsep0 rowsep0" align="left">0.8</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1.1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Compounds were dosed po (1 mg kg<sup>–1</sup>) with crystalline material as an aqueous suspension with 1% methylcellulose and iv (0.5 mg kg<sup>–1</sup>) as a 20–60% NMP solution.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">In vitro stability in cryopreserved hepatocytes.</p></div><div class="footnote" id="t4fn3"><sup>c</sup><p class="last">Cl<sub>u</sub> = unbound clearance = total clearance/<i>f</i><sub>up</sub>, where <i>f</i><sub>up</sub> is the unbound plasma free fraction.</p></div><div class="footnote" id="t4fn4"><sup>d</sup><p class="last">MDCK-MDR1 human P-gp transfected cell line.</p></div><div class="footnote" id="t4fn5"><sup>e</sup><p class="last">Efflux ratio.</p></div><div class="footnote" id="t4fn6"><sup>f</sup><p class="last">Basolateral-to-apical/apical-to-basolateral.</p></div><div class="footnote" id="t4fn7"><sup>g</sup><p class="last">Unbound brain/unbound plasma AUC ratio.</p></div><div class="footnote" id="t4fn8"><sup>h</sup><p class="last">CSF/unbound plasma AUC ratio.</p></div></div></div><div class="NLM_p">In the absence of a LRRK2-dependent PD efficacy model, in vivo PD knockdown for compounds <b>7</b>–<b>9</b> was assessed through the use of LRRK2 BAC transgenic mice expressing human LRRK2 protein with the G2019S mutation.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Inhibitors were evaluated for their ability to inhibit LRRK2 S1292 autophosphorylation in vivo. Tissue samples were harvested and examined from the hippocampus and spleen.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> Robust concentration-dependent inhibition of S1292 phosphorylation was observed for all inhibitors tested in both the brain (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>), and peripheral tissues. By use of a PD inhibition model, in vivo unbound brain IC<sub>50</sub> values of 7, 3, and 20 nM were calculated for <b>7</b>, <b>8</b>, and <b>9</b>, respectively. As was observed with tool compound <b>6</b>, the unbound in vivo LRRK2[G2019S] IC<sub>50</sub> values for <b>7</b>, <b>8</b>, and <b>9</b> are nearly identical to the in vitro LRRK2[G2019S/R1441G/Y1699C] cellular IC<sub>50</sub> determinations.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00261/20150904/images/medium/jm-2015-00261c_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00261/20150904/images/large/jm-2015-00261c_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. In vivo G2019S LRRK2 transgenic mouse PK/PD results measuring brain pS1292 autophosphorylation. The circles represent the observed data, and the lines represent the predicted data from a direct inhibition model. Percent inhibition is normalized to pS1292 levels observed in mice dosed with vehicle alone (<i>n</i> = 3). Plotted data are shown for mice treated with (A) <b>7</b> [15 mg kg<sup>–1</sup>, po, at 1, 3, and 6 h (<i>n</i> = 4/dose); 50 mg kg<sup>–1</sup>, po, at 1, 3, 6, and 12 h (<i>n</i> = 4/dose) and 24 h (<i>n</i> = 1); 10 mg kg<sup>–1</sup>, ip, at 1 and 2.5 h (<i>n</i> = 3/dose); 50 mg kg<sup>–1</sup>, ip, at 1 and 6 h (<i>n</i> = 3/dose)], (B) <b>8</b> [10 and 50 mg kg<sup>–1</sup>, ip, at 1, 3, and 6 h (<i>n</i> = 3/dose)], and (C) <b>9</b> [10 and 50 mg kg<sup>–1</sup>, ip, at 1 and 6 h (<i>n</i> = 3/dose)]. The figure was reproduced and modified from Estrada 2012 and Estrada 2014,<a onclick="showRef(event, 'ref81 ref83'); return false;" href="javascript:void(0);" class="ref ref81 ref83">(81, 83)</a> with permission from <i>Journal of Medicinal Chemistry</i>. Copyright 2012 and 2014 American Chemical Society.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00261/20150904/images/large/jm-2015-00261c_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00261&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Toxicities Observed with Aminopyrimidine LRRK2 Inhibitors</h3><div class="NLM_p">In 2011, Novartis published a report indicating that lung and kidney abnormalities existed in LRRK2 genetic knockout mice.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> In order to assess these potential liabilities, aminopyrimidine compounds were advanced into safety studies. A recent Genentech publication summarizes the toxicity and toxicokinetic profiles of advanced inhibitors <b>7</b> and <b>8</b> in mice, rats, and NHPs.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Because of the aforementioned low anti-pS1292 antibody sensitivity, in vivo PD target engagement in all of these studies was assessed using pS935.</div><div class="NLM_p">Male C57BL/6 mice were dosed po with <b>7</b> (200 and 300 mg kg<sup>–1</sup> b.i.d.) and <b>8</b> (30 and 65 mg kg<sup>–1</sup> b.i.d.) for 15 days. Toxicokinetic analysis showed dose-dependent increases in plasma and brain levels with average free drug exposures of 5- and 36-fold above pS1292 cellular IC<sub>50</sub> values for the higher doses. While evidence of lung, kidney, and brain PD knockdown was observed with both inhibitors, no microscopic effects were observed in the lung or kidney, and both compounds were well tolerated.</div><div class="NLM_p">Similar 7-day repeat-dosing studies were conducted in male and female Sprague–Dawley rats. Once-daily po administration of <b>7</b> (10, 50, and 100 mg kg<sup>–1</sup>) and <b>8</b> (30, 75, and 200 mg kg<sup>–1</sup>) showed dose-related exposure increases. The highest tolerated doses for compounds <b>7</b> (100 mg kg<sup>–1</sup>) and <b>8</b> (30 mg kg<sup>–1</sup>) translated to maximum free drug exposures of 22- and 185-fold over the cellular IC<sub>50</sub> of <b>7</b> and <b>8</b>, respectively. No macroscopic or microscopic effects were seen in the lung or kidney with either compound.</div><div class="NLM_p">Lastly, NHPs were dosed orally with <b>7</b> (10, 25, and 65 mg kg<sup>–1</sup> q.d.) for 7 days. Toxicokinetic analysis showed a dose-dependent increase in plasma exposures with average free drug levels correlating to 4-, 14-, and 35-fold above the cellular IC<sub>50</sub>. Terminal <i>B</i><sub>u</sub>/<i>P</i><sub>u</sub> and CSF/<i>P</i><sub>u</sub> AUC ratios of 0.6 and 0.8 were achieved respectively showing a high degree of brain penetration. Statistically significant PD inhibition of pS935 was observed at all doses tested. Transient and reversible clinical observations included tremors (≥10 mg kg<sup>–1</sup>) and hypoactivity and decreased reactivity to stimulus (25 and 65 mg kg<sup>–1</sup>). The sole anatomic pathology observation linked to compound <b>7</b> was limited to the lung and characterized by abnormal cytoplasmic accumulation of secretory lysosome-related organelles known as lamellar bodies in type II pneumocytes of all animals administered 25 and 65 mg kg<sup>–1</sup> in both sexes. Comparison of these findings with the published LRRK2 knockout mouse data showed that the lung phenotypes were essentially identical.</div><div class="NLM_p">With the goal of examining potential on-target versus off-target related effects, structurally distinct aminopyrazole <b>8</b> (6 and 20 mg kg<sup>–1</sup> b.i.d.) and anilinoaminopyrimidine <b>7</b> (30 mg kg<sup>–1</sup> b.i.d.) were administered to NHPs in a 29-day repeat-dose study. Significant free drug coverage above cellular IC<sub>50</sub> values and excellent brain penetration were achieved with both test articles. Robust PK/PD knockdown of pS935 in PBMCs, brain, kidney, and lung was confirmed at all doses. Upon microscopic evaluation of lung, abnormalities identical to those observed in LRRK2 knockout mice were observed at all doses with both inhibitors. These findings are consistent with an on-target effect of reduction of LRRK2 kinase activity that leads to lamellar body accumulation in type II pneumocytes in the lung of certain species. It should be noted that the morphologic abnormality described for the LRRK2 knockout mouse kidney was absent in both NHP studies.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Physicochemical Property, Activity, and Selectivity Profiles of Reported LRRK2 Inhibitors <b>10</b>, <b>10b</b>, and <b>11</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00261/20150904/images/medium/jm-2015-00261c_0008.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">CNS MPO score</th><th class="colsep0 rowsep0" align="center">MW</th><th class="colsep0 rowsep0" align="center">cLogP</th><th class="colsep0 rowsep0" align="center">TPSA (Å<sup>2</sup>)</th><th class="colsep0 rowsep0" align="center">LRRK2 IC<sub>50</sub> <a class="ref internalNav" href="#t5fn1" aria-label="a">a</a> (nM)</th><th class="colsep0 rowsep0" align="center">LLE</th><th class="colsep0 rowsep0" align="center">kinase selectivity</th><th class="colsep0 rowsep0" align="center">pLRRK2 IC<sub>50</sub> <a class="ref internalNav" href="#t5fn2" aria-label="b">b</a> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b><a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a></td><td class="colsep0 rowsep0" align="left">3.9</td><td class="colsep0 rowsep0" align="left">399</td><td class="colsep0 rowsep0" align="left">4.3</td><td class="colsep0 rowsep0" align="left">64</td><td class="colsep0 rowsep0" align="left">9</td><td class="colsep0 rowsep0" align="left">3.8</td><td class="colsep0 rowsep0" align="left">2/449 < 10% of control<a class="ref internalNav" href="#t5fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">nr<a class="ref internalNav" href="#t5fn7" aria-label="g">g</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10b</b><a onclick="showRef(event, 'ref88 ref89'); return false;" href="javascript:void(0);" class="ref ref88 ref89">(88, 89)</a></td><td class="colsep0 rowsep0" align="left">4.8</td><td class="colsep0 rowsep0" align="left">402</td><td class="colsep0 rowsep0" align="left">3.5</td><td class="colsep0 rowsep0" align="left">57</td><td class="colsep0 rowsep0" align="left">6<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">4.7</td><td class="colsep0 rowsep0" align="left">3/449 < 10% of control<a class="ref internalNav" href="#t5fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">94</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b><a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a></td><td class="colsep0 rowsep0" align="left">5.4</td><td class="colsep0 rowsep0" align="left">291</td><td class="colsep0 rowsep0" align="left">2.8</td><td class="colsep0 rowsep0" align="left">66</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">5.5</td><td class="colsep0 rowsep0" align="left">11/39 > 50%<a class="ref internalNav" href="#t5fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left">140</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Biochemical assay; Nictide used for compound <b>10</b>, and LRRKtide used for compounds <b>10b</b> and <b>11</b>; LRRK2 (G2019S) IC<sub>50</sub> at 100 μM ATP for compounds <b>10</b> and <b>11</b>.</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">pSer935 G2019S mutant cellular assay (HEK293 cells).</p></div><div class="footnote" id="t5fn3"><sup>c</sup><p class="last">Lanthascreen LRRK2 <i>K</i><sub>i</sub>.</p></div><div class="footnote" id="t5fn4"><sup>d</sup><p class="last">KINOMEscan profiling (10 μM, 1111-fold over LRRK2 IC<sub>50</sub>).</p></div><div class="footnote" id="t5fn5"><sup>e</sup><p class="last">KINOMEscan profiling (1 μM, 167-fold over LRRK2 IC<sub>50</sub>).</p></div><div class="footnote" id="t5fn6"><sup>f</sup><p class="last">Invitrogen profiling (1 μM, 200-fold over LRRK2 IC<sub>50</sub>).</p></div><div class="footnote" id="t5fn7"><sup>g</sup><p class="last">Not reported.</p></div></div></div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> GSK Arylbenzamides</h3><div class="NLM_p">In July of 2012, Reith et al. disclosed the characterization of arylbenzamide GSK2578215A (<b>10</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>).<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> Compound <b>10</b> is structurally distinct from the diaminopyrimidine LRRK2 inhibitors and is a potent and highly selective [2/449 kinases with <10% activity of control (ALK and FLT3), 1111-fold over LRRK2 IC<sub>50</sub>] LRRK2 kinase inhibitor with moderate mouse plasma clearance (30 mL min<sup>–1</sup> kg<sup>–1</sup>), low oral bioavailability (12% at 10 mg/kg), and a total <i>B</i>/<i>P</i> ratio of 1.4 (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). In addition, Reith and co-workers were able to demonstrate dose-dependent inhibition of pS910 and pS935 in stably transfected HEK293 cells (wild-type and G2019S LRRK2), with endogenous LRRK2 from lymphoblastoid cells (G2019S PD patient sample) and in mouse Swiss 3T3 cells at approximately 0.3–1.0 μM. In vivo PK/PD analysis of normal mice revealed strong inhibition of pS910 and pS935 in peripheral tissues (spleen and kidney lysates); however, no significant inhibition was detected in the mouse brain despite a total brain to plasma ratio of 1.4 for inhibitor <b>10</b>. One possible explanation for the lack of brain target engagement could be insufficient free drug levels in the brain relative to the cellular potency. Compound <b>10</b> has recently been used to probe the relationship between kinase activity and synaptic vesicle release.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> Additionally, a patented <i>N</i>-methylpiperazine inhibitor BMPBB-32 (<b>10b</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>)<a onclick="showRef(event, 'ref88 ref89'); return false;" href="javascript:void(0);" class="ref ref88 ref89">(88, 89)</a> closely related to 2-fluoropyridine <b>10</b> was profiled. It was reported that piperazine <b>10b</b> could improve contrast sensitivity in Drosophila that overexpress the human LRRK2[G2019S] transgene. Finally, these workers observed that <i>N</i>-methylpiperazine benzamide <b>10b</b> lacks the off-target effects seen with the less selective inhibitor <b>2</b> in Drosophila in vivo models.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. In Vitro and In Vivo Mouse DMPK Profile of Reported Brain-Penetrant LRRK2 Inhibitor <b>10</b><a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">Cl (mL min<sup>–1</sup> kg<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center">iv <i>t</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center"><i>F</i> (%)</th><th class="colsep0 rowsep0" align="center">total <i>B</i>/<i>P</i> <a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b><a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a></td><td class="colsep0 rowsep0" align="left">30</td><td class="colsep0 rowsep0" align="left">1.1</td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">1.4</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">Compound <b>10</b> was dosed po (10 mg kg<sup>–1</sup>) and iv (1 mg kg<sup>–1</sup>) for both systemic and brain PK.</p></div><div class="footnote" id="t6fn2"><sup>b</sup><p class="last">Total brain/plasma AUC ratio.</p></div></div></div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Elan Quinolines</h3><div class="NLM_p">In February of 2013, scientists at Elan Pharmaceuticals published their findings on a series of quinoline LRRK2 small molecules inhibitors, which were identified from a kinase-focused HTS screen.<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> Hits from this scaffold were P-gp substrates and inhibitors of PDE4 and CSF1R. Using a MLK1-based homology model, Garofalo and co-workers employed structure-based drug design to develop potent and modestly LRRK2 selective quinolines represented by compound <b>11</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>, biochemical IC<sub>50</sub> = 5 nM; cellular pS935 EC<sub>50</sub> = 140 nM; 11/39 kinases with >50% inhibition, 200-fold over LRRK2 IC<sub>50</sub>). Guided by the hypothesis that an amide functionality in the original HTS hit was linked to the P-gp-mediated efflux, suitable replacements were discovered such as the 3-cyano substitution in <b>11</b>, which attenuated this liability. This translated to a total mouse <i>B</i>/<i>P</i> ratio of 1.3 for 3-cyanoquinoline <b>11</b> and statistically significant reduction of pS935 in the brains of G2019S LRRK2 transgenic mice at 3 h following oral doses of 30 and 100 mg/kg (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>).</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00261/20150904/images/medium/jm-2015-00261c_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00261/20150904/images/large/jm-2015-00261c_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. In vivo G2019S LRRK2 transgenic mouse PK/PD results with compound <b>11</b> measuring brain pSer935 levels. pSer935 levels were determined by ELISA and normalized to total LRRK2. Data are expressed as the mean ratio of pSer935 to total LRRK2 values observed in the vehicle control group. Error bars represent SEM. Plotted data are shown for mice treated with <b>11</b> [30 mg kg<sup>–1</sup>, po, at 3 h (<i>n</i> = 5/dose); 100 mg kg<sup>–1</sup>, po, at 3 h (<i>n</i> = 5/dose). This figure was reproduced and adapted from  <cite>Bioorganic & Medicinal Chemistry Letters</cite> (<a href="http://www.sciencedirect.com/science/journal/0960894X" class="ext-link">http://www.sciencedirect.com/science/journal/0960894X</a>), Vol. <em>23</em>, <contrib-group>Garofalo, A. W.; Adler, M.; Aubele, D. L.; Brigham, E. F.; Chian, D.; Franzini, M.; Goldbach, E.; Kwong, G. T.; Motter, R.; Probst, G. D.; Quinn, K. P.; Ruslim, L.; Sham, H. L.; Tam, D.; Tanaka, P.; Truong, A. P.; Ye, X. M.; Ren, Z.</contrib-group>, Discovery of 4-alkylamino-7-aryl-3-cyanoquinoline LRRK2 kinase inhibitors, pp 1974–1977, Copyright <span class="NLM_year">2013</span>, with permission from Elsevier.<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00261/20150904/images/large/jm-2015-00261c_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00261&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Novartis Indolinones</h3><div class="NLM_p">One of the originally identified LRRK2 inhibitor tool compounds was sunitinib; however, high kinase promiscuity precluded the use of this compound for reliable model studies of LRRK2 function. Recently, Troxler et al. reported the optimization of sunitinib to indolinones <b>12</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">07</a>) and Nov-LRRK2-11 (<b>13</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">07</a>) with single-digit nanomolar LRRK2 biochemical activity and modest in vivo pharmacokinetic properties.<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> By use of an IRAK4-based homology model, the 5-position of the indolinone core was targeted for improving kinase selectivity. This strategy led to the introduction of 5-alkoxy substituents in <b>12</b> and <b>13</b> that demonstrated improved selectivity profiles over other indolinone-based inhibitors against a small panel of off-target kinases (ALK, KDR, LCK, PDGFRa, and RET).</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Physicochemical Property, Activity, and in Vivo Mouse DMPK Profiles of Reported LRRK2 Inhibitors <b>12</b> and <b>13</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00261/20150904/images/medium/jm-2015-00261c_0009.gif" alt="" id="fx4" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">CNS MPO score</th><th class="colsep0 rowsep0" align="center">MW</th><th class="colsep0 rowsep0" align="center">cLogP</th><th class="colsep0 rowsep0" align="center">TPSA (Å<sup>2</sup>)</th><th class="colsep0 rowsep0" align="center">LRRK2 IC<sub>50</sub> <a class="ref internalNav" href="#t7fn1" aria-label="a">a</a> (nM)</th><th class="colsep0 rowsep0" align="center">LLE</th><th class="colsep0 rowsep0" align="center">pLRRK2 IC<sub>50</sub> <a class="ref internalNav" href="#t7fn2" aria-label="b">b</a> (nM)</th><th class="colsep0 rowsep0" align="center">Cl<sub>b</sub> (mL min<sup>–1</sup> kg<sup>–1</sup>)<a class="ref internalNav" href="#t7fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">iv <i>t</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center"><i>F</i> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b><a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a></td><td class="colsep0 rowsep0" align="left">5.1</td><td class="colsep0 rowsep0" align="left">421</td><td class="colsep0 rowsep0" align="left">1.6</td><td class="colsep0 rowsep0" align="left">80</td><td class="colsep0 rowsep0" align="left">9</td><td class="colsep0 rowsep0" align="left">6.4</td><td class="colsep0 rowsep0" align="left">nr<a class="ref internalNav" href="#t7fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">28</td><td class="colsep0 rowsep0" align="left">2.2</td><td class="colsep0 rowsep0" align="left">88</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b><a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a></td><td class="colsep0 rowsep0" align="left">5.5</td><td class="colsep0 rowsep0" align="left">365</td><td class="colsep0 rowsep0" align="left">2.4</td><td class="colsep0 rowsep0" align="left">74</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">6.0</td><td class="colsep0 rowsep0" align="left">380</td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">0.4</td><td class="colsep0 rowsep0" align="left">57</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last">Biochemical assay; LRRK2 IC<sub>50</sub> at 200 μM ATP.</p></div><div class="footnote" id="t7fn2"><sup>b</sup><p class="last">pSer935 cellular assay (NIH3T3 cells).</p></div><div class="footnote" id="t7fn3"><sup>c</sup><p class="last">Compounds <b>12</b> and <b>13</b> were dosed po (3 mg kg<sup>–1</sup>) and iv (1 mg kg<sup>–1</sup>); Cl<sub>b</sub> = blood clearance.</p></div><div class="footnote" id="t7fn4"><sup>d</sup><p class="last">Not reported.</p></div></div></div><div class="NLM_p last">When administered to mice, compound <b>13</b> reduced LRRK2 protein levels in the kidney, a phenotype also observed in mice expressing a LRRK2 kinase-dead mutant.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Inhibitor <b>13</b>, along with the less selective LRRK2-kinase inhibitor H-1152,<a onclick="showRef(event, 'ref92 ref93'); return false;" href="javascript:void(0);" class="ref ref92 ref93">(92, 93)</a> was subsequently used by Longo et al. to ameliorate the observed age-dependent hyperkinetic phenotype of LRRK2[G2019S] knockin mice.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> These results suggest that the enhanced kinase activity of the LRRK2[G2019S] protein is responsible for the observed lack of age-related decline in stepping activity and immobility time that was demonstrated by wild-type littermates. Compounds <b>13</b> and H-1152 did not cause any behavioral changes when administered to wild-type or kinase-dead mice. Brain target engagement was confirmed through PD knockdown of S935 in the striatum and the cortex of 12 month old G2019S knockin mice 30 min after ip injection of 10 mg/kg of compound <b>13</b>.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a></div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Pfizer Pyrrolopyrimidines</h3><div class="NLM_p">ATP-hinge-binding pyrazolopyrimidine ring systems are abundantly exemplified in the LRRK2 patent literature.<a onclick="showRef(event, 'ref94 ref95 ref96 ref97 ref98 ref99 ref100'); return false;" href="javascript:void(0);" class="ref ref94 ref95 ref96 ref97 ref98 ref99 ref100">(94-100)</a> In November of 2014, Pfizer reported the identification of a pyrrolopyrimidine scaffold that provided a highly efficient starting point with favorable CNS properties for lead optimization.<a onclick="showRef(event, 'ref101 ref102'); return false;" href="javascript:void(0);" class="ref ref101 ref102">(101, 102)</a> Using MST3 as a crystallographic surrogate for LRRK2 (reported MST3-LRRK2 ATP-binding site residue similarity of 73%), Henderson et al. improved the off-target liabilities of early HTS leads. This led to the discovery of PF-06447475 (<b>14</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a>) with in vitro LRRK2[wild-type] and LRRK2[G2019S] biochemical IC<sub>50</sub> values of 3 and 11 nM, respectively, and a pS935 cellular IC<sub>50</sub> of 25 nM. Kinase selectivity profiling at 1 μM using the DiscoveRx KINOMEscan platform revealed 32/449 kinases with <30% activity of control (91-fold over LRRK2 IC<sub>50</sub>). Selectivity profiling of pyrrolopyrimidine <b>14</b> in a cellular context was performed using the ActivX KiNativ technology demonstrating good selectivity in human peripheral blood mononuclear cells at 1 μM and an ActivX LRRK2 cellular IC<sub>50</sub> of 15 nM.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a></div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Physicochemical Property, Activity, and Selectivity Profile of Reported Pyrrolopyrimidine LRRK2 Inhibitor <b>14</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00261/20150904/images/medium/jm-2015-00261c_0010.gif" alt="" id="fx5" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">CNS MPO score</th><th class="colsep0 rowsep0" align="center">MW</th><th class="colsep0 rowsep0" align="center">cLogP</th><th class="colsep0 rowsep0" align="center">TPSA (Å<sup>2</sup>)</th><th class="colsep0 rowsep0" align="center">LRRK2 IC<sub>50</sub> <a class="ref internalNav" href="#t8fn1" aria-label="a">a</a> (nM)</th><th class="colsep0 rowsep0" align="center">LLE</th><th class="colsep0 rowsep0" align="center">kinase selectivity</th><th class="colsep0 rowsep0" align="center">pLRRK2 IC<sub>50</sub> <a class="ref internalNav" href="#t8fn2" aria-label="b">b</a> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b><a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a></td><td class="colsep0 rowsep0" align="left">5.7</td><td class="colsep0 rowsep0" align="left">305</td><td class="colsep0 rowsep0" align="left">2.2</td><td class="colsep0 rowsep0" align="left">77</td><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="left">5.8</td><td class="colsep0 rowsep0" align="left">32/449 < 30% of control<a class="ref internalNav" href="#t8fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">25</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup>a</sup><p class="last">Biochemical assay using LRRKtide; LRRK2 (G2019S) IC<sub>50</sub> at 50 μM ATP.</p></div><div class="footnote" id="t8fn2"><sup>b</sup><p class="last">pSer935 cellular assay (HEK293 cells).</p></div><div class="footnote" id="t8fn3"><sup>c</sup><p class="last">KINOMEscan profiling (1 μM, 91-fold over LRRK2 IC<sub>50</sub>).</p></div></div></div><div class="NLM_p">Compound <b>14</b> is not a P-gp substrate and has moderate and high turnover in human and rat liver microsomes, respectively (Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a>). The oral in vivo PK profile for <b>14</b> in rat, dog, and NHP was also determined. While low oral exposure in higher species precluded further clinical advancement, sufficient oral bioavailability in rodents was achieved to enable in vivo mouse PK/PD studies. Additionally, inhibitor <b>14</b> exhibited approximate equal distribution of free drug between rat brain, plasma, and kidney tissues. By use of wild-type (pS935 readout) and G2019S BAC transgenic mice (pS935 and pS1292 readout), dose-dependent reduction in phosphorylation in brain and kidney were observed.<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a> From these experiments, in vivo unbound brain EC<sub>50</sub> values of 8 nM (wild-type) and 103 nM (G2019S) were calculated using the pS935 biomarker, and 21 nM (G2019S) was calculated for pS1292.</div><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. In Vitro and in Vivo DMPK Profile of Reported Brain-Penetrant LRRK2 Inhibitor <b>14</b><a class="ref internalNav" href="#t9fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">LM Cl (mL min<sup>–1</sup> kg<sup>–1</sup>)<a class="ref internalNav" href="#t9fn2" aria-label="b">b</a> h/r<a class="ref internalNav" href="#t9fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">P-gp ER<a class="ref internalNav" href="#t9fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center">po <i>t</i><sub>1/2</sub> (h) r/d/NHP<a class="ref internalNav" href="#t9fn5" aria-label="e">e</a></th><th class="colsep0 rowsep0" align="center">AUC (ng·h/mL) r/d/NHP</th><th class="colsep0 rowsep0" align="center"><i>F</i> (%) r/d/NHP</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b><a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a></td><td class="colsep0 rowsep0" align="left">36/131</td><td class="colsep0 rowsep0" align="left">1.0</td><td class="colsep0 rowsep0" align="left">6.2/0.8/2.3</td><td class="colsep0 rowsep0" align="left">629/10/78</td><td class="colsep0 rowsep0" align="left">41/0.6/3.5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t9fn1"><div class="footnote" id="t9fn1"><sup>a</sup><p class="last">Compound <b>14</b> was dosed po (5 mg kg<sup>–1</sup>).</p></div><div class="footnote" id="t9fn2"><sup>b</sup><p class="last">Liver microsome-intrinsic clearance.</p></div><div class="footnote" id="t9fn3"><sup>c</sup><p class="last">h/r = human/rat.</p></div><div class="footnote" id="t9fn4"><sup>d</sup><p class="last">Efflux ratio.</p></div><div class="footnote" id="t9fn5"><sup>e</sup><p class="last">r/d/NHP = rat/dog/non-human primate.</p></div></div></div><div class="NLM_p last">On the basis of a clean in vitro safety profile (Ames, MNT, THLE cell viability), pyrrolopyrimidine <b>14</b> was evaluated in a 14-day repeat-dose rat toxicity study (3, 10, and 30 mg kg<sup>–1</sup> b.i.d.). No major test article related findings were observed with day 11 maximum free drug exposures 6-, 25-, and 70-fold over the cellular EC<sub>50</sub> (15 nM), respectively. Similar to the rat toxicity studies carried out with Genentech aminopyrimidines, no changes were noted upon close examination of kidney and lung tissue.</div></div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">LRRK2 GTP-Binding Small Molecule Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56224" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56224" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Li et al. recently disclosed the identification of novel LRRK2 GTP-binding and kinase small molecule inhibitors <b>15</b> and <b>16</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>) discovered through virtual screening using an LRRK2 GTPase ROC domain crystal structure (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2zej">2zej</a>).<a onclick="showRef(event, 'ref104 ref105'); return false;" href="javascript:void(0);" class="ref ref104 ref105">(104, 105)</a> Both compounds demonstrate in vitro LRRK2 GTP-binding and kinase inhibitory activities in the nanomolar range. Inhibitors <b>15</b> and <b>16</b> also inhibited LRRK2-induced neuronal degeneration in SH-SY5Y cells and mouse primary cortical neurons at nanomolar concentrations. On the basis of an enhanced solubility profile, arylsulfonamide <b>15</b> was selected for in vivo studies using G2019S BAC transgenic mice. At 1 h after ip injection of 20 mg/kg, reduction of LRRK2 GTP-binding activity and LRRK2 phosphorylation in mouse brains was observed, indicative of CNS penetration. On the basis of recent findings that demonstrate increases in LRRK2 expression and kinase activity following lipopolysaccharide (LPS) stimulation,<a onclick="showRef(event, 'ref36 ref106'); return false;" href="javascript:void(0);" class="ref ref36 ref106">(36, 106)</a> Li and co-workers examined the effects of compound <b>15</b> in G2019S BAC transgenic mice following LPS injection. Reduction in LPS-induced microglia activation, LRRK2 expression, and LRRK2 phosphorylation in activated microglia cells was observed. These studies support a potentially promising and orthogonal role, compared to ATP-kinase inhibitors, for the use of LRRK2 GTP-inhibitors in LRRK2-associated PD.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00261/20150904/images/medium/jm-2015-00261c_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00261/20150904/images/large/jm-2015-00261c_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. LRRK2 GTP-binding inhibitors <b>15</b> and <b>16</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00261/20150904/images/large/jm-2015-00261c_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00261&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53380" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53380" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">LRRK2 was discovered to be unequivocally linked to PD in GWAS studies and in the examination of families with high incidence of disease. A community of academic, nonprofit, and pharmaceutical scientists have contributed to advancing our understanding of the LRRK2 protein in the past decade. In particular, multiple laboratories have documented activities of LRRK2 that can be monitored in vivo, and a number of structurally diverse inhibitors of LRRK2 function have been identified. These molecules, if used appropriately, will continue to contribute to our understanding of the cellular biology of LRRK2 (see ref <a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">107</a> for the commercial or MTA availability of LRRK2 inhibitors recommended in this review). On the basis of their structural diversity and documented selectivity, we particularly recommend employing inhibitors <b>5</b>, <b>8</b>, <b>10</b>, and <b>14</b> for in vitro cellular studies assessing the role of LRRK2 kinase activity. Ideally, these studies should be performed at moderate concentrations (<1 μM) of the inhibitors and employ the pS1292 biomarker/antibody to assess the inhibition of LRRK2 kinase activity. For in vivo rodent experiments where high levels of CNS penetration are desired, we recommend the use of compounds <b>7</b>, <b>8</b>, and <b>14</b>. Finally, for examining the role of LRRK2 and LRRK2 kinase inhibition in the brain and periphery of higher species, only reported inhibitors <b>7</b>, <b>8</b>, and <b>9</b> appear to be suitable at this time. Given the significant expense and complexity of clinical studies assessing inhibitors of neurodegeneration, a more complete understanding of the cellular function of LRRK2 will probably be required before studies can be performed to assess the clinical utility of LRRK2 inhibitors.</div><div class="NLM_p last">Although initially it appeared that LRRK2-focused genetic manipulation of rodents would result in age-dependent accumulation of deficits that resemble PD, in general these animals have exhibited fairly subtle and variable phenotypes. Only recently has a selective LRRK2 kinase inhibitor been reported to modulate some of these deficits. Perhaps more critically, LRRK2 knockout rodents and the LRRK2 kinase-dead knockin mice display unusual lung and/or kidney pathology. While several LRRK2 kinase inhibitors have been well-tolerated in rats, two molecules have been found to be associated with lung toxicities in NHPs that are histopathologically identical to the LRRK2 knockout rodent phenotype, suggesting an LRRK2-related effect. There is some uncertainty surrounding the clinical consequences of this type II pneumocyte lamellar body accumulation in the lungs of patients, and pulmonary toxicities are challenging to monitor in the clinic. Further examination of the toxicities associated with structurally diverse LRRK2 inhibitors in higher species will permit a more complete assessment of the risks of inhibiting LRRK2 kinase activity in man. Given the absence of direct biomarkers of LRRK2 function and the lack of suitable efficacy models, however, a large degree of uncertainty around the potential therapeutic index of LRRK2 inhibitors is likely to remain. On a positive note, the emerging literature reports from academic laboratories and industrial groups alike, as well as the highly impactful contributions and efforts of nonprofit and government organizations, suggest that answers to the many questions surrounding LRRK2 will be forthcoming.</div></div><div class="NLM_back"><div class="NLM_notes" id="notes-1"><span class="title" id="d67328050e2581">Author Contributions</span><p class="last">The manuscript was written through contributions of both authors. Both authors have given approval to the final version of the manuscript.</p></div><div class="NLM_notes" id="NOTES-d1418e3644-autogenerated"><p class="first last">The authors declare no competing financial interest.</p></div><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.5b00261" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24341" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24341" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anthony A. Estrada</span> - <span class="hlFld-Affiliation affiliation">Department of Discovery Chemistry, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#8beef8fff9eaefeaa5eae5ffe3e4e5f2cbeceee5eea5e8e4e6"><span class="__cf_email__" data-cfemail="caafb9beb8abaeabe4aba4bea2a5a4b38aadafa4afe4a9a5a7">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zachary K. Sweeney</span> - <span class="hlFld-Affiliation affiliation">Department of Discovery Chemistry, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#bbc1dad8d3dac9c295c8ccdeded5dec2fbc2dad3d4d495d8d4d6"><span class="__cf_email__" data-cfemail="fe849f9d969f8c87d08d899b9b909b87be879f969191d09d9193">[email protected]</span></a></span></div></li></ul></li><li><ul></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of both authors. Both authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><p>The authors declare no competing financial interest.<br /></br></p></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01857" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01857" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Anthony A. Estrada</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00261&amp;id=BIO-d1418e3631-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Anthony A. Estrada</b> is a Senior Scientist in the Discovery Chemistry Department at Genentech, Inc. (South San Francisco, CA). He received a B.S. in Chemistry from The University of La Verne, CA, and a M.S. and Ph.D. in Organic Chemistry from the University of California, San Diego. His current research interests include the identification, lead optimization, and development of small molecule inhibitors for the treatment of neurodegenerative diseases. Anthony has authored or coauthored approximately 24 research papers and 19 published patent applications.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Zachary K. Sweeney</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00261&amp;id=BIO-d1418e3636-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Zachary K. Sweeney</b> received a B.S. in Chemistry from Stanford University, CA, and a Ph.D. in Chemistry from the University of California, Berkeley, and completed a postdoctoral fellowship at Harvard University, MA. He also worked at Roche Palo Alto, Genentech, and Novartis. Zach’s current research interests include neurodegeneration, anti-infective drug discovery, and informatics approaches to lead discovery. He has coauthored approximately 30 research papers and 35 published patent applications.</p></figure></div><div class="ack" id="ACK-d1418e3641-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i26">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27515" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27515" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Bryan K. Chan, Reina Fuji, Kimberly Scearce-Levie, and the reviewers for critical evaluations of the manuscript.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i27" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i27"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i28" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i28"> Abbreviations Used</h2><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area under the curve</p></td></tr><tr><td class="NLM_term">BAC</td><td class="NLM_def"><p class="first last">bacterial artificial chromosome</p></td></tr><tr><td class="NLM_term">BCRP</td><td class="NLM_def"><p class="first last">breast cancer resistance protein</p></td></tr><tr><td class="NLM_term"><i>B</i><sub>u</sub></td><td class="NLM_def"><p class="first last">unbound brain concentration</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">CSF</td><td class="NLM_def"><p class="first last">cerebrospinal fluid</p></td></tr><tr><td class="NLM_term">ER</td><td class="NLM_def"><p class="first last">efflux ratio</p></td></tr><tr><td class="NLM_term">h</td><td class="NLM_def"><p class="first last">human</p></td></tr><tr><td class="NLM_term">ip</td><td class="NLM_def"><p class="first last">intraperotineal</p></td></tr><tr><td class="NLM_term">iv</td><td class="NLM_def"><p class="first last">intravenous</p></td></tr><tr><td class="NLM_term">JAK2</td><td class="NLM_def"><p class="first last">Janus kinase 2</p></td></tr><tr><td class="NLM_term">LM</td><td class="NLM_def"><p class="first last">liver microsome</p></td></tr><tr><td class="NLM_term">LRRK2</td><td class="NLM_def"><p class="first last">leucine-rich repeat kinase 2</p></td></tr><tr><td class="NLM_term">MDCK-MDR1</td><td class="NLM_def"><p class="first last">Madin–Darby canine kidney cells–multidrug resistance protein 1</p></td></tr><tr><td class="NLM_term">NHP</td><td class="NLM_def"><p class="first last">non-human primate</p></td></tr><tr><td class="NLM_term">PD</td><td class="NLM_def"><p class="first last">Parkinson’s disease</p></td></tr><tr><td class="NLM_term">PEG</td><td class="NLM_def"><p class="first last">polyethylene glycol</p></td></tr><tr><td class="NLM_term">P-gp</td><td class="NLM_def"><p class="first last">P-glycoprotein</p></td></tr><tr><td class="NLM_term">PK/PD</td><td class="NLM_def"><p class="first last">pharmacokinetics/pharmacodynamics</p></td></tr><tr><td class="NLM_term">pLRRK2</td><td class="NLM_def"><p class="first last">phospho-LRRK2</p></td></tr><tr><td class="NLM_term">PPB</td><td class="NLM_def"><p class="first last">plasma protein binding</p></td></tr><tr><td class="NLM_term"><i>P</i><sub>u</sub></td><td class="NLM_def"><p class="first last">unbound plasma concentration</p></td></tr><tr><td class="NLM_term">r</td><td class="NLM_def"><p class="first last">rat</p></td></tr><tr><td class="NLM_term">TPSA</td><td class="NLM_def"><p class="first last">topological polar surface area</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i29">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33103" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33103" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 107 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Jankovic, J.</span><span> </span><span class="NLM_article-title">Parkinson’s disease: clinical features and diagnosis</span> <span class="citation_source-journal">J. Neurol. Neurosurg. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">368</span><span class="NLM_x">–</span> <span class="NLM_lpage">376</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1136%2Fjnnp.2007.131045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=18344392" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A280%3ADC%252BD1c7oslamtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2008&pages=368-376&author=J.+Jankovic&title=Parkinson%E2%80%99s+disease%3A+clinical+features+and+diagnosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Parkinson's disease: clinical features and diagnosis</span></div><div class="casAuthors">Jankovic J</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neurology, neurosurgery, and psychiatry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">368-76</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  Parkinson's disease (PD) is a progressive neurological disorder characterised by a large number of motor and non-motor features that can impact on function to a variable degree.  This review describes the clinical characteristics of PD with emphasis on those features that differentiate the disease from other parkinsonian disorders.  METHODS:  A MedLine search was performed to identify studies that assess the clinical characteristics of PD.  Search terms included "Parkinson's disease", "diagnosis" and "signs and symptoms".  RESULTS:  Because there is no definitive test for the diagnosis of PD, the disease must be diagnosed based on clinical criteria.  Rest tremor, bradykinesia, rigidity and loss of postural reflexes are generally considered the cardinal signs of PD.  The presence and specific presentation of these features are used to differentiate PD from related parkinsonian disorders.  Other clinical features include secondary motor symptoms (eg, hypomimia, dysarthria, dysphagia, sialorrhoea, micrographia, shuffling gait, festination, freezing, dystonia, glabellar reflexes), non-motor symptoms (eg, autonomic dysfunction, cognitive/neurobehavioral abnormalities, sleep disorders and sensory abnormalities such as anosmia, paresthesias and pain).  Absence of rest tremor, early occurrence of gait difficulty, postural instability, dementia, hallucinations, and the presence of dysautonomia, ophthalmoparesis, ataxia and other atypical features, coupled with poor or no response to levodopa, suggest diagnoses other than PD.  CONCLUSIONS:  A thorough understanding of the broad spectrum of clinical manifestations of PD is essential to the proper diagnosis of the disease.  Genetic mutations or variants, neuroimaging abnormalities and other tests are potential biomarkers that may improve diagnosis and allow the identification of persons at risk.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTx3pH5zglCwUcLvDNbOD4DfW6udTcc2eYpM_S96TENxrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c7oslamtA%253D%253D&md5=bb6d7781e6fce93cfb785215840149cb</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1136%2Fjnnp.2007.131045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fjnnp.2007.131045%26sid%3Dliteratum%253Aachs%26aulast%3DJankovic%26aufirst%3DJ.%26atitle%3DParkinson%25E2%2580%2599s%2520disease%253A%2520clinical%2520features%2520and%2520diagnosis%26jtitle%3DJ.%2520Neurol.%2520Neurosurg.%2520Psychiatry%26date%3D2008%26volume%3D79%26spage%3D368%26epage%3D376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Braak, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghebremedhin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rüb, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bratzke, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Tredici, K.</span><span> </span><span class="NLM_article-title">Stages in the development of Parkinson’s disease-related pathology</span> <span class="citation_source-journal">Cell Tissue Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">318</span><span class="NLM_x">, </span> <span class="NLM_fpage">121</span><span class="NLM_x">–</span> <span class="NLM_lpage">134</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1007%2Fs00441-004-0956-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=15338272" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A280%3ADC%252BD2crjtVagtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=318&publication_year=2004&pages=121-134&author=H.+Braakauthor=E.+Ghebremedhinauthor=U.+R%C3%BCbauthor=H.+Bratzkeauthor=K.+Del+Tredici&title=Stages+in+the+development+of+Parkinson%E2%80%99s+disease-related+pathology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Stages in the development of Parkinson's disease-related pathology</span></div><div class="casAuthors">Braak Heiko; Ghebremedhin Estifanos; Rub Udo; Bratzke Hansjurgen; Del Tredici Kelly</div><div class="citationInfo"><span class="NLM_cas:title">Cell and tissue research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">318</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">121-34</span>
        ISSN:<span class="NLM_cas:issn">0302-766X</span>.
    </div><div class="casAbstract">The synucleinopathy, idiopathic Parkinson's disease, is a multisystem disorder that involves only a few predisposed nerve cell types in specific regions of the human nervous system.  The intracerebral formation of abnormal proteinaceous Lewy bodies and Lewy neurites begins at defined induction sites and advances in a topographically predictable sequence.  As the disease progresses, components of the autonomic, limbic, and somatomotor systems become particularly badly damaged.  During presymptomatic stages 1-2, inclusion body pathology is confined to the medulla oblongata/pontine tegmentum and olfactory bulb/anterior olfactory nucleus.  In stages 3-4, the substantia nigra and other nuclear grays of the midbrain and forebrain become the focus of initially slight and, then, severe pathological changes.  At this point, most individuals probably cross the threshold to the symptomatic phase of the illness.  In the end-stages 5-6, the process enters the mature neocortex, and the disease manifests itself in all of its clinical dimensions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTieyTnw1SgY5otVjB3IRIyfW6udTcc2eYpM_S96TENxrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2crjtVagtw%253D%253D&md5=240031e02a342ffcdb005c55eb452887</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1007%2Fs00441-004-0956-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00441-004-0956-9%26sid%3Dliteratum%253Aachs%26aulast%3DBraak%26aufirst%3DH.%26aulast%3DGhebremedhin%26aufirst%3DE.%26aulast%3DR%25C3%25BCb%26aufirst%3DU.%26aulast%3DBratzke%26aufirst%3DH.%26aulast%3DDel%2BTredici%26aufirst%3DK.%26atitle%3DStages%2520in%2520the%2520development%2520of%2520Parkinson%25E2%2580%2599s%2520disease-related%2520pathology%26jtitle%3DCell%2520Tissue%2520Res.%26date%3D2004%26volume%3D318%26spage%3D121%26epage%3D134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Schapira, A. H. V.</span><span> </span><span class="NLM_article-title">Neurobiology and treatment of Parkinson’s disease</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">47</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=41-47&author=A.+H.+V.+Schapira&title=Neurobiology+and+treatment+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchapira%26aufirst%3DA.%2BH.%2BV.%26atitle%3DNeurobiology%2520and%2520treatment%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2009%26volume%3D30%26spage%3D41%26epage%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Kamb, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harper, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefansson, K.</span><span> </span><span class="NLM_article-title">Human genetics as a foundation for innovative drug development</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">975</span><span class="NLM_x">–</span> <span class="NLM_lpage">978</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2013&pages=975-978&author=A.+Kambauthor=S.+Harperauthor=K.+Stefansson&title=Human+genetics+as+a+foundation+for+innovative+drug+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKamb%26aufirst%3DA.%26aulast%3DHarper%26aufirst%3DS.%26aulast%3DStefansson%26aufirst%3DK.%26atitle%3DHuman%2520genetics%2520as%2520a%2520foundation%2520for%2520innovative%2520drug%2520development%26jtitle%3DNat.%2520Biotechnol.%26date%3D2013%26volume%3D31%26spage%3D975%26epage%3D978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Kauselmann, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dopazo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Link, W.</span><span> </span><span class="NLM_article-title">Identification of disease-relevant genes for molecularly-targeted drug discovery</span> <span class="citation_source-journal">Curr. Cancer Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">13</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.2174%2F156800912798888947" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=22165964" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFOqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=1-13&author=G.+Kauselmannauthor=A.+Dopazoauthor=W.+Link&title=Identification+of+disease-relevant+genes+for+molecularly-targeted+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of disease-relevant genes for molecularly-targeted drug discovery</span></div><div class="casAuthors">Kauselmann, G.; Dopazo, A.; Link, W.</div><div class="citationInfo"><span class="NLM_cas:title">Current Cancer Drug Targets</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-13</span>CODEN:
                <span class="NLM_cas:coden">CCDTB9</span>;
        ISSN:<span class="NLM_cas:issn">1568-0096</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The current paradigm for cancer therapy is undergoing a change from non-specific cytotoxic agents to more specific approaches based on unique mol. features of cancer cells.  The identification and validation of disease relevant targets are crucial for the development of molecularly targeted anticancer therapies.  Advances in our understanding of the mol. basis of cancer together with novel approaches to interfere with signal transduction pathways have opened new horizons for anticancer target discovery.  In particular, the image-based large scale anal. of cellular phenotypes that arise from genetic or chem. perturbations paved the way for the identification and validation of disease relevant mol. targets independent of preconceived notions of mechanistic relationships.  In addn., novel and sophisticated techniques of genome manipulation allow for the use of mouse models that faithfully recapitulate crit. elements of human cancer for target validation in vivo.  We believe that these advances will translate into more and better validated drug targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo55zb4TDKD8LVg90H21EOLACvtfcHk0lj4QgqQ41nNIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFOqtbk%253D&md5=41296fb1a1e032c2d9270023dd992a5d</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.2174%2F156800912798888947&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156800912798888947%26sid%3Dliteratum%253Aachs%26aulast%3DKauselmann%26aufirst%3DG.%26aulast%3DDopazo%26aufirst%3DA.%26aulast%3DLink%26aufirst%3DW.%26atitle%3DIdentification%2520of%2520disease-relevant%2520genes%2520for%2520molecularly-targeted%2520drug%2520discovery%26jtitle%3DCurr.%2520Cancer%2520Drug%2520Targets%26date%3D2012%26volume%3D12%26spage%3D1%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Lin, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrer, M. J.</span><span> </span><span class="NLM_article-title">Genetics and genomics of Parkinson’s disease</span> <span class="citation_source-journal">Genome Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">48</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1186%2Fgm566" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=25061481" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A280%3ADC%252BC2cbmtFChsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=48&author=M.+K.+Linauthor=M.+J.+Farrer&title=Genetics+and+genomics+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Genetics and genomics of Parkinson's disease</span></div><div class="casAuthors">Lin Michelle K; Farrer Matthew J</div><div class="citationInfo"><span class="NLM_cas:title">Genome medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">48</span>
        ISSN:<span class="NLM_cas:issn">1756-994X</span>.
    </div><div class="casAbstract">Parkinson's disease (PD) is a progressively debilitating neurodegenerative syndrome.  Although best described as a movement disorder, the condition has prominent autonomic, cognitive, psychiatric, sensory and sleep components.  Striatal dopaminergic innervation and nigral neurons are progressively lost, with associated Lewy pathology readily apparent on autopsy.  Nevertheless, knowledge of the molecular events leading to this pathophysiology is limited.  Current therapies offer symptomatic benefit but they fail to slow progression and patients continue to deteriorate.  Recent discoveries in sporadic, Mendelian and more complex forms of parkinsonism provide novel insight into disease etiology; 28 genes, including those encoding alpha-synuclein (SNCA), leucine-rich repeat kinase 2 (LRRK2) and microtubule-associated protein tau (MAPT), have been linked and/or associated with PD.  A consensus regarding the affected biological pathways and molecular processes has also started to emerge.  In early-onset and more a typical PD, deficits in mitophagy pathways and lysosomal function appear to be prominent.  By contrast, in more typical late-onset PD, chronic, albeit subtle, dysfunction in synaptic transmission, early endosomal trafficking and receptor recycling, as well as chaperone-mediated autophagy, provide a unifying synthesis of the molecular pathways involved.  Disease-modification (neuroprotection) is no longer such an elusive goal given the unparalleled opportunity for diagnosis, translational neuroscience and therapeutic development provided by genetic discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRZ98nLXyY0xUNoizSOkG_FfW6udTcc2eZuFKLoaQlvXrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cbmtFChsg%253D%253D&md5=2812917436574ba10ba7170d48bf4eb4</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1186%2Fgm566&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fgm566%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DM.%2BK.%26aulast%3DFarrer%26aufirst%3DM.%2BJ.%26atitle%3DGenetics%2520and%2520genomics%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DGenome%2520Med.%26date%3D2014%26volume%3D6%26spage%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Martin, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, V. L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, T. T. M.</span><span> </span><span class="NLM_article-title">Recent advances in the genetics of Parkinson’s disease</span> <span class="citation_source-journal">Annu. Rev. Genomics Hum. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">301</span><span class="NLM_x">–</span> <span class="NLM_lpage">325</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1146%2Fannurev-genom-082410-101440" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=21639795" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1yksbvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=301-325&author=I.+Martinauthor=V.+L.+V.+Dawsonauthor=T.+T.+M.+Dawson&title=Recent+advances+in+the+genetics+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the genetics of Parkinson's disease</span></div><div class="casAuthors">Martin, Ian; Dawson, Valina L.; Dawson, Ted M.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Genomics and Human Genetics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">301-325</span>CODEN:
                <span class="NLM_cas:coden">ARGHC4</span>;
        ISSN:<span class="NLM_cas:issn">1527-8204</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Genetic studies have provided valuable insight into the pathol. mechanisms underlying Parkinson's disease (PD).  The elucidation of genetic components to what was once largely considered a nongenetic disease has given rise to a multitude of cell and animal models enabling the dissection of mol. pathways involved in disease etiol.  Here, the authors review advances obtained from models of dominant mutations in α-synuclein and LRRK2 as well as recessive PINK1, parkin and DJ-1 mutations.  Recent genome-wide assocn. studies have implicated genetic variability at two of these loci, α-synuclein and LRRK2, as significant risk factors for developing sporadic PD.  This, coupled with the established role of mitochondrial impairment in both familial and sporadic PD, highlights the likelihood of common mechanisms fundamental to the etiol. of both.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmr___jOFrRLVg90H21EOLACvtfcHk0liqQzq0-KL7lA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1yksbvN&md5=d535f7971e5175d6a98c2d796c3725bb</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1146%2Fannurev-genom-082410-101440&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-genom-082410-101440%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DI.%26aulast%3DDawson%26aufirst%3DV.%2BL.%2BV.%26aulast%3DDawson%26aufirst%3DT.%2BT.%2BM.%26atitle%3DRecent%2520advances%2520in%2520the%2520genetics%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DAnnu.%2520Rev.%2520Genomics%2520Hum.%2520Genet.%26date%3D2011%26volume%3D12%26spage%3D301%26epage%3D325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Nuytemans, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theuns, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cruts, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Broeckhoven, C.</span><span> </span><span class="NLM_article-title">Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update</span> <span class="citation_source-journal">Hum. Mutat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">763</span><span class="NLM_x">–</span> <span class="NLM_lpage">780</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1002%2Fhumu.21277" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=20506312" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpslagtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=763-780&author=K.+Nuytemansauthor=J.+Theunsauthor=M.+Crutsauthor=C.+Van+Broeckhoven&title=Genetic+etiology+of+Parkinson+disease+associated+with+mutations+in+the+SNCA%2C+PARK2%2C+PINK1%2C+PARK7%2C+and+LRRK2+genes%3A+a+mutation+update"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update</span></div><div class="casAuthors">Nuytemans, Karen; Theuns, Jessie; Cruts, Marc; Van Broeckhoven, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Human Mutation</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">763-780</span>CODEN:
                <span class="NLM_cas:coden">HUMUE3</span>;
        ISSN:<span class="NLM_cas:issn">1059-7794</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  To date, mol. genetic analyses have identified over 500 distinct DNA variants in five disease genes assocd. with familial Parkinson disease; α-synuclein (SNCA), parkin (PARK2), PTEN-induced putative kinase 1 (PINK1), DJ-1 (PARK7), and Leucine-rich repeat kinase 2 (LRRK2).  These genetic variants include ∼82% simple mutations and ∼18% copy no. variations.  Some mutation subtypes are likely underestimated because only few studies reported extensive mutation analyses of all five genes, by both exonic sequencing and dosage analyses.  Here we present an update of all mutations published to date in the literature, systematically organized in a novel mutation database (http://www.molgen.ua.ac.be/PDmutDB).  In addn., we address the biol. relevance of putative pathogenic mutations.  This review emphasizes the need for comprehensive genetic screening of Parkinson patients followed by an insightful study of the functional relevance of obsd. genetic variants.  Moreover, while capturing existing data from the literature it became apparent that several of the five Parkinson genes were also contributing to the genetic etiol. of other Lewy Body Diseases and Parkinson-plus syndromes, indicating that mutation screening is recommendable in these patient groups.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyXdisuECrL7Vg90H21EOLACvtfcHk0liqQzq0-KL7lA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpslagtL8%253D&md5=27bd963eceb4a51c8227997414530c2f</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1002%2Fhumu.21277&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhumu.21277%26sid%3Dliteratum%253Aachs%26aulast%3DNuytemans%26aufirst%3DK.%26aulast%3DTheuns%26aufirst%3DJ.%26aulast%3DCruts%26aufirst%3DM.%26aulast%3DVan%2BBroeckhoven%26aufirst%3DC.%26atitle%3DGenetic%2520etiology%2520of%2520Parkinson%2520disease%2520associated%2520with%2520mutations%2520in%2520the%2520SNCA%252C%2520PARK2%252C%2520PINK1%252C%2520PARK7%252C%2520and%2520LRRK2%2520genes%253A%2520a%2520mutation%2520update%26jtitle%3DHum.%2520Mutat.%26date%3D2010%26volume%3D31%26spage%3D763%26epage%3D780" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Zimprich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biskup, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leitner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lincoln, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kachergus, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hulihan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uitti, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calne, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoessl, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfeiffer, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patenge, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carbajal, I. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vieregge, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asmus, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller-Myhsok, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickson, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meitinger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strom, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wszolek, Z. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasser, T.</span><span> </span><span class="NLM_article-title">Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">601</span><span class="NLM_x">–</span> <span class="NLM_lpage">607</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1016%2Fj.neuron.2004.11.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=15541309" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVKhurjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2004&pages=601-607&author=A.+Zimprichauthor=S.+Biskupauthor=P.+Leitnerauthor=P.+Lichtnerauthor=M.+Farrerauthor=S.+Lincolnauthor=J.+Kachergusauthor=M.+Hulihanauthor=R.+J.+Uittiauthor=D.+B.+Calneauthor=A.+J.+Stoesslauthor=R.+F.+Pfeifferauthor=N.+Patengeauthor=I.+C.+Carbajalauthor=P.+Viereggeauthor=F.+Asmusauthor=B.+Muller-Myhsokauthor=D.+W.+Dicksonauthor=T.+Meitingerauthor=T.+M.+Stromauthor=Z.+K.+Wszolekauthor=T.+Gasser&title=Mutations+in+LRRK2+cause+autosomal-dominant+parkinsonism+with+pleomorphic+pathology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology</span></div><div class="casAuthors">Zimprich, Alexander; Biskup, Saskia; Leitner, Petra; Lichtner, Peter; Farrer, Matthew; Lincoln, Sarah; Kachergus, Jennifer; Hulihan, Mary; Uitti, Ryan J.; Calne, Donald B.; Stoessl, A. Jon; Pfeiffer, Ronald F.; Patenge, Nadja; Carbajal, Iria Carballo; Vieregge, Peter; Asmus, Friedrich; Mueller-Myhsok, Bertram; Dickson, Dennis W.; Meitinger, Thomas; Strom, Tim M.; Wszolek, Zbigniew K.; Gasser, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">601-607</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">We have previously linked families with autosomaldominant, late-onset parkinsonism to chromosome 12p11.2-q13.1 (PARK8).  By high-resoln. recombination mapping and candidate gene sequencing in 46 families, we have found six disease-segregating mutations (five missense and one putative splice site mutation) in a gene encoding a large, multifunctional protein, LRRK2 (leucine-rich repeat kinase 2).  It belongs to the ROCO protein family and includes a protein kinase domain of the MAPKKK class and several other major functional domains.  Within affected carriers of families A and D, six post mortem diagnoses reveal brainstem dopaminergic degeneration accompanied by strikingly diverse pathologies.  These include abnormalities consistent with Lewy body Parkinson's disease, diffuse Lewy body disease, nigral degeneration without distinctive histopathol., and progressive supranuclear palsy-like pathol.  Clin. diagnoses of Parkinsonism with dementia or amyotrophy or both, with their assocd. pathologies, are also noted.  Hence, LRRK2 may be central to the pathogenesis of several major neurodegenerative disorders assocd. with parkinsonism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9aK6wacZJhbVg90H21EOLACvtfcHk0liqQzq0-KL7lA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVKhurjL&md5=9ae4c87ce3172e29829e317d94b5cdaa</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2004.11.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2004.11.005%26sid%3Dliteratum%253Aachs%26aulast%3DZimprich%26aufirst%3DA.%26aulast%3DBiskup%26aufirst%3DS.%26aulast%3DLeitner%26aufirst%3DP.%26aulast%3DLichtner%26aufirst%3DP.%26aulast%3DFarrer%26aufirst%3DM.%26aulast%3DLincoln%26aufirst%3DS.%26aulast%3DKachergus%26aufirst%3DJ.%26aulast%3DHulihan%26aufirst%3DM.%26aulast%3DUitti%26aufirst%3DR.%2BJ.%26aulast%3DCalne%26aufirst%3DD.%2BB.%26aulast%3DStoessl%26aufirst%3DA.%2BJ.%26aulast%3DPfeiffer%26aufirst%3DR.%2BF.%26aulast%3DPatenge%26aufirst%3DN.%26aulast%3DCarbajal%26aufirst%3DI.%2BC.%26aulast%3DVieregge%26aufirst%3DP.%26aulast%3DAsmus%26aufirst%3DF.%26aulast%3DMuller-Myhsok%26aufirst%3DB.%26aulast%3DDickson%26aufirst%3DD.%2BW.%26aulast%3DMeitinger%26aufirst%3DT.%26aulast%3DStrom%26aufirst%3DT.%2BM.%26aulast%3DWszolek%26aufirst%3DZ.%2BK.%26aulast%3DGasser%26aufirst%3DT.%26atitle%3DMutations%2520in%2520LRRK2%2520cause%2520autosomal-dominant%2520parkinsonism%2520with%2520pleomorphic%2520pathology%26jtitle%3DNeuron%26date%3D2004%26volume%3D44%26spage%3D601%26epage%3D607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Paisan-Ruiz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilks, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Brug, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez de Munain, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aparicio, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gil, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholl, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrera, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pena, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Silva, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lees, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marti-Masso, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Tur, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singleton, A. B.</span><span> </span><span class="NLM_article-title">Cloning of the gene containing mutations that cause PARK8-linked Parkinson’s disease</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">595</span><span class="NLM_x">–</span> <span class="NLM_lpage">600</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2004&pages=595-600&author=C.+Paisan-Ruizauthor=S.+Jainauthor=E.+W.+Evansauthor=W.+P.+Gilksauthor=J.+Simonauthor=M.+van+der+Brugauthor=A.+Lopez+de+Munainauthor=S.+Aparicioauthor=A.+M.+Gilauthor=N.+Khanauthor=J.+Johnsonauthor=J.+R.+Martinezauthor=D.+Nichollauthor=I.+M.+Carreraauthor=A.+S.+Penaauthor=R.+de+Silvaauthor=A.+Leesauthor=J.+F.+Marti-Massoauthor=J.+Perez-Turauthor=N.+W.+Woodauthor=A.+B.+Singleton&title=Cloning+of+the+gene+containing+mutations+that+cause+PARK8-linked+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPaisan-Ruiz%26aufirst%3DC.%26aulast%3DJain%26aufirst%3DS.%26aulast%3DEvans%26aufirst%3DE.%2BW.%26aulast%3DGilks%26aufirst%3DW.%2BP.%26aulast%3DSimon%26aufirst%3DJ.%26aulast%3Dvan%2Bder%2BBrug%26aufirst%3DM.%26aulast%3DLopez%2Bde%2BMunain%26aufirst%3DA.%26aulast%3DAparicio%26aufirst%3DS.%26aulast%3DGil%26aufirst%3DA.%2BM.%26aulast%3DKhan%26aufirst%3DN.%26aulast%3DJohnson%26aufirst%3DJ.%26aulast%3DMartinez%26aufirst%3DJ.%2BR.%26aulast%3DNicholl%26aufirst%3DD.%26aulast%3DCarrera%26aufirst%3DI.%2BM.%26aulast%3DPena%26aufirst%3DA.%2BS.%26aulast%3Dde%2BSilva%26aufirst%3DR.%26aulast%3DLees%26aufirst%3DA.%26aulast%3DMarti-Masso%26aufirst%3DJ.%2BF.%26aulast%3DPerez-Tur%26aufirst%3DJ.%26aulast%3DWood%26aufirst%3DN.%2BW.%26aulast%3DSingleton%26aufirst%3DA.%2BB.%26atitle%3DCloning%2520of%2520the%2520gene%2520containing%2520mutations%2520that%2520cause%2520PARK8-linked%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DNeuron%26date%3D2004%26volume%3D44%26spage%3D595%26epage%3D600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Paisan-Ruiz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawarai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salehi-Rad, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisman, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Khairallah, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George-Hyslop, P.,  St</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singleton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogaeva, E.</span><span> </span><span class="NLM_article-title">LRRK2 gene in Parkinson disease: mutation analysis and case control association study</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">696</span><span class="NLM_x">–</span> <span class="NLM_lpage">700</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=696-700&author=C.+Paisan-Ruizauthor=A.+E.+Langauthor=T.+Kawaraiauthor=C.+Satoauthor=S.+Salehi-Radauthor=G.+K.+Fismanauthor=T.+Al-Khairallahauthor=P.+George-Hyslopauthor=A.+Singletonauthor=E.+Rogaeva&title=LRRK2+gene+in+Parkinson+disease%3A+mutation+analysis+and+case+control+association+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPaisan-Ruiz%26aufirst%3DC.%26aulast%3DLang%26aufirst%3DA.%2BE.%26aulast%3DKawarai%26aufirst%3DT.%26aulast%3DSato%26aufirst%3DC.%26aulast%3DSalehi-Rad%26aufirst%3DS.%26aulast%3DFisman%26aufirst%3DG.%2BK.%26aulast%3DAl-Khairallah%26aufirst%3DT.%26aulast%3DGeorge-Hyslop%26aufirst%3DP.%26aulast%3DSingleton%26aufirst%3DA.%26aulast%3DRogaeva%26aufirst%3DE.%26atitle%3DLRRK2%2520gene%2520in%2520Parkinson%2520disease%253A%2520mutation%2520analysis%2520and%2520case%2520control%2520association%2520study%26jtitle%3DNeurology%26date%3D2005%26volume%3D65%26spage%3D696%26epage%3D700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Paisán-Ruiz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singleton, A. B.</span><span> </span><span class="NLM_article-title">LRRK2: Cause, risk, and mechanism</span> <span class="citation_source-journal">J. Parkinson’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">85</span><span class="NLM_x">–</span> <span class="NLM_lpage">103</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=23938341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFygs73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=85-103&author=C.+Pais%C3%A1n-Ruizauthor=P.+A.+Lewisauthor=A.+B.+Singleton&title=LRRK2%3A+Cause%2C+risk%2C+and+mechanism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">LRRK2: cause, risk, and mechanism</span></div><div class="casAuthors">Paisan-Ruiz, Coro; Lewis, Patrick A.; Singleton, Andrew B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Parkinson's Disease</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">85-103</span>CODEN:
                <span class="NLM_cas:coden">JPDOAP</span>;
        ISSN:<span class="NLM_cas:issn">1877-7171</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">A review.  In 2004 it was first shown that mutations in LRRK2 can cause Parkinson's disease.  This initial discovery was quickly followed by the observation that a single particular mutation is a relatively common cause of Parkinson's disease across varied populations.  Further genetic investigation has revealed a variety of genetic ties to Parkinson's disease across this gene.  These include common alleles with quite broad effects on risk, likely through both alterations at the protein sequence level, and in the context of expression.  A great deal of functional characterization of LRRK2 and disease-causing mutations in this protein has occurred over the last 9 years, and considerable progress has been made.  Particular attention has been paid to the kinase activity of LRRK2 as a therapeutic target, and while it is no means certain that this is viable target it is likely that this hypothesis will be tested in clin. trials sooner rather than later.  We believe that the future goals for LRRK2 research are, while challenging, relatively clear and that the next 10 years of research promises to be perhaps more exciting than the last.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqk1IVJK9Tqs7Vg90H21EOLACvtfcHk0lhD67W66vNpdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFygs73M&md5=6e7ceb0477f0a4551ac71849daa4a0b1</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPais%25C3%25A1n-Ruiz%26aufirst%3DC.%26aulast%3DLewis%26aufirst%3DP.%2BA.%26aulast%3DSingleton%26aufirst%3DA.%2BB.%26atitle%3DLRRK2%253A%2520Cause%252C%2520risk%252C%2520and%2520mechanism%26jtitle%3DJ.%2520Parkinson%25E2%2580%2599s%2520Dis.%26date%3D2013%26volume%3D3%26spage%3D85%26epage%3D103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Thévenet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobert, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Huijsduijnen, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiessner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sagot, Y. J.</span><span> </span><span class="NLM_article-title">Regulation of LRRK2 expression points to a functional role in human monocyte maturation</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">e21519</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e21519&author=J.+Th%C3%A9venetauthor=R.+Gobertauthor=R.+H.+van+Huijsduijnenauthor=C.+Wiessnerauthor=Y.+J.+Sagot&title=Regulation+of+LRRK2+expression+points+to+a+functional+role+in+human+monocyte+maturation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTh%25C3%25A9venet%26aufirst%3DJ.%26aulast%3DGobert%26aufirst%3DR.%26aulast%3Dvan%2BHuijsduijnen%26aufirst%3DR.%2BH.%26aulast%3DWiessner%26aufirst%3DC.%26aulast%3DSagot%26aufirst%3DY.%2BJ.%26atitle%3DRegulation%2520of%2520LRRK2%2520expression%2520points%2520to%2520a%2520functional%2520role%2520in%2520human%2520monocyte%2520maturation%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26spage%3De21519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Sharma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bandopadhyay, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lashley, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renton, A. E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kingsbury, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumaran, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kallis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilariño-Güell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Sullivan, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lees, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Revesz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holton, J. L.</span><span> </span><span class="NLM_article-title">LRRK2 expression in idiopathic and G2019S positive Parkinson’s disease subjects: a morphological and quantitative study</span> <span class="citation_source-journal">Neuropathol. Appl. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">777</span><span class="NLM_x">–</span> <span class="NLM_lpage">790</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1111%2Fj.1365-2990.2011.01187.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=21696411" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1KjsbnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2011&pages=777-790&author=S.+Sharmaauthor=R.+Bandopadhyayauthor=T.+Lashleyauthor=A.+E.+M.+Rentonauthor=A.+E.+Kingsburyauthor=R.+Kumaranauthor=C.+Kallisauthor=C.+Vilari%C3%B1o-G%C3%BCellauthor=S.+S.+O%E2%80%99Sullivanauthor=A.+J.+Leesauthor=T.+Reveszauthor=N.+W.+Woodauthor=J.+L.+Holton&title=LRRK2+expression+in+idiopathic+and+G2019S+positive+Parkinson%E2%80%99s+disease+subjects%3A+a+morphological+and+quantitative+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">LRRK2 expression in idiopathic and G2019S positive Parkinson's disease subjects: a morphological and quantitative study</span></div><div class="casAuthors">Sharma, S.; Bandopadhyay, R.; Lashley, T.; Renton, A. E. M.; Kingsbury, A. E.; Kumaran, R.; Kallis, C.; Vilarino-Guell, C.; O'Sullivan, S. S.; Lees, A. J.; Revesz, T.; Wood, N. W.; Holton, J. L.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropathology and Applied Neurobiology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">777-790</span>CODEN:
                <span class="NLM_cas:coden">NANEDL</span>;
        ISSN:<span class="NLM_cas:issn">0305-1846</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Aims: Mutations in the gene encoding leucine-rich repeat kinase-2 (LRRK2) have been established as a common genetic cause of Parkinson's disease (PD).  The distribution of LRRK2 mRNA and protein in the human brain has previously been described, although it has not been reported in PD cases with the common LRRK2 G2019S mutation.  Methods: To further elucidate the role of LRRK2 in PD, we detd. the localization of LRRK2 mRNA and protein in post-mortem brain tissue from control, idiopathic PD (IPD) and G2019S pos. PD cases.  Results: Widespread neuronal expression of LRRK2 mRNA and protein was recorded and no difference was obsd. in the morphol. localization of LRRK2 mRNA or protein between control, IPD and G2019S pos. PD cases.  Using quant. real-time polymerase chain reaction, we demonstrated that there is no regional variation in LRRK2 mRNA in normal human brain, but we have identified differential expression of LRRK2 mRNA with significant redns. recorded in limbic and neocortical regions of IPD cases compared with controls.  Semi-quant. anal. of LRRK2 immunohistochem. staining demonstrated regional variation in staining intensity, with weak LRRK2 immunoreactivity consistently recorded in the striatum and substantia nigra.  No clear differences were identified in LRRK2 immunoreactivity between control, IPD and G2019S pos. PD cases.  LRRK2 protein was identified in a small proportion of Lewy bodies.  Conclusions: Our data suggest that widespread dysregulation of LRRK2 mRNA expression may contribute to the pathogenesis of IPD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqArcjWRuByHrVg90H21EOLACvtfcHk0lha4r9hO7lhug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1KjsbnM&md5=f5be255aaff70f27329ee13ea6747d5e</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2990.2011.01187.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2990.2011.01187.x%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DBandopadhyay%26aufirst%3DR.%26aulast%3DLashley%26aufirst%3DT.%26aulast%3DRenton%26aufirst%3DA.%2BE.%2BM.%26aulast%3DKingsbury%26aufirst%3DA.%2BE.%26aulast%3DKumaran%26aufirst%3DR.%26aulast%3DKallis%26aufirst%3DC.%26aulast%3DVilari%25C3%25B1o-G%25C3%25BCell%26aufirst%3DC.%26aulast%3DO%25E2%2580%2599Sullivan%26aufirst%3DS.%2BS.%26aulast%3DLees%26aufirst%3DA.%2BJ.%26aulast%3DRevesz%26aufirst%3DT.%26aulast%3DWood%26aufirst%3DN.%2BW.%26aulast%3DHolton%26aufirst%3DJ.%2BL.%26atitle%3DLRRK2%2520expression%2520in%2520idiopathic%2520and%2520G2019S%2520positive%2520Parkinson%25E2%2580%2599s%2520disease%2520subjects%253A%2520a%2520morphological%2520and%2520quantitative%2520study%26jtitle%3DNeuropathol.%2520Appl.%2520Neurobiol.%26date%3D2011%26volume%3D37%26spage%3D777%26epage%3D790" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Mills, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulhern, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Culvenor, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H. C.</span><span> </span><span class="NLM_article-title">Prediction of the repeat domain structures and impact of parkinsonism-associated variations on structure and function of all functional domains of leucine-rich repeat kinase 2 (LRRK2)</span> <span class="citation_source-journal">Hum. Mutat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">395</span><span class="NLM_x">–</span> <span class="NLM_lpage">412</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1002%2Fhumu.22515" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=24470158" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC2cXktlKmurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=395-412&author=R.+D.+Millsauthor=T.+D.+Mulhernauthor=F.+Liuauthor=J.+G.+Culvenorauthor=H.+C.+Cheng&title=Prediction+of+the+repeat+domain+structures+and+impact+of+parkinsonism-associated+variations+on+structure+and+function+of+all+functional+domains+of+leucine-rich+repeat+kinase+2+%28LRRK2%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Prediction of the Repeat Domain Structures and Impact of Parkinsonism-Associated Variations on Structure and Function of all Functional Domains of Leucine-Rich Repeat Kinase 2 (LRRK2)</span></div><div class="casAuthors">Mills, Ryan D.; Mulhern, Terrence D.; Liu, Fei; Culvenor, Janetta G.; Cheng, Heung-Chin</div><div class="citationInfo"><span class="NLM_cas:title">Human Mutation</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">395-412</span>CODEN:
                <span class="NLM_cas:coden">HUMUE3</span>;
        ISSN:<span class="NLM_cas:issn">1059-7794</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  Genetic variations of leucine-rich repeat kinase 2 (LRRK2) are the major cause of dominantly inherited Parkinson disease (PD).  LRRK2 protein contains seven predicted domains: a tandem Ras-like GTPase (ROC) domain and C-terminal of Roc (COR) domain, a protein kinase domain, and four repeat domains.  PD-causative variations arise in all domains, suggesting that aberrant functioning of any domain can contribute to neurotoxic mechanisms of LRRK2.  Detn. of the three-dimensional structure of LRRK2 is one of the best avenues to decipher its neurotoxic mechanism.  However, with the exception of the Roc domain, the three-dimensional structures of the functional domains of LRRK2 have yet to be detd.  Based on the known three-dimensional structures of repeat domains of other proteins, the tandem Roc-COR domains of the Chlorobium tepidum Rab family protein, and the kinase domain of the Dictyostelium discoideum Roco4 protein, we predicted (1) the motifs essential for protein-protein interactions in all domains, (2) the motifs crit. for catalysis and substrate recognition in the tandem Roc-COR and kinase domains, and (3) the effects of some PD-assocd. missense variations on the neurotoxic action of LRRK2.  Results of our anal. provide a conceptual framework for future investigation into the regulation and the neurotoxic mechanism of LRRK2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCQyitGjwuJ7Vg90H21EOLACvtfcHk0lha4r9hO7lhug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXktlKmurg%253D&md5=71fb35dc3def1fa847bad36b1b38f035</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2Fhumu.22515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhumu.22515%26sid%3Dliteratum%253Aachs%26aulast%3DMills%26aufirst%3DR.%2BD.%26aulast%3DMulhern%26aufirst%3DT.%2BD.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DCulvenor%26aufirst%3DJ.%2BG.%26aulast%3DCheng%26aufirst%3DH.%2BC.%26atitle%3DPrediction%2520of%2520the%2520repeat%2520domain%2520structures%2520and%2520impact%2520of%2520parkinsonism-associated%2520variations%2520on%2520structure%2520and%2520function%2520of%2520all%2520functional%2520domains%2520of%2520leucine-rich%2520repeat%2520kinase%25202%2520%2528LRRK2%2529%26jtitle%3DHum.%2520Mutat.%26date%3D2014%26volume%3D35%26spage%3D395%26epage%3D412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Anand, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braithwaite, S. P.</span><span> </span><span class="NLM_article-title">LRRK2 in Parkinson’s disease: biochemical functions</span> <span class="citation_source-journal">FEBS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">6428</span><span class="NLM_x">–</span> <span class="NLM_lpage">6435</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2009&pages=6428-6435&author=V.+S.+Anandauthor=S.+P.+Braithwaite&title=LRRK2+in+Parkinson%E2%80%99s+disease%3A+biochemical+functions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAnand%26aufirst%3DV.%2BS.%26aulast%3DBraithwaite%26aufirst%3DS.%2BP.%26atitle%3DLRRK2%2520in%2520Parkinson%25E2%2580%2599s%2520disease%253A%2520biochemical%2520functions%26jtitle%3DFEBS%2520J.%26date%3D2009%26volume%3D276%26spage%3D6428%26epage%3D6435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Drolet, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanders, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kern, J. T.</span><span> </span><span class="NLM_article-title">Leucine-rich repeat kinase 2 (LRRK2) cellular biology: a review of recent advances in identifying physiological substrates and cellular functions</span> <span class="citation_source-journal">J. Neurogenet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">140</span><span class="NLM_x">–</span> <span class="NLM_lpage">151</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.3109%2F01677063.2011.627072" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=22077787" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsV2hs7bL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=140-151&author=R.+E.+Droletauthor=J.+M.+Sandersauthor=J.+T.+Kern&title=Leucine-rich+repeat+kinase+2+%28LRRK2%29+cellular+biology%3A+a+review+of+recent+advances+in+identifying+physiological+substrates+and+cellular+functions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Leucine-Rich Repeat Kinase 2 (LRRK2) Cellular Biology: A Review of Recent Advances in Identifying Physiological Substrates and Cellular Functions</span></div><div class="casAuthors">Drolet, Robert E.; Sanders, John M.; Kern, Jonathan T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurogenetics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">140-151</span>CODEN:
                <span class="NLM_cas:coden">JLNEDK</span>;
        ISSN:<span class="NLM_cas:issn">0167-7063</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are the most common forms of inheritable Parkinson's disease and likely play a role in sporadic disease as well.  LRRK2 is a large multidomain protein contg. two key groups, a Ras-like GTP binding domain and a serine, threonine kinase domain.  Mutations in the LRRK2 gene that assoc. with Parkinson's disease reside primarily within the two functional domains of the protein, suggesting that LRRK2 function is crit. to the pathogenesis of the disease.  The most common LRRK2 mutation increases kinase activity, making LRRK2 kinase inhibition an attractive target for small mol. drug development.  However, the physiol. function of LRRK2 kinase as well as its endogenous protein substrates remains poorly understood and has hindered drug development efforts.  Recent advances in LRRK2 biol. have revealed several potential cellular roles, interacting proteins, and putative physiol. substrates.  Together, a picture emerges of a complex multifunctional protein that exists in multiple cellular compartments.  Through unclear mechanisms, LRRK2 kinase regulates cytoskeleton architecture through control of protein translation, phosphorylation of cytoskeletal proteins, and response to cellular stressors.  This article will briefly cover some interesting recent studies in LRRK2 cellular biol. and highlight emerging cellular models of LRRK2 kinase function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIaZnsxyLANrVg90H21EOLACvtfcHk0lhnxf5DVrWkfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsV2hs7bL&md5=b4b40ac3ccfa45091410f59e1401587c</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.3109%2F01677063.2011.627072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F01677063.2011.627072%26sid%3Dliteratum%253Aachs%26aulast%3DDrolet%26aufirst%3DR.%2BE.%26aulast%3DSanders%26aufirst%3DJ.%2BM.%26aulast%3DKern%26aufirst%3DJ.%2BT.%26atitle%3DLeucine-rich%2520repeat%2520kinase%25202%2520%2528LRRK2%2529%2520cellular%2520biology%253A%2520a%2520review%2520of%2520recent%2520advances%2520in%2520identifying%2520physiological%2520substrates%2520and%2520cellular%2520functions%26jtitle%3DJ.%2520Neurogenet.%26date%3D2011%26volume%3D25%26spage%3D140%26epage%3D151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Gilsbach, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, F. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vetter, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Haastert, P. J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittinghofer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kortholt, A.</span><span> </span><span class="NLM_article-title">Roco kinase structures give insights into the mechanism of Parkinson disease-related leucine-rich-repeat kinase 2 mutations</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">10322</span><span class="NLM_x">–</span> <span class="NLM_lpage">10327</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=10322-10327&author=B.+K.+Gilsbachauthor=F.+Y.+Hoauthor=I.+R.+Vetterauthor=P.+J.+M.+van+Haastertauthor=A.+Wittinghoferauthor=A.+Kortholt&title=Roco+kinase+structures+give+insights+into+the+mechanism+of+Parkinson+disease-related+leucine-rich-repeat+kinase+2+mutations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGilsbach%26aufirst%3DB.%2BK.%26aulast%3DHo%26aufirst%3DF.%2BY.%26aulast%3DVetter%26aufirst%3DI.%2BR.%26aulast%3Dvan%2BHaastert%26aufirst%3DP.%2BJ.%2BM.%26aulast%3DWittinghofer%26aufirst%3DA.%26aulast%3DKortholt%26aufirst%3DA.%26atitle%3DRoco%2520kinase%2520structures%2520give%2520insights%2520into%2520the%2520mechanism%2520of%2520Parkinson%2520disease-related%2520leucine-rich-repeat%2520kinase%25202%2520mutations%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2012%26volume%3D109%26spage%3D10322%26epage%3D10327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Liu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bender, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuny, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherman, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glicksman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, S. S.</span><span> </span><span class="NLM_article-title">Type II kinase inhibitors show an unexpected inhibition mode against Parkinson’s disease-linked LRRK2 mutant G2019S</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1725</span><span class="NLM_x">–</span> <span class="NLM_lpage">1736</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi3012077" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=1725-1736&author=M.+Liuauthor=S.+A.+Benderauthor=G.+D.+Cunyauthor=W.+Shermanauthor=M.+Glicksmanauthor=S.+S.+Ray&title=Type+II+kinase+inhibitors+show+an+unexpected+inhibition+mode+against+Parkinson%E2%80%99s+disease-linked+LRRK2+mutant+G2019S"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fbi3012077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi3012077%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DBender%26aufirst%3DS.%2BA.%26aulast%3DCuny%26aufirst%3DG.%2BD.%26aulast%3DSherman%26aufirst%3DW.%26aulast%3DGlicksman%26aufirst%3DM.%26aulast%3DRay%26aufirst%3DS.%2BS.%26atitle%3DType%2520II%2520kinase%2520inhibitors%2520show%2520an%2520unexpected%2520inhibition%2520mode%2520against%2520Parkinson%25E2%2580%2599s%2520disease-linked%2520LRRK2%2520mutant%2520G2019S%26jtitle%3DBiochemistry%26date%3D2013%26volume%3D52%26spage%3D1725%26epage%3D1736" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Gilsbach, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kortholt, A.</span><span> </span><span class="NLM_article-title">Structural biology of the LRRK2 GTPase and kinase domains: implications for regulation</span> <span class="citation_source-journal">Front. Mol. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">32</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.3389%2Ffnmol.2014.00032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=24847205" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVChsLbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2014&pages=32&author=B.+K.+Gilsbachauthor=A.+Kortholt&title=Structural+biology+of+the+LRRK2+GTPase+and+kinase+domains%3A+implications+for+regulation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Structural biology of the LRRK2 GTPase and kinase domains: implications for regulation</span></div><div class="casAuthors">Gilsbach, Bernd K.; Kortholt, Arjan</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Molecular Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">32/1-32/9, 9 pp.</span>CODEN:
                <span class="NLM_cas:coden">FMNRAJ</span>;
        ISSN:<span class="NLM_cas:issn">1662-5099</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Human leucine rich repeat kinase 2 (LRRK2) belongs to the Roco family of proteins, which are characterized by the presence of a Ras-like G-domain (Roc), a C-terminal of Roc domain (COR), and a kinase domain.  Mutations in LRRK2 have been found to be thus far the most frequent cause of late-onset Parkinson's disease (PD).  Several of the pathogenic mutations in LRRK2 result in decreased GTPase activity and enhanced kinase activity, suggesting a possible PD-related gain of abnormal function.  Important progress in the structural understanding of LRRK2 has come from our work with related Roco proteins from lower organisms.  Atomic structures of Roco proteins from prokaryotes revealed that Roco proteins belong to the GAD class of mol. switches (G proteins activated by nucleotide dependent dimerization).  As in LRRK2, PD-analogous mutations in Roco proteins from bacteria decrease the GTPase reaction.  Studies with Roco proteins from the model organism Dictyostelium discoideum revealed that PD mutants have different effects and most importantly they explained the G2019S-related increased LRRK2 kinase activity.  Furthermore, the structure of Dictyostelium Roco4 kinase in complex with the LRRK2 inhibitor H1152 showed that Roco4 and other Roco family proteins can be important for the optimization of the current, and identification of new, LRRK2 kinase inhibitors.  In this review we highlight the recent progress in structural and biochem. characterization of Roco proteins and discuss its implication for the understanding of the complex regulatory mechanism of LRRK2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnWPIGCCasqLVg90H21EOLACvtfcHk0lhy5ftUPvof0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVChsLbN&md5=de1cef27dd0b8e5b5b242a4a1607192f</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.3389%2Ffnmol.2014.00032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnmol.2014.00032%26sid%3Dliteratum%253Aachs%26aulast%3DGilsbach%26aufirst%3DB.%2BK.%26aulast%3DKortholt%26aufirst%3DA.%26atitle%3DStructural%2520biology%2520of%2520the%2520LRRK2%2520GTPase%2520and%2520kinase%2520domains%253A%2520implications%2520for%2520regulation%26jtitle%3DFront.%2520Mol.%2520Neurosci.%26date%3D2014%26volume%3D7%26spage%3D32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Sen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webber, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, A. B.</span><span> </span><span class="NLM_article-title">Dependence of leucine-rich repeat kinase 2 (LRRK2) kinase activity on dimerization</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x">, </span> <span class="NLM_fpage">36346</span><span class="NLM_x">–</span> <span class="NLM_lpage">36356</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=36346-36356&author=S.+Senauthor=P.+J.+Webberauthor=A.+B.+West&title=Dependence+of+leucine-rich+repeat+kinase+2+%28LRRK2%29+kinase+activity+on+dimerization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSen%26aufirst%3DS.%26aulast%3DWebber%26aufirst%3DP.%2BJ.%26aulast%3DWest%26aufirst%3DA.%2BB.%26atitle%3DDependence%2520of%2520leucine-rich%2520repeat%2520kinase%25202%2520%2528LRRK2%2529%2520kinase%2520activity%2520on%2520dimerization%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D36346%26epage%3D36356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Ito, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujino, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichijo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katada, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwatsubo, T.</span><span> </span><span class="NLM_article-title">GTP binding is essential to the protein kinase activity of LRRK2, a causative gene product for familial Parkinson’s disease</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">1380</span><span class="NLM_x">–</span> <span class="NLM_lpage">1388</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi061960m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=1380-1388&author=G.+Itoauthor=T.+Okaiauthor=G.+Fujinoauthor=K.+Takedaauthor=H.+Ichijoauthor=T.+Katadaauthor=T.+Iwatsubo&title=GTP+binding+is+essential+to+the+protein+kinase+activity+of+LRRK2%2C+a+causative+gene+product+for+familial+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fbi061960m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi061960m%26sid%3Dliteratum%253Aachs%26aulast%3DIto%26aufirst%3DG.%26aulast%3DOkai%26aufirst%3DT.%26aulast%3DFujino%26aufirst%3DG.%26aulast%3DTakeda%26aufirst%3DK.%26aulast%3DIchijo%26aufirst%3DH.%26aulast%3DKatada%26aufirst%3DT.%26aulast%3DIwatsubo%26aufirst%3DT.%26atitle%3DGTP%2520binding%2520is%2520essential%2520to%2520the%2520protein%2520kinase%2520activity%2520of%2520LRRK2%252C%2520a%2520causative%2520gene%2520product%2520for%2520familial%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DBiochemistry%26date%3D2007%26volume%3D46%26spage%3D1380%26epage%3D1388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Sheng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bustos, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleinheinz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Pichon, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominguez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solanoy, H. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drummond, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yue, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Brug, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burdick, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunzner-Toste, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estrada, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweeney, Z. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scearce-Levie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moffat, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirkpatrick, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.</span><span> </span><span class="NLM_article-title">Ser<sup>1292</sup> autophosphorylation is an indicator of LRRK2 kinase activity and contributes to the cellular effects of PD mutations</span> <span class="citation_source-journal">Sci. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">164ra161</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1126%2Fscitranslmed.3004485" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=23241745" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=164ra161&author=Z.+Shengauthor=S.+Zhangauthor=D.+Bustosauthor=T.+Kleinheinzauthor=C.+E.+Le+Pichonauthor=S.+Dominguezauthor=H.+O.+Solanoyauthor=J.+Drummondauthor=X.+Zhangauthor=X.+Dingauthor=F.+Caiauthor=Q.+Songauthor=X.+Liauthor=Z.+Yueauthor=M.+P.+van+der+Brugauthor=D.+J.+Burdickauthor=J.+Gunzner-Tosteauthor=H.+Chenauthor=X.+Liuauthor=A.+A.+Estradaauthor=Z.+K.+Sweeneyauthor=K.+Scearce-Levieauthor=J.+G.+Moffatauthor=D.+S.+Kirkpatrickauthor=H.+Zhu&title=Ser1292+autophosphorylation+is+an+indicator+of+LRRK2+kinase+activity+and+contributes+to+the+cellular+effects+of+PD+mutations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3004485&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3004485%26sid%3Dliteratum%253Aachs%26aulast%3DSheng%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DBustos%26aufirst%3DD.%26aulast%3DKleinheinz%26aufirst%3DT.%26aulast%3DLe%2BPichon%26aufirst%3DC.%2BE.%26aulast%3DDominguez%26aufirst%3DS.%26aulast%3DSolanoy%26aufirst%3DH.%2BO.%26aulast%3DDrummond%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DDing%26aufirst%3DX.%26aulast%3DCai%26aufirst%3DF.%26aulast%3DSong%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DYue%26aufirst%3DZ.%26aulast%3Dvan%2Bder%2BBrug%26aufirst%3DM.%2BP.%26aulast%3DBurdick%26aufirst%3DD.%2BJ.%26aulast%3DGunzner-Toste%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DEstrada%26aufirst%3DA.%2BA.%26aulast%3DSweeney%26aufirst%3DZ.%2BK.%26aulast%3DScearce-Levie%26aufirst%3DK.%26aulast%3DMoffat%26aufirst%3DJ.%2BG.%26aulast%3DKirkpatrick%26aufirst%3DD.%2BS.%26aulast%3DZhu%26aufirst%3DH.%26atitle%3DSer1292%2520autophosphorylation%2520is%2520an%2520indicator%2520of%2520LRRK2%2520kinase%2520activity%2520and%2520contributes%2520to%2520the%2520cellular%2520effects%2520of%2520PD%2520mutations%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2012%26volume%3D4%26spage%3D164ra161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">West, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biskup, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bugayenko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, T. M.</span><span> </span><span class="NLM_article-title">Parkinson’s disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">16842</span><span class="NLM_x">–</span> <span class="NLM_lpage">16847</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=16842-16847&author=A.+B.+Westauthor=D.+J.+Mooreauthor=S.+Biskupauthor=A.+Bugayenkoauthor=W.+W.+Smithauthor=C.+A.+Rossauthor=V.+L.+Dawsonauthor=T.+M.+Dawson&title=Parkinson%E2%80%99s+disease-associated+mutations+in+leucine-rich+repeat+kinase+2+augment+kinase+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWest%26aufirst%3DA.%2BB.%26aulast%3DMoore%26aufirst%3DD.%2BJ.%26aulast%3DBiskup%26aufirst%3DS.%26aulast%3DBugayenko%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DW.%2BW.%26aulast%3DRoss%26aufirst%3DC.%2BA.%26aulast%3DDawson%26aufirst%3DV.%2BL.%26aulast%3DDawson%26aufirst%3DT.%2BM.%26atitle%3DParkinson%25E2%2580%2599s%2520disease-associated%2520mutations%2520in%2520leucine-rich%2520repeat%2520kinase%25202%2520augment%2520kinase%2520activity%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2005%26volume%3D102%26spage%3D16842%26epage%3D16847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">West, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrabi, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dikeman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biskup, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, T. M.</span><span> </span><span class="NLM_article-title">Parkinson’s disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity</span> <span class="citation_source-journal">Hum. Mol. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">223</span><span class="NLM_x">–</span> <span class="NLM_lpage">232</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1093%2Fhmg%2Fddl471" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=17200152" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVKkt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2007&pages=223-232&author=A.+B.+Westauthor=D.+J.+Mooreauthor=C.+Choiauthor=S.+A.+Andrabiauthor=X.+Liauthor=D.+Dikemanauthor=S.+Biskupauthor=Z.+Zhangauthor=K.+L.+Limauthor=V.+L.+Dawsonauthor=T.+M.+Dawson&title=Parkinson%E2%80%99s+disease-associated+mutations+in+LRRK2+link+enhanced+GTP-binding+and+kinase+activities+to+neuronal+toxicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity</span></div><div class="casAuthors">West, Andrew B.; Moore, Darren J.; Choi, Catherine; Andrabi, Shaida A.; Li, Xiaojie; Dikeman, Dustin; Biskup, Saskia; Zhang, Zhenshui; Lim, Kah-Leong; Dawson, Valina L.; Dawson, Ted M.</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">223-232</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Mutations in the leucine-rich repeat kinase 2 gene (LRRK2) cause late-onset Parkinson's disease indistinguishable from idiopathic disease.  The mechanisms whereby missense alterations in the LRRK2 gene initiate neurodegeneration remain unknown.  Here, we demonstrate that seven of 10 suspected familial-linked mutations result in increased kinase activity.  Functional and disease-assocd. mutations in conserved residues reveal the crit. link between intrinsic guanosine triphosphatase (GTPase) activity and downstream kinase activity.  LRRK2 kinase activity requires GTPase activity, whereas GTPase activity functions independently of kinase activity.  Both LRRK2 kinase and GTPase activity are required for neurotoxicity and potentiate peroxide-induced cell death, although LRRK2 does not function as a canonical MAP-kinase-kinase-kinase.  These results suggest a link between LRRK2 kinase activity and pathogenic mechanisms relating to neurodegeneration, further supporting a gain-of-function role for LRRK2 mutations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrt9g3fmGyJFLVg90H21EOLACvtfcHk0liXPopsdpF3Xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVKkt70%253D&md5=b98933d068e9443ae10181b3343a471f</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddl471&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddl471%26sid%3Dliteratum%253Aachs%26aulast%3DWest%26aufirst%3DA.%2BB.%26aulast%3DMoore%26aufirst%3DD.%2BJ.%26aulast%3DChoi%26aufirst%3DC.%26aulast%3DAndrabi%26aufirst%3DS.%2BA.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DDikeman%26aufirst%3DD.%26aulast%3DBiskup%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DLim%26aufirst%3DK.%2BL.%26aulast%3DDawson%26aufirst%3DV.%2BL.%26aulast%3DDawson%26aufirst%3DT.%2BM.%26atitle%3DParkinson%25E2%2580%2599s%2520disease-associated%2520mutations%2520in%2520LRRK2%2520link%2520enhanced%2520GTP-binding%2520and%2520kinase%2520activities%2520to%2520neuronal%2520toxicity%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2007%26volume%3D16%26spage%3D223%26epage%3D232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Jaleel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillardon, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knebel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span> </span><span class="NLM_article-title">LRRK2 phosphorylates moesin at threonine-558: characterization of how Parkinson’s disease mutants affect kinase activity</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">405</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">317</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=405&publication_year=2007&pages=307-317&author=M.+Jaleelauthor=R.+J.+Nicholsauthor=M.+Deakauthor=D.+G.+Campbellauthor=F.+Gillardonauthor=A.+Knebelauthor=D.+R.+Alessi&title=LRRK2+phosphorylates+moesin+at+threonine-558%3A+characterization+of+how+Parkinson%E2%80%99s+disease+mutants+affect+kinase+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJaleel%26aufirst%3DM.%26aulast%3DNichols%26aufirst%3DR.%2BJ.%26aulast%3DDeak%26aufirst%3DM.%26aulast%3DCampbell%26aufirst%3DD.%2BG.%26aulast%3DGillardon%26aufirst%3DF.%26aulast%3DKnebel%26aufirst%3DA.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26atitle%3DLRRK2%2520phosphorylates%2520moesin%2520at%2520threonine-558%253A%2520characterization%2520of%2520how%2520Parkinson%25E2%2580%2599s%2520disease%2520mutants%2520affect%2520kinase%2520activity%26jtitle%3DBiochem.%2520J.%26date%3D2007%26volume%3D405%26spage%3D307%26epage%3D317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Silva, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geoghegan, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aulabaugh, A.</span><span> </span><span class="NLM_article-title">A continuous and direct assay to monitor leucine-rich repeat kinase 2 activity</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">450</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">–</span> <span class="NLM_lpage">69</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=450&publication_year=2014&pages=63-69&author=R.+G.+Silvaauthor=K.+F.+Geogheganauthor=X.+Qiuauthor=A.+Aulabaugh&title=A+continuous+and+direct+assay+to+monitor+leucine-rich+repeat+kinase+2+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSilva%26aufirst%3DR.%2BG.%26aulast%3DGeoghegan%26aufirst%3DK.%2BF.%26aulast%3DQiu%26aufirst%3DX.%26aulast%3DAulabaugh%26aufirst%3DA.%26atitle%3DA%2520continuous%2520and%2520direct%2520assay%2520to%2520monitor%2520leucine-rich%2520repeat%2520kinase%25202%2520activity%26jtitle%3DAnal.%2520Biochem.%26date%3D2014%26volume%3D450%26spage%3D63%26epage%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Kachergus, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mata, I. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hulihan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lincoln, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aasly, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, O. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payami, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nutt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maraganore, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czyzewski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Styczynska, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wszolek, Z. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrer, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toft, M.</span><span> </span><span class="NLM_article-title">Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations</span> <span class="citation_source-journal">Am. J. Hum. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x">, </span> <span class="NLM_fpage">672</span><span class="NLM_x">–</span> <span class="NLM_lpage">680</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1086%2F429256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=15726496" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisleisLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2005&pages=672-680&author=J.+Kachergusauthor=I.+F.+Mataauthor=M.+Hulihanauthor=J.+P.+Taylorauthor=S.+Lincolnauthor=J.+Aaslyauthor=J.+M.+Gibsonauthor=O.+W.+Rossauthor=T.+Lynchauthor=J.+Wileyauthor=H.+Payamiauthor=J.+Nuttauthor=D.+M.+Maraganoreauthor=K.+Czyzewskiauthor=M.+Styczynskaauthor=Z.+K.+Wszolekauthor=M.+J.+Farrerauthor=M.+Toft&title=Identification+of+a+novel+LRRK2+mutation+linked+to+autosomal+dominant+parkinsonism%3A+evidence+of+a+common+founder+across+European+populations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations</span></div><div class="casAuthors">Kachergus, Jennifer; Mata, Ignacio F.; Hulihan, Mary; Taylor, Julie P.; Lincoln, Sarah; Aasly, Jan; Gibson, J. Mark; Ross, Owen A.; Lynch, Timothy; Wiley, Joseph; Payami, Haydeh; Nutt, John; Maraganore, Demetrius M.; Czyzewski, Krzysztof; Styczynska, Maria; Wszolek, Zbigniew K.; Farrer, Matthew J.; Toft, Mathias</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Human Genetics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">672-680</span>CODEN:
                <span class="NLM_cas:coden">AJHGAG</span>;
        ISSN:<span class="NLM_cas:issn">0002-9297</span>.
    
            (<span class="NLM_cas:orgname">University of Chicago Press</span>)
        </div><div class="casAbstract">Autosomal dominant parkinsonism has been attributed to pathogenic amino acid substitutions in leucine-rich repeat kinase 2 (LRRK2).  By sequencing multiplex families consistent with a PARK8 assignment, the authors identified a novel heterozygous LRRK2 mutation.  A referral sample of 248 affected probands from families with autosomal dominant parkinsonism was subsequently assessed; 7 (2.8%) were found to carry a heterozygous LRRK2 6055G→A transition (G2019S).  These seven patients originate from the United States, Norway, Ireland, and Poland.  In samples of patients with idiopathic Parkinson disease (PD) from the same populations, further screening identified six more patients with LRRK2 G2019S; no mutations were found in matched control individuals.  Subsequently, 42 family members of the 13 probands were examd.; 22 have an LRRK2 G2019S substitution, 7 with a diagnosis of PD.  Of note, all patients share an ancestral haplotype indicative of a common founder, and, within families, LRRK2 G2019S segregates with disease (multipoint LOD score 2.41).  Penetrance is age dependent, increasing from 17% at age 50 years to 85% at age 70 years.  In summary, the authors' study demonstrates that LRRK2 G2019S accounts for parkinsonism in several families within Europe and North America.  The authors' work highlights the fact that a proportion of clin. typical, late-onset PD cases have a genetic basis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnPfJFU1UPybVg90H21EOLACvtfcHk0liJ0O3VgXDLQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisleisLY%253D&md5=a3ffc5c6ee4170a12bd11437a95aca35</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1086%2F429256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F429256%26sid%3Dliteratum%253Aachs%26aulast%3DKachergus%26aufirst%3DJ.%26aulast%3DMata%26aufirst%3DI.%2BF.%26aulast%3DHulihan%26aufirst%3DM.%26aulast%3DTaylor%26aufirst%3DJ.%2BP.%26aulast%3DLincoln%26aufirst%3DS.%26aulast%3DAasly%26aufirst%3DJ.%26aulast%3DGibson%26aufirst%3DJ.%2BM.%26aulast%3DRoss%26aufirst%3DO.%2BW.%26aulast%3DLynch%26aufirst%3DT.%26aulast%3DWiley%26aufirst%3DJ.%26aulast%3DPayami%26aufirst%3DH.%26aulast%3DNutt%26aufirst%3DJ.%26aulast%3DMaraganore%26aufirst%3DD.%2BM.%26aulast%3DCzyzewski%26aufirst%3DK.%26aulast%3DStyczynska%26aufirst%3DM.%26aulast%3DWszolek%26aufirst%3DZ.%2BK.%26aulast%3DFarrer%26aufirst%3DM.%2BJ.%26aulast%3DToft%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520a%2520novel%2520LRRK2%2520mutation%2520linked%2520to%2520autosomal%2520dominant%2520parkinsonism%253A%2520evidence%2520of%2520a%2520common%2520founder%2520across%2520European%2520populations%26jtitle%3DAm.%2520J.%2520Hum.%2520Genet.%26date%3D2005%26volume%3D76%26spage%3D672%26epage%3D680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Smith, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pei, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, C. A.</span><span> </span><span class="NLM_article-title">Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">18676</span><span class="NLM_x">–</span> <span class="NLM_lpage">18681</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=18676-18681&author=W.+W.+Smithauthor=Z.+Peiauthor=H.+Jiangauthor=D.+J.+Mooreauthor=Y.+Liangauthor=A.+B.+Westauthor=V.+L.+Dawsonauthor=T.+M.+Dawsonauthor=C.+A.+Ross&title=Leucine-rich+repeat+kinase+2+%28LRRK2%29+interacts+with+parkin%2C+and+mutant+LRRK2+induces+neuronal+degeneration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DW.%2BW.%26aulast%3DPei%26aufirst%3DZ.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DMoore%26aufirst%3DD.%2BJ.%26aulast%3DLiang%26aufirst%3DY.%26aulast%3DWest%26aufirst%3DA.%2BB.%26aulast%3DDawson%26aufirst%3DV.%2BL.%26aulast%3DDawson%26aufirst%3DT.%2BM.%26aulast%3DRoss%26aufirst%3DC.%2BA.%26atitle%3DLeucine-rich%2520repeat%2520kinase%25202%2520%2528LRRK2%2529%2520interacts%2520with%2520parkin%252C%2520and%2520mutant%2520LRRK2%2520induces%2520neuronal%2520degeneration%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2005%26volume%3D102%26spage%3D18676%26epage%3D18681" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Gloeckner, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinkl, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schumacher, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braun, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meitinger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolch, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prokisch, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueffing, M.</span><span> </span><span class="NLM_article-title">The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity</span> <span class="citation_source-journal">Hum. Mol. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">223</span><span class="NLM_x">–</span> <span class="NLM_lpage">232</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1093%2Fhmg%2Fddi439" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=16321986" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BD28XktF2gtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2006&pages=223-232&author=C.+J.+Gloecknerauthor=N.+Kinklauthor=A.+Schumacherauthor=R.+J.+Braunauthor=E.+O%E2%80%99Neillauthor=T.+Meitingerauthor=W.+Kolchauthor=H.+Prokischauthor=M.+Ueffing&title=The+Parkinson+disease+causing+LRRK2+mutation+I2020T+is+associated+with+increased+kinase+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity</span></div><div class="casAuthors">Gloeckner, Christian Johannes; Kinkl, Norbert; Schumacher, Annette; Braun, Ralf J.; O'Neill, Eric; Meitinger, Thomas; Kolch, Walter; Prokisch, Holger; Ueffing, Marius</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">223-232</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Mutations in the leucine-rich repeat kinase 2 gene (LRRK2) have been recently identified in families with autosomal dominant late-onset Parkinson disease (PD).  The LRRK2 protein consists of multiple domains and belongs to the Roco family, a novel group of the Ras/GTPase superfamily.  Besides the GTPase (Roc) domain, it contains a predicted kinase domain, with homol. to MAP kinase kinase kinases.  Using cell fractionation and immunofluorescence microscopy, we show that LRRK2 is localized in the cytoplasm and is assocd. with cellular membrane structures.  The purified LRRK2 protein demonstrates autokinase activity.  The disease-assocd. I2020T mutant shows a significant increase in autophosphorylation of ∼40% in comparison to wild-type protein in vitro.  This suggests that the pathol. of PD caused by the I2020T mutation is assocd. with an increase rather than a loss in LRRK2 kinase activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqm5pHX4t5L17Vg90H21EOLACvtfcHk0liNnEOppPVldg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XktF2gtQ%253D%253D&md5=191962d8ff4cdf80546e916d74d57f3a</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddi439&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddi439%26sid%3Dliteratum%253Aachs%26aulast%3DGloeckner%26aufirst%3DC.%2BJ.%26aulast%3DKinkl%26aufirst%3DN.%26aulast%3DSchumacher%26aufirst%3DA.%26aulast%3DBraun%26aufirst%3DR.%2BJ.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DE.%26aulast%3DMeitinger%26aufirst%3DT.%26aulast%3DKolch%26aufirst%3DW.%26aulast%3DProkisch%26aufirst%3DH.%26aulast%3DUeffing%26aufirst%3DM.%26atitle%3DThe%2520Parkinson%2520disease%2520causing%2520LRRK2%2520mutation%2520I2020T%2520is%2520associated%2520with%2520increased%2520kinase%2520activity%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2006%26volume%3D15%26spage%3D223%26epage%3D232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Deng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buhrlage, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Leucine-rich repeat kinase 2 inhibitors: a patent review (2006–2011)</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1415</span><span class="NLM_x">–</span> <span class="NLM_lpage">1426</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1517%2F13543776.2012.729041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=23126385" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs12itLfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=1415-1426&author=X.+Dengauthor=H.+G.+Choiauthor=S.+J.+Buhrlageauthor=N.+S.+Gray&title=Leucine-rich+repeat+kinase+2+inhibitors%3A+a+patent+review+%282006%E2%80%932011%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Leucine-rich repeat kinase 2 inhibitors: a patent review (2006 - 2011)</span></div><div class="casAuthors">Deng, Xianming; Choi, Hwan Geun; Buhrlage, Sara J.; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1415-1426</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Leucine-rich repeat kinase 2 (LRRK2) has received considerable attention since the discovery of LRRK2 mutations in families with dominantly inherited Parkinson's disease (PD) in 2004.  The missense mutation G2019S is the most common LRRK2 mutation and has been identified in both familial and sporadic PD cases.  The G2019S mutation enhances kinase activity suggesting that LRRK2 could be an attractive therapeutic target for PD and small-mol. ATP-competitive LRRK2 kinase inhibitors are one way to investigate this possibility.Areas covered: Currently, LRRK2 kinase inhibitors are being actively pursued by industry and academia.  Herein, patents detailing the discovery of LRRK2 kinase inhibitors from 2006 through 2011 and the corresponding publications from 2006 through July of 2012 are summarized.Expert opinion: Wild-type and mutant forms of LRRK2 are currently being actively pursued as therapeutic targets for the potential treatment of PD.  The increasing no. of patent applications being filed for inhibitors of LRRK2 is a testament to this activity.  Numerous distinct chemo-types have been reported as LRRK2 inhibitors with some demonstrating exceptional potency and selectivity for LRRK2 relative to other kinases.  These compds. are being used as pharmacol. tools' to elucidate the physiol. and pathophysiol. function of LRRK2 and it appears likely that some will be investigated for their potential therapeutic effects for the treatment of PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqXrD7fzsqS7Vg90H21EOLACvtfcHk0liNnEOppPVldg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs12itLfI&md5=35f36ce3bdb3b40162263b9be0f85243</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1517%2F13543776.2012.729041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2012.729041%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DChoi%26aufirst%3DH.%2BG.%26aulast%3DBuhrlage%26aufirst%3DS.%2BJ.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DLeucine-rich%2520repeat%2520kinase%25202%2520inhibitors%253A%2520a%2520patent%2520review%2520%25282006%25E2%2580%25932011%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2012%26volume%3D22%26spage%3D1415%26epage%3D1426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Smith, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pei, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, C. A.</span><span> </span><span class="NLM_article-title">Kinase activity of mutant LRRK2 mediates neuronal toxicity</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1231</span><span class="NLM_x">–</span> <span class="NLM_lpage">1233</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1038%2Fnn1776" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=16980962" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVSgu7fJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=1231-1233&author=W.+W.+Smithauthor=Z.+Peiauthor=H.+Jiangauthor=V.+L.+Dawsonauthor=T.+M.+Dawsonauthor=C.+A.+Ross&title=Kinase+activity+of+mutant+LRRK2+mediates+neuronal+toxicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32aR"><div class="casContent"><span class="casTitleNuber">32a</span><div class="casTitle"><span class="NLM_cas:atitle">Kinase activity of mutant LRRK2 mediates neuronal toxicity</span></div><div class="casAuthors">Smith, Wanli W.; Pei, Zhong; Jiang, Haibing; Dawson, Valina L.; Dawson, Ted M.; Ross, Christopher A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1231-1233</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Mutations in the leucine-rich repeat kinase-2 (LRRK2) gene cause autosomal-dominant Parkinson disease and some cases of sporadic Parkinson disease.  Here we found that LRRK2 kinase activity was regulated by GTP via the intrinsic GTPase Roc domain, and alterations of LRRK2 protein that reduced kinase activity of mutant LRRK2 correspondingly reduced neuronal toxicity.  These data elucidate the pathogenesis of LRRK2-linked Parkinson disease, potentially illuminate mechanisms of sporadic Parkinson disease and suggest therapeutic targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqS61-FFqaSfLVg90H21EOLACvtfcHk0lggwxnotQxaLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVSgu7fJ&md5=353c92fdf5be0efb00e23b6d0b8141d6</span></div><a href="/servlet/linkout?suffix=cit32a&amp;dbid=16384&amp;doi=10.1038%2Fnn1776&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn1776%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DW.%2BW.%26aulast%3DPei%26aufirst%3DZ.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DDawson%26aufirst%3DV.%2BL.%26aulast%3DDawson%26aufirst%3DT.%2BM.%26aulast%3DRoss%26aufirst%3DC.%2BA.%26atitle%3DKinase%2520activity%2520of%2520mutant%2520LRRK2%2520mediates%2520neuronal%2520toxicity%26jtitle%3DNat.%2520Neurosci.%26date%3D2006%26volume%3D9%26spage%3D1231%26epage%3D1233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit32b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Greggio, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kingsbury, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bandopadhyay, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaganovich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Brug, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beilina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackinton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmad, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kesavapany, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singleton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lees, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cookson, M. R.</span><span> </span><span class="NLM_article-title">Kinase activity is required for the toxic effects of mutant LRRK2/dardarin</span> <span class="citation_source-journal">Neurobiol. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">341</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1016%2Fj.nbd.2006.04.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2006&pages=329-341&author=E.+Greggioauthor=S.+Jainauthor=A.+Kingsburyauthor=R.+Bandopadhyayauthor=P.+Lewisauthor=A.+Kaganovichauthor=M.+P.+van+der+Brugauthor=A.+Beilinaauthor=J.+Blackintonauthor=K.+J.+Thomasauthor=R.+Ahmadauthor=D.+W.+Millerauthor=S.+Kesavapanyauthor=A.+Singletonauthor=A.+Leesauthor=R.+J.+Harveyauthor=K.+Harveyauthor=M.+R.+Cookson&title=Kinase+activity+is+required+for+the+toxic+effects+of+mutant+LRRK2%2Fdardarin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32b&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2006.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2006.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DGreggio%26aufirst%3DE.%26aulast%3DJain%26aufirst%3DS.%26aulast%3DKingsbury%26aufirst%3DA.%26aulast%3DBandopadhyay%26aufirst%3DR.%26aulast%3DLewis%26aufirst%3DP.%26aulast%3DKaganovich%26aufirst%3DA.%26aulast%3Dvan%2Bder%2BBrug%26aufirst%3DM.%2BP.%26aulast%3DBeilina%26aufirst%3DA.%26aulast%3DBlackinton%26aufirst%3DJ.%26aulast%3DThomas%26aufirst%3DK.%2BJ.%26aulast%3DAhmad%26aufirst%3DR.%26aulast%3DMiller%26aufirst%3DD.%2BW.%26aulast%3DKesavapany%26aufirst%3DS.%26aulast%3DSingleton%26aufirst%3DA.%26aulast%3DLees%26aufirst%3DA.%26aulast%3DHarvey%26aufirst%3DR.%2BJ.%26aulast%3DHarvey%26aufirst%3DK.%26aulast%3DCookson%26aufirst%3DM.%2BR.%26atitle%3DKinase%2520activity%2520is%2520required%2520for%2520the%2520toxic%2520effects%2520of%2520mutant%2520LRRK2%252Fdardarin%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2006%26volume%3D2%26spage%3D329%26epage%3D341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit32c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">MacLeod, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammond, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leete, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abeliovich, A.</span><span> </span><span class="NLM_article-title">The familial parkinsonism gene LRRK2 regulates neurite process morphology</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">587</span><span class="NLM_x">–</span> <span class="NLM_lpage">593</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2006&pages=587-593&author=D.+MacLeodauthor=J.+Dowmanauthor=R.+Hammondauthor=T.+Leeteauthor=K.+Inoueauthor=A.+Abeliovich&title=The+familial+parkinsonism+gene+LRRK2+regulates+neurite+process+morphology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMacLeod%26aufirst%3DD.%26aulast%3DDowman%26aufirst%3DJ.%26aulast%3DHammond%26aufirst%3DR.%26aulast%3DLeete%26aufirst%3DT.%26aulast%3DInoue%26aufirst%3DK.%26aulast%3DAbeliovich%26aufirst%3DA.%26atitle%3DThe%2520familial%2520parkinsonism%2520gene%2520LRRK2%2520regulates%2520neurite%2520process%2520morphology%26jtitle%3DNeuron%26date%3D2006%26volume%3D52%26spage%3D587%26epage%3D593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Pchelina, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emelyanov, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Usenko, T. S.</span><span> </span><span class="NLM_article-title">Molecular basis of Parkinsons’s disease linked to LRRK2 mutations</span> <span class="citation_source-journal">Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">10</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1134%2FS0026893314010117" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtlWhsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2014&pages=1-10&author=S.+N.+Pchelinaauthor=A.+K.+Emelyanovauthor=T.+S.+Usenko&title=Molecular+basis+of+Parkinsons%E2%80%99s+disease+linked+to+LRRK2+mutations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular basis of Parkinsons's disease linked to LRRK2 mutations</span></div><div class="casAuthors">Pchelina, S. N.; Emelyanov, A. K.; Usenko, T. S.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Biology (Moscow, Russian Federation, English Edition)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-10</span>CODEN:
                <span class="NLM_cas:coden">MOLBBJ</span>;
        ISSN:<span class="NLM_cas:issn">0026-8933</span>.
    
            (<span class="NLM_cas:orgname">SP MAIK Nauka/Interperiodica</span>)
        </div><div class="casAbstract">A review.  Parkinson's disease (PD) is a common neurodegenerative disorder whose symptoms are consistent with death of dopaminergic neurons in the substantia nigra of the brain.  The pathogenesis of PD involves several factors, such as α-synuclein aggregation, oxidative stress, mitochondrial dysfunction, and activation of apoptosis, but the exact mol. mechanism of neurodegeneration remains obscure.  PD is usually sporadic, while rare monogenic forms have been identified and described in the past 15 years.  Familial Parkinson's disease is most commonly assocd. with mutations of the leucine repeat-rich kinase 2 gene (LRRK2).  The mechanism of the disease due to LRRK2 mutations is unknown.  The signaling cascades regulated by LRRK2 are difficult to study because the physiol. substrates of the enzyme are unidentified.  The G2019S substitution has been found to be the most common LRRK2 mutation, facilitating a search for patients with LRRK2-assocd. PD in various populations.  The review considers the effects of LRRK2 mutations on protein and, in particular, α-synuclein aggregation, cytoskeletal dynamics, the inflammatory response, and the induction of apoptosis as revealed in both in vitro expts. and studies in PD patients.  Investigation of rare hereditary PD forms with known etiol. provides for a better understanding of the mechanism of neurodegeneration in more common sporadic PD forms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWCLUFIR7w9bVg90H21EOLACvtfcHk0lhU_NvFKPzPLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtlWhsro%253D&md5=5f13c7249aa8dffd85d2bb696a7ce461</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1134%2FS0026893314010117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1134%252FS0026893314010117%26sid%3Dliteratum%253Aachs%26aulast%3DPchelina%26aufirst%3DS.%2BN.%26aulast%3DEmelyanov%26aufirst%3DA.%2BK.%26aulast%3DUsenko%26aufirst%3DT.%2BS.%26atitle%3DMolecular%2520basis%2520of%2520Parkinsons%25E2%2580%2599s%2520disease%2520linked%2520to%2520LRRK2%2520mutations%26jtitle%3DMol.%2520Biol.%26date%3D2014%26volume%3D48%26spage%3D1%26epage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Zhu, H.; Chen, H.; Cho, W.; Estrada, A. A.; Sweeney, Z. K.</span><span> </span><span class="NLM_article-title">From human genetics to drug candidates: An industrial perspective on LRRK2 inhibition as a treatment for Parkinson’s disease</span>. In  <span class="citation_source-book">Medicinal Chemistry Approaches to Personalized Medicine</span>; <span class="NLM_contrib-group">Lackey, K.; Roth, B. D.</span>, Eds.; <span class="NLM_publisher-name">Wiley-VCH Verlag GmbH & Co. KGaA</span>: <span class="NLM_publisher-loc">Weinheim, Germany</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">227</span><span class="NLM_x">–</span> <span class="NLM_lpage">254</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1002%2F9783527677252.ch10" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=227-254&author=H.+Zhu&author=H.+Chen&author=W.+Cho&author=A.+A.+Estrada&author=Z.+K.+Sweeneyauthor=K.+Lackey&author=B.+D.+Roth&title=Medicinal+Chemistry+Approaches+to+Personalized+Medicine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34a&amp;dbid=16384&amp;doi=10.1002%2F9783527677252.ch10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9783527677252.ch10%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DH.%26atitle%3DFrom%2520human%2520genetics%2520to%2520drug%2520candidates%253A%2520An%2520industrial%2520perspective%2520on%2520LRRK2%2520inhibition%2520as%2520a%2520treatment%2520for%2520Parkinson%25E2%2580%2599s%2520disease%26btitle%3DMedicinal%2520Chemistry%2520Approaches%2520to%2520Personalized%2520Medicine%26aulast%3DLackey%26aufirst%3DK.%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26date%3D2013%26spage%3D227%26epage%3D254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit34b"><span><span class="NLM_label">(b) </span><div class="note"><p class="first last">For a recent proposed LRRK2 substrate see the following: </p></div><span class="NLM_contrib-group">Martin, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stankowski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrabi, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickson, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wszolek, Z. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, V. L.</span><span> </span><span class="NLM_article-title">Ribosomal protein s15 phosphorylation mediates LRRK2 neurodegeneration in Parkinson’s disease</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">157</span><span class="NLM_x">, </span> <span class="NLM_fpage">472</span><span class="NLM_x">–</span> <span class="NLM_lpage">485</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=2014&pages=472-485&author=I.+Martinauthor=J.+W.+Kimauthor=B.+D.+Leeauthor=H.+C.+Kangauthor=J.+C.+Xuauthor=H.+Jiaauthor=J.+Stankowskiauthor=M.+S.+Kimauthor=J.+Zhongauthor=M.+Kumarauthor=S.+A.+Andrabiauthor=Y.+Xiongauthor=D.+W.+Dicksonauthor=Z.+K.+Wszolekauthor=A.+Pandeyauthor=T.+M.+Dawsonauthor=V.+L.+Dawson&title=Ribosomal+protein+s15+phosphorylation+mediates+LRRK2+neurodegeneration+in+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DI.%26aulast%3DKim%26aufirst%3DJ.%2BW.%26aulast%3DLee%26aufirst%3DB.%2BD.%26aulast%3DKang%26aufirst%3DH.%2BC.%26aulast%3DXu%26aufirst%3DJ.%2BC.%26aulast%3DJia%26aufirst%3DH.%26aulast%3DStankowski%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DM.%2BS.%26aulast%3DZhong%26aufirst%3DJ.%26aulast%3DKumar%26aufirst%3DM.%26aulast%3DAndrabi%26aufirst%3DS.%2BA.%26aulast%3DXiong%26aufirst%3DY.%26aulast%3DDickson%26aufirst%3DD.%2BW.%26aulast%3DWszolek%26aufirst%3DZ.%2BK.%26aulast%3DPandey%26aufirst%3DA.%26aulast%3DDawson%26aufirst%3DT.%2BM.%26aulast%3DDawson%26aufirst%3DV.%2BL.%26atitle%3DRibosomal%2520protein%2520s15%2520phosphorylation%2520mediates%2520LRRK2%2520neurodegeneration%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DCell%26date%3D2014%26volume%3D157%26spage%3D472%26epage%3D485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Russo, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bubacco, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greggio, E.</span><span> </span><span class="NLM_article-title">LRRK2 and neuroinflammation: partners in crime in Parkinson’s disease?</span> <span class="citation_source-journal">J. Neuroinflammation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">52</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1186%2F1742-2094-11-52" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=24655756" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs12hu7%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2014&pages=52&author=I.+Russoauthor=L.+Bubaccoauthor=E.+Greggio&title=LRRK2+and+neuroinflammation%3A+partners+in+crime+in+Parkinson%E2%80%99s+disease%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">LRRK2 and neuroinflammation: partners in crime in Parkinson's disease?</span></div><div class="casAuthors">Russo, Isabella; Bubacco, Luigi; Greggio, Elisa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroinflammation</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">52/1-52/9, 9</span>CODEN:
                <span class="NLM_cas:coden">JNOEB3</span>;
        ISSN:<span class="NLM_cas:issn">1742-2094</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  It is now well established that chronic inflammation is a prominent feature of several neurodegenerative disorders including Parkinson's disease (PD).  Growing evidence indicates that neuroinflammation can contribute greatly to dopaminergic neuron degeneration and progression of the disease.  Recent literature highlights that leucine-rich repeat kinase 2 (LRRK2), a kinase mutated in both autosomal-dominantly inherited and sporadic PD cases, modulates inflammation in response to different pathol. stimuli.  In this review, we outline the state of the art of LRRK2 functions in microglia cells and in neuroinflammation.  Furthermore, we discuss the potential role of LRRK2 in cytoskeleton remodeling and vesicle trafficking in microglia cells under physiol. and pathol. conditions.  We also hypothesize that LRRK2 mutations might sensitize microglia cells toward a pro-inflammatory state, which in turn results in exacerbated inflammation with consequent neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjNPc_MEt2tLVg90H21EOLACvtfcHk0lhueDs07tQ-Pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs12hu7%252FJ&md5=1d8b2a0eb7291a89ac461234ef0a4a54</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1186%2F1742-2094-11-52&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1742-2094-11-52%26sid%3Dliteratum%253Aachs%26aulast%3DRusso%26aufirst%3DI.%26aulast%3DBubacco%26aufirst%3DL.%26aulast%3DGreggio%26aufirst%3DE.%26atitle%3DLRRK2%2520and%2520neuroinflammation%253A%2520partners%2520in%2520crime%2520in%2520Parkinson%25E2%2580%2599s%2520disease%253F%26jtitle%3DJ.%2520Neuroinflammation%26date%3D2014%26volume%3D11%26spage%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Moehle, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webber, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tse, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sukar, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Standaert, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeSilva, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowell, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, A. B.</span><span> </span><span class="NLM_article-title">LRRK2 inhibition attenuates microglial inflammatory responses</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">1602</span><span class="NLM_x">–</span> <span class="NLM_lpage">1611</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1523%2FJNEUROSCI.5601-11.2012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=22302802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC38XitFOls7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=1602-1611&author=M.+S.+Moehleauthor=P.+J.+Webberauthor=T.+Tseauthor=N.+Sukarauthor=D.+G.+Standaertauthor=T.+M.+DeSilvaauthor=R.+M.+Cowellauthor=A.+B.+West&title=LRRK2+inhibition+attenuates+microglial+inflammatory+responses"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">LRRK2 inhibition attenuates microglial inflammatory responses</span></div><div class="casAuthors">Moehle, Mark S.; Webber, Philip J.; Tse, Tonia; Sukar, Nour; Standaert, David G.; De Silva, Tara M.; Cowell, Rita M.; West, Andrew B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1602-1611</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Missense mutations in leucine-rich repeat kinase 2 (LRRK2) cause late-onset Parkinson's disease (PD), and common genetic variation in LRRK2 modifies susceptibility to Crohn's disease and leprosy.  High levels of LRRK2 expression in peripheral monocytes and macrophages suggest a role for LRRK2 in these cells, yet little is known about LRRK2 expression and function in immune cells of the brain.  Here, we demonstrate a role for LRRK2 in mediating microglial proinflammatory responses and morphol.  In a murine model of neuroinflammation, we observe robust induction of LRRK2 in microglia.  Expts. with toll-like receptor 4 (TLR4)-stimulated rat primary microglia show that inflammation increases LRRK2 activity and expression, while inhibition of LRRK2 kinase activity or knockdown of protein attenuates TNFα secretion and nitric oxide synthase (iNOS) induction.  LRRK2 inhibition blocks TLR4 stimulated microglial process outgrowth and impairs ADP stimulated microglial chemotaxis.  However, actin inhibitors that phenocopy inhibition of process outgrowth and chemotaxis fail to modify TLR4 stimulation of TNFα secretion and inducible iNOS induction, suggesting that LRRK2 acts upstream of cytoskeleton control as a stress-responsive kinase.  These data demonstrate LRRK2 in regulating responses in immune cells of the brain and further implicate microglial involvement in late-onset PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruQzN_xrHcLLVg90H21EOLACvtfcHk0lhueDs07tQ-Pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XitFOls7g%253D&md5=75dc1c0d0b2277c0fb20b857b5654f53</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.5601-11.2012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.5601-11.2012%26sid%3Dliteratum%253Aachs%26aulast%3DMoehle%26aufirst%3DM.%2BS.%26aulast%3DWebber%26aufirst%3DP.%2BJ.%26aulast%3DTse%26aufirst%3DT.%26aulast%3DSukar%26aufirst%3DN.%26aulast%3DStandaert%26aufirst%3DD.%2BG.%26aulast%3DDeSilva%26aufirst%3DT.%2BM.%26aulast%3DCowell%26aufirst%3DR.%2BM.%26aulast%3DWest%26aufirst%3DA.%2BB.%26atitle%3DLRRK2%2520inhibition%2520attenuates%2520microglial%2520inflammatory%2520responses%26jtitle%3DJ.%2520Neurosci.%26date%3D2012%26volume%3D32%26spage%3D1602%26epage%3D1611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Reynolds, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doggett, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riddle, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebakken, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, R. J.</span><span> </span><span class="NLM_article-title">LRRK2 kinase activity and biology are not uniformly predicted by its autophosphorylation and cellular phosphorylation site status</span> <span class="citation_source-journal">Front. Mol. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">54</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.3389%2Ffnmol.2014.00054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=25009464" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVaqsLzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2014&pages=54&author=A.+Reynoldsauthor=E.+A.+Doggettauthor=S.+M.+Riddleauthor=C.+S.+Lebakkenauthor=R.+J.+Nichols&title=LRRK2+kinase+activity+and+biology+are+not+uniformly+predicted+by+its+autophosphorylation+and+cellular+phosphorylation+site+status"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">LRRK2 kinase activity and biology are not uniformly predicted by its autophosphorylation and cellular phosphorylation site status</span></div><div class="casAuthors">Reynolds, April; Doggett, Elizabeth A.; Riddle, Steve M.; Lebakken, Connie S.; Nichols, R. Jeremy</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Molecular Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">54/1-54/14, 14 pp.</span>CODEN:
                <span class="NLM_cas:coden">FMNRAJ</span>;
        ISSN:<span class="NLM_cas:issn">1662-5099</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Missense mutations in the Leucine-Rich Repeat protein Kinase 2 (LRRK2) gene are the most common genetic predisposition to develop Parkinson's disease (PD).  LRRK2 is a large multi-domain phosphoprotein with a GTPase domain and a serine/threonine protein kinase domain whose activity is implicated in neuronal toxicity; however the precise mechanism is unknown.  LRRK2 autophosphorylates on several serine/threonine residues across the enzyme and is found constitutively phosphorylated on Ser910, Ser935, Ser955, and Ser973, which are proposed to be regulated by upstream kinases.  Here we investigate the phosphoregulation at these sites by analyzing the effects of disease-assocd. mutations Arg1441Cys, Arg1441Gly, Ala1442Pro, Tyr1699Cys, Ile2012Thr, Gly2019Ser, and Ile2020Thr.  We also studied alanine substitutions of phosphosite serines 910, 935, 955, and 973 and specific LRRK2 inhibition on autophosphorylation of LRRK2 Ser1292, Thr1491, Thr2483 and phosphorylation at the cellular sites.  We found that mutants in the Roc-COR domains, including Arg1441Cys, Arg1441His, Ala1442Pro, and Tyr1699Cys, can pos. enhance LRRK2 kinase activity, while concomitantly inducing the dephosphorylation of the cellular sites.  Mutation of the cellular sites individually did not affect LRRK2 intrinsic kinase activity; however, Ser910/935/955/973Ala mutations trended toward increased kinase activity of LRRK2.  Increased cAMP levels did not lead to increased LRRK2 cellular site phosphorylation, 14-3-3 binding or kinase activity.  In cells, inhibition of LRRK2 kinase activity leads to dephosphorylation of Ser1292 by Calyculin A and Okadaic acid sensitive phosphatases, while the cellular sites are dephosphorylated by Calyculin A sensitive phosphatases.  These findings indicate that comparative anal. of both Ser1292 and Ser910/935/955/973 phosphorylation sites will provide important and distinct measures of LRRK2 kinase and biol. activity in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6oWoQ9m-jtrVg90H21EOLACvtfcHk0lhueDs07tQ-Pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVaqsLzE&md5=f737969c3defba76566a36330ffb64d2</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.3389%2Ffnmol.2014.00054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnmol.2014.00054%26sid%3Dliteratum%253Aachs%26aulast%3DReynolds%26aufirst%3DA.%26aulast%3DDoggett%26aufirst%3DE.%2BA.%26aulast%3DRiddle%26aufirst%3DS.%2BM.%26aulast%3DLebakken%26aufirst%3DC.%2BS.%26aulast%3DNichols%26aufirst%3DR.%2BJ.%26atitle%3DLRRK2%2520kinase%2520activity%2520and%2520biology%2520are%2520not%2520uniformly%2520predicted%2520by%2520its%2520autophosphorylation%2520and%2520cellular%2520phosphorylation%2520site%2520status%26jtitle%3DFront.%2520Mol.%2520Neurosci.%26date%3D2014%26volume%3D7%26spage%3D54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Vancraenenbroeck, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Raeymaecker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lobbestael, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Maeyer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voet, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baekelandt, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taymans, J. M.</span><span> </span><span class="NLM_article-title">In silico, in vitro and cellular analysis with a kinome-wide inhibitor panel correlates cellular LRRK2 dephosphorylation to inhibitor activity on LRRK2</span> <span class="citation_source-journal">Front. Mol. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">51</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.3389%2Ffnmol.2014.00051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=24917786" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVChsb%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2014&pages=51&author=R.+Vancraenenbroeckauthor=J.+De+Raeymaeckerauthor=E.+Lobbestaelauthor=F.+Gaoauthor=M.+De+Maeyerauthor=A.+Voetauthor=V.+Baekelandtauthor=J.+M.+Taymans&title=In+silico%2C+in+vitro+and+cellular+analysis+with+a+kinome-wide+inhibitor+panel+correlates+cellular+LRRK2+dephosphorylation+to+inhibitor+activity+on+LRRK2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">In silico, in vitro and cellular analysis with a kinome-wide inhibitor panel correlates cellular LRRK2 dephosphorylation to inhibitor activity on LRRK2</span></div><div class="casAuthors">Vancraenenbroeck, Renee; De Raeymaecker, Joren; Lobbestael, Evy; Gao, Fangye; De Maeyer, Marc; Voet, Arnout; Baekelandt, Veerle; Taymans, Jean-Marc</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Molecular Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">51/1-51/19, 19 pp.</span>CODEN:
                <span class="NLM_cas:coden">FMNRAJ</span>;
        ISSN:<span class="NLM_cas:issn">1662-5099</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">A review.  Leucine-rich repeat kinase 2 (LRRK2) is a complex, multidomain protein which is considered a valuable target for potential disease-modifying therapeutic strategies for Parkinson's disease (PD).  In mammalian cells and brain, LRRK2 is phosphorylated and treatment of cells with inhibitors of LRRK2 kinase activity can induce LRRK2 dephosphorylation at a cluster of serines including Ser910/935/955/973.  It has been suggested that phosphorylation levels at these sites reflect LRRK2 kinase activity, however kinase-dead variants of LRRK2 or kinase activating variants do not display altered Ser935 phosphorylation levels compared to wild type.  Furthermore, Ser910/935/955/973 are not autophosphorylation sites, therefore, it is unclear if inhibitor induced dephosphorylation depends on the activity of compds. on LRRK2 or on yet to be identified upstream kinases.  Here we used a panel of 160 ATP competitive and cell permeable kinase inhibitors directed against all branches of the kinome and tested their activity on LRRK2 in vitro using a peptide-substrate-based kinase assay.  In neuronal SH-SY5Y cells overexpressing LRRK2 we used compd.-induced dephosphorylation of Ser935 as readout.  In silico docking of selected compds. was performed using a modeled LRRK2 kinase structure.  Receiver operating characteristic plots demonstrated that the obtained docking scores to the LRRK2 ATP binding site correlated with in vitro and cellular compd. activity.  We also found that in vitro potency showed a high degree of correlation to cellular compd. induced LRRK2 dephosphorylation activity across multiple compd. classes.  Therefore, acute LRRK2 dephosphorylation at Ser935 in inhibitor treated cells involves a strong component of inhibitor activity on LRRK2 itself, without excluding a role for upstream kinases.  Understanding the regulation of LRRK2 phosphorylation by kinase inhibitors aids our understanding of LRRK2 signaling and may lead to development of new classes of LRRK2 kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOkDJX9D3umrVg90H21EOLACvtfcHk0ljLyy2nfq6BTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVChsb%252FK&md5=e489943d1d2337897ddb460ff21f9cb7</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.3389%2Ffnmol.2014.00051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnmol.2014.00051%26sid%3Dliteratum%253Aachs%26aulast%3DVancraenenbroeck%26aufirst%3DR.%26aulast%3DDe%2BRaeymaecker%26aufirst%3DJ.%26aulast%3DLobbestael%26aufirst%3DE.%26aulast%3DGao%26aufirst%3DF.%26aulast%3DDe%2BMaeyer%26aufirst%3DM.%26aulast%3DVoet%26aufirst%3DA.%26aulast%3DBaekelandt%26aufirst%3DV.%26aulast%3DTaymans%26aufirst%3DJ.%2BM.%26atitle%3DIn%2520silico%252C%2520in%2520vitro%2520and%2520cellular%2520analysis%2520with%2520a%2520kinome-wide%2520inhibitor%2520panel%2520correlates%2520cellular%2520LRRK2%2520dephosphorylation%2520to%2520inhibitor%2520activity%2520on%2520LRRK2%26jtitle%3DFront.%2520Mol.%2520Neurosci.%26date%3D2014%26volume%3D7%26spage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Tieu, K.</span><span> </span><span class="NLM_article-title">A guide to neurotoxic animal models of Parkinson’s disease</span> <span class="citation_source-journal">Cold Spring Harbor Perspect. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">a009316</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2011&pages=a009316&author=K.+Tieu&title=A+guide+to+neurotoxic+animal+models+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTieu%26aufirst%3DK.%26atitle%3DA%2520guide%2520to%2520neurotoxic%2520animal%2520models%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspect.%2520Med.%26date%3D2011%26volume%3D1%26spage%3Da009316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Sweeney, Z. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewcock, J. W.</span><span> </span><span class="NLM_article-title">ACS chemical neuroscience spotlight on CEP-1347</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">4</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn1000793" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFWiurzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=3-4&author=Z.+K.+Sweeneyauthor=J.+W.+Lewcock&title=ACS+chemical+neuroscience+spotlight+on+CEP-1347"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">ACS Chemical Neuroscience Spotlight on CEP-1347</span></div><div class="casAuthors">Sweeney, Zachary K.; Lewcock, Joseph W.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-4</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6ot-9NHLazbVg90H21EOLACvtfcHk0ljLyy2nfq6BTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFWiurzE&md5=f2364649af4f96ac72753fbba21557f7</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fcn1000793&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn1000793%26sid%3Dliteratum%253Aachs%26aulast%3DSweeney%26aufirst%3DZ.%2BK.%26aulast%3DLewcock%26aufirst%3DJ.%2BW.%26atitle%3DACS%2520chemical%2520neuroscience%2520spotlight%2520on%2520CEP-1347%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2011%26volume%3D2%26spage%3D3%26epage%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Olanow, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schapira, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeWitt, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kieburtz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sauer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivieri, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pohlmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubble, J.</span><span> </span><span class="NLM_article-title">TCH346 as a neuroprotective drug in Parkinson’s disease: a double-blind, randomised, controlled trial</span> <span class="citation_source-journal">Lancet Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1013</span><span class="NLM_x">–</span> <span class="NLM_lpage">1020</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1016%2FS1474-4422%2806%2970602-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=17110281" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlCju77J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=1013-1020&author=C.+W.+Olanowauthor=A.+H.+Schapiraauthor=P.+A.+LeWittauthor=K.+Kieburtzauthor=D.+Sauerauthor=G.+Olivieriauthor=H.+Pohlmannauthor=J.+Hubble&title=TCH346+as+a+neuroprotective+drug+in+Parkinson%E2%80%99s+disease%3A+a+double-blind%2C+randomised%2C+controlled+trial"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">TCH346 as a nueroprotective drug in Parkinson's disease: a double-blind, randomised, controlled trial</span></div><div class="casAuthors">Olanow, C. Warren; Schapira, Anthony H. V.; LeWitt, Peter A.; Kieburtz, Karl; Sauer, Dirk; Olivieri, Gianfranco; Pohlmann, Harald; Hubble, Jean</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1013-1020</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Lancet Neurology</span>)
        </div><div class="casAbstract">Background There is an important unmet medical need in Parkinson's disease for a neuroprotective treatment that slows or stops disease progression.  TCH346 is a potent anti-apoptotic drug that protects against loss of dopaminergic neurons in lab. models.  Our aim was to assess TCH346 as a neuroprotective drug in patients with Parkinson's disease.  Methods Patients presenting at 45 international movement disorder clinics with early untreated Parkinson's disease were assessed as part of this parallel-group, double-blind, randomized controlled trial.  301 Eligible patients were randomly assigned 12-18 mo' treatment with TCH346 at a daily dose of 0.5 mg (n=78), 2.5 mg (n=79), or 10 mg (n=73), or placebo (n=71), followed by a 4 wk washout period.  The primary outcome measure was time to development of a disability requiring dopaminergic treatment.  Secondary outcome measures were the annual rate of change in the unified Parkinson's disease rating scale (UPDRS) and the PDQ-39, a measure of quality of life.  Analyses were by intention-to-treat.  This study is pending registration with ClinicalTrials.gov.  Findings 255 patients completed the study.  TCH346 did not differ from placebo for any of the study outcomes.  Treatment was needed in 26 (34%) patients in the TCH346 0.5 mg group, 30 (38%) in the TCH346 2.5 mg group, 24 (33%) in the TCH346 10 mg group, and 23 (32%) in the placebo group.  There were no significant differences between groups.  There were no differences between groups in the annual change in the UPDRS or PDQ-39 either.  Few patients withdrew because of adverse events and none was judged to be related to the study intervention.  Interpretation TCH346 did not show evidence of a neuroprotective effect.  The discrepancy between the preclin. promise of TCH346 and the clin. outcome could have arisen because of the use of lab. models that do not accurately reflect the pathogenesis of Parkinson's disease, the doses of study drug used, insensitive clin. endpoints, and the patient population selected for study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZisnEZsBV07Vg90H21EOLACvtfcHk0liWc744mibalw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlCju77J&md5=25b2cfd9942f21e1cf851fe52f8b861d</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2806%2970602-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252806%252970602-0%26sid%3Dliteratum%253Aachs%26aulast%3DOlanow%26aufirst%3DC.%2BW.%26aulast%3DSchapira%26aufirst%3DA.%2BH.%26aulast%3DLeWitt%26aufirst%3DP.%2BA.%26aulast%3DKieburtz%26aufirst%3DK.%26aulast%3DSauer%26aufirst%3DD.%26aulast%3DOlivieri%26aufirst%3DG.%26aulast%3DPohlmann%26aufirst%3DH.%26aulast%3DHubble%26aufirst%3DJ.%26atitle%3DTCH346%2520as%2520a%2520neuroprotective%2520drug%2520in%2520Parkinson%25E2%2580%2599s%2520disease%253A%2520a%2520double-blind%252C%2520randomised%252C%2520controlled%2520trial%26jtitle%3DLancet%2520Neurol.%26date%3D2006%26volume%3D5%26spage%3D1013%26epage%3D1020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Baptista, M. A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dave, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheth, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Silva, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aziz, Y. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiske, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherer, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frasier, M. A.</span><span> </span><span class="NLM_article-title">A strategy for the generation, characterization and distribution of animal models by The Michael J. Fox Foundation for Parkinson’s research</span> <span class="citation_source-journal">Dis. Models Mech.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1316</span><span class="NLM_x">–</span> <span class="NLM_lpage">1324</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1242%2Fdmm.011940" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=24046356" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1Shu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2013&pages=1316-1324&author=M.+A.+S.+Baptistaauthor=K.+D.+Daveauthor=N.+P.+Shethauthor=S.+N.+De+Silvaauthor=K.+M.+Carlsonauthor=Y.+N.+Azizauthor=B.+K.+Fiskeauthor=T.+M.+Shererauthor=M.+A.+Frasier&title=A+strategy+for+the+generation%2C+characterization+and+distribution+of+animal+models+by+The+Michael+J.+Fox+Foundation+for+Parkinson%E2%80%99s+research"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">A strategy for the generation, characterization and distribution of animal models by The Michael J. Fox Foundation for Parkinson's Research</span></div><div class="casAuthors">Baptista, Marco A. S.; Dave, Kuldip D.; Sheth, Niketa P.; De Silva, Shehan N.; Carlson, Kirsten M.; Aziz, Yasmin N.; Fiske, Brian K.; Sherer, Todd B.; Frasier, Mark A.</div><div class="citationInfo"><span class="NLM_cas:title">Disease Models & Mechanisms</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1316-1324</span>CODEN:
                <span class="NLM_cas:coden">DMMIAX</span>;
        ISSN:<span class="NLM_cas:issn">1754-8403</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">A review.  Progress in Parkinson's disease (PD) research and therapeutic development is hindered by many challenges, including a need for robust preclin. animal models.  Limited availability of these tools is due to tech. hurdles, patent issues, licensing restrictions and the high costs assocd. with generating and distributing these animal models.  Furthermore, the lack of standardization of phenotypic characterization and use of varying methodologies has made it difficult to compare outcome measures across labs.  In response, The Michael J. Fox Foundation for Parkinson's Research (MJFF) is directly sponsoring the generation, characterization and distribution of preclin. rodent models, enabling increased access to these crucial tools in order to accelerate PD research.  To date, MJFF has initiated and funded the generation of 30 different models, which include transgenic or knockout models of PD-relevant genes such as Park 1 (also known as Park4 and SNCA), Park8 (LRRK2), Park7 (DJ-1), Park6 (PINK1), Park2 (Parkin), VPS35, EiF4G1 and GBA.  The phenotypic characterization of these animals is performed in a uniform and streamlined manner at independent contract research organizations.  Finally, MJFF created a central repository at The Jackson Lab. (JAX) that houses both non-MJFF and MJFF-generated preclin. animal models.  Funding from MJFF, which subsidizes the costs involved in transfer, rederivation and colony expansion, has directly resulted in over 2500 rodents being distributed to the PD community for research use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoU8ctHnC1w47Vg90H21EOLACvtfcHk0liWc744mibalw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1Shu7s%253D&md5=f1cfb71533cc2741da93c7afe9c1efb1</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1242%2Fdmm.011940&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fdmm.011940%26sid%3Dliteratum%253Aachs%26aulast%3DBaptista%26aufirst%3DM.%2BA.%2BS.%26aulast%3DDave%26aufirst%3DK.%2BD.%26aulast%3DSheth%26aufirst%3DN.%2BP.%26aulast%3DDe%2BSilva%26aufirst%3DS.%2BN.%26aulast%3DCarlson%26aufirst%3DK.%2BM.%26aulast%3DAziz%26aufirst%3DY.%2BN.%26aulast%3DFiske%26aufirst%3DB.%2BK.%26aulast%3DSherer%26aufirst%3DT.%2BM.%26aulast%3DFrasier%26aufirst%3DM.%2BA.%26atitle%3DA%2520strategy%2520for%2520the%2520generation%252C%2520characterization%2520and%2520distribution%2520of%2520animal%2520models%2520by%2520The%2520Michael%2520J.%2520Fox%2520Foundation%2520for%2520Parkinson%25E2%2580%2599s%2520research%26jtitle%3DDis.%2520Models%2520Mech.%26date%3D2013%26volume%3D6%26spage%3D1316%26epage%3D1324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Xu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shenoy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span> </span><span class="NLM_article-title">Mouse models for LRRK2 Parkinson’s disease</span> <span class="citation_source-journal">Parkinsonism Relat. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">S186</span><span class="NLM_x">–</span> <span class="NLM_lpage">S189</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=S186-S189&issue=Suppl.+1&author=Q.+Xuauthor=S.+Shenoyauthor=C.+Li&title=Mouse+models+for+LRRK2+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DShenoy%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DC.%26atitle%3DMouse%2520models%2520for%2520LRRK2%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DParkinsonism%2520Relat.%2520Disord.%26date%3D2012%26volume%3D18%26issue%3DSuppl.%25201%26spage%3DS186%26epage%3DS189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit43b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lee, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">VanKampen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrucelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ko, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, Y. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maguire-Zeiss, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowers, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Federoff, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, T. M.</span><span> </span><span class="NLM_article-title">Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson’s disease</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">998</span><span class="NLM_x">–</span> <span class="NLM_lpage">1000</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1038%2Fnm.2199" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=20729864" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVGgtLbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=998-1000&author=B.+D.+Leeauthor=J.+H.+Shinauthor=J.+VanKampenauthor=L.+Petrucelliauthor=A.+B.+Westauthor=H.+S.+Koauthor=Y.+I.+Leeauthor=K.+A.+Maguire-Zeissauthor=W.+J.+Bowersauthor=H.+J.+Federoffauthor=V.+L.+Dawsonauthor=T.+M.+Dawson&title=Inhibitors+of+leucine-rich+repeat+kinase-2+protect+against+models+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43bR"><div class="casContent"><span class="casTitleNuber">43b</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease</span></div><div class="casAuthors">Lee, Byoung Dae; Shin, Joo-Ho; Van Kampen, Jackalina; Petrucelli, Leonard; West, Andrew B.; Ko, Han Seok; Lee, Yun-Il; Maguire-Zeiss, Kathleen A.; Bowers, William J.; Federoff, Howard J.; Dawson, Valina L.; Dawson, Ted M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">998-1000</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Leucine-rich repeat kinase-2 (LRRK2) mutations are a common cause of Parkinson's disease.  Here we identify inhibitors of LRRK2 kinase that are protective in in vitro and in vivo models of LRRK2-induced neurodegeneration.  These results establish that LRRK2-induced degeneration of neurons in vivo is kinase dependent and that LRRK2 kinase inhibition provides a potential new neuroprotective paradigm for the treatment of Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpn78Hm84uiebVg90H21EOLACvtfcHk0lhYxEp_G-Qqfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVGgtLbE&md5=d6c5df67511a2f154b21a523af408f65</span></div><a href="/servlet/linkout?suffix=cit43b&amp;dbid=16384&amp;doi=10.1038%2Fnm.2199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.2199%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DB.%2BD.%26aulast%3DShin%26aufirst%3DJ.%2BH.%26aulast%3DVanKampen%26aufirst%3DJ.%26aulast%3DPetrucelli%26aufirst%3DL.%26aulast%3DWest%26aufirst%3DA.%2BB.%26aulast%3DKo%26aufirst%3DH.%2BS.%26aulast%3DLee%26aufirst%3DY.%2BI.%26aulast%3DMaguire-Zeiss%26aufirst%3DK.%2BA.%26aulast%3DBowers%26aufirst%3DW.%2BJ.%26aulast%3DFederoff%26aufirst%3DH.%2BJ.%26aulast%3DDawson%26aufirst%3DV.%2BL.%26aulast%3DDawson%26aufirst%3DT.%2BM.%26atitle%3DInhibitors%2520of%2520leucine-rich%2520repeat%2520kinase-2%2520protect%2520against%2520models%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DNat.%2520Med.%26date%3D2010%26volume%3D16%26spage%3D998%26epage%3D1000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Yue, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lachenmayer, M. L.</span><span> </span><span class="NLM_article-title">Genetic LRRK2 models of Parkinson’s disease: dissecting the pathogenic pathway and exploring clinical applications</span> <span class="citation_source-journal">Mov. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">1386</span><span class="NLM_x">–</span> <span class="NLM_lpage">1397</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2011&pages=1386-1397&author=Z.+Yueauthor=M.+L.+Lachenmayer&title=Genetic+LRRK2+models+of+Parkinson%E2%80%99s+disease%3A+dissecting+the+pathogenic+pathway+and+exploring+clinical+applications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYue%26aufirst%3DZ.%26aulast%3DLachenmayer%26aufirst%3DM.%2BL.%26atitle%3DGenetic%2520LRRK2%2520models%2520of%2520Parkinson%25E2%2580%2599s%2520disease%253A%2520dissecting%2520the%2520pathogenic%2520pathway%2520and%2520exploring%2520clinical%2520applications%26jtitle%3DMov.%2520Disord.%26date%3D2011%26volume%3D26%26spage%3D1386%26epage%3D1397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Longo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russo, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimshek, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greggio, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morari, M.</span><span> </span><span class="NLM_article-title">Genetic and pharmacological evidence that G2019S LRRK2 confers a hyperkinetic phenotype, resistant to motor decline associated with aging</span> <span class="citation_source-journal">Neurobiol. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">62</span><span class="NLM_x">–</span> <span class="NLM_lpage">73</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1016%2Fj.nbd.2014.07.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=25107341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlCjt77N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2014&pages=62-73&author=F.+Longoauthor=I.+Russoauthor=D.+R.+Shimshekauthor=E.+Greggioauthor=M.+Morari&title=Genetic+and+pharmacological+evidence+that+G2019S+LRRK2+confers+a+hyperkinetic+phenotype%2C+resistant+to+motor+decline+associated+with+aging"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Genetic and pharmacological evidence that G2019S LRRK2 confers a hyperkinetic phenotype, resistant to motor decline associated with aging</span></div><div class="casAuthors">Longo, Francesco; Russo, Isabella; Shimshek, Derya R.; Greggio, Elisa; Morari, Michele</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">62-73</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">The leucine-rich repeat kinase 2 mutation G2019S in the kinase-domain is the most common genetic cause of Parkinson's disease.  To investigate the impact of the G2019S mutation on motor activity in vivo, a longitudinal phenotyping approach was developed in knock-in (KI) mice bearing this kinase-enhancing mutation.  Two cohorts of G2019S KI mice and wild-type littermates (WT) were subjected to behavioral tests, specific for akinesia, bradykinesia and overall gait ability, at different ages (3, 6, 10, 15 and 19 mo).  The motor performance of G2019S KI mice remained stable up to the age of 19 mo and did not show the typical age-related decline in immobility time and stepping activity of WT.  Several lines of evidence suggest that enhanced LRRK2 kinase activity is the main contributor to the obsd. hyperkinetic phenotype of G2019S KI mice: i) KI mice carrying a LRRK2 kinase-dead mutation (D1994S KD) showed a similar progressive motor decline as WT; ii) two LRRK2 kinase inhibitors, H-1152 and Nov-LRRK2-11, acutely reversed the hyperkinetic phenotype of G2019S KI mice, while being ineffective in WT or D1994S KD animals.  LRRK2 target engagement in vivo was further substantiated by redn. of LRRK2 phosphorylation at Ser935 in the striatum and cortex at efficacious doses of Nov-LRRK2-11, and in the striatum at efficacious doses of H-1152.  In summary, expression of the G2019S mutation in the mouse LRRK2 gene confers a hyperkinetic phenotype that is resistant to age-related motor decline, likely via enhancement of LRRK2 kinase activity.  This study provides an in vivo model to investigate the effects of LRRK2 inhibitors on motor function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGFbgFG6slMbVg90H21EOLACvtfcHk0lhYxEp_G-Qqfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlCjt77N&md5=d1ded3a5d247904ac1f6f42c02b744d8</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2014.07.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2014.07.013%26sid%3Dliteratum%253Aachs%26aulast%3DLongo%26aufirst%3DF.%26aulast%3DRusso%26aufirst%3DI.%26aulast%3DShimshek%26aufirst%3DD.%2BR.%26aulast%3DGreggio%26aufirst%3DE.%26aulast%3DMorari%26aufirst%3DM.%26atitle%3DGenetic%2520and%2520pharmacological%2520evidence%2520that%2520G2019S%2520LRRK2%2520confers%2520a%2520hyperkinetic%2520phenotype%252C%2520resistant%2520to%2520motor%2520decline%2520associated%2520with%2520aging%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2014%26volume%3D71%26spage%3D62%26epage%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Fuji, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flagella, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baca, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baptista, M. A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodbeck, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiske, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honigberg, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jubb, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katavolos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewin-Koh, S.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyssikatos, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Mahony, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reichelt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roose-Girma, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherer, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweeney, Z. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarrant, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urkowitz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warming, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yaylaoglu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estrada, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watts, R. J.</span><span> </span><span class="NLM_article-title">Effect of selective LRRK2 kinase inhibition on nonhuman primate lung</span> <span class="citation_source-journal">Sci. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">273ra15</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1126%2Fscitranslmed.aaa3634" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=25653221" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=273ra15&author=R.+Fujiauthor=M.+Flagellaauthor=M.+Bacaauthor=M.+A.+S.+Baptistaauthor=J.+Brodbeckauthor=B.+K.+Chanauthor=B.+K.+Fiskeauthor=L.+Honigbergauthor=A.+M.+Jubbauthor=P.+Katavolosauthor=D.+W.+Leeauthor=S.-C.+Lewin-Kohauthor=T.+Linauthor=X.+Liuauthor=S.+Liuauthor=J.+P.+Lyssikatosauthor=J.+O%E2%80%99Mahonyauthor=M.+Reicheltauthor=M.+Roose-Girmaauthor=Z.+Shengauthor=T.+B.+Shererauthor=A.+Smithauthor=M.+Solonauthor=Z.+K.+Sweeneyauthor=J.+Tarrantauthor=A.+Urkowitzauthor=S.+Warmingauthor=M.+Yaylaogluauthor=S.+Zhangauthor=H.+Zhuauthor=A.+A.+Estradaauthor=R.+J.+Watts&title=Effect+of+selective+LRRK2+kinase+inhibition+on+nonhuman+primate+lung"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.aaa3634&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.aaa3634%26sid%3Dliteratum%253Aachs%26aulast%3DFuji%26aufirst%3DR.%26aulast%3DFlagella%26aufirst%3DM.%26aulast%3DBaca%26aufirst%3DM.%26aulast%3DBaptista%26aufirst%3DM.%2BA.%2BS.%26aulast%3DBrodbeck%26aufirst%3DJ.%26aulast%3DChan%26aufirst%3DB.%2BK.%26aulast%3DFiske%26aufirst%3DB.%2BK.%26aulast%3DHonigberg%26aufirst%3DL.%26aulast%3DJubb%26aufirst%3DA.%2BM.%26aulast%3DKatavolos%26aufirst%3DP.%26aulast%3DLee%26aufirst%3DD.%2BW.%26aulast%3DLewin-Koh%26aufirst%3DS.-C.%26aulast%3DLin%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DLyssikatos%26aufirst%3DJ.%2BP.%26aulast%3DO%25E2%2580%2599Mahony%26aufirst%3DJ.%26aulast%3DReichelt%26aufirst%3DM.%26aulast%3DRoose-Girma%26aufirst%3DM.%26aulast%3DSheng%26aufirst%3DZ.%26aulast%3DSherer%26aufirst%3DT.%2BB.%26aulast%3DSmith%26aufirst%3DA.%26aulast%3DSolon%26aufirst%3DM.%26aulast%3DSweeney%26aufirst%3DZ.%2BK.%26aulast%3DTarrant%26aufirst%3DJ.%26aulast%3DUrkowitz%26aufirst%3DA.%26aulast%3DWarming%26aufirst%3DS.%26aulast%3DYaylaoglu%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DEstrada%26aufirst%3DA.%2BA.%26aulast%3DWatts%26aufirst%3DR.%2BJ.%26atitle%3DEffect%2520of%2520selective%2520LRRK2%2520kinase%2520inhibition%2520on%2520nonhuman%2520primate%2520lung%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2015%26volume%3D7%26spage%3D273ra15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Tong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giaime, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelleher, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, J.</span><span> </span><span class="NLM_article-title">Loss of leucine-rich repeat kinase 2 causes impairment of protein degradation pathways, accumulation of alpha-synuclein, and apoptotic cell death in aged mice</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">9879</span><span class="NLM_x">–</span> <span class="NLM_lpage">9884</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1073%2Fpnas.1004676107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=20457918" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntFWltrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=9879-9884&author=Y.+Tongauthor=H.+Yamaguchiauthor=E.+Giaimeauthor=S.+Boyleauthor=R.+Kopanauthor=R.+J.+Kelleherauthor=J.+Shen&title=Loss+of+leucine-rich+repeat+kinase+2+causes+impairment+of+protein+degradation+pathways%2C+accumulation+of+alpha-synuclein%2C+and+apoptotic+cell+death+in+aged+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Loss of leucine-rich repeat kinase 2 causes impairment of protein degradation pathways, accumulation of α-synuclein, and apoptotic cell death in aged mice</span></div><div class="casAuthors">Tong, Youren; Yamaguchi, Hiroo; Giaime, Emilie; Boyle, Scott; Kopan, Raphael; Kelleher, Raymond J., III; Shen, Jie</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9879-9884, S9879/1-S9879/4</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common genetic cause of Parkinson's disease.  LRRK2 is a large protein contg. a small GTPase domain and a kinase domain, but its physiol. role is unknown.  To identify the normal function of LRRK2 in vivo, we generated two independent lines of germ-line deletion mice.  The dopaminergic system of LRRK2-/- mice appears normal, and nos. of dopaminergic neurons and levels of striatal dopamine are unchanged.  However, LRRK2-/- kidneys, which suffer the greatest loss of LRRK compared with other organs, develop striking accumulation and aggregation of α-synuclein and ubiquitinated proteins at 20 mo of age.  The autophagy-lysosomal pathway is also impaired in the absence of LRRK2, as indicated by accumulation of lipofuscin granules as well as altered levels of LC3-II and p62.  Furthermore, loss of LRRK2 dramatically increases apoptotic cell death, inflammatory responses, and oxidative damage.  Collectively, our findings show that LRRK2 plays an essential and unexpected role in the regulation of protein homeostasis during aging, and suggest that LRRK2 mutations may cause Parkinson's disease and cell death via impairment of protein degrdn. pathways, leading to α-synuclein accumulation and aggregation over time.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwJUmT5o1nLLVg90H21EOLACvtfcHk0lhYtUCYMJ_9UQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntFWltrc%253D&md5=09474f2cb0fa155bb88311a5af0afbe1</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1004676107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1004676107%26sid%3Dliteratum%253Aachs%26aulast%3DTong%26aufirst%3DY.%26aulast%3DYamaguchi%26aufirst%3DH.%26aulast%3DGiaime%26aufirst%3DE.%26aulast%3DBoyle%26aufirst%3DS.%26aulast%3DKopan%26aufirst%3DR.%26aulast%3DKelleher%26aufirst%3DR.%2BJ.%26aulast%3DShen%26aufirst%3DJ.%26atitle%3DLoss%2520of%2520leucine-rich%2520repeat%2520kinase%25202%2520causes%2520impairment%2520of%2520protein%2520degradation%2520pathways%252C%2520accumulation%2520of%2520alpha-synuclein%252C%2520and%2520apoptotic%2520cell%2520death%2520in%2520aged%2520mice%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2010%26volume%3D107%26spage%3D9879%26epage%3D9884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Tong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giaime, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichimura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Si, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonventre, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, J.</span><span> </span><span class="NLM_article-title">Loss of leucine-rich repeat kinase 2 causes age-dependent bi-phasic alterations of the autophagy pathway</span> <span class="citation_source-journal">Mol. Neurodegener.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">2</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1186%2F1750-1326-7-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=22230652" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvVOqu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=2&author=Y.+Tongauthor=E.+Giaimeauthor=H.+Yamaguchiauthor=T.+Ichimuraauthor=Y.+Liuauthor=H.+Siauthor=H.+Caiauthor=J.+V.+Bonventreauthor=J.+Shen&title=Loss+of+leucine-rich+repeat+kinase+2+causes+age-dependent+bi-phasic+alterations+of+the+autophagy+pathway"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Loss of leucine-rich repeat kinase 2 causes age-dependent bi-phasic alterations of the autophagy pathway</span></div><div class="casAuthors">Tong, Youren; Giaime, Emilie; Yamaguchi, Hiroo; Ichimura, Takaharu; Liu, Yumin; Si, Huiqing; Cai, Huaibin; Bonventre, Joseph V.; Shen, Jie</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neurodegeneration</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2</span>CODEN:
                <span class="NLM_cas:coden">MNOEAZ</span>;
        ISSN:<span class="NLM_cas:issn">1750-1326</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Dominantly inherited missense mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common genetic cause of Parkinson's disease, but its normal physiol. function remains unclear.  We previously reported that loss of LRRK2 causes impairment of protein degrdn. pathways as well as increases of apoptotic cell death and inflammatory responses in the kidney of aged mice.  Results: Our anal. of LRRK2-/- kidneys at multiple ages, such as 1, 4, 7, and 20 mo, revealed unique age-dependent development of a variety of mol., cellular, and ultrastructural changes.  Gross morphol. abnormalities of the kidney, including altered size, wt., texture, and color, are evident in LRRK2-/- mice at 3-4 mo of age, along with increased accumulation of autofluorescent granules in proximal renal tubules.  The ratio of kidney/body wt. in LRRK2-/- mice is increased at 1, 4, and 7 mo of age (∼10% at 1 mo, and ∼20% at 4 and 7 mo), whereas the ratio is drastically decreased at 20 mo of age (∼50%).  While kidney filtration function evaluated by levels of blood urea nitrogen and serum creatinine is not significantly affected in LRRK2-/- mice at 12-14 mo of age, expression of kidney injury mol.-1, a sensitive and specific biomarker for epithelial cell injury of proximal renal tubules, is up-regulated (∼10-fold).  Surprisingly, loss of LRRK2 causes age-dependent bi-phasic alterations of the autophagic activity in LRRK2-/- kidneys, which is unchanged at 1 mo of age, enhanced at 7 mo but reduced at 20 mo, as evidenced by corresponding changes in the levels of LC3-I/II, a reliable autophagy marker, and p62, an autophagy substrate.  Levels of α-synuclein and protein carbonyls, a general oxidative damage marker, are also decreased in LRRK2-/- kidneys at 7 mo of age but increased at 20 mo.  Interestingly, the age-dependent bi-phasic alterations in autophagic activity in LRRK2-/- kidneys is accompanied by increased levels of lysosomal proteins and proteases at 1, 7, and 20 mo of age as well as progressive accumulation of autolysosomes and lipofuscin granules at 4, 7-10, and 20 mo of age.  Conclusions: LRRK2 is important for the dynamic regulation of autophagy function in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1NQ2pq6njq7Vg90H21EOLACvtfcHk0lhDGAp47ZMWew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvVOqu7w%253D&md5=d725f523a486c397369b182034df8323</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1186%2F1750-1326-7-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1750-1326-7-2%26sid%3Dliteratum%253Aachs%26aulast%3DTong%26aufirst%3DY.%26aulast%3DGiaime%26aufirst%3DE.%26aulast%3DYamaguchi%26aufirst%3DH.%26aulast%3DIchimura%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DSi%26aufirst%3DH.%26aulast%3DCai%26aufirst%3DH.%26aulast%3DBonventre%26aufirst%3DJ.%2BV.%26aulast%3DShen%26aufirst%3DJ.%26atitle%3DLoss%2520of%2520leucine-rich%2520repeat%2520kinase%25202%2520causes%2520age-dependent%2520bi-phasic%2520alterations%2520of%2520the%2520autophagy%2520pathway%26jtitle%3DMol.%2520Neurodegener.%26date%3D2012%26volume%3D7%26spage%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Herzig, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolly, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Persohn, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theil, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schweizer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hafner, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stemmelen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troxler, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmid, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnell, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinzel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grevot, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognani, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stirn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaupmann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Putten, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rovelli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimshek, D. R.</span><span> </span><span class="NLM_article-title">LRRK2 protein levels are determined by kinase function and are crucial for kidney and lung homeostasis in mice</span> <span class="citation_source-journal">Hum. Mol. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">4209</span><span class="NLM_x">–</span> <span class="NLM_lpage">4223</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1093%2Fhmg%2Fddr348" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=21828077" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1yltrnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2011&pages=4209-4223&author=M.+C.+Herzigauthor=C.+Kollyauthor=E.+Persohnauthor=D.+Theilauthor=T.+Schweizerauthor=T.+Hafnerauthor=C.+Stemmelenauthor=T.+J.+Troxlerauthor=P.+Schmidauthor=S.+Dannerauthor=C.+R.+Schnellauthor=M.+Muellerauthor=B.+Kinzelauthor=A.+Grevotauthor=F.+Bolognaniauthor=M.+Stirnauthor=R.+R.+Kuhnauthor=K.+Kaupmannauthor=P.+H.+van+der+Puttenauthor=G.+Rovelliauthor=D.+R.+Shimshek&title=LRRK2+protein+levels+are+determined+by+kinase+function+and+are+crucial+for+kidney+and+lung+homeostasis+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">LRRK2 protein levels are determined by kinase function and are crucial for kidney and lung homeostasis in mice</span></div><div class="casAuthors">Herzig, Martin C.; Kolly, Carine; Persohn, Elke; Theil, Diethilde; Schweizer, Tatjana; Hafner, Thomas; Stemmelen, Christine; Troxler, Thomas J.; Schmid, Peter; Danner, Simone; Schnell, Christian R.; Mueller, Matthias; Kinzel, Bernd; Grevot, Armelle; Bolognani, Federico; Stirn, Martina; Kuhn, Rainer R.; Kaupmann, Klemens; van der Putten, P. Herman; Rovelli, Giorgio; Shimshek, Derya R.</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">4209-4223</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Mutations in leucine-rich repeat kinase 2 (LRRK2) cause late-onset Parkinson's disease (PD), but the underlying pathophysiol. mechanisms and the normal function of this large multidomain protein remain speculative.  To address the role of this protein in vivo, we generated three different LRRK2 mutant mouse lines.  Mice completely lacking the LRRK2 protein (knock-out, KO) showed an early-onset (age 6 wk) marked increase in no. and size of secondary lysosomes in kidney proximal tubule cells and lamellar bodies in lung type II cells.  Mice expressing a LRRK2 kinase-dead (KD) mutant from the endogenous locus displayed similar early-onset pathophysiol. changes in kidney but not lung.  KD mutants had dramatically reduced full-length LRRK2 protein levels in the kidney and this genetic effect was mimicked pharmacol. in wild-type mice treated with a LRRK2-selective kinase inhibitor.  Knock-in (KI) mice expressing the G2019S PD-assocd. mutation that increases LRRK2 kinase activity showed none of the LRRK2 protein level and histopathol. changes obsd. in KD and KO mice.  The autophagy marker LC3 remained unchanged but kidney mTOR and TCS2 protein levels decreased in KD and increased in KO and KI mice.  Unexpectedly, KO and KI mice suffered from diastolic hypertension opposed to normal blood pressure in KD mice.  Our findings demonstrate a role for LRRK2 in kidney and lung physiol. and further show that LRRK2 kinase function affects LRRK2 protein steady-state levels thereby altering putative scaffold/GTPase activity.  These novel aspects of peripheral LRRK2 biol. critically impact ongoing attempts to develop LRRK2 selective kinase inhibitors as therapeutics for PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGol714w-ZIM5rVg90H21EOLACvtfcHk0lhDGAp47ZMWew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1yltrnI&md5=9c7935965c8f21e13b42bdc9e794cde0</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddr348&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddr348%26sid%3Dliteratum%253Aachs%26aulast%3DHerzig%26aufirst%3DM.%2BC.%26aulast%3DKolly%26aufirst%3DC.%26aulast%3DPersohn%26aufirst%3DE.%26aulast%3DTheil%26aufirst%3DD.%26aulast%3DSchweizer%26aufirst%3DT.%26aulast%3DHafner%26aufirst%3DT.%26aulast%3DStemmelen%26aufirst%3DC.%26aulast%3DTroxler%26aufirst%3DT.%2BJ.%26aulast%3DSchmid%26aufirst%3DP.%26aulast%3DDanner%26aufirst%3DS.%26aulast%3DSchnell%26aufirst%3DC.%2BR.%26aulast%3DMueller%26aufirst%3DM.%26aulast%3DKinzel%26aufirst%3DB.%26aulast%3DGrevot%26aufirst%3DA.%26aulast%3DBolognani%26aufirst%3DF.%26aulast%3DStirn%26aufirst%3DM.%26aulast%3DKuhn%26aufirst%3DR.%2BR.%26aulast%3DKaupmann%26aufirst%3DK.%26aulast%3Dvan%2Bder%2BPutten%26aufirst%3DP.%2BH.%26aulast%3DRovelli%26aufirst%3DG.%26aulast%3DShimshek%26aufirst%3DD.%2BR.%26atitle%3DLRRK2%2520protein%2520levels%2520are%2520determined%2520by%2520kinase%2520function%2520and%2520are%2520crucial%2520for%2520kidney%2520and%2520lung%2520homeostasis%2520in%2520mice%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2011%26volume%3D20%26spage%3D4209%26epage%3D4223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Hinkle, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behrouz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dächsel, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lincoln, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowles, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beevers, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dugger, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prots, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kent, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishioka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickson, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janus, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrer, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melrose, H. L.</span><span> </span><span class="NLM_article-title">LRRK2 knockout mice have an intact dopaminergic system but display alterations in exploratory and motor co-ordination behaviors</span> <span class="citation_source-journal">Mol. Neurodegener.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">25</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1186%2F1750-1326-7-25" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=22647713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVSiurnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=25&author=K.+M.+Hinkleauthor=M.+Yueauthor=B.+Behrouzauthor=J.+C.+D%C3%A4chselauthor=S.+J.+Lincolnauthor=E.+E.+Bowlesauthor=J.+E.+Beeversauthor=B.+Duggerauthor=B.+Winnerauthor=I.+Protsauthor=C.+B.+Kentauthor=K.+Nishiokaauthor=W.+L.+Linauthor=D.+W.+Dicksonauthor=C.+J.+Janusauthor=M.+J.+Farrerauthor=H.+L.+Melrose&title=LRRK2+knockout+mice+have+an+intact+dopaminergic+system+but+display+alterations+in+exploratory+and+motor+co-ordination+behaviors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">LRRK2 knockout mice have an intact dopaminergic system but display alterations in exploratory and motor co-ordination behaviors</span></div><div class="casAuthors">Hinkle, Kelly M.; Yue, Mei; Behrouz, Bahareh; Dachsel, Justus C.; Lincoln, Sarah J.; Bowles, Erin E.; Beevers, Joel E.; Dugger, Brittany; Winner, Beate; Prots, Iryna; Kent, Caroline B.; Nishioka, Kenya; Lin, Wen-Lang; Dickson, Dennis W.; Janus, Christopher J.; Farrer, Matthew J.; Melrose, Heather L.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neurodegeneration</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">25</span>CODEN:
                <span class="NLM_cas:coden">MNOEAZ</span>;
        ISSN:<span class="NLM_cas:issn">1750-1326</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Mutations in the LRRK2 gene are the most common cause of genetic Parkinson's disease.  Although the mechanisms behind the pathogenic effects of LRRK2 mutations are still not clear, data emerging from in vitro and in vivo models suggests roles in regulating neuronal polarity, neurotransmission, membrane and cytoskeletal dynamics and protein degrdn.  We created mice lacking exon 41 that encodes the activation hinge of the kinase domain of LRRK2.  We have performed a comprehensive anal. of these mice up to 20 mo of age, including evaluation of dopamine storage, release, uptake and synthesis, behavioral testing, dendritic spine and proliferation/neurogenesis anal.  Our results show that the dopaminergic system was not functionally comprised in LRRK2 knockout mice.  However, LRRK2 knockout mice displayed abnormal exploratory activity in the open-field test.  Moreover, LRRK2 knockout mice stayed longer than their wild type littermates on the accelerated rod during rotarod testing.  Finally, we confirm that loss of LRRK2 caused degeneration in the kidney, accompanied by a progressive enhancement of autophagic activity and accumulation of autofluorescent material, but without evidence of biphasic changes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3jk_BNWhPU7Vg90H21EOLACvtfcHk0lipNBoLTU39cQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVSiurnM&md5=d877c7237d22675e464a905af797679c</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1186%2F1750-1326-7-25&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1750-1326-7-25%26sid%3Dliteratum%253Aachs%26aulast%3DHinkle%26aufirst%3DK.%2BM.%26aulast%3DYue%26aufirst%3DM.%26aulast%3DBehrouz%26aufirst%3DB.%26aulast%3DD%25C3%25A4chsel%26aufirst%3DJ.%2BC.%26aulast%3DLincoln%26aufirst%3DS.%2BJ.%26aulast%3DBowles%26aufirst%3DE.%2BE.%26aulast%3DBeevers%26aufirst%3DJ.%2BE.%26aulast%3DDugger%26aufirst%3DB.%26aulast%3DWinner%26aufirst%3DB.%26aulast%3DProts%26aufirst%3DI.%26aulast%3DKent%26aufirst%3DC.%2BB.%26aulast%3DNishioka%26aufirst%3DK.%26aulast%3DLin%26aufirst%3DW.%2BL.%26aulast%3DDickson%26aufirst%3DD.%2BW.%26aulast%3DJanus%26aufirst%3DC.%2BJ.%26aulast%3DFarrer%26aufirst%3DM.%2BJ.%26aulast%3DMelrose%26aufirst%3DH.%2BL.%26atitle%3DLRRK2%2520knockout%2520mice%2520have%2520an%2520intact%2520dopaminergic%2520system%2520but%2520display%2520alterations%2520in%2520exploratory%2520and%2520motor%2520co-ordination%2520behaviors%26jtitle%3DMol.%2520Neurodegener.%26date%3D2012%26volume%3D7%26spage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Baptista, M. A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dave, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frasier, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherer, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greeley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varsho, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Churchill, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meshul, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiske, B. K.</span><span> </span><span class="NLM_article-title">Loss of leucine-rich repeat kinase 2 (LRRK2) in rats leads to progressive abnormal phenotypes in peripheral organs</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e80705</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e80705&author=M.+A.+S.+Baptistaauthor=K.+D.+Daveauthor=M.+A.+Frasierauthor=T.+B.+Shererauthor=M.+Greeleyauthor=M.+J.+Beckauthor=J.+S.+Varshoauthor=G.+A.+Parkerauthor=C.+Mooreauthor=M.+J.+Churchillauthor=C.+K.+Meshulauthor=B.+K.+Fiske&title=Loss+of+leucine-rich+repeat+kinase+2+%28LRRK2%29+in+rats+leads+to+progressive+abnormal+phenotypes+in+peripheral+organs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBaptista%26aufirst%3DM.%2BA.%2BS.%26aulast%3DDave%26aufirst%3DK.%2BD.%26aulast%3DFrasier%26aufirst%3DM.%2BA.%26aulast%3DSherer%26aufirst%3DT.%2BB.%26aulast%3DGreeley%26aufirst%3DM.%26aulast%3DBeck%26aufirst%3DM.%2BJ.%26aulast%3DVarsho%26aufirst%3DJ.%2BS.%26aulast%3DParker%26aufirst%3DG.%2BA.%26aulast%3DMoore%26aufirst%3DC.%26aulast%3DChurchill%26aufirst%3DM.%2BJ.%26aulast%3DMeshul%26aufirst%3DC.%2BK.%26aulast%3DFiske%26aufirst%3DB.%2BK.%26atitle%3DLoss%2520of%2520leucine-rich%2520repeat%2520kinase%25202%2520%2528LRRK2%2529%2520in%2520rats%2520leads%2520to%2520progressive%2520abnormal%2520phenotypes%2520in%2520peripheral%2520organs%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De80705" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Miklavc, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehinger, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hobi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimshek, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frick, M.</span><span> </span><span class="NLM_article-title">Surfactant secretion in LRRK2 knock-out rats: changes in lamellar body morphology and rate of exocytosis</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">e84926</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e84926&author=P.+Miklavcauthor=K.+Ehingerauthor=K.+E.+Thompsonauthor=N.+Hobiauthor=D.+R.+Shimshekauthor=M.+Frick&title=Surfactant+secretion+in+LRRK2+knock-out+rats%3A+changes+in+lamellar+body+morphology+and+rate+of+exocytosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMiklavc%26aufirst%3DP.%26aulast%3DEhinger%26aufirst%3DK.%26aulast%3DThompson%26aufirst%3DK.%2BE.%26aulast%3DHobi%26aufirst%3DN.%26aulast%3DShimshek%26aufirst%3DD.%2BR.%26aulast%3DFrick%26aufirst%3DM.%26atitle%3DSurfactant%2520secretion%2520in%2520LRRK2%2520knock-out%2520rats%253A%2520changes%2520in%2520lamellar%2520body%2520morphology%2520and%2520rate%2520of%2520exocytosis%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De84926" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Kramer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo Monte, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Göring, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amombo, G. M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, B.</span><span> </span><span class="NLM_article-title">Small molecule kinase inhibitors for LRRK2 and their application to Parkinson’s disease models</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">151</span><span class="NLM_x">–</span> <span class="NLM_lpage">160</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn200117j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC38XosFentA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=151-160&author=T.+Kramerauthor=F.+Lo+Monteauthor=S.+G%C3%B6ringauthor=G.+M.+O.+Amomboauthor=B.+Schmidt&title=Small+molecule+kinase+inhibitors+for+LRRK2+and+their+application+to+Parkinson%E2%80%99s+disease+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Small Molecule Kinase Inhibitors for LRRK2 and Their Application to Parkinson's Disease Models</span></div><div class="casAuthors">Kramer, Thomas; Lo Monte, Fabio; Goering, Stefan; Okala Amombo, Ghislaine Marlyse; Schmidt, Boris</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">151-160</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Parkinson's disease (PD) is the second most common neurodegenerative disorder.  Several single gene mutations have been linked to this disease.  Mutations in the gene encoding leucine-rich repeat kinase 2 (LRRK2) indicate LRRK2 as promising therapeutic target for the treatment of PD.  LRRK2 mutations were obsd. in sporadic as well as familial PD patients and have been investigated intensively.  LRRK2 is a large and complex protein, with multiple enzymic and protein-interaction domains, each of which is effected by mutations.  The most common mutation in PD patients is G2019S.  Several LRRK2 inhibitors have been reported already, although the crystal structure of LRRK2 has not yet been detd.  This review provides a summary of known LRRK2 inhibitors and will discuss recent in vitro and in vivo results of these inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqUiu7gx3NxLVg90H21EOLACvtfcHk0liThs-6pzbN-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XosFentA%253D%253D&md5=bda078bde5e0b515ca9d6f183d8b06f8</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fcn200117j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn200117j%26sid%3Dliteratum%253Aachs%26aulast%3DKramer%26aufirst%3DT.%26aulast%3DLo%2BMonte%26aufirst%3DF.%26aulast%3DG%25C3%25B6ring%26aufirst%3DS.%26aulast%3DAmombo%26aufirst%3DG.%2BM.%2BO.%26aulast%3DSchmidt%26aufirst%3DB.%26atitle%3DSmall%2520molecule%2520kinase%2520inhibitors%2520for%2520LRRK2%2520and%2520their%2520application%2520to%2520Parkinson%25E2%2580%2599s%2520disease%2520models%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2012%26volume%3D3%26spage%3D151%26epage%3D160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Kavanagh, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doddareddy, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassiou, M.</span><span> </span><span class="NLM_article-title">The development of CNS-active LRRK2 inhibitors using property-directed optimisation</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3690</span><span class="NLM_x">–</span> <span class="NLM_lpage">3696</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=3690-3696&author=M.+E.+Kavanaghauthor=M.+R.+Doddareddyauthor=M.+Kassiou&title=The+development+of+CNS-active+LRRK2+inhibitors+using+property-directed+optimisation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKavanagh%26aufirst%3DM.%2BE.%26aulast%3DDoddareddy%26aufirst%3DM.%2BR.%26aulast%3DKassiou%26aufirst%3DM.%26atitle%3DThe%2520development%2520of%2520CNS-active%2520LRRK2%2520inhibitors%2520using%2520property-directed%2520optimisation%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D3690%26epage%3D3696" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Dzamko, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halliday, G. M.</span><span> </span><span class="NLM_article-title">Unlocking the secrets of LRRK2 function with selective kinase inhibitors</span> <span class="citation_source-journal">Future Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">347</span><span class="NLM_x">–</span> <span class="NLM_lpage">357</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.2217%2Ffnl.13.9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmvFOjurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=347-357&author=N.+Dzamkoauthor=G.+M.+Halliday&title=Unlocking+the+secrets+of+LRRK2+function+with+selective+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Unlocking the secrets of LRRK2 function with selective kinase inhibitors</span></div><div class="casAuthors">Dzamko, Nicolas; Halliday, Glenda M.</div><div class="citationInfo"><span class="NLM_cas:title">Future Neurology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">347-357</span>CODEN:
                <span class="NLM_cas:coden">FNUEAM</span>;
        ISSN:<span class="NLM_cas:issn">1479-6708</span>.
    
            (<span class="NLM_cas:orgname">Future Medicine Ltd.</span>)
        </div><div class="casAbstract">A review.  LRRK2 is currently considered to be a potential therapeutic target for the treatment of Parkinson's disease.  A no. of pathol. mutations, the majority of which lie in the dual catalytic domains of LRRK2, segregate with Parkinson's disease in an autosomal-dominant fashion.  The most common mutation, G2019S, results in an increase in the kinase activity of LRRK2 and much work has, therefore, gone into the development of potent and specific inhibitors of LRRK2 kinase activity.  A no. of LRRK2 kinase inhibitors have now been employed in the search for the physiol. function of LRRK2 and the targets of LRRK2 kinase activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6NRBdq_2uUbVg90H21EOLACvtfcHk0liThs-6pzbN-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmvFOjurk%253D&md5=e0eb24e6bcc30784715dcbda9832d586</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.2217%2Ffnl.13.9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252Ffnl.13.9%26sid%3Dliteratum%253Aachs%26aulast%3DDzamko%26aufirst%3DN.%26aulast%3DHalliday%26aufirst%3DG.%2BM.%26atitle%3DUnlocking%2520the%2520secrets%2520of%2520LRRK2%2520function%2520with%2520selective%2520kinase%2520inhibitors%26jtitle%3DFuture%2520Neurol.%26date%3D2013%26volume%3D8%26spage%3D347%26epage%3D357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Schulz, S.; Goring, S.; Schmidt, B.; Hopf, C.</span><span> </span><span class="NLM_article-title">LRRK2 kinase inhibitors as new drugs for Parkinson’s disease?</span> In  <span class="citation_source-book">Emerging Drugs and Targets for Parkinson’s Disease</span>; <span class="NLM_contrib-group">Martinez, A.; Gil, C.</span>, Eds.; RSC Drug Discovery Series No. 34; <span class="NLM_publisher-name">The Royal Society of Chemistry</span>: <span class="NLM_publisher-loc">London</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">266</span><span class="NLM_x">–</span> <span class="NLM_lpage">293</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1039%2F9781849737357-00266" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=266-293&author=S.+Schulz&author=S.+Goring&author=B.+Schmidt&author=C.+Hopfauthor=A.+Martinez&author=C.+Gil&title=Emerging+Drugs+and+Targets+for+Parkinson%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1039%2F9781849737357-00266&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1039%252F9781849737357-00266%26sid%3Dliteratum%253Aachs%26aulast%3DSchulz%26aufirst%3DS.%26atitle%3DLRRK2%2520kinase%2520inhibitors%2520as%2520new%2520drugs%2520for%2520Parkinson%25E2%2580%2599s%2520disease%253F%26btitle%3DEmerging%2520Drugs%2520and%2520Targets%2520for%2520Parkinson%25E2%2580%2599s%2520Disease%26aulast%3DMartinez%26aufirst%3DA.%26pub%3DThe%2520Royal%2520Society%2520of%2520Chemistry%26date%3D2013%26spage%3D266%26epage%3D293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Galatsis, P.; Henderson, J. L.; Kormos, B. L.; Hirst, W. D.</span><span> </span><span class="NLM_article-title">Leucine-rich repeat kinase 2 (LRRK2) inhibitors</span>. In  <span class="citation_source-book">Topics in Medicinal Chemistry</span>; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Berlin</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">; </span>DOI: <span class="refDoi"> DOI: 10.1007/7355_2014_69</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1007%2F7355_2014_69" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=P.+Galatsis&author=J.+L.+Henderson&author=B.+L.+Kormos&author=W.+D.+Hirst&title=Topics+in+Medicinal+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1007%2F7355_2014_69&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F7355_2014_69%26sid%3Dliteratum%253Aachs%26aulast%3DGalatsis%26aufirst%3DP.%26atitle%3DLeucine-rich%2520repeat%2520kinase%25202%2520%2528LRRK2%2529%2520inhibitors%26btitle%3DTopics%2520in%2520Medicinal%2520Chemistry%26pub%3DSpringer%26date%3D2014%26doi%3D10.1007%2F7355_2014_69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Burdick, D. J.</span><span> </span><span class="NLM_article-title">Response to Deng et al.’s LRRK2 patent review</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">279</span><span class="NLM_x">–</span> <span class="NLM_lpage">279</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1517%2F13543776.2013.757594" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=23268730" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpt1Glsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=279-279&author=D.+J.+Burdick&title=Response+to+Deng+et+al.%E2%80%99s+LRRK2+patent+review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Response to Deng et al.'s LRRK2 patent review</span></div><div class="casAuthors">Burdick, Daniel Jon</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">279</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">In response to a recent article entitled "Leucine-rich repeat kinase 2 inhibitors: a patent review (2006-2011).  The authors appear to claim that they were the first to discover compd. 11 and that Genentech/Roche discovered 11 in a parallel effort, however, the patent and non-patent literature clearly shows that Genentech/Roche was the first to discover compd. 11 and that the Gray group found it later.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMsbAAgdiBdLVg90H21EOLACvtfcHk0ljED0Y_nopB5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpt1Glsg%253D%253D&md5=273a70f208da6933a24df1c914e18849</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1517%2F13543776.2013.757594&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2013.757594%26sid%3Dliteratum%253Aachs%26aulast%3DBurdick%26aufirst%3DD.%2BJ.%26atitle%3DResponse%2520to%2520Deng%2520et%2520al.%25E2%2580%2599s%2520LRRK2%2520patent%2520review%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2013%26volume%3D23%26spage%3D279%26epage%3D279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Kethiri, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakthavatchalam, R.</span><span> </span><span class="NLM_article-title">Leucine-rich repeat kinase 2 inhibitors: a review of recent patents (2011–2013)</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">745</span><span class="NLM_x">–</span> <span class="NLM_lpage">757</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1517%2F13543776.2014.907275" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2013&pages=745-757&author=R.+R.+Kethiriauthor=R.+Bakthavatchalam&title=Leucine-rich+repeat+kinase+2+inhibitors%3A+a+review+of+recent+patents+%282011%E2%80%932013%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1517%2F13543776.2014.907275&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2014.907275%26sid%3Dliteratum%253Aachs%26aulast%3DKethiri%26aufirst%3DR.%2BR.%26aulast%3DBakthavatchalam%26aufirst%3DR.%26atitle%3DLeucine-rich%2520repeat%2520kinase%25202%2520inhibitors%253A%2520a%2520review%2520of%2520recent%2520patents%2520%25282011%25E2%2580%25932013%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2013%26volume%3D24%26spage%3D745%26epage%3D757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Ramsden, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zinn, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bova, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewes, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bantscheff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bard, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopf, C.</span><span> </span><span class="NLM_article-title">Chemoproteomics-based design of potent LRRK2-selective lead compounds that attenuate Parkinson’s disease-related toxicity in human neurons</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1021</span><span class="NLM_x">–</span> <span class="NLM_lpage">1028</span></span><div class="citationLinks">[<a href="/doi/10.1021/cb2002413" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=1021-1028&author=N.+Ramsdenauthor=J.+Perrinauthor=Z.+Renauthor=B.+D.+Leeauthor=N.+Zinnauthor=V.+L.+Dawsonauthor=D.+Tamauthor=M.+Bovaauthor=M.+Langauthor=G.+Drewesauthor=M.+Bantscheffauthor=F.+Bardauthor=T.+M.+Dawsonauthor=C.+Hopf&title=Chemoproteomics-based+design+of+potent+LRRK2-selective+lead+compounds+that+attenuate+Parkinson%E2%80%99s+disease-related+toxicity+in+human+neurons"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1021%2Fcb2002413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb2002413%26sid%3Dliteratum%253Aachs%26aulast%3DRamsden%26aufirst%3DN.%26aulast%3DPerrin%26aufirst%3DJ.%26aulast%3DRen%26aufirst%3DZ.%26aulast%3DLee%26aufirst%3DB.%2BD.%26aulast%3DZinn%26aufirst%3DN.%26aulast%3DDawson%26aufirst%3DV.%2BL.%26aulast%3DTam%26aufirst%3DD.%26aulast%3DBova%26aufirst%3DM.%26aulast%3DLang%26aufirst%3DM.%26aulast%3DDrewes%26aufirst%3DG.%26aulast%3DBantscheff%26aufirst%3DM.%26aulast%3DBard%26aufirst%3DF.%26aulast%3DDawson%26aufirst%3DT.%2BM.%26aulast%3DHopf%26aufirst%3DC.%26atitle%3DChemoproteomics-based%2520design%2520of%2520potent%2520LRRK2-selective%2520lead%2520compounds%2520that%2520attenuate%2520Parkinson%25E2%2580%2599s%2520disease-related%2520toxicity%2520in%2520human%2520neurons%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2011%26volume%3D6%26spage%3D1021%26epage%3D1028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Deng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dzamko, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prescott, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.-D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patricelli, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomanbhoy, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Characterization of a selective inhibitor of the Parkinson’s disease kinase LRRK2</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">–</span> <span class="NLM_lpage">205</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1038%2Fnchembio.538" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=21378983" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkvVKqsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=203-205&author=X.+Dengauthor=N.+Dzamkoauthor=A.+Prescottauthor=P.+Daviesauthor=Q.+Liuauthor=Q.+Yangauthor=J.-D.+Leeauthor=M.+P.+Patricelliauthor=T.+K.+Nomanbhoyauthor=D.+R.+Alessiauthor=N.+S.+Gray&title=Characterization+of+a+selective+inhibitor+of+the+Parkinson%E2%80%99s+disease+kinase+LRRK2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2</span></div><div class="casAuthors">Deng, Xianming; Dzamko, Nicolas; Prescott, Alan; Davies, Paul; Liu, Qingsong; Yang, Qingkai; Lee, Jiing-Dwan; Patricelli, Matthew P.; Nomanbhoy, Tyzoon K.; Alessi, Dario R.; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">203-205</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Mutations in leucine-rich repeat kinase 2 (LRRK2) are strongly assocd. with late-onset autosomal dominant Parkinson's disease.  We employed a new, parallel, compd.-centric approach to identify a potent and selective LRRK2 inhibitor, LRRK2-IN-1, and demonstrated that inhibition of LRRK2 induces dephosphorylation of Ser910 and Ser935 and accumulation of LRRK2 within aggregate structures.  LRRK2-IN-1 will serve as a versatile tool to pharmacol. interrogate LRRK2 biol. and study its role in Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwLpGURHqDULVg90H21EOLACvtfcHk0ljED0Y_nopB5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkvVKqsL0%253D&md5=9f48f74cad9988e3ea8bb7af280473c1</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.538&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.538%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DDzamko%26aufirst%3DN.%26aulast%3DPrescott%26aufirst%3DA.%26aulast%3DDavies%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DQ.%26aulast%3DLee%26aufirst%3DJ.-D.%26aulast%3DPatricelli%26aufirst%3DM.%2BP.%26aulast%3DNomanbhoy%26aufirst%3DT.%2BK.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DCharacterization%2520of%2520a%2520selective%2520inhibitor%2520of%2520the%2520Parkinson%25E2%2580%2599s%2520disease%2520kinase%2520LRRK2%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2011%26volume%3D7%26spage%3D203%26epage%3D205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Parisiadou, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sgobio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, X.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowley, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovinger, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, H.</span><span> </span><span class="NLM_article-title">LRRK2 regulates synaptogenesis and dopamine receptor activation through modulation of PKA activity</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">367</span><span class="NLM_x">–</span> <span class="NLM_lpage">376</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1038%2Fnn.3636" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=24464040" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1yju7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2014&pages=367-376&author=L.+Parisiadouauthor=J.+Yuauthor=C.+Sgobioauthor=C.+Xieauthor=G.+Liuauthor=L.+Sunauthor=X.-L.+Guauthor=X.+Linauthor=N.+A.+Crowleyauthor=D.+M.+Lovingerauthor=H.+Cai&title=LRRK2+regulates+synaptogenesis+and+dopamine+receptor+activation+through+modulation+of+PKA+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">LRRK2 regulates synaptogenesis and dopamine receptor activation through modulation of PKA activity</span></div><div class="casAuthors">Parisiadou, Loukia; Yu, Jia; Sgobio, Carmelo; Xie, Chengsong; Liu, Guoxiang; Sun, Lixin; Gu, Xing-Long; Lin, Xian; Crowley, Nicole A.; Lovinger, David M.; Cai, Huaibin</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">367-376</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Leucine-rich repeat kinase 2 (LRRK2) is enriched in the striatal projection neurons (SPNs).  We found that LRRK2 neg. regulates protein kinase A (PKA) activity in the SPNs during synaptogenesis and in response to dopamine receptor Drd1 activation.  LRRK2 interacted with PKA regulatory subunit IIβ (PKARIIβ).  A lack of LRRK2 promoted the synaptic translocation of PKA and increased PKA-mediated phosphorylation of actin-disassembling enzyme cofilin and glutamate receptor GluR1, resulting in abnormal synaptogenesis and transmission in the developing SPNs.  Furthermore, PKA-dependent phosphorylation of GluR1 was also aberrantly enhanced in the striatum of young and aged Lrrk2-/- mice after treatment with a Drd1 agonist.  Notably, a Parkinson's disease-related Lrrk2 R1441C missense mutation that impaired the interaction of LRRK2 with PKARIIβ also induced excessive PKA activity in the SPNs.  Our findings reveal a previously unknown regulatory role for LRRK2 in PKA signaling and suggest a pathogenic mechanism of SPN dysfunction in Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBNKCM4t2-prVg90H21EOLACvtfcHk0lgrH0eIxa0C1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1yju7c%253D&md5=a36b3bc5f61a78bbaf3e97885b67f85b</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1038%2Fnn.3636&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn.3636%26sid%3Dliteratum%253Aachs%26aulast%3DParisiadou%26aufirst%3DL.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DSgobio%26aufirst%3DC.%26aulast%3DXie%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DGu%26aufirst%3DX.-L.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DCrowley%26aufirst%3DN.%2BA.%26aulast%3DLovinger%26aufirst%3DD.%2BM.%26aulast%3DCai%26aufirst%3DH.%26atitle%3DLRRK2%2520regulates%2520synaptogenesis%2520and%2520dopamine%2520receptor%2520activation%2520through%2520modulation%2520of%2520PKA%2520activity%26jtitle%3DNat.%2520Neurosci.%26date%3D2014%26volume%3D17%26spage%3D367%26epage%3D376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Kuss, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adamopoulou, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahle, P. J.</span><span> </span><span class="NLM_article-title">Interferon-γ induces leucine-rich repeat kinase LRRK2 via extracellular signal-regulated kinase ERK5 in macrophages</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">129</span><span class="NLM_x">, </span> <span class="NLM_fpage">980</span><span class="NLM_x">–</span> <span class="NLM_lpage">987</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1111%2Fjnc.12668" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=24479685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpsVKrsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2014&pages=980-987&author=M.+Kussauthor=E.+Adamopoulouauthor=P.+J.+Kahle&title=Interferon-%CE%B3+induces+leucine-rich+repeat+kinase+LRRK2+via+extracellular+signal-regulated+kinase+ERK5+in+macrophages"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Interferon-γ induces leucine-rich repeat kinase LRRK2 via extracellular signal-regulated kinase ERK5 in macrophages</span></div><div class="casAuthors">Kuss, Martin; Adamopoulou, Eleni; Kahle, Philipp J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">980-987</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The gene encoding leucine-rich repeat kinase 2 (LRRK2) comprises a major risk factor for Parkinson's disease.  Recently, it has emerged that LRRK2 plays important roles in the immune system.  LRRK2 is induced by interferon-γ (IFN-γ) in monocytes, but the signaling pathway is not known.  Here, we show that IFN-γ-mediated induction of LRRK2 was suppressed by pharmacol. inhibition and RNA interference of the extracellular signal-regulated kinase 5 (ERK5).  This was confirmed by LRRK2 immunostaining, which also revealed that the morphol. responses to IFN-γ were suppressed by ERK5 inhibitor treatment.  Both human acute monocytic leukemia THP-1 cells and human peripheral blood monocytes stimulated the ERK5-LRRK2 pathway after differentiation into macrophages.  Thus, LRRK2 is induced via a novel, ERK5-dependent IFN-γ signal transduction pathway, pointing to new functions of ERK5 and LRRK2 in human macrophages.  Leucine-rich repeat kinase 2 (LRRK2) is a major risk factor for the development of Parkinson's disease (PD).  However, the role of LRRK2 in the affected neurons remains enigmatic.  Recently, LRRK2 has been reported to be strongly expressed in the immune system.  Here, we demonstrate that LRRK2 is induced by interferon gamma via extracellular signal-regulated kinase 5 (ERK5) in macrophages, thus providing new insights in LRRK2 and ERK5 biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLdgRFksIqCbVg90H21EOLACvtfcHk0lgrH0eIxa0C1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpsVKrsL0%253D&md5=7b0bdb62727ea3d1aebb1a789ec244c2</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1111%2Fjnc.12668&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjnc.12668%26sid%3Dliteratum%253Aachs%26aulast%3DKuss%26aufirst%3DM.%26aulast%3DAdamopoulou%26aufirst%3DE.%26aulast%3DKahle%26aufirst%3DP.%2BJ.%26atitle%3DInterferon-%25CE%25B3%2520induces%2520leucine-rich%2520repeat%2520kinase%2520LRRK2%2520via%2520extracellular%2520signal-regulated%2520kinase%2520ERK5%2520in%2520macrophages%26jtitle%3DJ.%2520Neurochem.%26date%3D2014%26volume%3D129%26spage%3D980%26epage%3D987" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Elkins, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pattison, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arthur, J. S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erazo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lizcano, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span> </span><span class="NLM_article-title">X-ray crystal structure of ERK5 (MAPK7) in complex with a specific inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">4413</span><span class="NLM_x">–</span> <span class="NLM_lpage">4421</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm4000837" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4413-4421&author=J.+M.+Elkinsauthor=J.+Wangauthor=X.+Dengauthor=M.+J.+Pattisonauthor=J.+S.+C.+Arthurauthor=T.+Erazoauthor=N.+Gomezauthor=J.+M.+Lizcanoauthor=N.+S.+Grayauthor=S.+Knapp&title=X-ray+crystal+structure+of+ERK5+%28MAPK7%29+in+complex+with+a+specific+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Fjm4000837&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4000837%26sid%3Dliteratum%253Aachs%26aulast%3DElkins%26aufirst%3DJ.%2BM.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DPattison%26aufirst%3DM.%2BJ.%26aulast%3DArthur%26aufirst%3DJ.%2BS.%2BC.%26aulast%3DErazo%26aufirst%3DT.%26aulast%3DGomez%26aufirst%3DN.%26aulast%3DLizcano%26aufirst%3DJ.%2BM.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DKnapp%26aufirst%3DS.%26atitle%3DX-ray%2520crystal%2520structure%2520of%2520ERK5%2520%2528MAPK7%2529%2520in%2520complex%2520with%2520a%2520specific%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4413%26epage%3D4421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Weygant, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">May, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandrakesan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sureban, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janknecht, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houchen, C. W.</span><span> </span><span class="NLM_article-title">Small molecule kinase inhibitor LRRK2-IN-1 demonstrates potent activity against colorectal and pancreatic cancer through inhibition of doublecortin-like kinase 1</span> <span class="citation_source-journal">Mol. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">103</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1186%2F1476-4598-13-103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=24885928" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC2MXivFWns7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=103&author=N.+Weygantauthor=D.+Quauthor=W.+L.+Berryauthor=R.+Mayauthor=P.+Chandrakesanauthor=D.+B.+Owenauthor=S.+M.+Surebanauthor=N.+Aliauthor=R.+Janknechtauthor=C.+W.+Houchen&title=Small+molecule+kinase+inhibitor+LRRK2-IN-1+demonstrates+potent+activity+against+colorectal+and+pancreatic+cancer+through+inhibition+of+doublecortin-like+kinase+1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule kinase inhibitor LRRK2-IN-1 demonstrates potent activity against colorectal and pancreatic cancer through inhibition of doublecortin-like kinase 1</span></div><div class="casAuthors">Weygant, Nathaniel; Qu, Dongfeng; Berry, William L.; May, Randal; Chandrakesan, Parthasarathy; Owen, Daniel B.; Sureban, Sripathi M.; Ali, Naushad; Janknecht, Ralf; Houchen, Courtney W.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">103/1-103/14, 14 pp.</span>CODEN:
                <span class="NLM_cas:coden">MCOACG</span>;
        ISSN:<span class="NLM_cas:issn">1476-4598</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Doublecortin-like kinase 1 (DCLK1) is emerging as a tumor specific stem cell marker in colorectal and pancreatic cancer.  Previous in vitro and in vivo studies have demonstrated the therapeutic effects of inhibiting DCLK1 with small interfering RNA (siRNA) as well as genetically targeting the DCLK1+ cell for deletion.  However, the effects of inhibiting DCLK1 kinase activity have not been studied directly.  Therefore, we assessed the effects of inhibiting DCLK1 kinase activity using the novel small mol. kinase inhibitor, LRRK2-IN-1, which demonstrates significant affinity for DCLK1.  Results: Here we report that LRRK2-IN-1 demonstrates potent anti-cancer activity including inhibition of cancer cell proliferation, migration, and invasion as well as induction of apoptosis and cell cycle arrest.  Addnl. we found that it regulates stemness, epithelial-mesenchymal transition, and oncogenic targets on the mol. level.  Moreover, we show that LRRK2-IN-1 suppresses DCLK1 kinase activity and downstream DCLK1 effector c-MYC, and demonstrate that DCLK1 kinase activity is a significant factor in resistance to LRRK2-IN-1.  Conclusions: Given DCLK1's tumor stem cell marker status, a strong understanding of its biol. role and interactions in gastrointestinal tumors may lead to discoveries that improve patient outcomes.  The results of this study suggest that small mol. inhibitors of DCLK1 kinase should be further investigated as they may hold promise as anti-tumor stem cell drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2e_YpWjFtarVg90H21EOLACvtfcHk0lgdkc_a1_8hDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXivFWns7w%253D&md5=922f240a73513dbdad1e5df5eba20b83</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1186%2F1476-4598-13-103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1476-4598-13-103%26sid%3Dliteratum%253Aachs%26aulast%3DWeygant%26aufirst%3DN.%26aulast%3DQu%26aufirst%3DD.%26aulast%3DBerry%26aufirst%3DW.%2BL.%26aulast%3DMay%26aufirst%3DR.%26aulast%3DChandrakesan%26aufirst%3DP.%26aulast%3DOwen%26aufirst%3DD.%2BB.%26aulast%3DSureban%26aufirst%3DS.%2BM.%26aulast%3DAli%26aufirst%3DN.%26aulast%3DJanknecht%26aufirst%3DR.%26aulast%3DHouchen%26aufirst%3DC.%2BW.%26atitle%3DSmall%2520molecule%2520kinase%2520inhibitor%2520LRRK2-IN-1%2520demonstrates%2520potent%2520activity%2520against%2520colorectal%2520and%2520pancreatic%2520cancer%2520through%2520inhibition%2520of%2520doublecortin-like%2520kinase%25201%26jtitle%3DMol.%2520Cancer%26date%3D2014%26volume%3D13%26spage%3D103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Luerman, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samaroo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurtado-Lorenzo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Needle, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noell, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galatsis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunlop, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geoghegan, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirst, W. D.</span><span> </span><span class="NLM_article-title">Phosphoproteomic evaluation of pharmacological inhibition of leucine-rich repeat kinase 2 reveals significant off-target effects of LRRK-2-IN-1</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">128</span><span class="NLM_x">, </span> <span class="NLM_fpage">561</span><span class="NLM_x">–</span> <span class="NLM_lpage">576</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1111%2Fjnc.12483" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=24117733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFWktL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2014&pages=561-576&author=G.+C.+Luermanauthor=C.+Nguyenauthor=H.+Samarooauthor=P.+Loosauthor=H.+Xiauthor=A.+Hurtado-Lorenzoauthor=E.+Needleauthor=G.+S.+Noellauthor=P.+Galatsisauthor=J.+Dunlopauthor=K.+F.+Geogheganauthor=W.+D.+Hirst&title=Phosphoproteomic+evaluation+of+pharmacological+inhibition+of+leucine-rich+repeat+kinase+2+reveals+significant+off-target+effects+of+LRRK-2-IN-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphoproteomic evaluation of pharmacological inhibition of leucine-rich repeat kinase 2 reveals significant off-target effects of LRRK-2-IN-1</span></div><div class="casAuthors">Luerman, Gregory C.; Nguyen, Chuong; Samaroo, Harry; Loos, Paula; Xi, Hualin; Hurtado-Lorenzo, Andres; Needle, Elie; Stephen Noell, G.; Galatsis, Paul; Dunlop, John; Geoghegan, Kieran F.; Hirst, Warren D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">561-576</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Genetic mutations in leucine-rich repeat kinase 2 (LRRK2) have been linked to autosomal dominant Parkinson's disease.  The most prevalent mutation, G2019S, results in enhanced LRRK2 kinase activity that potentially contributes to the etiol. of Parkinson's disease.  Consequently, disease progression is potentially mediated by poorly characterized phosphorylation-dependent LRRK2 substrate pathways.  To address this gap in knowledge, we transduced SH-SY5Y neuroblastoma cells with LRRK2 G2019S via adenovirus, then detd. quant. changes in the phosphoproteome upon LRRK2 kinase inhibition (LRRK2-IN-1 treatment) using stable isotope labeling of amino acids in culture combined with phosphopeptide enrichment and LC-MS/MS anal.  We identified 776 phosphorylation sites that were increased or decreased at least 50% in response to LRRK2-IN-1 treatment, including sites on proteins previously known to assoc. with LRRK2.  Bioinformatic anal. of those phosphoproteins suggested a potential role for LRRK2 kinase activity in regulating pro-inflammatory responses and neurite morphol., among other pathways.  In follow-up expts., LRRK2-IN-1 inhibited lipopolysaccharide-induced tumor necrosis factor alpha (TNFα) and C-X-C motif chemokine 10 (CXCL10) levels in astrocytes and also enhanced multiple neurite characteristics in primary neuronal cultures.  However, LRRK2-IN-1 had almost identical effects in primary glial and neuronal cultures from LRRK2 knockout mice.  These data suggest LRRK2-IN-1 may inhibit pathways of perceived LRRK2 pathophysiol. function independently of LRRK2 highlighting the need to use multiple pharmacol. tools and genetic approaches in studies detg. LRRK2 function.  Genetic mutations in leucine-rich repeat kinase 2 (LRRK2) have been linked to Parkinson's disease, potentially contributing to the pathogenesis through increased kinase activity acting via phosphorylation-dependent LRRK2 substrate pathways.  To det. the potential pathways, we performed SILAC combined with phosphopeptide enrichment and LC-MS/MS anal. +/- LRRK2 inhibitor.  Bioinformatic anal. of those phosphoproteins suggested a potential role for LRRK2 kinase activity in regulating pro-inflammatory responses and neurite morphol., among other pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnRsstKaXLjrVg90H21EOLACvtfcHk0lgdkc_a1_8hDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFWktL8%253D&md5=b2da1a4134ae04f9aa5e00672ef4e058</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1111%2Fjnc.12483&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjnc.12483%26sid%3Dliteratum%253Aachs%26aulast%3DLuerman%26aufirst%3DG.%2BC.%26aulast%3DNguyen%26aufirst%3DC.%26aulast%3DSamaroo%26aufirst%3DH.%26aulast%3DLoos%26aufirst%3DP.%26aulast%3DXi%26aufirst%3DH.%26aulast%3DHurtado-Lorenzo%26aufirst%3DA.%26aulast%3DNeedle%26aufirst%3DE.%26aulast%3DNoell%26aufirst%3DG.%2BS.%26aulast%3DGalatsis%26aufirst%3DP.%26aulast%3DDunlop%26aufirst%3DJ.%26aulast%3DGeoghegan%26aufirst%3DK.%2BF.%26aulast%3DHirst%26aufirst%3DW.%2BD.%26atitle%3DPhosphoproteomic%2520evaluation%2520of%2520pharmacological%2520inhibition%2520of%2520leucine-rich%2520repeat%2520kinase%25202%2520reveals%2520significant%2520off-target%2520effects%2520of%2520LRRK-2-IN-1%26jtitle%3DJ.%2520Neurochem.%26date%3D2014%26volume%3D128%26spage%3D561%26epage%3D576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Characterization of TAE684 as a potent LRRK2 kinase inhibitor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1864</span><span class="NLM_x">–</span> <span class="NLM_lpage">1869</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=1864-1869&author=J.+Zhangauthor=X.+Dengauthor=H.+G.+Choiauthor=D.+R.+Alessiauthor=N.+S.+Gray&title=Characterization+of+TAE684+as+a+potent+LRRK2+kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DChoi%26aufirst%3DH.%2BG.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DCharacterization%2520of%2520TAE684%2520as%2520a%2520potent%2520LRRK2%2520kinase%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D1864%26epage%3D1869" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Galkin, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melnick, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hood, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steensma, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopiuk, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warmuth, M.</span><span> </span><span class="NLM_article-title">Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALK</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">270</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=270-275&author=A.+V.+Galkinauthor=J.+S.+Melnickauthor=S.+Kimauthor=T.+L.+Hoodauthor=N.+Liauthor=L.+Liauthor=G.+Xiaauthor=R.+Steensmaauthor=G.+Chopiukauthor=J.+Jiangauthor=Y.+Wanauthor=P.+Dingauthor=Y.+Liuauthor=F.+Sunauthor=P.+G.+Schultzauthor=N.+S.+Grayauthor=M.+Warmuth&title=Identification+of+NVP-TAE684%2C+a+potent%2C+selective%2C+and+efficacious+inhibitor+of+NPM-ALK"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGalkin%26aufirst%3DA.%2BV.%26aulast%3DMelnick%26aufirst%3DJ.%2BS.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DHood%26aufirst%3DT.%2BL.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DXia%26aufirst%3DG.%26aulast%3DSteensma%26aufirst%3DR.%26aulast%3DChopiuk%26aufirst%3DG.%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DWan%26aufirst%3DY.%26aulast%3DDing%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DF.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DWarmuth%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520NVP-TAE684%252C%2520a%2520potent%252C%2520selective%252C%2520and%2520efficacious%2520inhibitor%2520of%2520NPM-ALK%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2007%26volume%3D104%26spage%3D270%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Davis, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrgard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciceri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wodicka, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallares, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hocker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinkar, P. P.</span><span> </span><span class="NLM_article-title">Comprehensive analysis of kinase inhibitor selectivity</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1046</span><span class="NLM_x">–</span> <span class="NLM_lpage">1051</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1038%2Fnbt.1990" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=22037378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlyisrrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=1046-1051&author=M.+I.+Davisauthor=J.+P.+Huntauthor=S.+Herrgardauthor=P.+Ciceriauthor=L.+M.+Wodickaauthor=G.+Pallaresauthor=M.+Hockerauthor=D.+K.+Treiberauthor=P.+P.+Zarrinkar&title=Comprehensive+analysis+of+kinase+inhibitor+selectivity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Comprehensive analysis of kinase inhibitor selectivity</span></div><div class="casAuthors">Davis, Mindy I.; Hunt, Jeremy P.; Herrgard, Sanna; Ciceri, Pietro; Wodicka, Lisa M.; Pallares, Gabriel; Hocker, Michael; Treiber, Daniel K.; Zarrinkar, Patrick P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1046-1051</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We tested the interaction of 72 kinase inhibitors with 442 kinases covering >80% of the human catalytic protein kinome.  Our data show that, as a class, type II inhibitors are more selective than type I inhibitors, but that there are important exceptions to this trend.  The data further illustrate that selective inhibitors have been developed against the majority of kinases targeted by the compds. tested.  Anal. of the interaction patterns reveals a class of 'group-selective' inhibitors broadly active against a single subfamily of kinases, but selective outside that subfamily.  The data set suggests compds. to use as tools to study kinases for which no dedicated inhibitors exist.  It also provides a foundation for further exploring kinase inhibitor biol. and toxicity, as well as for studying the structural basis of the obsd. interaction patterns.  Our findings will help to realize the direct enabling potential of genomics for drug development and basic research about cellular signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEZnKVs6Xt5rVg90H21EOLACvtfcHk0lhVt68eQ0z7OA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlyisrrK&md5=67639f702cb48ffb2c60e9a250f0df5e</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1038%2Fnbt.1990&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.1990%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DM.%2BI.%26aulast%3DHunt%26aufirst%3DJ.%2BP.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DPallares%26aufirst%3DG.%26aulast%3DHocker%26aufirst%3DM.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26atitle%3DComprehensive%2520analysis%2520of%2520kinase%2520inhibitor%2520selectivity%26jtitle%3DNat.%2520Biotechnol.%26date%3D2011%26volume%3D29%26spage%3D1046%26epage%3D1051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Galatsis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henderson, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kormos, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurumbail, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noell, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Needle, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steyn, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houle, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirst, W. D.</span><span> </span><span class="NLM_article-title">Kinase domain inhibition of leucine rich repeat kinase 2 (LRRK2) using a [1,2,4]triazolo[4,3-<i>b</i>]pyridazine scaffold</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">4132</span><span class="NLM_x">–</span> <span class="NLM_lpage">4140</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=4132-4140&author=P.+Galatsisauthor=J.+L.+Hendersonauthor=B.+L.+Kormosauthor=S.+Hanauthor=R.+G.+Kurumbailauthor=T.+T.+Wagerauthor=P.+R.+Verhoestauthor=G.+S.+Noellauthor=Y.+Chenauthor=E.+Needleauthor=Z.+Bergerauthor=S.+J.+Steynauthor=C.+Houleauthor=W.+D.+Hirst&title=Kinase+domain+inhibition+of+leucine+rich+repeat+kinase+2+%28LRRK2%29+using+a+%5B1%2C2%2C4%5Dtriazolo%5B4%2C3-b%5Dpyridazine+scaffold"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGalatsis%26aufirst%3DP.%26aulast%3DHenderson%26aufirst%3DJ.%2BL.%26aulast%3DKormos%26aufirst%3DB.%2BL.%26aulast%3DHan%26aufirst%3DS.%26aulast%3DKurumbail%26aufirst%3DR.%2BG.%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DNoell%26aufirst%3DG.%2BS.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DNeedle%26aufirst%3DE.%26aulast%3DBerger%26aufirst%3DZ.%26aulast%3DSteyn%26aufirst%3DS.%2BJ.%26aulast%3DHoule%26aufirst%3DC.%26aulast%3DHirst%26aufirst%3DW.%2BD.%26atitle%3DKinase%2520domain%2520inhibition%2520of%2520leucine%2520rich%2520repeat%2520kinase%25202%2520%2528LRRK2%2529%2520using%2520a%2520%255B1%252C2%252C4%255Dtriazolo%255B4%252C3-b%255Dpyridazine%2520scaffold%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D4132%26epage%3D4140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Franzini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, X. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aubele, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garofalo, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauby, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldbach, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Probst, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santiago, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sham, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truong, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, Z.</span><span> </span><span class="NLM_article-title">Triazolopyridazine LRRK2 kinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1967</span><span class="NLM_x">–</span> <span class="NLM_lpage">1973</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=1967-1973&author=M.+Franziniauthor=X.+M.+Yeauthor=M.+Adlerauthor=D.+L.+Aubeleauthor=A.+W.+Garofaloauthor=S.+Gaubyauthor=E.+Goldbachauthor=G.+D.+Probstauthor=K.+P.+Quinnauthor=P.+Santiagoauthor=H.+L.+Shamauthor=D.+Tamauthor=A.+Truongauthor=Z.+Ren&title=Triazolopyridazine+LRRK2+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFranzini%26aufirst%3DM.%26aulast%3DYe%26aufirst%3DX.%2BM.%26aulast%3DAdler%26aufirst%3DM.%26aulast%3DAubele%26aufirst%3DD.%2BL.%26aulast%3DGarofalo%26aufirst%3DA.%2BW.%26aulast%3DGauby%26aufirst%3DS.%26aulast%3DGoldbach%26aufirst%3DE.%26aulast%3DProbst%26aufirst%3DG.%2BD.%26aulast%3DQuinn%26aufirst%3DK.%2BP.%26aulast%3DSantiago%26aufirst%3DP.%26aulast%3DSham%26aufirst%3DH.%2BL.%26aulast%3DTam%26aufirst%3DD.%26aulast%3DTruong%26aufirst%3DA.%26aulast%3DRen%26aufirst%3DZ.%26atitle%3DTriazolopyridazine%2520LRRK2%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D1967%26epage%3D1973" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Rankovic, Z.</span><span> </span><span class="NLM_article-title">CNS drug design: balancing physicochemical properties for optimal brain exposure</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">2584</span><span class="NLM_x">–</span> <span class="NLM_lpage">2608</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm501535r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVyhsrrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2584-2608&author=Z.+Rankovic&title=CNS+drug+design%3A+balancing+physicochemical+properties+for+optimal+brain+exposure"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">CNS Drug Design: Balancing Physicochemical Properties for Optimal Brain Exposure</span></div><div class="casAuthors">Rankovic, Zoran</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2584-2608</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The human brain is a uniquely complex organ, which has evolved a sophisticated protection system to prevent injury from external insults and toxins.  Designing mols. that can overcome this protection system and achieve optimal concn. at the desired therapeutic target in the brain is a specific and major challenge for medicinal chemists working in CNS drug discovery.  Analogous to the now widely accepted rule of 5 in the design of oral drugs, the physicochem. properties required for optimal brain exposure have been extensively studied in an attempt to similarly define the attributes of successful CNS drugs and drug candidates.  This body of work is systematically reviewed here, with a particular emphasis on the interplay between the most crit. physicochem. and pharmacokinetic parameters of CNS drugs as well as their impact on medicinal chem. strategies toward mols. with optimal brain exposure.  A summary of modern CNS pharmacokinetic concepts and methods is also provided.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8V0N1j49uuLVg90H21EOLACvtfcHk0lhQed046sAscA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVyhsrrP&md5=f01e3f2dc4e2eff7b0618124277a5cf8</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1021%2Fjm501535r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501535r%26sid%3Dliteratum%253Aachs%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DCNS%2520drug%2520design%253A%2520balancing%2520physicochemical%2520properties%2520for%2520optimal%2520brain%2520exposure%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2584%26epage%3D2608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span> </span><span class="NLM_article-title">Moving beyond the rules: The development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn100008c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=435-449&author=T.+T.+Wagerauthor=X.+Houauthor=P.+R.+Verhoestauthor=A.+Villalobos&title=Moving+beyond+the+rules%3A+The+development+of+a+central+nervous+system+multiparameter+optimization+%28CNS+MPO%29+approach+to+enable+alignment+of+druglike+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span></div><div class="casAuthors">Wager, Travis T.; Hou, Xinjun; Verhoest, Patrick R.; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">435-449</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The interplay among commonly used physicochem. properties in drug design was examd. and utilized to create a prospective design tool focused on the alignment of key druglike attributes.  Using a set of six physicochem. parameters ((a) lipophilicity, calcd. partition coeff. (ClogP); (b) calcd. distribution coeff. at pH = 7.4 (ClogD); (c) mol. wt. (MW); (d) topol. polar surface area (TPSA); (e) no. of hydrogen bond donors (HBD); (f) most basic center (pKa)), a druglikeness central nervous system multiparameter optimization (CNS MPO) algorithm was built and applied to a set of marketed CNS drugs (N = 119) and Pfizer CNS candidates (N = 108), as well as to a large diversity set of Pfizer proprietary compds. (N = 11 303).  The novel CNS MPO algorithm showed that 74% of marketed CNS drugs displayed a high CNS MPO score (MPO desirability score ≥ 4, using a scale of 0-6), in comparison to 60% of the Pfizer CNS candidates.  This anal. suggests that this algorithm could potentially be used to identify compds. with a higher probability of successfully testing hypotheses in the clinic.  In addn., a relationship between an increasing CNS MPO score and alignment of key in vitro attributes of drug discovery (favorable permeability, P-glycoprotein (P-gp) efflux, metabolic stability, and safety) was seen in the marketed CNS drug set, the Pfizer candidate set, and the Pfizer proprietary diversity set.  The CNS MPO scoring function offers advantages over hard cutoffs or utilization of single parameters to optimize structure-activity relationships (SAR) by expanding medicinal chem. design space through a holistic assessment approach.  Based on six physicochem. properties commonly used by medicinal chemists, the CNS MPO function may be used prospectively at the design stage to accelerate the identification of compds. with increased probability of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB3Mvkgm_X5bVg90H21EOLACvtfcHk0lheXKvfg9mGzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D&md5=e94998f65a420be6ee4dec4a987cb983</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1021%2Fcn100008c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100008c%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DMoving%2520beyond%2520the%2520rules%253A%2520The%2520development%2520of%2520a%2520central%2520nervous%2520system%2520multiparameter%2520optimization%2520%2528CNS%2520MPO%2529%2520approach%2520to%2520enable%2520alignment%2520of%2520druglike%2520properties%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D435%26epage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span> </span><span class="NLM_article-title">Structural modifications that alter the P-glycoprotein efflux properties of a compound</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">4877</span><span class="NLM_x">–</span> <span class="NLM_lpage">4895</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201136z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4877-4895&author=S.+A.+Hitchcock&title=Structural+modifications+that+alter+the+P-glycoprotein+efflux+properties+of+a+compound"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1021%2Fjm201136z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201136z%26sid%3Dliteratum%253Aachs%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26atitle%3DStructural%2520modifications%2520that%2520alter%2520the%2520P-glycoprotein%2520efflux%2520properties%2520of%2520a%2520compound%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4877%26epage%3D4895" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennington, L. D.</span><span> </span><span class="NLM_article-title">Structure–brain exposure relationships</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7559</span><span class="NLM_x">–</span> <span class="NLM_lpage">7583</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060642i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7559-7583&author=S.+A.+Hitchcockauthor=L.+D.+Pennington&title=Structure%E2%80%93brain+exposure+relationships"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1021%2Fjm060642i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060642i%26sid%3Dliteratum%253Aachs%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DPennington%26aufirst%3DL.%2BD.%26atitle%3DStructure%25E2%2580%2593brain%2520exposure%2520relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7559%26epage%3D7583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">Pajouhesh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, G. R.</span><span> </span><span class="NLM_article-title">Medicinal chemical properties of succesful central nervous system drugs</span> <span class="citation_source-journal">NeuroRx</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">541</span><span class="NLM_x">–</span> <span class="NLM_lpage">553</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=541-553&author=H.+Pajouheshauthor=G.+R.+Lenz&title=Medicinal+chemical+properties+of+succesful+central+nervous+system+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPajouhesh%26aufirst%3DH.%26aulast%3DLenz%26aufirst%3DG.%2BR.%26atitle%3DMedicinal%2520chemical%2520properties%2520of%2520succesful%2520central%2520nervous%2520system%2520drugs%26jtitle%3DNeuroRx%26date%3D2005%26volume%3D2%26spage%3D541%26epage%3D553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group">Ghose, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herbertz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudkins, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorsey, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallamo, J. P.</span><span> </span><span class="NLM_article-title">Knowledge-based, central nervous system (CNS) lead selection and lead optimization for CNS drug discovery</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">50</span><span class="NLM_x">–</span> <span class="NLM_lpage">68</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn200100h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=50-68&author=A.+K.+Ghoseauthor=T.+Herbertzauthor=R.+L.+Hudkinsauthor=B.+D.+Dorseyauthor=J.+P.+Mallamo&title=Knowledge-based%2C+central+nervous+system+%28CNS%29+lead+selection+and+lead+optimization+for+CNS+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1021%2Fcn200100h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn200100h%26sid%3Dliteratum%253Aachs%26aulast%3DGhose%26aufirst%3DA.%2BK.%26aulast%3DHerbertz%26aufirst%3DT.%26aulast%3DHudkins%26aufirst%3DR.%2BL.%26aulast%3DDorsey%26aufirst%3DB.%2BD.%26aulast%3DMallamo%26aufirst%3DJ.%2BP.%26atitle%3DKnowledge-based%252C%2520central%2520nervous%2520system%2520%2528CNS%2529%2520lead%2520selection%2520and%2520lead%2520optimization%2520for%2520CNS%2520drug%2520discovery%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2012%26volume%3D18%26spage%3D50%26epage%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hop, C. E. C. A.</span><span> </span><span class="NLM_article-title">Rational use of plasma protein and tissue binding data in drug design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">8238</span><span class="NLM_x">–</span> <span class="NLM_lpage">8248</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm5007935" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1Git77M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8238-8248&author=X.+Liuauthor=M.+Wrightauthor=C.+E.+C.+A.+Hop&title=Rational+use+of+plasma+protein+and+tissue+binding+data+in+drug+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Use of Plasma Protein and Tissue Binding Data in Drug Design</span></div><div class="casAuthors">Liu, Xingrong; Wright, Matthew; Hop, Cornelis E. C. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8238-8248</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  It is a commonly accepted assumption that only unbound drug mols. are available to interact with their targets.  Therefore, one of the objectives in drug design is to optimize the compd. structure to increase in vivo unbound drug concn.  In this review, theor. analyses and exptl. observations are presented to illustrate that low plasma protein binding does not necessarily lead to high in vivo unbound plasma concn.  Similarly, low brain tissue binding does not lead to high in vivo unbound brain tissue concn.  Instead, low intrinsic clearance leads to high in vivo unbound plasma concn., and low efflux transport activity at the blood-brain barrier leads to high unbound brain concn.  Plasma protein and brain tissue binding are very important parameters in understanding pharmacokinetics, pharmacodynamics, and toxicities of drugs, but these parameters should not be targeted for optimization in drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKiYUz9ljIDrVg90H21EOLACvtfcHk0liXppFHyWFuDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1Git77M&md5=53ffbdb88ddf500a90a0eee14b0e641f</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1021%2Fjm5007935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5007935%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DWright%26aufirst%3DM.%26aulast%3DHop%26aufirst%3DC.%2BE.%2BC.%2BA.%26atitle%3DRational%2520use%2520of%2520plasma%2520protein%2520and%2520tissue%2520binding%2520data%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D8238%26epage%3D8248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drummond, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estrada, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunzner-Toste, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moffat, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shore, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweeney, Z. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burdick, D. J.</span><span> </span><span class="NLM_article-title">Discovery of selective LRRK2 inhibitors guided by computational analysis and molecular modeling</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">5536</span><span class="NLM_x">–</span> <span class="NLM_lpage">5545</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300452p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC38XntVOlu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=5536-5545&author=H.+Chenauthor=B.+K.+Chanauthor=J.+Drummondauthor=A.+A.+Estradaauthor=J.+Gunzner-Tosteauthor=X.+Liuauthor=Y.+Liuauthor=J.+G.+Moffatauthor=D.+Shoreauthor=Z.+K.+Sweeneyauthor=T.+Tranauthor=S.+Wangauthor=G.+Zhaoauthor=H.+Zhuauthor=D.+J.+Burdick&title=Discovery+of+selective+LRRK2+inhibitors+guided+by+computational+analysis+and+molecular+modeling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Selective LRRK2 Inhibitors Guided by Computational Analysis and Molecular Modeling</span></div><div class="casAuthors">Chen, Huifen; Chan, Bryan K.; Drummond, Jason; Estrada, Anthony A.; Gunzner-Toste, Janet; Liu, Xingrong; Liu, Yichin; Moffat, John; Shore, Daniel; Sweeney, Zachary K.; Tran, Thuy; Wang, Shumei; Zhao, Guiling; Zhu, Haitao; Burdick, Daniel J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5536-5545</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mutations in the genetic sequence of leucine-rich repeat kinase 2 (LRRK2) have been linked to increased LRRK2 activity and risk for the development of Parkinson's disease (PD).  Potent and selective small mols. capable of inhibiting the kinase activity of LRRK2 will be important tools for establishing a link between the kinase activity of LRRK2 and PD.  In the absence of LRRK2 kinase domain crystal structures, a LRRK2 homol. model was developed that provided robust guidance in the hit-to-lead optimization of small mol. LRRK2 inhibitors.  Through a combination of mol. modeling, sequence anal., and matched mol. pair (MMP) activity cliff anal., a potent and selective lead inhibitor was discovered.  The selectivity of this compd. could be understood using the LRRK2 homol. model, and application of this learning to a series of 2,4-diaminopyrimidine inhibitors in a scaffold hopping exercise led to the identification of highly potent and selective LRRK2 inhibitors that were also brain penetrable.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1YrcBmeoRILVg90H21EOLACvtfcHk0liXppFHyWFuDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XntVOlu7Y%253D&md5=fe4d3a709a35f94e3c092b73bdb09936</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1021%2Fjm300452p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300452p%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DH.%26aulast%3DChan%26aufirst%3DB.%2BK.%26aulast%3DDrummond%26aufirst%3DJ.%26aulast%3DEstrada%26aufirst%3DA.%2BA.%26aulast%3DGunzner-Toste%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DMoffat%26aufirst%3DJ.%2BG.%26aulast%3DShore%26aufirst%3DD.%26aulast%3DSweeney%26aufirst%3DZ.%2BK.%26aulast%3DTran%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DG.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DBurdick%26aufirst%3DD.%2BJ.%26atitle%3DDiscovery%2520of%2520selective%2520LRRK2%2520inhibitors%2520guided%2520by%2520computational%2520analysis%2520and%2520molecular%2520modeling%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D5536%26epage%3D5545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group">Choi, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatcher, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patricelli, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Brain penetrant LRRK2 inhibitor</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">658</span><span class="NLM_x">–</span> <span class="NLM_lpage">662</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml300123a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=658-662&author=H.+G.+Choiauthor=J.+Zhangauthor=X.+Dengauthor=J.+M.+Hatcherauthor=M.+P.+Patricelliauthor=Z.+Zhaoauthor=D.+R.+Alessiauthor=N.+S.+Gray&title=Brain+penetrant+LRRK2+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1021%2Fml300123a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300123a%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DH.%2BG.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DHatcher%26aufirst%3DJ.%2BM.%26aulast%3DPatricelli%26aufirst%3DM.%2BP.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DBrain%2520penetrant%2520LRRK2%2520inhibitor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D658%26epage%3D662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group">Estrada, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker-Glenn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beresford, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burdick, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiPasquale, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominguez, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dotson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drummond, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flagella, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuji, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gill, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunzner-Toste, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heffron, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleinheinz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Pichon, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyssikatos, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medhurst, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moffat, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukund, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nash, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scearce-Levie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shore, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trivedi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweeney, Z. K.</span><span> </span><span class="NLM_article-title">Discovery of highly potent, selective and brain-penetrable leucine-rich repeat kinase 2 (LRRK2) small molecule inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9416</span><span class="NLM_x">–</span> <span class="NLM_lpage">9433</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301020q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9416-9433&author=A.+A.+Estradaauthor=X.+Liuauthor=C.+Baker-Glennauthor=A.+Beresfordauthor=D.+J.+Burdickauthor=M.+Chambersauthor=B.+K.+Chanauthor=H.+Chenauthor=X.+Dingauthor=A.+G.+DiPasqualeauthor=S.+L.+Dominguezauthor=J.+Dotsonauthor=J.+Drummondauthor=M.+Flagellaauthor=S.+Flynnauthor=R.+Fujiauthor=A.+Gillauthor=J.+Gunzner-Tosteauthor=S.+F.+Harrisauthor=T.+P.+Heffronauthor=T.+Kleinheinzauthor=D.+W.+Leeauthor=C.+E.+Le+Pichonauthor=J.+P.+Lyssikatosauthor=A.+D.+Medhurstauthor=J.+G.+Moffatauthor=S.+Mukundauthor=K.+Nashauthor=K.+Scearce-Levieauthor=Z.+Shengauthor=D.+G.+Shoreauthor=T.+Tranauthor=N.+Trivediauthor=S.+Wangauthor=S.+Zhangauthor=X.+Zhangauthor=G.+Zhaoauthor=H.+Zhuauthor=Z.+K.+Sweeney&title=Discovery+of+highly+potent%2C+selective+and+brain-penetrable+leucine-rich+repeat+kinase+2+%28LRRK2%29+small+molecule+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1021%2Fjm301020q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301020q%26sid%3Dliteratum%253Aachs%26aulast%3DEstrada%26aufirst%3DA.%2BA.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DBaker-Glenn%26aufirst%3DC.%26aulast%3DBeresford%26aufirst%3DA.%26aulast%3DBurdick%26aufirst%3DD.%2BJ.%26aulast%3DChambers%26aufirst%3DM.%26aulast%3DChan%26aufirst%3DB.%2BK.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DDing%26aufirst%3DX.%26aulast%3DDiPasquale%26aufirst%3DA.%2BG.%26aulast%3DDominguez%26aufirst%3DS.%2BL.%26aulast%3DDotson%26aufirst%3DJ.%26aulast%3DDrummond%26aufirst%3DJ.%26aulast%3DFlagella%26aufirst%3DM.%26aulast%3DFlynn%26aufirst%3DS.%26aulast%3DFuji%26aufirst%3DR.%26aulast%3DGill%26aufirst%3DA.%26aulast%3DGunzner-Toste%26aufirst%3DJ.%26aulast%3DHarris%26aufirst%3DS.%2BF.%26aulast%3DHeffron%26aufirst%3DT.%2BP.%26aulast%3DKleinheinz%26aufirst%3DT.%26aulast%3DLee%26aufirst%3DD.%2BW.%26aulast%3DLe%2BPichon%26aufirst%3DC.%2BE.%26aulast%3DLyssikatos%26aufirst%3DJ.%2BP.%26aulast%3DMedhurst%26aufirst%3DA.%2BD.%26aulast%3DMoffat%26aufirst%3DJ.%2BG.%26aulast%3DMukund%26aufirst%3DS.%26aulast%3DNash%26aufirst%3DK.%26aulast%3DScearce-Levie%26aufirst%3DK.%26aulast%3DSheng%26aufirst%3DZ.%26aulast%3DShore%26aufirst%3DD.%2BG.%26aulast%3DTran%26aufirst%3DT.%26aulast%3DTrivedi%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DG.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DSweeney%26aufirst%3DZ.%2BK.%26atitle%3DDiscovery%2520of%2520highly%2520potent%252C%2520selective%2520and%2520brain-penetrable%2520leucine-rich%2520repeat%2520kinase%25202%2520%2528LRRK2%2529%2520small%2520molecule%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9416%26epage%3D9433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group">Leeson, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springthorpe, B.</span><span> </span><span class="NLM_article-title">The influence of drug-like concepts on decision-making in medicinal chemistry</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">890</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1038%2Fnrd2445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=17971784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=881-890&author=P.+D.+Leesonauthor=B.+Springthorpe&title=The+influence+of+drug-like+concepts+on+decision-making+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of drug-like concepts on decision-making in medicinal chemistry</span></div><div class="casAuthors">Leeson, Paul D.; Springthorpe, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">881-890</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite the wide acceptance of drug-like principles such as the 'rule of five', this anal. of mols. currently being synthesized in leading pharmaceutical companies reveals that their phys. properties differ significantly from those of recently discovered oral drugs.  The marked increase in lipophilicity in particular could increase the likelihood of attrition in drug development.  The application of guidelines linked to the concept of drug-likeness, such as the 'rule of five', has gained wide acceptance as an approach to reduce attrition in drug discovery and development.  However, despite this acceptance, anal. of recent trends reveals that the phys. properties of mols. that are currently being synthesized in leading drug discovery companies differ significantly from those of recently discovered oral drugs and compds. in clin. development.  The consequences of the marked increase in lipophilicity - the most important drug-like phys. property - include a greater likelihood of lack of selectivity and attrition in drug development.  Tackling the threat of compd.-related toxicol. attrition needs to move to the mainstream of medicinal chem. decision-making.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTUeonLD6iebVg90H21EOLACvtfcHk0lgoDlF2r3XERA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL&md5=5665a9e2dc266a1ee096e20625757ef7</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1038%2Fnrd2445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2445%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DSpringthorpe%26aufirst%3DB.%26atitle%3DThe%2520influence%2520of%2520drug-like%2520concepts%2520on%2520decision-making%2520in%2520medicinal%2520chemistry%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D881%26epage%3D890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group">Estrada, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker-Glenn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beresford, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burdick, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominguez, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dotson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drummond, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flagella, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuji, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gill, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halladay, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heffron, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleinheinz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Pichon, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyssikatos, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medhurst, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moffat, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nash, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scearce-Levie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shore, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweeney, Z. K.</span><span> </span><span class="NLM_article-title">Discovery of highly potent, selective, and brain-penetrant aminopyrazole leucine-rich repeat kinase 2 (LRRK2) small molecule inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">921</span><span class="NLM_x">–</span> <span class="NLM_lpage">936</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm401654j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=921-936&author=A.+A.+Estradaauthor=B.+K.+Chanauthor=C.+Baker-Glennauthor=A.+Beresfordauthor=D.+J.+Burdickauthor=M.+Chambersauthor=H.+Chenauthor=S.+L.+Dominguezauthor=J.+Dotsonauthor=J.+Drummondauthor=M.+Flagellaauthor=R.+Fujiauthor=A.+Gillauthor=J.+Halladayauthor=S.+F.+Harrisauthor=T.+P.+Heffronauthor=T.+Kleinheinzauthor=D.+W.+Leeauthor=C.+E.+Le+Pichonauthor=X.+Liuauthor=J.+P.+Lyssikatosauthor=A.+D.+Medhurstauthor=J.+G.+Moffatauthor=K.+Nashauthor=K.+Scearce-Levieauthor=Z.+Shengauthor=D.+G.+Shoreauthor=S.+Wongauthor=S.+Zhangauthor=X.+Zhangauthor=H.+Zhuauthor=Z.+K.+Sweeney&title=Discovery+of+highly+potent%2C+selective%2C+and+brain-penetrant+aminopyrazole+leucine-rich+repeat+kinase+2+%28LRRK2%29+small+molecule+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1021%2Fjm401654j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401654j%26sid%3Dliteratum%253Aachs%26aulast%3DEstrada%26aufirst%3DA.%2BA.%26aulast%3DChan%26aufirst%3DB.%2BK.%26aulast%3DBaker-Glenn%26aufirst%3DC.%26aulast%3DBeresford%26aufirst%3DA.%26aulast%3DBurdick%26aufirst%3DD.%2BJ.%26aulast%3DChambers%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DDominguez%26aufirst%3DS.%2BL.%26aulast%3DDotson%26aufirst%3DJ.%26aulast%3DDrummond%26aufirst%3DJ.%26aulast%3DFlagella%26aufirst%3DM.%26aulast%3DFuji%26aufirst%3DR.%26aulast%3DGill%26aufirst%3DA.%26aulast%3DHalladay%26aufirst%3DJ.%26aulast%3DHarris%26aufirst%3DS.%2BF.%26aulast%3DHeffron%26aufirst%3DT.%2BP.%26aulast%3DKleinheinz%26aufirst%3DT.%26aulast%3DLee%26aufirst%3DD.%2BW.%26aulast%3DLe%2BPichon%26aufirst%3DC.%2BE.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLyssikatos%26aufirst%3DJ.%2BP.%26aulast%3DMedhurst%26aufirst%3DA.%2BD.%26aulast%3DMoffat%26aufirst%3DJ.%2BG.%26aulast%3DNash%26aufirst%3DK.%26aulast%3DScearce-Levie%26aufirst%3DK.%26aulast%3DSheng%26aufirst%3DZ.%26aulast%3DShore%26aufirst%3DD.%2BG.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DSweeney%26aufirst%3DZ.%2BK.%26atitle%3DDiscovery%2520of%2520highly%2520potent%252C%2520selective%252C%2520and%2520brain-penetrant%2520aminopyrazole%2520leucine-rich%2520repeat%2520kinase%25202%2520%2528LRRK2%2529%2520small%2520molecule%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D921%26epage%3D936" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callegari, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cianfronga, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doran, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doran, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbs, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosea, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szewc, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Deusen, J.</span><span> </span><span class="NLM_article-title">Evaluation of cerebrospinal fluid concentration and plasma free concentration as a surrogate measurement for brain free concentration</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1443</span><span class="NLM_x">–</span> <span class="NLM_lpage">1447</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1124%2Fdmd.105.008201" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=16760229" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BD28Xpt1Sksrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2006&pages=1443-1447&author=X.+Liuauthor=B.+J.+Smithauthor=C.+Chenauthor=E.+Callegariauthor=S.+L.+Beckerauthor=X.+Chenauthor=J.+Cianfrongaauthor=A.+C.+Doranauthor=S.+D.+Doranauthor=J.+P.+Gibbsauthor=N.+Hoseaauthor=J.+Liuauthor=F.+R.+Nelsonauthor=M.+A.+Szewcauthor=J.+Van+Deusen&title=Evaluation+of+cerebrospinal+fluid+concentration+and+plasma+free+concentration+as+a+surrogate+measurement+for+brain+free+concentration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of cerebrospinal fluid concentration and plasma free concentration as a surrogate measurement for brain free concentration</span></div><div class="casAuthors">Liu, Xingrong; Smith, Bill J.; Chen, Cuiping; Callegari, Ernesto; Becker, Stacey L.; Chen, Xi; Cianfrogna, Julie; Doran, Angela C.; Doran, Shawn D.; Gibbs, John P.; Hosea, Natilie; Liu, Jianhua; Nelson, Frederick R.; Szewc, Mark A.; Van Deusen, Jeffrey</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1443-1447</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">This study was designed to evaluate the use of cerebrospinal fluid (CSF) drug concn. and plasma unbound concn. (Cu,plasma) to predict brain unbound concn. (Cu,brain).  The concn.-time profiles in CSF, plasma, and brain of seven model compds. were detd. after s.c. administration in rats.  The Cu,brain was estd. from the product of total brain concns. and unbound fractions, which were detd. using brain tissue slice and brain homogenate methods.  For theobromine, theophylline, caffeine, fluoxetine, and propranolol, which represent rapid brain penetration compds. with a simple diffusion mechanism, the ratios of the area under the curve of Cu,brain/CCSF and Cu,brain/Cu,plasma were 0.27 to 1.5 and 0.29 to 2.1, resp., using the brain slice method, and were 0.27 to 2.9 and 0.36 to 3.9, resp., using the brain homogenate method.  A P-glycoprotein substrate, CP-141938 (methoxy-3-[(2-phenyl-piperidinyl-3-amino)-methyl]-phenyl-N-methyl-methane-sulfonamide), had Cu,brain/CCSF and Cu,brain/Cu,plasma ratios of 0.57 and 0.066, using the brain slice method, and 1.1 and 0.13, using the brain homogenate method, resp.  The slow brain-penetrating compd., N[3-(4'-fluorophenyl)-3-(4'-phenylphenoxy)propyl]sarcosine, had Cu,brain/CCSF and Cu,brain/Cu,plasma ratios of 0.94 and 0.12 using the brain slice method and 0.15 and 0.018 using the brain homogenate method, resp.  Therefore, for quick brain penetration with simple diffusion mechanism compds., CCSF and Cu,plasma represent Cu,brain equally well; for efflux substrates or slow brain penetration compds., CCSF appears to be equiv. to or more accurate than Cu,plasma to represent Cu,brain.  Thus, we hypothesize that CCSF is equiv. to or better than Cu,plasma to predict Cu,brain.  This hypothesis is supported by the literature data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpw43dRkq9lx7Vg90H21EOLACvtfcHk0ljieJu4hi7XlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xpt1Sksrc%253D&md5=cef079e1a667dbddf9d5a2f7d01889e8</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1124%2Fdmd.105.008201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.105.008201%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DSmith%26aufirst%3DB.%2BJ.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DCallegari%26aufirst%3DE.%26aulast%3DBecker%26aufirst%3DS.%2BL.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DCianfronga%26aufirst%3DJ.%26aulast%3DDoran%26aufirst%3DA.%2BC.%26aulast%3DDoran%26aufirst%3DS.%2BD.%26aulast%3DGibbs%26aufirst%3DJ.%2BP.%26aulast%3DHosea%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DNelson%26aufirst%3DF.%2BR.%26aulast%3DSzewc%26aufirst%3DM.%2BA.%26aulast%3DVan%2BDeusen%26aufirst%3DJ.%26atitle%3DEvaluation%2520of%2520cerebrospinal%2520fluid%2520concentration%2520and%2520plasma%2520free%2520concentration%2520as%2520a%2520surrogate%2520measurement%2520for%2520brain%2520free%2520concentration%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2006%26volume%3D34%26spage%3D1443%26epage%3D1447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group">Lin, J. H.</span><span> </span><span class="NLM_article-title">CSF as a surrogate for assessing CNS exposure: An industrial perspective</span> <span class="citation_source-journal">Curr. Drug Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">46</span><span class="NLM_x">–</span> <span class="NLM_lpage">59</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.2174%2F138920008783331077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=18220571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFSitbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=46-59&author=J.+H.+Lin&title=CSF+as+a+surrogate+for+assessing+CNS+exposure%3A+An+industrial+perspective"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">CSF as a surrogate for assessing CNS exposure: an industrial perspective</span></div><div class="casAuthors">Lin, Jiunn H.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">46-59</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  For drugs that directly act on targets in the central nervous system (CNS), sufficient drug delivery into the brain is a prerequisite for drug action.  Systemically administered drugs can reach CNS by passage across the endothelium of capillary vasculatures, the so-called blood-brain barrier (BBB).  Literature data suggest that most marketed CNS drugs have good membrane permeability and relatively high plasma unbound fraction, but are not good P-glycoprotein (P-gp) substrates.  Therefore, it is important to use the in vitro parameters of P-gp function activity, membrane permeability and plasma unbound fraction as key criteria for lead optimization during the early stage of drug discovery.  Evidence from preclin. and clin. studies suggests that drug concn. in cerebrospinal fluid (CSF) appears to be reasonably accurate in predicting unbound drug concn. in the brain.  Therefore, CSF can be used as a useful surrogate for in vivo assessment of CNS exposure and provides an important basis for the selection of drug candidates for entry into development.  However, it is important to point out that CSF drug concn. is not always an accurate surrogate for predicting unbound drug concn. in the brain.  Depending on the physicochem. properties of drugs and the site/timing of CSF sampling, the unbound drug concn. at the biophase within the brain could differ significantly from the corresponding CSF drug concn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrft1JtBu-LmrVg90H21EOLACvtfcHk0ljieJu4hi7XlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFSitbo%253D&md5=cfea50f80a3bcf592477e8ecb8825084</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.2174%2F138920008783331077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920008783331077%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DJ.%2BH.%26atitle%3DCSF%2520as%2520a%2520surrogate%2520for%2520assessing%2520CNS%2520exposure%253A%2520An%2520industrial%2520perspective%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2008%26volume%3D9%26spage%3D46%26epage%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group">Reith, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamborough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jandu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreotti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mensah, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dossang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">GSK2578215A; a potent and highly selective 2-arylmethyloxy-5-substituent-N-arylbenzamide LRRK2 kinase inhibitor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">5625</span><span class="NLM_x">–</span> <span class="NLM_lpage">5629</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=5625-5629&author=A.+D.+Reithauthor=P.+Bamboroughauthor=K.+Janduauthor=D.+Andreottiauthor=L.+Mensahauthor=P.+Dossangauthor=H.+G.+Choiauthor=X.+Dengauthor=J.+Zhangauthor=D.+R.+Alessiauthor=N.+S.+Gray&title=GSK2578215A%3B+a+potent+and+highly+selective+2-arylmethyloxy-5-substituent-N-arylbenzamide+LRRK2+kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReith%26aufirst%3DA.%2BD.%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DJandu%26aufirst%3DK.%26aulast%3DAndreotti%26aufirst%3DD.%26aulast%3DMensah%26aufirst%3DL.%26aulast%3DDossang%26aufirst%3DP.%26aulast%3DChoi%26aufirst%3DH.%2BG.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DGSK2578215A%253B%2520a%2520potent%2520and%2520highly%2520selective%25202-arylmethyloxy-5-substituent-N-arylbenzamide%2520LRRK2%2520kinase%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D5625%26epage%3D5629" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group">Cirnaru, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marte, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belluzzi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russo, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabrielli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Longo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arcuri, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murru, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bubacco, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matteoli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedele, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sala, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Passafaro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morari, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greggio, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onofri, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piccoli, G.</span><span> </span><span class="NLM_article-title">LRRK2 kinase activity regulates synaptic vesicle trafficking and neurotransmitter release through modulation of LRRK2 macro-molecular complex</span> <span class="citation_source-journal">Front. Mol. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">49</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.3389%2Ffnmol.2014.00049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=24904275" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVaqsLzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2014&pages=49&author=M.+D.+Cirnaruauthor=A.+Marteauthor=E.+Belluzziauthor=I.+Russoauthor=M.+Gabrielliauthor=F.+Longoauthor=L.+Arcuriauthor=L.+Murruauthor=L.+Bubaccoauthor=M.+Matteoliauthor=E.+Fedeleauthor=C.+Salaauthor=M.+Passafaroauthor=M.+Morariauthor=E.+Greggioauthor=F.+Onofriauthor=G.+Piccoli&title=LRRK2+kinase+activity+regulates+synaptic+vesicle+trafficking+and+neurotransmitter+release+through+modulation+of+LRRK2+macro-molecular+complex"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">LRRK2 kinase activity regulates synaptic vesicle trafficking and neurotransmitter release through modulation of LRRK2 macro-molecular complex</span></div><div class="casAuthors">Cirnaru, Maria D.; Marte, Antonella; Belluzzi, Elisa; Russo, Isabella; Gabrielli, Martina; Longo, Francesco; Arcuri, Ludovico; Murru, Luca; Bubacco, Luigi; Matteoli, Michela; Fedele, Ernesto; Sala, Carlo; Passafaro, Maria; Morari, Michele; Greggio, Elisa; Onofri, Franco; Piccoli, Giovanni</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Molecular Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">49/1-49/12, 12 pp.</span>CODEN:
                <span class="NLM_cas:coden">FMNRAJ</span>;
        ISSN:<span class="NLM_cas:issn">1662-5099</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Mutations in Leucine-rich repeat kinase 2 gene (LRRK2) are assocd. with familial and sporadic Parkinson's disease (PD).  LRRK2 is a complex protein that consists of multiple domains executing several functions, including GTP hydrolysis, kinase activity, and protein binding.  Robust evidence suggests that LRRK2 acts at the synaptic site as a mol. hub connecting synaptic vesicles to cytoskeletal elements via a complex panel of protein-protein interactions.  Here we investigated the impact of pharmacol. inhibition of LRRK2 kinase activity on synaptic function.  Acute treatment with LRRK2 inhibitors reduced the frequency of spontaneous currents, the rate of synaptic vesicle trafficking and the release of neurotransmitter from isolated synaptosomes.  The investigation of complementary models lacking LRRK2 expression allowed us to exclude potential off-side effects of kinase inhibitors on synaptic functions.  Next we studied whether kinase inhibition affects LRRK2 heterologous interactions.  We found that the binding among LRRK2, presynaptic proteins and synaptic vesicles is affected by kinase inhibition.  Our results suggest that LRRK2 kinase activity influences synaptic vesicle release via modulation of LRRK2 macro-mol. complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiZWGhHzhQ5rVg90H21EOLACvtfcHk0lgZPTR3AD-k-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVaqsLzK&md5=06ff91fbc02b7a90a3c01ac241801643</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.3389%2Ffnmol.2014.00049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnmol.2014.00049%26sid%3Dliteratum%253Aachs%26aulast%3DCirnaru%26aufirst%3DM.%2BD.%26aulast%3DMarte%26aufirst%3DA.%26aulast%3DBelluzzi%26aufirst%3DE.%26aulast%3DRusso%26aufirst%3DI.%26aulast%3DGabrielli%26aufirst%3DM.%26aulast%3DLongo%26aufirst%3DF.%26aulast%3DArcuri%26aufirst%3DL.%26aulast%3DMurru%26aufirst%3DL.%26aulast%3DBubacco%26aufirst%3DL.%26aulast%3DMatteoli%26aufirst%3DM.%26aulast%3DFedele%26aufirst%3DE.%26aulast%3DSala%26aufirst%3DC.%26aulast%3DPassafaro%26aufirst%3DM.%26aulast%3DMorari%26aufirst%3DM.%26aulast%3DGreggio%26aufirst%3DE.%26aulast%3DOnofri%26aufirst%3DF.%26aulast%3DPiccoli%26aufirst%3DG.%26atitle%3DLRRK2%2520kinase%2520activity%2520regulates%2520synaptic%2520vesicle%2520trafficking%2520and%2520neurotransmitter%2520release%2520through%2520modulation%2520of%2520LRRK2%2520macro-molecular%2520complex%26jtitle%3DFront.%2520Mol.%2520Neurosci.%26date%3D2014%26volume%3D7%26spage%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group">Nichols, P. L.; Eatherton, A. J.; Bamborough, P.; Jandu, K. S.; Philps, O. J.; Andreotti, D.</span><span> </span><span class="NLM_article-title">Novel compounds</span>. WO 2011/038572 A1,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=P.+L.+Nichols&author=A.+J.+Eatherton&author=P.+Bamborough&author=K.+S.+Jandu&author=O.+J.+Philps&author=D.+Andreotti&title=Novel+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DNichols%26aufirst%3DP.%2BL.%26atitle%3DNovel%2520compounds%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group">Afsari, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hentzer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nippe, O. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, C. J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wade, A. R.</span><span> </span><span class="NLM_article-title">Abnormal visual gain control in a Parkinson’s disease model</span> <span class="citation_source-journal">Hum. Mol. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4465</span><span class="NLM_x">–</span> <span class="NLM_lpage">4478</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1093%2Fhmg%2Fddu159" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=24718285" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1OrsbzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2014&pages=4465-4478&author=F.+Afsariauthor=K.+V.+Christensenauthor=G.+P.+Smithauthor=M.+Hentzerauthor=O.+M.+Nippeauthor=C.+J.+H.+Elliottauthor=A.+R.+Wade&title=Abnormal+visual+gain+control+in+a+Parkinson%E2%80%99s+disease+model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Abnormal visual gain control in a Parkinson's disease model</span></div><div class="casAuthors">Afsari, Farinaz; Christensen, Kenneth V.; Smith, Garrick Paul; Hentzer, Morten; Nippe, Olivia M.; Elliott, Christopher J. H.; Wade, Alex R.</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4465-4478</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Our understanding of Parkinson's disease (PD) has been revolutionized by the discovery of disease-causing genetic mutations.  The most common of these is the G2019S mutation in the LRRK2 kinase gene, which leads to increased kinase activity.  However, the link between increased kinase activity and PD is unclear.  Previously, we showed that dopaminergic expression of the human LRRK2-G2019S transgene in flies led to an activity-dependent loss of vision in older animals and we hypothesized that this may have been preceded by a failure to regulate neuronal activity correctly in younger animals.  To test this hypothesis, we used a sensitive measure of visual function based on frequency-tagged steady-state visually evoked potentials.  Spectral anal. allowed us to identify signals from multiple levels of the fly visual system and wild-type visual response curves were qual. similar to those from human cortex.  Dopaminergic expression of hLRRK2-G2019S increased contrast sensitivity throughout the retinal network.  To test whether this was due to increased kinase activity, we fed Drosophila with kinase inhibitors targeted at LRRK2.  Contrast sensitivity in both day 1 and day 14 flies was normalized by a novel LRRK2 kinase inhibitor 'BMPPB-32'.  Biochem. and cellular assays suggested that BMPPB-32 would be a more specific kinase inhibitor than LRRK2-IN-1.  We confirmed this in vivo, finding that dLRRK- null flies show large off-target effects with LRRK2-IN-1 but not BMPPB-32.  Our data link the increased Kinase activity of the G2019S-LRRK2 mutation to neuronal dysfunction and demonstrate the power of the Drosophila visual system in assaying the neurol. effects of genetic diseases and therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpa_glJRmFOqrVg90H21EOLACvtfcHk0lhaNQbT2RAKTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1OrsbzF&md5=8804121c354a2d548151649497b52bdb</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddu159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddu159%26sid%3Dliteratum%253Aachs%26aulast%3DAfsari%26aufirst%3DF.%26aulast%3DChristensen%26aufirst%3DK.%2BV.%26aulast%3DSmith%26aufirst%3DG.%2BP.%26aulast%3DHentzer%26aufirst%3DM.%26aulast%3DNippe%26aufirst%3DO.%2BM.%26aulast%3DElliott%26aufirst%3DC.%2BJ.%2BH.%26aulast%3DWade%26aufirst%3DA.%2BR.%26atitle%3DAbnormal%2520visual%2520gain%2520control%2520in%2520a%2520Parkinson%25E2%2580%2599s%2520disease%2520model%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2014%26volume%3D23%26spage%3D4465%26epage%3D4478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group">Garofalo, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aubele, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brigham, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chian, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franzini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldbach, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwong, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Motter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Probst, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruslim, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sham, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truong, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, X. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, Z.</span><span> </span><span class="NLM_article-title">Discovery of 4-alkylamino-7-aryl-3-cyanoquinoline LRRK2 kinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1974</span><span class="NLM_x">–</span> <span class="NLM_lpage">1977</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=1974-1977&author=A.+W.+Garofaloauthor=M.+Adlerauthor=D.+L.+Aubeleauthor=E.+F.+Brighamauthor=D.+Chianauthor=M.+Franziniauthor=E.+Goldbachauthor=G.+T.+Kwongauthor=R.+Motterauthor=G.+D.+Probstauthor=K.+P.+Quinnauthor=L.+Ruslimauthor=H.+L.+Shamauthor=D.+Tamauthor=P.+Tanakaauthor=A.+P.+Truongauthor=X.+M.+Yeauthor=Z.+Ren&title=Discovery+of+4-alkylamino-7-aryl-3-cyanoquinoline+LRRK2+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGarofalo%26aufirst%3DA.%2BW.%26aulast%3DAdler%26aufirst%3DM.%26aulast%3DAubele%26aufirst%3DD.%2BL.%26aulast%3DBrigham%26aufirst%3DE.%2BF.%26aulast%3DChian%26aufirst%3DD.%26aulast%3DFranzini%26aufirst%3DM.%26aulast%3DGoldbach%26aufirst%3DE.%26aulast%3DKwong%26aufirst%3DG.%2BT.%26aulast%3DMotter%26aufirst%3DR.%26aulast%3DProbst%26aufirst%3DG.%2BD.%26aulast%3DQuinn%26aufirst%3DK.%2BP.%26aulast%3DRuslim%26aufirst%3DL.%26aulast%3DSham%26aufirst%3DH.%2BL.%26aulast%3DTam%26aufirst%3DD.%26aulast%3DTanaka%26aufirst%3DP.%26aulast%3DTruong%26aufirst%3DA.%2BP.%26aulast%3DYe%26aufirst%3DX.%2BM.%26aulast%3DRen%26aufirst%3DZ.%26atitle%3DDiscovery%2520of%25204-alkylamino-7-aryl-3-cyanoquinoline%2520LRRK2%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D1974%26epage%3D1977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group">Troxler, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenidge, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmermann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desrayaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Druckes, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schweizer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rovelli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimshek, D. R.</span><span> </span><span class="NLM_article-title">Discovery of novel indolinone-based, potent, selective and brain penetrant inhibitors of LRRK2</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4085</span><span class="NLM_x">–</span> <span class="NLM_lpage">4090</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4085-4090&author=T.+Troxlerauthor=P.+Greenidgeauthor=K.+Zimmermannauthor=S.+Desrayaudauthor=P.+Druckesauthor=T.+Schweizerauthor=D.+Staufferauthor=G.+Rovelliauthor=D.+R.+Shimshek&title=Discovery+of+novel+indolinone-based%2C+potent%2C+selective+and+brain+penetrant+inhibitors+of+LRRK2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTroxler%26aufirst%3DT.%26aulast%3DGreenidge%26aufirst%3DP.%26aulast%3DZimmermann%26aufirst%3DK.%26aulast%3DDesrayaud%26aufirst%3DS.%26aulast%3DDruckes%26aufirst%3DP.%26aulast%3DSchweizer%26aufirst%3DT.%26aulast%3DStauffer%26aufirst%3DD.%26aulast%3DRovelli%26aufirst%3DG.%26aulast%3DShimshek%26aufirst%3DD.%2BR.%26atitle%3DDiscovery%2520of%2520novel%2520indolinone-based%252C%2520potent%252C%2520selective%2520and%2520brain%2520penetrant%2520inhibitors%2520of%2520LRRK2%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D4085%26epage%3D4090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group">Nichols, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dzamko, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutti, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantley, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moran, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamborough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span> </span><span class="NLM_article-title">Substrate specificity and inhibitors of LRRK2, a protein kinase mutated in Parkinson’s disease</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">424</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">60</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=424&publication_year=2009&pages=47-60&author=R.+J.+Nicholsauthor=N.+Dzamkoauthor=J.+E.+Huttiauthor=L.+C.+Cantleyauthor=M.+Deakauthor=J.+Moranauthor=P.+Bamboroughauthor=A.+D.+Reithauthor=D.+R.+Alessi&title=Substrate+specificity+and+inhibitors+of+LRRK2%2C+a+protein+kinase+mutated+in+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNichols%26aufirst%3DR.%2BJ.%26aulast%3DDzamko%26aufirst%3DN.%26aulast%3DHutti%26aufirst%3DJ.%2BE.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26aulast%3DDeak%26aufirst%3DM.%26aulast%3DMoran%26aufirst%3DJ.%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DReith%26aufirst%3DA.%2BD.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26atitle%3DSubstrate%2520specificity%2520and%2520inhibitors%2520of%2520LRRK2%252C%2520a%2520protein%2520kinase%2520mutated%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DBiochem.%2520J.%26date%3D2009%26volume%3D424%26spage%3D47%26epage%3D60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group">Dzamko, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hentati, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prescott, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, R. J.</span><span> </span><span class="NLM_article-title">Inhibition of LRRK2 kinase activity leads to dephosphorylation of Ser(910)/Ser(935), disruption of 14-3-3 binding and altered cytoplasmic localization</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">430</span><span class="NLM_x">, </span> <span class="NLM_fpage">405</span><span class="NLM_x">–</span> <span class="NLM_lpage">413</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=430&publication_year=2010&pages=405-413&author=N.+Dzamkoauthor=M.+Deakauthor=F.+Hentatiauthor=A.+D.+Reithauthor=A.+R.+Prescottauthor=D.+R.+Alessiauthor=R.+J.+Nichols&title=Inhibition+of+LRRK2+kinase+activity+leads+to+dephosphorylation+of+Ser%28910%29%2FSer%28935%29%2C+disruption+of+14-3-3+binding+and+altered+cytoplasmic+localization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDzamko%26aufirst%3DN.%26aulast%3DDeak%26aufirst%3DM.%26aulast%3DHentati%26aufirst%3DF.%26aulast%3DReith%26aufirst%3DA.%2BD.%26aulast%3DPrescott%26aufirst%3DA.%2BR.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DNichols%26aufirst%3DR.%2BJ.%26atitle%3DInhibition%2520of%2520LRRK2%2520kinase%2520activity%2520leads%2520to%2520dephosphorylation%2520of%2520Ser%2528910%2529%252FSer%2528935%2529%252C%2520disruption%2520of%252014-3-3%2520binding%2520and%2520altered%2520cytoplasmic%2520localization%26jtitle%3DBiochem.%2520J.%26date%3D2010%26volume%3D430%26spage%3D405%26epage%3D413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group">Chan, B. K.; Chen, H.; Estrada, A.; Shore, D.; Sweeney, Z.; McIver, E. G.</span><span> </span><span class="NLM_article-title">Compounds and their administration for treating a neurodegerative disease as well as a method for identifying a compound capable of inhibiting a kinase, such as LRRK2</span>. US 8569281 B2,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=B.+K.+Chan&author=H.+Chen&author=A.+Estrada&author=D.+Shore&author=Z.+Sweeney&author=E.+G.+McIver&title=Compounds+and+their+administration+for+treating+a+neurodegerative+disease+as+well+as+a+method+for+identifying+a+compound+capable+of+inhibiting+a+kinase%2C+such+as+LRRK2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DB.%2BK.%26atitle%3DCompounds%2520and%2520their%2520administration%2520for%2520treating%2520a%2520neurodegerative%2520disease%2520as%2520well%2520as%2520a%2520method%2520for%2520identifying%2520a%2520compound%2520capable%2520of%2520inhibiting%2520a%2520kinase%252C%2520such%2520as%2520LRRK2%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group">Chan, B.; Estrada, A.; Shore, D.; Sweeney, Z.</span><span> </span><span class="NLM_article-title">Pyrazolopyridines for treatment of Parkinson’s disease</span>. WO 2013/139882 A1,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=B.+Chan&author=A.+Estrada&author=D.+Shore&author=Z.+Sweeney&title=Pyrazolopyridines+for+treatment+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DB.%26atitle%3DPyrazolopyridines%2520for%2520treatment%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group">Vankayalapati, H.; Appalaneni, R. P.; Reddy, Y. V. K.</span><span> </span><span class="NLM_article-title">Substituted 5-(pyrazin-2-yl)-1H-pyrazolo[3,4-<i>B</i>]pyridine and pyrazolo[3,4-<i>B</i>]pyridine derivatives as protein kinase inhibitors</span>. WO 2012/135631 A1,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=H.+Vankayalapati&author=R.+P.+Appalaneni&author=Y.+V.+K.+Reddy&title=Substituted+5-%28pyrazin-2-yl%29-1H-pyrazolo%5B3%2C4-B%5Dpyridine+and+pyrazolo%5B3%2C4-B%5Dpyridine+derivatives+as+protein+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DVankayalapati%26aufirst%3DH.%26atitle%3DSubstituted%25205-%2528pyrazin-2-yl%2529-1H-pyrazolo%255B3%252C4-B%255Dpyridine%2520and%2520pyrazolo%255B3%252C4-B%255Dpyridine%2520derivatives%2520as%2520protein%2520kinase%2520inhibitors%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group">Almstetter, M.; Thormann, M.; Treml, A.; Koestler, R.; Yehia, N.</span><span> </span><span class="NLM_article-title">Heterocyclic compounds as kinase inhibitors</span>. WO 2012/143143 A1,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=M.+Almstetter&author=M.+Thormann&author=A.+Treml&author=R.+Koestler&author=N.+Yehia&title=Heterocyclic+compounds+as+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAlmstetter%26aufirst%3DM.%26atitle%3DHeterocyclic%2520compounds%2520as%2520kinase%2520inhibitors%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group">Almstetter, M.; Thormann, M.; Treml, A.; Traube, N.</span><span> </span><span class="NLM_article-title">Pyrazolo[4,3-D]pyrimidines useful as kinase inhibitors</span>. WO 2012/143144 A1,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=M.+Almstetter&author=M.+Thormann&author=A.+Treml&author=N.+Traube&title=Pyrazolo%5B4%2C3-D%5Dpyrimidines+useful+as+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAlmstetter%26aufirst%3DM.%26atitle%3DPyrazolo%255B4%252C3-D%255Dpyrimidines%2520useful%2520as%2520kinase%2520inhibitors%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group">Chan, B.; Estrada, A.; Sweeney, Z.; McIver, E. G.</span><span> </span><span class="NLM_article-title">Pyrazolopyridines as inhibitors of the kinase LRRK2</span>. WO 2011/141756 A1,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=B.+Chan&author=A.+Estrada&author=Z.+Sweeney&author=E.+G.+McIver&title=Pyrazolopyridines+as+inhibitors+of+the+kinase+LRRK2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DB.%26atitle%3DPyrazolopyridines%2520as%2520inhibitors%2520of%2520the%2520kinase%2520LRRK2%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group">McIver, E. G.; Smiljanic, E.; Harding, D. J.; Hough, J.</span><span> </span><span class="NLM_article-title">Compounds</span>. WO 2010/106333 A1,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=E.+G.+McIver&author=E.+Smiljanic&author=D.+J.+Harding&author=J.+Hough&title=Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMcIver%26aufirst%3DE.%2BG.%26atitle%3DCompounds%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group">Henderson, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kormos, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayward, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coffman, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jasti, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurumbail, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noell, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Needle, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steyn, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houle, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirst, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galatsis, P.</span><span> </span><span class="NLM_article-title">Discovery and preclinical profiling of 3-[4-(morpholin-4-yl)-7H-pyrrolo[2,3-<i>d</i>]pyrimidin-5-yl]benzonitrile (PF-06447475), a highly potent, selective, brain penetrant, and in vivo active LRRK2 kinase inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">419</span><span class="NLM_x">–</span> <span class="NLM_lpage">432</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm5014055" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=419-432&author=J.+L.+Hendersonauthor=B.+L.+Kormosauthor=M.+M.+Haywardauthor=K.+J.+Coffmanauthor=J.+Jastiauthor=R.+G.+Kurumbailauthor=T.+T.+Wagerauthor=P.+R.+Verhoestauthor=G.+S.+Noellauthor=Y.+Chenauthor=E.+Needleauthor=Z.+Bergerauthor=S.+J.+Steynauthor=C.+Houleauthor=W.+D.+Hirstauthor=P.+Galatsis&title=Discovery+and+preclinical+profiling+of+3-%5B4-%28morpholin-4-yl%29-7H-pyrrolo%5B2%2C3-d%5Dpyrimidin-5-yl%5Dbenzonitrile+%28PF-06447475%29%2C+a+highly+potent%2C+selective%2C+brain+penetrant%2C+and+in+vivo+active+LRRK2+kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1021%2Fjm5014055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5014055%26sid%3Dliteratum%253Aachs%26aulast%3DHenderson%26aufirst%3DJ.%2BL.%26aulast%3DKormos%26aufirst%3DB.%2BL.%26aulast%3DHayward%26aufirst%3DM.%2BM.%26aulast%3DCoffman%26aufirst%3DK.%2BJ.%26aulast%3DJasti%26aufirst%3DJ.%26aulast%3DKurumbail%26aufirst%3DR.%2BG.%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DNoell%26aufirst%3DG.%2BS.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DNeedle%26aufirst%3DE.%26aulast%3DBerger%26aufirst%3DZ.%26aulast%3DSteyn%26aufirst%3DS.%2BJ.%26aulast%3DHoule%26aufirst%3DC.%26aulast%3DHirst%26aufirst%3DW.%2BD.%26aulast%3DGalatsis%26aufirst%3DP.%26atitle%3DDiscovery%2520and%2520preclinical%2520profiling%2520of%25203-%255B4-%2528morpholin-4-yl%2529-7H-pyrrolo%255B2%252C3-d%255Dpyrimidin-5-yl%255Dbenzonitrile%2520%2528PF-06447475%2529%252C%2520a%2520highly%2520potent%252C%2520selective%252C%2520brain%2520penetrant%252C%2520and%2520in%2520vivo%2520active%2520LRRK2%2520kinase%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D419%26epage%3D432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group">Galatsis, P.; Hayward, M. M.; Kormos, B. L.; Wager, T. T.; Zhang, L.; Stepan, A. F.; Henderson, J. L.; Kurumbail, R. G.; Verhoest, P. R.</span><span> </span><span class="NLM_article-title">Novel 4-(substituted-amino)-7H-pyrrolo[2,3-d]pyrimidines as LRRK2 inhibitors</span>. WO 2014/001973 A1,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=P.+Galatsis&author=M.+M.+Hayward&author=B.+L.+Kormos&author=T.+T.+Wager&author=L.+Zhang&author=A.+F.+Stepan&author=J.+L.+Henderson&author=R.+G.+Kurumbail&author=P.+R.+Verhoest&title=Novel+4-%28substituted-amino%29-7H-pyrrolo%5B2%2C3-d%5Dpyrimidines+as+LRRK2+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGalatsis%26aufirst%3DP.%26atitle%3DNovel%25204-%2528substituted-amino%2529-7H-pyrrolo%255B2%252C3-d%255Dpyrimidines%2520as%2520LRRK2%2520inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group">Patricelli, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomanbhoy, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagannathan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aban, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okerberg, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herring, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nordin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weissig, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.-D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozarich, J. W.</span><span> </span><span class="NLM_article-title">In situ kinase profiling reveals functionally relevant properties of native kinases</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">699</span><span class="NLM_x">–</span> <span class="NLM_lpage">710</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1016%2Fj.chembiol.2011.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=21700206" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotVejtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=699-710&author=M.+P.+Patricelliauthor=T.+K.+Nomanbhoyauthor=J.+Wuauthor=H.+Brownauthor=D.+Zhouauthor=J.+Zhangauthor=S.+Jagannathanauthor=A.+Abanauthor=E.+Okerbergauthor=C.+Herringauthor=B.+Nordinauthor=H.+Weissigauthor=Q.+Yangauthor=J.-D.+Leeauthor=N.+S.+Grayauthor=J.+W.+Kozarich&title=In+situ+kinase+profiling+reveals+functionally+relevant+properties+of+native+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">In Situ Kinase Profiling Reveals Functionally Relevant Properties of Native Kinases</span></div><div class="casAuthors">Patricelli, Matthew P.; Nomanbhoy, Tyzoon K.; Wu, Jiangyue; Brown, Heidi; Zhou, David; Zhang, Jianming; Jagannathan, Subadhra; Aban, Arwin; Okerberg, Eric; Herring, Chris; Nordin, Brian; Weissig, Helge; Yang, Qingkai; Lee, Jiing-Dwan; Gray, Nathanael S.; Kozarich, John W.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">699-710</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Protein kinases are intensely studied mediators of cellular signaling, yet important questions remain regarding their regulation and in vivo properties.  Here, we use a probe-based chemoprotemics platform to profile several well studied kinase inhibitors against >200 kinases in native cell proteomes and reveal biol. targets for some of these inhibitors.  Several striking differences were identified between native and recombinant kinase inhibitory profiles, in particular, for the Raf kinases.  The native kinase binding profiles presented here closely mirror the cellular activity of these inhibitors, even when the inhibition profiles differ dramatically from recombinant assay results.  Addnl., Raf activation events could be detected on live cell treatment with inhibitors.  These studies highlight the complexities of protein kinase behavior in the cellular context and demonstrate that profiling with only recombinant/purified enzymes can be misleading.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopb21npuaC_rVg90H21EOLACvtfcHk0lhUSU0jErI1Yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotVejtbo%253D&md5=dda091b895850c95131f80c3aba9e8c7</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2011.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2011.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DPatricelli%26aufirst%3DM.%2BP.%26aulast%3DNomanbhoy%26aufirst%3DT.%2BK.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DBrown%26aufirst%3DH.%26aulast%3DZhou%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DJagannathan%26aufirst%3DS.%26aulast%3DAban%26aufirst%3DA.%26aulast%3DOkerberg%26aufirst%3DE.%26aulast%3DHerring%26aufirst%3DC.%26aulast%3DNordin%26aufirst%3DB.%26aulast%3DWeissig%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DQ.%26aulast%3DLee%26aufirst%3DJ.-D.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DKozarich%26aufirst%3DJ.%2BW.%26atitle%3DIn%2520situ%2520kinase%2520profiling%2520reveals%2520functionally%2520relevant%2520properties%2520of%2520native%2520kinases%26jtitle%3DChem.%2520Biol.%26date%3D2011%26volume%3D18%26spage%3D699%26epage%3D710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group">Deng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greggio, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sluch, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beilina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cookson, M. R.</span><span> </span><span class="NLM_article-title">Structure of the ROC domain from the Parkinson’s disease-associated leucine-rich repeat kinase 2 reveals a dimeric GTPase</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">1499</span><span class="NLM_x">–</span> <span class="NLM_lpage">1504</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=1499-1504&author=J.+Dengauthor=P.+A.+Lewisauthor=E.+Greggioauthor=E.+Sluchauthor=A.+Beilinaauthor=M.+R.+Cookson&title=Structure+of+the+ROC+domain+from+the+Parkinson%E2%80%99s+disease-associated+leucine-rich+repeat+kinase+2+reveals+a+dimeric+GTPase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DJ.%26aulast%3DLewis%26aufirst%3DP.%2BA.%26aulast%3DGreggio%26aufirst%3DE.%26aulast%3DSluch%26aufirst%3DE.%26aulast%3DBeilina%26aufirst%3DA.%26aulast%3DCookson%26aufirst%3DM.%2BR.%26atitle%3DStructure%2520of%2520the%2520ROC%2520domain%2520from%2520the%2520Parkinson%25E2%2580%2599s%2520disease-associated%2520leucine-rich%2520repeat%2520kinase%25202%2520reveals%2520a%2520dimeric%2520GTPase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2008%26volume%3D105%26spage%3D1499%26epage%3D1504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group">Li, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voulalas, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassan, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacKerell, A. D.,  Jr</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, W. W.</span><span> </span><span class="NLM_article-title">Novel LRRK2 GTP-binding inhibitors reduced degeneration in Parkinson’s disease cell and mouse models</span> <span class="citation_source-journal">Hum. Mol. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">6212</span><span class="NLM_x">–</span> <span class="NLM_lpage">6222</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1093%2Fhmg%2Fddu341" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=24993787" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A280%3ADC%252BC2cfpsFWisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2014&pages=6212-6222&author=T.+Liauthor=D.+Yangauthor=S.+Zhongauthor=J.+M.+Thomasauthor=F.+Xueauthor=J.+Liuauthor=L.+Kongauthor=P.+Voulalasauthor=H.+E.+Hassanauthor=J.-S.+Parkauthor=A.+D.+MacKerellauthor=W.+W.+Smith&title=Novel+LRRK2+GTP-binding+inhibitors+reduced+degeneration+in+Parkinson%E2%80%99s+disease+cell+and+mouse+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Novel LRRK2 GTP-binding inhibitors reduced degeneration in Parkinson's disease cell and mouse models</span></div><div class="casAuthors">Li Tianxia; Yang Dejun; Zhong Shijun; Thomas Joseph M; Xue Fengtian; Liu Jingnan; Kong Lingbo; Voulalas Pamela; Hassan Hazem E; Park Jae-Sung; MacKerell Alexander D Jr; Smith Wanli W</div><div class="citationInfo"><span class="NLM_cas:title">Human molecular genetics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6212-22</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Mutations in the leucine-rich repeat kinase-2 (LRRK2) gene cause autosomal-dominant Parkinson's disease (PD) and contribute to sporadic PD.  LRRK2 contains Guanosine-5'-triphosphate (GTP) binding, GTPase and kinase activities that have been implicated in the neuronal degeneration of PD pathogenesis, making LRRK2, a potential drug target.  To date, there is no disease-modifying drug to slow the neuronal degeneration of PD and no published LRRK2 GTP domain inhibitor.  Here, the biological functions of two novel GTP-binding inhibitors of LRRK2 were examined in PD cell and mouse models.  Through a combination of computer-aided drug design (CADD) and LRRK2 bio-functional screens, two novel compounds, 68: and 70: , were shown to reduce LRRK2 GTP binding and to inhibit LRRK2 kinase activity in vitro and in cultured cell assays.  Moreover, these two compounds attenuated neuronal degeneration in human SH-SY5Y neuroblastoma cells and mouse primary neurons expressing mutant LRRK2 variants.  Although both compounds inhibited LRRK2 kinase activity and reduced neuronal degeneration, solubility problems with 70: prevented further testing in mice.  Thus, only 68: was tested in a LRRK2-based lipopolysaccharide (LPS)-induced pre-inflammatory mouse model. 68: reduced LRRK2 GTP-binding activity and kinase activity in brains of LRRK2 transgenic mice after intraperitoneal injection.  Moreover, LPS induced LRRK2 upregulation and microglia activation in mouse brains.  These findings suggest that disruption of GTP binding to LRRK2 represents a potential novel therapeutic approach for PD intervention and that these novel GTP-binding inhibitors provide both tools and lead compounds for future drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR8AnCN662wR90Q2ypr7jHkfW6udTcc2ebVY9GrEYHWN7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cfpsFWisA%253D%253D&md5=492b71c9c7d37fe2eaca4568076bb25c</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddu341&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddu341%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DT.%26aulast%3DYang%26aufirst%3DD.%26aulast%3DZhong%26aufirst%3DS.%26aulast%3DThomas%26aufirst%3DJ.%2BM.%26aulast%3DXue%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DKong%26aufirst%3DL.%26aulast%3DVoulalas%26aufirst%3DP.%26aulast%3DHassan%26aufirst%3DH.%2BE.%26aulast%3DPark%26aufirst%3DJ.-S.%26aulast%3DMacKerell%26aufirst%3DA.%2BD.%26aulast%3DSmith%26aufirst%3DW.%2BW.%26atitle%3DNovel%2520LRRK2%2520GTP-binding%2520inhibitors%2520reduced%2520degeneration%2520in%2520Parkinson%25E2%2580%2599s%2520disease%2520cell%2520and%2520mouse%2520models%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2014%26volume%3D23%26spage%3D6212%26epage%3D6222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group">Gardet, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benita, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sands, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballester, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korzenik, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rioux, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daly, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xavier, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podolsky, D. K.</span><span> </span><span class="NLM_article-title">LRRK2 is involved in the IFN-gamma response and host response to pathogens</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">185</span><span class="NLM_x">, </span> <span class="NLM_fpage">5577</span><span class="NLM_x">–</span> <span class="NLM_lpage">5585</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=185&publication_year=2010&pages=5577-5585&author=A.+Gardetauthor=Y.+Benitaauthor=C.+Liauthor=B.+E.+Sandsauthor=I.+Ballesterauthor=C.+Stevensauthor=J.+R.+Korzenikauthor=J.+D.+Riouxauthor=M.+J.+Dalyauthor=R.+J.+Xavierauthor=D.+K.+Podolsky&title=LRRK2+is+involved+in+the+IFN-gamma+response+and+host+response+to+pathogens"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGardet%26aufirst%3DA.%26aulast%3DBenita%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DSands%26aufirst%3DB.%2BE.%26aulast%3DBallester%26aufirst%3DI.%26aulast%3DStevens%26aufirst%3DC.%26aulast%3DKorzenik%26aufirst%3DJ.%2BR.%26aulast%3DRioux%26aufirst%3DJ.%2BD.%26aulast%3DDaly%26aufirst%3DM.%2BJ.%26aulast%3DXavier%26aufirst%3DR.%2BJ.%26aulast%3DPodolsky%26aufirst%3DD.%2BK.%26atitle%3DLRRK2%2520is%2520involved%2520in%2520the%2520IFN-gamma%2520response%2520and%2520host%2520response%2520to%2520pathogens%26jtitle%3DJ.%2520Immunol.%26date%3D2010%26volume%3D185%26spage%3D5577%26epage%3D5585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="note"><p class="first last">G7080 (<b>5</b>), GNE-7915 (<b>7</b>), GNE-0877 (<b>8</b>), and GNE-9605 (<b>9</b>) can be requested through the Genentech Research Contracts and Reagents Program. GSK2578215A (<b>10</b>, CAS = 1285515-21-0); PF-06447475 (<b>14</b>, CAS = 1527473-33-1).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32a','cit32b','cit32c'],'ref33':['cit33'],'ref34':['cit34a','cit34b'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43a','cit43b'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':[]}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 22 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Zhouling Xie, Xiaoxiao Yang, Yajun Duan, Jihong Han, <span class="NLM_string-name hlFld-ContribAuthor">Chenzhong Liao</span>. </span><span class="cited-content_cbyCitation_article-title">Small-Molecule Kinase Inhibitors for the Treatment of Nononcologic Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (3)
                                     , 1283-1345. <a href="https://doi.org/10.1021/acs.jmedchem.0c01511" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01511</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01511%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall-Molecule%252BKinase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BNononcologic%252BDiseases%26aulast%3DXie%26aufirst%3DZhouling%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D29082020%26date%3D22012021%26volume%3D64%26issue%3D3%26spage%3D1283%26epage%3D1345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Michael Siu, Arundhati Sengupta Ghosh, <span class="NLM_string-name hlFld-ContribAuthor">Joseph W. Lewcock</span>. </span><span class="cited-content_cbyCitation_article-title">Dual Leucine Zipper Kinase Inhibitors for the Treatment of Neurodegeneration. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (18)
                                     , 8078-8087. <a href="https://doi.org/10.1021/acs.jmedchem.8b00370" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00370</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00370&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00370%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDual%252BLeucine%252BZipper%252BKinase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BNeurodegeneration%26aulast%3DSiu%26aufirst%3DMichael%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D08032018%26date%3D04062018%26volume%3D61%26issue%3D18%26spage%3D8078%26epage%3D8087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Douglas S.  Williamson</span>, <span class="hlFld-ContribAuthor ">Garrick P.  Smith</span>, <span class="hlFld-ContribAuthor ">Pamela  Acheson-Dossang</span>, <span class="hlFld-ContribAuthor ">Simon T.  Bedford</span>, <span class="hlFld-ContribAuthor ">Victoria  Chell</span>, <span class="hlFld-ContribAuthor ">I-Jen  Chen</span>, <span class="hlFld-ContribAuthor ">Justus C. A.  Daechsel</span>, <span class="hlFld-ContribAuthor ">Zoe  Daniels</span>, <span class="hlFld-ContribAuthor ">Laurent  David</span>, <span class="hlFld-ContribAuthor ">Pawel  Dokurno</span>, <span class="hlFld-ContribAuthor ">Morten  Hentzer</span>, <span class="hlFld-ContribAuthor ">Martin C.  Herzig</span>, <span class="hlFld-ContribAuthor ">Roderick E.  Hubbard</span>, <span class="hlFld-ContribAuthor ">Jonathan D.  Moore</span>, <span class="hlFld-ContribAuthor ">James B.  Murray</span>, <span class="hlFld-ContribAuthor ">Samantha  Newland</span>, <span class="hlFld-ContribAuthor ">Stuart C.  Ray</span>, <span class="hlFld-ContribAuthor ">Terry  Shaw</span>, <span class="hlFld-ContribAuthor ">Allan E.  Surgenor</span>, <span class="hlFld-ContribAuthor ">Lindsey  Terry</span>, <span class="hlFld-ContribAuthor ">Kenneth  Thirstrup</span>, <span class="hlFld-ContribAuthor ">Yikang  Wang</span>, and <span class="hlFld-ContribAuthor ">Kenneth V.  Christensen</span>  . </span><span class="cited-content_cbyCitation_article-title">Design of Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors Using a Crystallographic Surrogate Derived from Checkpoint Kinase 1 (CHK1). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (21)
                                     , 8945-8962. <a href="https://doi.org/10.1021/acs.jmedchem.7b01186" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01186</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01186&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01186%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Bof%252BLeucine-Rich%252BRepeat%252BKinase%252B2%252B%252528LRRK2%252529%252BInhibitors%252BUsing%252Ba%252BCrystallographic%252BSurrogate%252BDerived%252Bfrom%252BCheckpoint%252BKinase%252B1%252B%252528CHK1%252529%26aulast%3DWilliamson%26aufirst%3DDouglas%2BS.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D15082017%26date%3D27102017%26date%3D09112017%26date%3D12102017%26volume%3D60%26issue%3D21%26spage%3D8945%26epage%3D8962" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>  . </span><span class="cited-content_cbyCitation_article-title">Improving Drug Design: An Update on Recent Applications of Efficiency Metrics, Strategies for Replacing Problematic Elements, and Compounds in Nontraditional Drug Space. </span><span class="cited-content_cbyCitation_journal-name">Chemical Research in Toxicology</span><span> <strong>2016,</strong> <em>29 </em>
                                    (4)
                                     , 564-616. <a href="https://doi.org/10.1021/acs.chemrestox.6b00043" title="DOI URL">https://doi.org/10.1021/acs.chemrestox.6b00043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrestox.6b00043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrestox.6b00043%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Research%2520in%2520Toxicology%26atitle%3DImproving%252BDrug%252BDesign%25253A%252BAn%252BUpdate%252Bon%252BRecent%252BApplications%252Bof%252BEfficiency%252BMetrics%25252C%252BStrategies%252Bfor%252BReplacing%252BProblematic%252BElements%25252C%252Band%252BCompounds%252Bin%252BNontraditional%252BDrug%252BSpace%26aulast%3DMeanwell%26aufirst%3DNicholas%2BA.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D03022016%26date%3D14032016%26date%3D18042016%26volume%3D29%26issue%3D4%26spage%3D564%26epage%3D616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hakan  Gunaydin</span>  . </span><span class="cited-content_cbyCitation_article-title">Probabilistic Approach to Generating MPOs and Its Application as a Scoring Function for CNS Drugs. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>7 </em>
                                    (1)
                                     , 89-93. <a href="https://doi.org/10.1021/acsmedchemlett.5b00390" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.5b00390</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.5b00390&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.5b00390%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DProbabilistic%252BApproach%252Bto%252BGenerating%252BMPOs%252Band%252BIts%252BApplication%252Bas%252Ba%252BScoring%252BFunction%252Bfor%252BCNS%252BDrugs%26aulast%3DGunaydin%26aufirst%3DHakan%26date%3D2016%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D06102015%26date%3D02122015%26date%3D04122015%26date%3D14012016%26date%3D02122015%26volume%3D7%26issue%3D1%26spage%3D89%26epage%3D93" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jillian H.  Kluss</span>, <span class="hlFld-ContribAuthor ">Melissa Conti  Mazza</span>, <span class="hlFld-ContribAuthor ">Yan  Li</span>, <span class="hlFld-ContribAuthor ">Claudia  Manzoni</span>, <span class="hlFld-ContribAuthor ">Patrick A.  Lewis</span>, <span class="hlFld-ContribAuthor ">Mark R.  Cookson</span>, <span class="hlFld-ContribAuthor ">Adamantios  Mamais</span>. </span><span class="cited-content_cbyCitation_article-title">Preclinical modeling of chronic inhibition of the Parkinson’s disease associated kinase LRRK2 reveals altered function of the endolysosomal system in vivo. </span><span class="cited-content_cbyCitation_journal-name">Molecular Neurodegeneration</span><span> <strong>2021,</strong> <em>16 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13024-021-00441-8" title="DOI URL">https://doi.org/10.1186/s13024-021-00441-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13024-021-00441-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13024-021-00441-8%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Neurodegeneration%26atitle%3DPreclinical%252Bmodeling%252Bof%252Bchronic%252Binhibition%252Bof%252Bthe%252BParkinson%2525E2%252580%252599s%252Bdisease%252Bassociated%252Bkinase%252BLRRK2%252Breveals%252Baltered%252Bfunction%252Bof%252Bthe%252Bendolysosomal%252Bsystem%252Bin%252Bvivo%26aulast%3DKluss%26aufirst%3DJillian%2BH.%26date%3D2021%26date%3D2021%26volume%3D16%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Saida  Khamouli</span>, <span class="hlFld-ContribAuthor ">Salah  Belaidi</span>, <span class="hlFld-ContribAuthor ">Mebarka  Ouassaf</span>, <span class="hlFld-ContribAuthor ">Touhami  Lanez</span>, <span class="hlFld-ContribAuthor ">Said  Belaaouad</span>, <span class="hlFld-ContribAuthor ">Samir  Chtita</span>. </span><span class="cited-content_cbyCitation_article-title">Multi-combined 3D-QSAR, docking molecular and ADMET prediction of 5-azaindazole derivatives as LRRK2 tyrosine kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2020,</strong> <em> </em>, 1-14. <a href="https://doi.org/10.1080/07391102.2020.1824815" title="DOI URL">https://doi.org/10.1080/07391102.2020.1824815</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2020.1824815&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2020.1824815%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DMulti-combined%252B3D-QSAR%25252C%252Bdocking%252Bmolecular%252Band%252BADMET%252Bprediction%252Bof%252B5-azaindazole%252Bderivatives%252Bas%252BLRRK2%252Btyrosine%252Bkinase%252Binhibitors%26aulast%3DKhamouli%26aufirst%3DSaida%26date%3D2020%26date%3D2020%26spage%3D1%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sofia  Domingos</span>, <span class="hlFld-ContribAuthor ">Teresa  Duarte</span>, <span class="hlFld-ContribAuthor ">Lucília  Saraiva</span>, <span class="hlFld-ContribAuthor ">Rita C  Guedes</span>, <span class="hlFld-ContribAuthor ">Rui  Moreira</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting leucine-rich repeat kinase 2 (LRRK2) for the treatment of Parkinson's disease. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2019,</strong> <em>11 </em>
                                    (15)
                                     , 1953-1977. <a href="https://doi.org/10.4155/fmc-2018-0484" title="DOI URL">https://doi.org/10.4155/fmc-2018-0484</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2018-0484&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2018-0484%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DTargeting%252Bleucine-rich%252Brepeat%252Bkinase%252B2%252B%252528LRRK2%252529%252Bfor%252Bthe%252Btreatment%252Bof%252BParkinson%252527s%252Bdisease%26aulast%3DDomingos%26aufirst%3DSofia%26date%3D2019%26volume%3D11%26issue%3D15%26spage%3D1953%26epage%3D1977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Víctor  Sebastián-Pérez</span>, <span class="hlFld-ContribAuthor ">María Jimena  Martínez</span>, <span class="hlFld-ContribAuthor ">Carmen  Gil</span>, <span class="hlFld-ContribAuthor ">Nuria Eugenia  Campillo</span>, <span class="hlFld-ContribAuthor ">Ana  Martínez</span>, <span class="hlFld-ContribAuthor ">Ignacio  Ponzoni</span>. </span><span class="cited-content_cbyCitation_article-title">QSAR Modelling to Identify LRRK2 Inhibitors for Parkinson’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Integrative Bioinformatics</span><span> <strong>2019,</strong> <em>16 </em>
                                    (1)
                                     <a href="https://doi.org/10.1515/jib-2018-0063" title="DOI URL">https://doi.org/10.1515/jib-2018-0063</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1515/jib-2018-0063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1515%2Fjib-2018-0063%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Integrative%2520Bioinformatics%26atitle%3DQSAR%252BModelling%252Bto%252BIdentify%252BLRRK2%252BInhibitors%252Bfor%252BParkinson%2525E2%252580%252599s%252BDisease%26aulast%3DSebasti%25C3%25A1n-P%25C3%25A9rez%26aufirst%3DV%25C3%25ADctor%26date%3D2019%26volume%3D16%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel G.M.  Shore</span>, <span class="hlFld-ContribAuthor ">Zachary K.  Sweeney</span>, <span class="hlFld-ContribAuthor ">Alan  Beresford</span>, <span class="hlFld-ContribAuthor ">Bryan K.  Chan</span>, <span class="hlFld-ContribAuthor ">Huifen  Chen</span>, <span class="hlFld-ContribAuthor ">Jason  Drummond</span>, <span class="hlFld-ContribAuthor ">Andrew  Gill</span>, <span class="hlFld-ContribAuthor ">Tracy  Kleinheinz</span>, <span class="hlFld-ContribAuthor ">Xingrong  Liu</span>, <span class="hlFld-ContribAuthor ">Andrew D.  Medhurst</span>, <span class="hlFld-ContribAuthor ">Edward G.  McIver</span>, <span class="hlFld-ContribAuthor ">John G.  Moffat</span>, <span class="hlFld-ContribAuthor ">Haitao  Zhu</span>, <span class="hlFld-ContribAuthor ">Anthony A.  Estrada</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of potent azaindazole leucine-rich repeat kinase 2 (LRRK2) inhibitors possessing a key intramolecular hydrogen bond – Part 2. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (4)
                                     , 674-680. <a href="https://doi.org/10.1016/j.bmcl.2018.10.017" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.10.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.10.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.10.017%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bpotent%252Bazaindazole%252Bleucine-rich%252Brepeat%252Bkinase%252B2%252B%252528LRRK2%252529%252Binhibitors%252Bpossessing%252Ba%252Bkey%252Bintramolecular%252Bhydrogen%252Bbond%252B%2525E2%252580%252593%252BPart%252B2%26aulast%3DShore%26aufirst%3DDaniel%2BG.M.%26date%3D2019%26volume%3D29%26issue%3D4%26spage%3D674%26epage%3D680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Víctor  Sebastián-Pérez</span>, <span class="hlFld-ContribAuthor ">María J.  Martínez</span>, <span class="hlFld-ContribAuthor ">Carmen  Gil</span>, <span class="hlFld-ContribAuthor ">Nuria E.  Campillo</span>, <span class="hlFld-ContribAuthor ">Ana  Martínez</span>, <span class="hlFld-ContribAuthor ">Ignacio  Ponzoni</span>. </span><span class="cited-content_cbyCitation_article-title">QSAR Modelling for Drug Discovery: Predicting the Activity of LRRK2 Inhibitors for Parkinson’s Disease Using Cheminformatics Approaches. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 63-70. <a href="https://doi.org/10.1007/978-3-319-98702-6_8" title="DOI URL">https://doi.org/10.1007/978-3-319-98702-6_8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-98702-6_8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-98702-6_8%26sid%3Dliteratum%253Aachs%26atitle%3DQSAR%252BModelling%252Bfor%252BDrug%252BDiscovery%25253A%252BPredicting%252Bthe%252BActivity%252Bof%252BLRRK2%252BInhibitors%252Bfor%252BParkinson%2525E2%252580%252599s%252BDisease%252BUsing%252BCheminformatics%252BApproaches%26aulast%3DSebasti%25C3%25A1n-P%25C3%25A9rez%26aufirst%3DV%25C3%25ADctor%26date%3D2019%26date%3D2018%26spage%3D63%26epage%3D70%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DPractical%252BApplications%252Bof%252BComputational%252BBiology%252Band%252BBioinformatics%25252C%252B12th%252BInternational%252BConference%26aulast%3DFdez-Riverola%26aufirst%3DFlorentino%26date%3D2019%26volume%3D803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuan  Shi</span>, <span class="hlFld-ContribAuthor ">Mary  Mader</span>. </span><span class="cited-content_cbyCitation_article-title">Brain penetrant kinase inhibitors: Learning from kinase neuroscience discovery. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (11)
                                     , 1981-1991. <a href="https://doi.org/10.1016/j.bmcl.2018.05.007" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.05.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.05.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.05.007%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DBrain%252Bpenetrant%252Bkinase%252Binhibitors%25253A%252BLearning%252Bfrom%252Bkinase%252Bneuroscience%252Bdiscovery%26aulast%3DShi%26aufirst%3DYuan%26date%3D2018%26volume%3D28%26issue%3D11%26spage%3D1981%26epage%3D1991" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Garrick P.  Smith</span>, <span class="hlFld-ContribAuthor ">Lassina  Badolo</span>, <span class="hlFld-ContribAuthor ">Victoria  Chell</span>, <span class="hlFld-ContribAuthor ">I-Jen  Chen</span>, <span class="hlFld-ContribAuthor ">Kenneth Vielsted  Christensen</span>, <span class="hlFld-ContribAuthor ">Laurent  David</span>, <span class="hlFld-ContribAuthor ">Justus Alfred  Daechsel</span>, <span class="hlFld-ContribAuthor ">Morten  Hentzer</span>, <span class="hlFld-ContribAuthor ">Martin Christian  Herzig</span>, <span class="hlFld-ContribAuthor ">Gitte Kobberøe  Mikkelsen</span>, <span class="hlFld-ContribAuthor ">Stephen P.  Watson</span>, <span class="hlFld-ContribAuthor ">Douglas S.  Williamson</span>. </span><span class="cited-content_cbyCitation_article-title">The design and SAR of a novel series of 2-aminopyridine based LRRK2 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (18)
                                     , 4500-4505. <a href="https://doi.org/10.1016/j.bmcl.2017.07.072" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.07.072</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.07.072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.07.072%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DThe%252Bdesign%252Band%252BSAR%252Bof%252Ba%252Bnovel%252Bseries%252Bof%252B2-aminopyridine%252Bbased%252BLRRK2%252Binhibitors%26aulast%3DSmith%26aufirst%3DGarrick%2BP.%26date%3D2017%26volume%3D27%26issue%3D18%26spage%3D4500%26epage%3D4505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Irene G.  Salado</span>, <span class="hlFld-ContribAuthor ">Josefa  Zaldivar-Diez</span>, <span class="hlFld-ContribAuthor ">Víctor  Sebastián-Pérez</span>, <span class="hlFld-ContribAuthor ">Lingling  Li</span>, <span class="hlFld-ContribAuthor ">Larissa  Geiger</span>, <span class="hlFld-ContribAuthor ">Silvia  González</span>, <span class="hlFld-ContribAuthor ">Nuria E.  Campillo</span>, <span class="hlFld-ContribAuthor ">Carmen  Gil</span>, <span class="hlFld-ContribAuthor ">Aixa V.  Morales</span>, <span class="hlFld-ContribAuthor ">Daniel I.  Perez</span>, <span class="hlFld-ContribAuthor ">Ana  Martinez</span>. </span><span class="cited-content_cbyCitation_article-title">Leucine rich repeat kinase 2 (LRRK2) inhibitors based on indolinone scaffold: Potential pro-neurogenic agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>138 </em>, 328-342. <a href="https://doi.org/10.1016/j.ejmech.2017.06.060" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.06.060</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.06.060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.06.060%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DLeucine%252Brich%252Brepeat%252Bkinase%252B2%252B%252528LRRK2%252529%252Binhibitors%252Bbased%252Bon%252Bindolinone%252Bscaffold%25253A%252BPotential%252Bpro-neurogenic%252Bagents%26aulast%3DSalado%26aufirst%3DIrene%2BG.%26date%3D2017%26volume%3D138%26spage%3D328%26epage%3D342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Susanna  Cogo</span>, <span class="hlFld-ContribAuthor ">Elisa  Greggio</span>, <span class="hlFld-ContribAuthor ">Patrick A  Lewis</span>. </span><span class="cited-content_cbyCitation_article-title">Leucine Rich Repeat Kinase 2: beyond Parkinson’s and beyond kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Targets</span><span> <strong>2017,</strong> <em>21 </em>
                                    (8)
                                     , 751-753. <a href="https://doi.org/10.1080/14728222.2017.1342968" title="DOI URL">https://doi.org/10.1080/14728222.2017.1342968</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14728222.2017.1342968&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14728222.2017.1342968%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Targets%26atitle%3DLeucine%252BRich%252BRepeat%252BKinase%252B2%25253A%252Bbeyond%252BParkinson%2525E2%252580%252599s%252Band%252Bbeyond%252Bkinase%252Binhibitors%26aulast%3DCogo%26aufirst%3DSusanna%26date%3D2017%26date%3D2017%26volume%3D21%26issue%3D8%26spage%3D751%26epage%3D753" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joan  Mayol-Llinàs</span>, <span class="hlFld-ContribAuthor ">Adam  Nelson</span>, <span class="hlFld-ContribAuthor ">William  Farnaby</span>, <span class="hlFld-ContribAuthor ">Andrew  Ayscough</span>. </span><span class="cited-content_cbyCitation_article-title">Assessing molecular scaffolds for CNS drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2017,</strong> <em>22 </em>
                                    (7)
                                     , 965-969. <a href="https://doi.org/10.1016/j.drudis.2017.01.008" title="DOI URL">https://doi.org/10.1016/j.drudis.2017.01.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2017.01.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2017.01.008%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DAssessing%252Bmolecular%252Bscaffolds%252Bfor%252BCNS%252Bdrug%252Bdiscovery%26aulast%3DMayol-Llin%25C3%25A0s%26aufirst%3DJoan%26date%3D2017%26volume%3D22%26issue%3D7%26spage%3D965%26epage%3D969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hendra  Gunosewoyo</span>, <span class="hlFld-ContribAuthor ">Lifang  Yu</span>, <span class="hlFld-ContribAuthor ">Lenka  Munoz</span>, <span class="hlFld-ContribAuthor ">Michael  Kassiou</span>. </span><span class="cited-content_cbyCitation_article-title">Kinase targets in CNS drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2017,</strong> <em>9 </em>
                                    (3)
                                     , 303-314. <a href="https://doi.org/10.4155/fmc-2016-0214" title="DOI URL">https://doi.org/10.4155/fmc-2016-0214</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2016-0214&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2016-0214%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DKinase%252Btargets%252Bin%252BCNS%252Bdrug%252Bdiscovery%26aulast%3DGunosewoyo%26aufirst%3DHendra%26date%3D2017%26volume%3D9%26issue%3D3%26spage%3D303%26epage%3D314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Min  Wang</span>, <span class="hlFld-ContribAuthor ">Mingzhang  Gao</span>, <span class="hlFld-ContribAuthor ">Zhidong  Xu</span>, <span class="hlFld-ContribAuthor ">Qi-Huang  Zheng</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of [11C]HG-10-102-01 as a new potential PET agent for imaging of LRRK2 enzyme in Parkinson’s disease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (6)
                                     , 1351-1355. <a href="https://doi.org/10.1016/j.bmcl.2017.02.019" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.02.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.02.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.02.019%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Bof%252B%25255B11C%25255DHG-10-102-01%252Bas%252Ba%252Bnew%252Bpotential%252BPET%252Bagent%252Bfor%252Bimaging%252Bof%252BLRRK2%252Benzyme%252Bin%252BParkinson%2525E2%252580%252599s%252Bdisease%26aulast%3DWang%26aufirst%3DMin%26date%3D2017%26volume%3D27%26issue%3D6%26spage%3D1351%26epage%3D1355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qi  Qin</span>, <span class="hlFld-ContribAuthor ">Lian-Teng  Zhi</span>, <span class="hlFld-ContribAuthor ">Xian-Ting  Li</span>, <span class="hlFld-ContribAuthor ">Zhen-Yu  Yue</span>, <span class="hlFld-ContribAuthor ">Guo-Zhong  Li</span>, <span class="hlFld-ContribAuthor ">Hui  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Effects of LRRK2 Inhibitors on Nigrostriatal Dopaminergic Neurotransmission. </span><span class="cited-content_cbyCitation_journal-name">CNS Neuroscience & Therapeutics</span><span> <strong>2017,</strong> <em>23 </em>
                                    (2)
                                     , 162-173. <a href="https://doi.org/10.1111/cns.12660" title="DOI URL">https://doi.org/10.1111/cns.12660</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cns.12660&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcns.12660%26sid%3Dliteratum%253Aachs%26jtitle%3DCNS%2520Neuroscience%2520%2526%2520Therapeutics%26atitle%3DEffects%252Bof%252BLRRK2%252BInhibitors%252Bon%252BNigrostriatal%252BDopaminergic%252BNeurotransmission%26aulast%3DQin%26aufirst%3DQi%26date%3D2017%26date%3D2016%26volume%3D23%26issue%3D2%26spage%3D162%26epage%3D173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">K.V.  Christensen</span>, <span class="hlFld-ContribAuthor ">G.P.  Smith</span>, <span class="hlFld-ContribAuthor ">D.S.  Williamson</span>. </span><span class="cited-content_cbyCitation_article-title">Development of LRRK2 Inhibitors for the Treatment of Parkinson's Disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 37-80. <a href="https://doi.org/10.1016/bs.pmch.2016.11.002" title="DOI URL">https://doi.org/10.1016/bs.pmch.2016.11.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.pmch.2016.11.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.pmch.2016.11.002%26sid%3Dliteratum%253Aachs%26atitle%3DDevelopment%252Bof%252BLRRK2%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BParkinson%252527s%252BDisease%26aulast%3DChristensen%26aufirst%3DK.V.%26date%3D2017%26spage%3D37%26epage%3D80%26pub%3DElsevier%26date%3D2017%26volume%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katharina E.  Rosenbusch</span>, <span class="hlFld-ContribAuthor ">Arjan  Kortholt</span>. </span><span class="cited-content_cbyCitation_article-title">Activation Mechanism of LRRK2 and Its Cellular Functions in Parkinson’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Parkinson's Disease</span><span> <strong>2016,</strong> <em>2016 </em>, 1-8. <a href="https://doi.org/10.1155/2016/7351985" title="DOI URL">https://doi.org/10.1155/2016/7351985</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2016/7351985&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2016%2F7351985%26sid%3Dliteratum%253Aachs%26jtitle%3DParkinson%2527s%2520Disease%26atitle%3DActivation%252BMechanism%252Bof%252BLRRK2%252Band%252BIts%252BCellular%252BFunctions%252Bin%252BParkinson%2525E2%252580%252599s%252BDisease%26aulast%3DRosenbusch%26aufirst%3DKatharina%2BE.%26date%3D2016%26volume%3D2016%26spage%3D1%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dong Hwan  Ho</span>, <span class="hlFld-ContribAuthor ">Jihoon  Jang</span>, <span class="hlFld-ContribAuthor ">Eun-hye  Joe</span>, <span class="hlFld-ContribAuthor ">Ilhong  Son</span>, <span class="hlFld-ContribAuthor ">Hyemyung  Seo</span>, <span class="hlFld-ContribAuthor ">Wongi  Seol</span>. </span><span class="cited-content_cbyCitation_article-title">G2385R and I2020T Mutations Increase LRRK2 GTPase Activity. </span><span class="cited-content_cbyCitation_journal-name">BioMed Research International</span><span> <strong>2016,</strong> <em>2016 </em>, 1-8. <a href="https://doi.org/10.1155/2016/7917128" title="DOI URL">https://doi.org/10.1155/2016/7917128</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2016/7917128&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2016%2F7917128%26sid%3Dliteratum%253Aachs%26jtitle%3DBioMed%2520Research%2520International%26atitle%3DG2385R%252Band%252BI2020T%252BMutations%252BIncrease%252BLRRK2%252BGTPase%252BActivity%26aulast%3DHo%26aufirst%3DDong%2BHwan%26date%3D2016%26volume%3D2016%26spage%3D1%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00261/20150904/images/medium/jm-2015-00261c_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00261/20150904/images/large/jm-2015-00261c_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00261&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00261/20150904/images/medium/jm-2015-00261c_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00261/20150904/images/large/jm-2015-00261c_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Schematic of LRRK2 protein structure with reported PD pathogenic familial mutations (red), risk factors (black), and cellular phosphorylation (blue) and autophosphorylation (green) sites.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00261/20150904/images/large/jm-2015-00261c_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00261&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00261/20150904/images/medium/jm-2015-00261c_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00261/20150904/images/large/jm-2015-00261c_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Docking model of <b>5</b> (cyan) in LRRK2 (green with L1949 in yellow). The side chain of Y931 of JAK2 is also shown (magenta). Intermolecular hydrogen bond interactions are shown as yellow dashed lines. The figure was reproduced from Estrada 2012<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> with permission from Journal of Medicinal Chemistry. Copyright 2012 American Chemical Society.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00261/20150904/images/large/jm-2015-00261c_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00261&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00261/20150904/images/medium/jm-2015-00261c_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00261/20150904/images/large/jm-2015-00261c_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. In vivo G2019S LRRK2 transgenic mouse PK/PD results measuring brain pS1292 autophosphorylation. The circles represent the observed data, and the lines represent the predicted data from a direct inhibition model. Percent inhibition is normalized to pS1292 levels observed in mice dosed with vehicle alone (<i>n</i> = 3). Plotted data are shown for mice treated with (A) <b>7</b> [15 mg kg<sup>–1</sup>, po, at 1, 3, and 6 h (<i>n</i> = 4/dose); 50 mg kg<sup>–1</sup>, po, at 1, 3, 6, and 12 h (<i>n</i> = 4/dose) and 24 h (<i>n</i> = 1); 10 mg kg<sup>–1</sup>, ip, at 1 and 2.5 h (<i>n</i> = 3/dose); 50 mg kg<sup>–1</sup>, ip, at 1 and 6 h (<i>n</i> = 3/dose)], (B) <b>8</b> [10 and 50 mg kg<sup>–1</sup>, ip, at 1, 3, and 6 h (<i>n</i> = 3/dose)], and (C) <b>9</b> [10 and 50 mg kg<sup>–1</sup>, ip, at 1 and 6 h (<i>n</i> = 3/dose)]. The figure was reproduced and modified from Estrada 2012 and Estrada 2014,<a onclick="showRef(event, 'ref81 ref83'); return false;" href="javascript:void(0);" class="ref ref81 ref83">(81, 83)</a> with permission from <i>Journal of Medicinal Chemistry</i>. Copyright 2012 and 2014 American Chemical Society.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00261/20150904/images/large/jm-2015-00261c_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00261&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00261/20150904/images/medium/jm-2015-00261c_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00261/20150904/images/large/jm-2015-00261c_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. In vivo G2019S LRRK2 transgenic mouse PK/PD results with compound <b>11</b> measuring brain pSer935 levels. pSer935 levels were determined by ELISA and normalized to total LRRK2. Data are expressed as the mean ratio of pSer935 to total LRRK2 values observed in the vehicle control group. Error bars represent SEM. Plotted data are shown for mice treated with <b>11</b> [30 mg kg<sup>–1</sup>, po, at 3 h (<i>n</i> = 5/dose); 100 mg kg<sup>–1</sup>, po, at 3 h (<i>n</i> = 5/dose). This figure was reproduced and adapted from  <cite>Bioorganic & Medicinal Chemistry Letters</cite> (<a href="http://www.sciencedirect.com/science/journal/0960894X" class="ext-link">http://www.sciencedirect.com/science/journal/0960894X</a>), Vol. <em>23</em>, <contrib-group>Garofalo, A. W.; Adler, M.; Aubele, D. L.; Brigham, E. F.; Chian, D.; Franzini, M.; Goldbach, E.; Kwong, G. T.; Motter, R.; Probst, G. D.; Quinn, K. P.; Ruslim, L.; Sham, H. L.; Tam, D.; Tanaka, P.; Truong, A. P.; Ye, X. M.; Ren, Z.</contrib-group>, Discovery of 4-alkylamino-7-aryl-3-cyanoquinoline LRRK2 kinase inhibitors, pp 1974–1977, Copyright <span class="NLM_year">2013</span>, with permission from Elsevier.<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00261/20150904/images/large/jm-2015-00261c_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00261&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00261/20150904/images/medium/jm-2015-00261c_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00261/20150904/images/large/jm-2015-00261c_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. LRRK2 GTP-binding inhibitors <b>15</b> and <b>16</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00261/20150904/images/large/jm-2015-00261c_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00261&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i29">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86583" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86583" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 107 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Jankovic, J.</span><span> </span><span class="NLM_article-title">Parkinson’s disease: clinical features and diagnosis</span> <span class="citation_source-journal">J. Neurol. Neurosurg. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">368</span><span class="NLM_x">–</span> <span class="NLM_lpage">376</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1136%2Fjnnp.2007.131045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=18344392" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A280%3ADC%252BD1c7oslamtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2008&pages=368-376&author=J.+Jankovic&title=Parkinson%E2%80%99s+disease%3A+clinical+features+and+diagnosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Parkinson's disease: clinical features and diagnosis</span></div><div class="casAuthors">Jankovic J</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neurology, neurosurgery, and psychiatry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">368-76</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  Parkinson's disease (PD) is a progressive neurological disorder characterised by a large number of motor and non-motor features that can impact on function to a variable degree.  This review describes the clinical characteristics of PD with emphasis on those features that differentiate the disease from other parkinsonian disorders.  METHODS:  A MedLine search was performed to identify studies that assess the clinical characteristics of PD.  Search terms included "Parkinson's disease", "diagnosis" and "signs and symptoms".  RESULTS:  Because there is no definitive test for the diagnosis of PD, the disease must be diagnosed based on clinical criteria.  Rest tremor, bradykinesia, rigidity and loss of postural reflexes are generally considered the cardinal signs of PD.  The presence and specific presentation of these features are used to differentiate PD from related parkinsonian disorders.  Other clinical features include secondary motor symptoms (eg, hypomimia, dysarthria, dysphagia, sialorrhoea, micrographia, shuffling gait, festination, freezing, dystonia, glabellar reflexes), non-motor symptoms (eg, autonomic dysfunction, cognitive/neurobehavioral abnormalities, sleep disorders and sensory abnormalities such as anosmia, paresthesias and pain).  Absence of rest tremor, early occurrence of gait difficulty, postural instability, dementia, hallucinations, and the presence of dysautonomia, ophthalmoparesis, ataxia and other atypical features, coupled with poor or no response to levodopa, suggest diagnoses other than PD.  CONCLUSIONS:  A thorough understanding of the broad spectrum of clinical manifestations of PD is essential to the proper diagnosis of the disease.  Genetic mutations or variants, neuroimaging abnormalities and other tests are potential biomarkers that may improve diagnosis and allow the identification of persons at risk.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTx3pH5zglCwUcLvDNbOD4DfW6udTcc2eY4iFZx624xJrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c7oslamtA%253D%253D&md5=bb6d7781e6fce93cfb785215840149cb</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1136%2Fjnnp.2007.131045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fjnnp.2007.131045%26sid%3Dliteratum%253Aachs%26aulast%3DJankovic%26aufirst%3DJ.%26atitle%3DParkinson%25E2%2580%2599s%2520disease%253A%2520clinical%2520features%2520and%2520diagnosis%26jtitle%3DJ.%2520Neurol.%2520Neurosurg.%2520Psychiatry%26date%3D2008%26volume%3D79%26spage%3D368%26epage%3D376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Braak, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghebremedhin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rüb, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bratzke, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Tredici, K.</span><span> </span><span class="NLM_article-title">Stages in the development of Parkinson’s disease-related pathology</span> <span class="citation_source-journal">Cell Tissue Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">318</span><span class="NLM_x">, </span> <span class="NLM_fpage">121</span><span class="NLM_x">–</span> <span class="NLM_lpage">134</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1007%2Fs00441-004-0956-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=15338272" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A280%3ADC%252BD2crjtVagtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=318&publication_year=2004&pages=121-134&author=H.+Braakauthor=E.+Ghebremedhinauthor=U.+R%C3%BCbauthor=H.+Bratzkeauthor=K.+Del+Tredici&title=Stages+in+the+development+of+Parkinson%E2%80%99s+disease-related+pathology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Stages in the development of Parkinson's disease-related pathology</span></div><div class="casAuthors">Braak Heiko; Ghebremedhin Estifanos; Rub Udo; Bratzke Hansjurgen; Del Tredici Kelly</div><div class="citationInfo"><span class="NLM_cas:title">Cell and tissue research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">318</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">121-34</span>
        ISSN:<span class="NLM_cas:issn">0302-766X</span>.
    </div><div class="casAbstract">The synucleinopathy, idiopathic Parkinson's disease, is a multisystem disorder that involves only a few predisposed nerve cell types in specific regions of the human nervous system.  The intracerebral formation of abnormal proteinaceous Lewy bodies and Lewy neurites begins at defined induction sites and advances in a topographically predictable sequence.  As the disease progresses, components of the autonomic, limbic, and somatomotor systems become particularly badly damaged.  During presymptomatic stages 1-2, inclusion body pathology is confined to the medulla oblongata/pontine tegmentum and olfactory bulb/anterior olfactory nucleus.  In stages 3-4, the substantia nigra and other nuclear grays of the midbrain and forebrain become the focus of initially slight and, then, severe pathological changes.  At this point, most individuals probably cross the threshold to the symptomatic phase of the illness.  In the end-stages 5-6, the process enters the mature neocortex, and the disease manifests itself in all of its clinical dimensions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTieyTnw1SgY5otVjB3IRIyfW6udTcc2eYE1H9sNx7Pyrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2crjtVagtw%253D%253D&md5=240031e02a342ffcdb005c55eb452887</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1007%2Fs00441-004-0956-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00441-004-0956-9%26sid%3Dliteratum%253Aachs%26aulast%3DBraak%26aufirst%3DH.%26aulast%3DGhebremedhin%26aufirst%3DE.%26aulast%3DR%25C3%25BCb%26aufirst%3DU.%26aulast%3DBratzke%26aufirst%3DH.%26aulast%3DDel%2BTredici%26aufirst%3DK.%26atitle%3DStages%2520in%2520the%2520development%2520of%2520Parkinson%25E2%2580%2599s%2520disease-related%2520pathology%26jtitle%3DCell%2520Tissue%2520Res.%26date%3D2004%26volume%3D318%26spage%3D121%26epage%3D134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Schapira, A. H. V.</span><span> </span><span class="NLM_article-title">Neurobiology and treatment of Parkinson’s disease</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">47</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=41-47&author=A.+H.+V.+Schapira&title=Neurobiology+and+treatment+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchapira%26aufirst%3DA.%2BH.%2BV.%26atitle%3DNeurobiology%2520and%2520treatment%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2009%26volume%3D30%26spage%3D41%26epage%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Kamb, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harper, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefansson, K.</span><span> </span><span class="NLM_article-title">Human genetics as a foundation for innovative drug development</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">975</span><span class="NLM_x">–</span> <span class="NLM_lpage">978</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2013&pages=975-978&author=A.+Kambauthor=S.+Harperauthor=K.+Stefansson&title=Human+genetics+as+a+foundation+for+innovative+drug+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKamb%26aufirst%3DA.%26aulast%3DHarper%26aufirst%3DS.%26aulast%3DStefansson%26aufirst%3DK.%26atitle%3DHuman%2520genetics%2520as%2520a%2520foundation%2520for%2520innovative%2520drug%2520development%26jtitle%3DNat.%2520Biotechnol.%26date%3D2013%26volume%3D31%26spage%3D975%26epage%3D978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Kauselmann, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dopazo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Link, W.</span><span> </span><span class="NLM_article-title">Identification of disease-relevant genes for molecularly-targeted drug discovery</span> <span class="citation_source-journal">Curr. Cancer Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">13</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.2174%2F156800912798888947" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=22165964" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFOqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=1-13&author=G.+Kauselmannauthor=A.+Dopazoauthor=W.+Link&title=Identification+of+disease-relevant+genes+for+molecularly-targeted+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of disease-relevant genes for molecularly-targeted drug discovery</span></div><div class="casAuthors">Kauselmann, G.; Dopazo, A.; Link, W.</div><div class="citationInfo"><span class="NLM_cas:title">Current Cancer Drug Targets</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-13</span>CODEN:
                <span class="NLM_cas:coden">CCDTB9</span>;
        ISSN:<span class="NLM_cas:issn">1568-0096</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The current paradigm for cancer therapy is undergoing a change from non-specific cytotoxic agents to more specific approaches based on unique mol. features of cancer cells.  The identification and validation of disease relevant targets are crucial for the development of molecularly targeted anticancer therapies.  Advances in our understanding of the mol. basis of cancer together with novel approaches to interfere with signal transduction pathways have opened new horizons for anticancer target discovery.  In particular, the image-based large scale anal. of cellular phenotypes that arise from genetic or chem. perturbations paved the way for the identification and validation of disease relevant mol. targets independent of preconceived notions of mechanistic relationships.  In addn., novel and sophisticated techniques of genome manipulation allow for the use of mouse models that faithfully recapitulate crit. elements of human cancer for target validation in vivo.  We believe that these advances will translate into more and better validated drug targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo55zb4TDKD8LVg90H21EOLACvtfcHk0lhR3VmI8XLN1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFOqtbk%253D&md5=41296fb1a1e032c2d9270023dd992a5d</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.2174%2F156800912798888947&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156800912798888947%26sid%3Dliteratum%253Aachs%26aulast%3DKauselmann%26aufirst%3DG.%26aulast%3DDopazo%26aufirst%3DA.%26aulast%3DLink%26aufirst%3DW.%26atitle%3DIdentification%2520of%2520disease-relevant%2520genes%2520for%2520molecularly-targeted%2520drug%2520discovery%26jtitle%3DCurr.%2520Cancer%2520Drug%2520Targets%26date%3D2012%26volume%3D12%26spage%3D1%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Lin, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrer, M. J.</span><span> </span><span class="NLM_article-title">Genetics and genomics of Parkinson’s disease</span> <span class="citation_source-journal">Genome Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">48</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1186%2Fgm566" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=25061481" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A280%3ADC%252BC2cbmtFChsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=48&author=M.+K.+Linauthor=M.+J.+Farrer&title=Genetics+and+genomics+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Genetics and genomics of Parkinson's disease</span></div><div class="casAuthors">Lin Michelle K; Farrer Matthew J</div><div class="citationInfo"><span class="NLM_cas:title">Genome medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">48</span>
        ISSN:<span class="NLM_cas:issn">1756-994X</span>.
    </div><div class="casAbstract">Parkinson's disease (PD) is a progressively debilitating neurodegenerative syndrome.  Although best described as a movement disorder, the condition has prominent autonomic, cognitive, psychiatric, sensory and sleep components.  Striatal dopaminergic innervation and nigral neurons are progressively lost, with associated Lewy pathology readily apparent on autopsy.  Nevertheless, knowledge of the molecular events leading to this pathophysiology is limited.  Current therapies offer symptomatic benefit but they fail to slow progression and patients continue to deteriorate.  Recent discoveries in sporadic, Mendelian and more complex forms of parkinsonism provide novel insight into disease etiology; 28 genes, including those encoding alpha-synuclein (SNCA), leucine-rich repeat kinase 2 (LRRK2) and microtubule-associated protein tau (MAPT), have been linked and/or associated with PD.  A consensus regarding the affected biological pathways and molecular processes has also started to emerge.  In early-onset and more a typical PD, deficits in mitophagy pathways and lysosomal function appear to be prominent.  By contrast, in more typical late-onset PD, chronic, albeit subtle, dysfunction in synaptic transmission, early endosomal trafficking and receptor recycling, as well as chaperone-mediated autophagy, provide a unifying synthesis of the molecular pathways involved.  Disease-modification (neuroprotection) is no longer such an elusive goal given the unparalleled opportunity for diagnosis, translational neuroscience and therapeutic development provided by genetic discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRZ98nLXyY0xUNoizSOkG_FfW6udTcc2eb0URyfaIovobntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cbmtFChsg%253D%253D&md5=2812917436574ba10ba7170d48bf4eb4</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1186%2Fgm566&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fgm566%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DM.%2BK.%26aulast%3DFarrer%26aufirst%3DM.%2BJ.%26atitle%3DGenetics%2520and%2520genomics%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DGenome%2520Med.%26date%3D2014%26volume%3D6%26spage%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Martin, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, V. L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, T. T. M.</span><span> </span><span class="NLM_article-title">Recent advances in the genetics of Parkinson’s disease</span> <span class="citation_source-journal">Annu. Rev. Genomics Hum. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">301</span><span class="NLM_x">–</span> <span class="NLM_lpage">325</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1146%2Fannurev-genom-082410-101440" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=21639795" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1yksbvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=301-325&author=I.+Martinauthor=V.+L.+V.+Dawsonauthor=T.+T.+M.+Dawson&title=Recent+advances+in+the+genetics+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the genetics of Parkinson's disease</span></div><div class="casAuthors">Martin, Ian; Dawson, Valina L.; Dawson, Ted M.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Genomics and Human Genetics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">301-325</span>CODEN:
                <span class="NLM_cas:coden">ARGHC4</span>;
        ISSN:<span class="NLM_cas:issn">1527-8204</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Genetic studies have provided valuable insight into the pathol. mechanisms underlying Parkinson's disease (PD).  The elucidation of genetic components to what was once largely considered a nongenetic disease has given rise to a multitude of cell and animal models enabling the dissection of mol. pathways involved in disease etiol.  Here, the authors review advances obtained from models of dominant mutations in α-synuclein and LRRK2 as well as recessive PINK1, parkin and DJ-1 mutations.  Recent genome-wide assocn. studies have implicated genetic variability at two of these loci, α-synuclein and LRRK2, as significant risk factors for developing sporadic PD.  This, coupled with the established role of mitochondrial impairment in both familial and sporadic PD, highlights the likelihood of common mechanisms fundamental to the etiol. of both.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmr___jOFrRLVg90H21EOLACvtfcHk0lhObA8PZKdbaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1yksbvN&md5=d535f7971e5175d6a98c2d796c3725bb</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1146%2Fannurev-genom-082410-101440&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-genom-082410-101440%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DI.%26aulast%3DDawson%26aufirst%3DV.%2BL.%2BV.%26aulast%3DDawson%26aufirst%3DT.%2BT.%2BM.%26atitle%3DRecent%2520advances%2520in%2520the%2520genetics%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DAnnu.%2520Rev.%2520Genomics%2520Hum.%2520Genet.%26date%3D2011%26volume%3D12%26spage%3D301%26epage%3D325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Nuytemans, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theuns, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cruts, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Broeckhoven, C.</span><span> </span><span class="NLM_article-title">Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update</span> <span class="citation_source-journal">Hum. Mutat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">763</span><span class="NLM_x">–</span> <span class="NLM_lpage">780</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1002%2Fhumu.21277" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=20506312" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpslagtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=763-780&author=K.+Nuytemansauthor=J.+Theunsauthor=M.+Crutsauthor=C.+Van+Broeckhoven&title=Genetic+etiology+of+Parkinson+disease+associated+with+mutations+in+the+SNCA%2C+PARK2%2C+PINK1%2C+PARK7%2C+and+LRRK2+genes%3A+a+mutation+update"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update</span></div><div class="casAuthors">Nuytemans, Karen; Theuns, Jessie; Cruts, Marc; Van Broeckhoven, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Human Mutation</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">763-780</span>CODEN:
                <span class="NLM_cas:coden">HUMUE3</span>;
        ISSN:<span class="NLM_cas:issn">1059-7794</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  To date, mol. genetic analyses have identified over 500 distinct DNA variants in five disease genes assocd. with familial Parkinson disease; α-synuclein (SNCA), parkin (PARK2), PTEN-induced putative kinase 1 (PINK1), DJ-1 (PARK7), and Leucine-rich repeat kinase 2 (LRRK2).  These genetic variants include ∼82% simple mutations and ∼18% copy no. variations.  Some mutation subtypes are likely underestimated because only few studies reported extensive mutation analyses of all five genes, by both exonic sequencing and dosage analyses.  Here we present an update of all mutations published to date in the literature, systematically organized in a novel mutation database (http://www.molgen.ua.ac.be/PDmutDB).  In addn., we address the biol. relevance of putative pathogenic mutations.  This review emphasizes the need for comprehensive genetic screening of Parkinson patients followed by an insightful study of the functional relevance of obsd. genetic variants.  Moreover, while capturing existing data from the literature it became apparent that several of the five Parkinson genes were also contributing to the genetic etiol. of other Lewy Body Diseases and Parkinson-plus syndromes, indicating that mutation screening is recommendable in these patient groups.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyXdisuECrL7Vg90H21EOLACvtfcHk0lhObA8PZKdbaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpslagtL8%253D&md5=27bd963eceb4a51c8227997414530c2f</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1002%2Fhumu.21277&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhumu.21277%26sid%3Dliteratum%253Aachs%26aulast%3DNuytemans%26aufirst%3DK.%26aulast%3DTheuns%26aufirst%3DJ.%26aulast%3DCruts%26aufirst%3DM.%26aulast%3DVan%2BBroeckhoven%26aufirst%3DC.%26atitle%3DGenetic%2520etiology%2520of%2520Parkinson%2520disease%2520associated%2520with%2520mutations%2520in%2520the%2520SNCA%252C%2520PARK2%252C%2520PINK1%252C%2520PARK7%252C%2520and%2520LRRK2%2520genes%253A%2520a%2520mutation%2520update%26jtitle%3DHum.%2520Mutat.%26date%3D2010%26volume%3D31%26spage%3D763%26epage%3D780" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Zimprich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biskup, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leitner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lincoln, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kachergus, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hulihan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uitti, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calne, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoessl, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfeiffer, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patenge, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carbajal, I. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vieregge, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asmus, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller-Myhsok, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickson, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meitinger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strom, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wszolek, Z. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasser, T.</span><span> </span><span class="NLM_article-title">Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">601</span><span class="NLM_x">–</span> <span class="NLM_lpage">607</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1016%2Fj.neuron.2004.11.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=15541309" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVKhurjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2004&pages=601-607&author=A.+Zimprichauthor=S.+Biskupauthor=P.+Leitnerauthor=P.+Lichtnerauthor=M.+Farrerauthor=S.+Lincolnauthor=J.+Kachergusauthor=M.+Hulihanauthor=R.+J.+Uittiauthor=D.+B.+Calneauthor=A.+J.+Stoesslauthor=R.+F.+Pfeifferauthor=N.+Patengeauthor=I.+C.+Carbajalauthor=P.+Viereggeauthor=F.+Asmusauthor=B.+Muller-Myhsokauthor=D.+W.+Dicksonauthor=T.+Meitingerauthor=T.+M.+Stromauthor=Z.+K.+Wszolekauthor=T.+Gasser&title=Mutations+in+LRRK2+cause+autosomal-dominant+parkinsonism+with+pleomorphic+pathology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology</span></div><div class="casAuthors">Zimprich, Alexander; Biskup, Saskia; Leitner, Petra; Lichtner, Peter; Farrer, Matthew; Lincoln, Sarah; Kachergus, Jennifer; Hulihan, Mary; Uitti, Ryan J.; Calne, Donald B.; Stoessl, A. Jon; Pfeiffer, Ronald F.; Patenge, Nadja; Carbajal, Iria Carballo; Vieregge, Peter; Asmus, Friedrich; Mueller-Myhsok, Bertram; Dickson, Dennis W.; Meitinger, Thomas; Strom, Tim M.; Wszolek, Zbigniew K.; Gasser, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">601-607</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">We have previously linked families with autosomaldominant, late-onset parkinsonism to chromosome 12p11.2-q13.1 (PARK8).  By high-resoln. recombination mapping and candidate gene sequencing in 46 families, we have found six disease-segregating mutations (five missense and one putative splice site mutation) in a gene encoding a large, multifunctional protein, LRRK2 (leucine-rich repeat kinase 2).  It belongs to the ROCO protein family and includes a protein kinase domain of the MAPKKK class and several other major functional domains.  Within affected carriers of families A and D, six post mortem diagnoses reveal brainstem dopaminergic degeneration accompanied by strikingly diverse pathologies.  These include abnormalities consistent with Lewy body Parkinson's disease, diffuse Lewy body disease, nigral degeneration without distinctive histopathol., and progressive supranuclear palsy-like pathol.  Clin. diagnoses of Parkinsonism with dementia or amyotrophy or both, with their assocd. pathologies, are also noted.  Hence, LRRK2 may be central to the pathogenesis of several major neurodegenerative disorders assocd. with parkinsonism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9aK6wacZJhbVg90H21EOLACvtfcHk0liN86XUzrT2Vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVKhurjL&md5=9ae4c87ce3172e29829e317d94b5cdaa</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2004.11.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2004.11.005%26sid%3Dliteratum%253Aachs%26aulast%3DZimprich%26aufirst%3DA.%26aulast%3DBiskup%26aufirst%3DS.%26aulast%3DLeitner%26aufirst%3DP.%26aulast%3DLichtner%26aufirst%3DP.%26aulast%3DFarrer%26aufirst%3DM.%26aulast%3DLincoln%26aufirst%3DS.%26aulast%3DKachergus%26aufirst%3DJ.%26aulast%3DHulihan%26aufirst%3DM.%26aulast%3DUitti%26aufirst%3DR.%2BJ.%26aulast%3DCalne%26aufirst%3DD.%2BB.%26aulast%3DStoessl%26aufirst%3DA.%2BJ.%26aulast%3DPfeiffer%26aufirst%3DR.%2BF.%26aulast%3DPatenge%26aufirst%3DN.%26aulast%3DCarbajal%26aufirst%3DI.%2BC.%26aulast%3DVieregge%26aufirst%3DP.%26aulast%3DAsmus%26aufirst%3DF.%26aulast%3DMuller-Myhsok%26aufirst%3DB.%26aulast%3DDickson%26aufirst%3DD.%2BW.%26aulast%3DMeitinger%26aufirst%3DT.%26aulast%3DStrom%26aufirst%3DT.%2BM.%26aulast%3DWszolek%26aufirst%3DZ.%2BK.%26aulast%3DGasser%26aufirst%3DT.%26atitle%3DMutations%2520in%2520LRRK2%2520cause%2520autosomal-dominant%2520parkinsonism%2520with%2520pleomorphic%2520pathology%26jtitle%3DNeuron%26date%3D2004%26volume%3D44%26spage%3D601%26epage%3D607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Paisan-Ruiz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilks, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Brug, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez de Munain, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aparicio, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gil, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholl, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrera, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pena, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Silva, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lees, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marti-Masso, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Tur, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singleton, A. B.</span><span> </span><span class="NLM_article-title">Cloning of the gene containing mutations that cause PARK8-linked Parkinson’s disease</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">595</span><span class="NLM_x">–</span> <span class="NLM_lpage">600</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2004&pages=595-600&author=C.+Paisan-Ruizauthor=S.+Jainauthor=E.+W.+Evansauthor=W.+P.+Gilksauthor=J.+Simonauthor=M.+van+der+Brugauthor=A.+Lopez+de+Munainauthor=S.+Aparicioauthor=A.+M.+Gilauthor=N.+Khanauthor=J.+Johnsonauthor=J.+R.+Martinezauthor=D.+Nichollauthor=I.+M.+Carreraauthor=A.+S.+Penaauthor=R.+de+Silvaauthor=A.+Leesauthor=J.+F.+Marti-Massoauthor=J.+Perez-Turauthor=N.+W.+Woodauthor=A.+B.+Singleton&title=Cloning+of+the+gene+containing+mutations+that+cause+PARK8-linked+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPaisan-Ruiz%26aufirst%3DC.%26aulast%3DJain%26aufirst%3DS.%26aulast%3DEvans%26aufirst%3DE.%2BW.%26aulast%3DGilks%26aufirst%3DW.%2BP.%26aulast%3DSimon%26aufirst%3DJ.%26aulast%3Dvan%2Bder%2BBrug%26aufirst%3DM.%26aulast%3DLopez%2Bde%2BMunain%26aufirst%3DA.%26aulast%3DAparicio%26aufirst%3DS.%26aulast%3DGil%26aufirst%3DA.%2BM.%26aulast%3DKhan%26aufirst%3DN.%26aulast%3DJohnson%26aufirst%3DJ.%26aulast%3DMartinez%26aufirst%3DJ.%2BR.%26aulast%3DNicholl%26aufirst%3DD.%26aulast%3DCarrera%26aufirst%3DI.%2BM.%26aulast%3DPena%26aufirst%3DA.%2BS.%26aulast%3Dde%2BSilva%26aufirst%3DR.%26aulast%3DLees%26aufirst%3DA.%26aulast%3DMarti-Masso%26aufirst%3DJ.%2BF.%26aulast%3DPerez-Tur%26aufirst%3DJ.%26aulast%3DWood%26aufirst%3DN.%2BW.%26aulast%3DSingleton%26aufirst%3DA.%2BB.%26atitle%3DCloning%2520of%2520the%2520gene%2520containing%2520mutations%2520that%2520cause%2520PARK8-linked%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DNeuron%26date%3D2004%26volume%3D44%26spage%3D595%26epage%3D600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Paisan-Ruiz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawarai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salehi-Rad, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisman, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Khairallah, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George-Hyslop, P.,  St</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singleton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogaeva, E.</span><span> </span><span class="NLM_article-title">LRRK2 gene in Parkinson disease: mutation analysis and case control association study</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">696</span><span class="NLM_x">–</span> <span class="NLM_lpage">700</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=696-700&author=C.+Paisan-Ruizauthor=A.+E.+Langauthor=T.+Kawaraiauthor=C.+Satoauthor=S.+Salehi-Radauthor=G.+K.+Fismanauthor=T.+Al-Khairallahauthor=P.+George-Hyslopauthor=A.+Singletonauthor=E.+Rogaeva&title=LRRK2+gene+in+Parkinson+disease%3A+mutation+analysis+and+case+control+association+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPaisan-Ruiz%26aufirst%3DC.%26aulast%3DLang%26aufirst%3DA.%2BE.%26aulast%3DKawarai%26aufirst%3DT.%26aulast%3DSato%26aufirst%3DC.%26aulast%3DSalehi-Rad%26aufirst%3DS.%26aulast%3DFisman%26aufirst%3DG.%2BK.%26aulast%3DAl-Khairallah%26aufirst%3DT.%26aulast%3DGeorge-Hyslop%26aufirst%3DP.%26aulast%3DSingleton%26aufirst%3DA.%26aulast%3DRogaeva%26aufirst%3DE.%26atitle%3DLRRK2%2520gene%2520in%2520Parkinson%2520disease%253A%2520mutation%2520analysis%2520and%2520case%2520control%2520association%2520study%26jtitle%3DNeurology%26date%3D2005%26volume%3D65%26spage%3D696%26epage%3D700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Paisán-Ruiz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singleton, A. B.</span><span> </span><span class="NLM_article-title">LRRK2: Cause, risk, and mechanism</span> <span class="citation_source-journal">J. Parkinson’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">85</span><span class="NLM_x">–</span> <span class="NLM_lpage">103</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=23938341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFygs73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=85-103&author=C.+Pais%C3%A1n-Ruizauthor=P.+A.+Lewisauthor=A.+B.+Singleton&title=LRRK2%3A+Cause%2C+risk%2C+and+mechanism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">LRRK2: cause, risk, and mechanism</span></div><div class="casAuthors">Paisan-Ruiz, Coro; Lewis, Patrick A.; Singleton, Andrew B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Parkinson's Disease</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">85-103</span>CODEN:
                <span class="NLM_cas:coden">JPDOAP</span>;
        ISSN:<span class="NLM_cas:issn">1877-7171</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">A review.  In 2004 it was first shown that mutations in LRRK2 can cause Parkinson's disease.  This initial discovery was quickly followed by the observation that a single particular mutation is a relatively common cause of Parkinson's disease across varied populations.  Further genetic investigation has revealed a variety of genetic ties to Parkinson's disease across this gene.  These include common alleles with quite broad effects on risk, likely through both alterations at the protein sequence level, and in the context of expression.  A great deal of functional characterization of LRRK2 and disease-causing mutations in this protein has occurred over the last 9 years, and considerable progress has been made.  Particular attention has been paid to the kinase activity of LRRK2 as a therapeutic target, and while it is no means certain that this is viable target it is likely that this hypothesis will be tested in clin. trials sooner rather than later.  We believe that the future goals for LRRK2 research are, while challenging, relatively clear and that the next 10 years of research promises to be perhaps more exciting than the last.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqk1IVJK9Tqs7Vg90H21EOLACvtfcHk0liN86XUzrT2Vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFygs73M&md5=6e7ceb0477f0a4551ac71849daa4a0b1</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPais%25C3%25A1n-Ruiz%26aufirst%3DC.%26aulast%3DLewis%26aufirst%3DP.%2BA.%26aulast%3DSingleton%26aufirst%3DA.%2BB.%26atitle%3DLRRK2%253A%2520Cause%252C%2520risk%252C%2520and%2520mechanism%26jtitle%3DJ.%2520Parkinson%25E2%2580%2599s%2520Dis.%26date%3D2013%26volume%3D3%26spage%3D85%26epage%3D103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Thévenet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobert, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Huijsduijnen, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiessner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sagot, Y. J.</span><span> </span><span class="NLM_article-title">Regulation of LRRK2 expression points to a functional role in human monocyte maturation</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">e21519</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e21519&author=J.+Th%C3%A9venetauthor=R.+Gobertauthor=R.+H.+van+Huijsduijnenauthor=C.+Wiessnerauthor=Y.+J.+Sagot&title=Regulation+of+LRRK2+expression+points+to+a+functional+role+in+human+monocyte+maturation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTh%25C3%25A9venet%26aufirst%3DJ.%26aulast%3DGobert%26aufirst%3DR.%26aulast%3Dvan%2BHuijsduijnen%26aufirst%3DR.%2BH.%26aulast%3DWiessner%26aufirst%3DC.%26aulast%3DSagot%26aufirst%3DY.%2BJ.%26atitle%3DRegulation%2520of%2520LRRK2%2520expression%2520points%2520to%2520a%2520functional%2520role%2520in%2520human%2520monocyte%2520maturation%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26spage%3De21519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Sharma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bandopadhyay, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lashley, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renton, A. E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kingsbury, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumaran, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kallis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilariño-Güell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Sullivan, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lees, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Revesz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holton, J. L.</span><span> </span><span class="NLM_article-title">LRRK2 expression in idiopathic and G2019S positive Parkinson’s disease subjects: a morphological and quantitative study</span> <span class="citation_source-journal">Neuropathol. Appl. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">777</span><span class="NLM_x">–</span> <span class="NLM_lpage">790</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1111%2Fj.1365-2990.2011.01187.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=21696411" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1KjsbnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2011&pages=777-790&author=S.+Sharmaauthor=R.+Bandopadhyayauthor=T.+Lashleyauthor=A.+E.+M.+Rentonauthor=A.+E.+Kingsburyauthor=R.+Kumaranauthor=C.+Kallisauthor=C.+Vilari%C3%B1o-G%C3%BCellauthor=S.+S.+O%E2%80%99Sullivanauthor=A.+J.+Leesauthor=T.+Reveszauthor=N.+W.+Woodauthor=J.+L.+Holton&title=LRRK2+expression+in+idiopathic+and+G2019S+positive+Parkinson%E2%80%99s+disease+subjects%3A+a+morphological+and+quantitative+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">LRRK2 expression in idiopathic and G2019S positive Parkinson's disease subjects: a morphological and quantitative study</span></div><div class="casAuthors">Sharma, S.; Bandopadhyay, R.; Lashley, T.; Renton, A. E. M.; Kingsbury, A. E.; Kumaran, R.; Kallis, C.; Vilarino-Guell, C.; O'Sullivan, S. S.; Lees, A. J.; Revesz, T.; Wood, N. W.; Holton, J. L.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropathology and Applied Neurobiology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">777-790</span>CODEN:
                <span class="NLM_cas:coden">NANEDL</span>;
        ISSN:<span class="NLM_cas:issn">0305-1846</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Aims: Mutations in the gene encoding leucine-rich repeat kinase-2 (LRRK2) have been established as a common genetic cause of Parkinson's disease (PD).  The distribution of LRRK2 mRNA and protein in the human brain has previously been described, although it has not been reported in PD cases with the common LRRK2 G2019S mutation.  Methods: To further elucidate the role of LRRK2 in PD, we detd. the localization of LRRK2 mRNA and protein in post-mortem brain tissue from control, idiopathic PD (IPD) and G2019S pos. PD cases.  Results: Widespread neuronal expression of LRRK2 mRNA and protein was recorded and no difference was obsd. in the morphol. localization of LRRK2 mRNA or protein between control, IPD and G2019S pos. PD cases.  Using quant. real-time polymerase chain reaction, we demonstrated that there is no regional variation in LRRK2 mRNA in normal human brain, but we have identified differential expression of LRRK2 mRNA with significant redns. recorded in limbic and neocortical regions of IPD cases compared with controls.  Semi-quant. anal. of LRRK2 immunohistochem. staining demonstrated regional variation in staining intensity, with weak LRRK2 immunoreactivity consistently recorded in the striatum and substantia nigra.  No clear differences were identified in LRRK2 immunoreactivity between control, IPD and G2019S pos. PD cases.  LRRK2 protein was identified in a small proportion of Lewy bodies.  Conclusions: Our data suggest that widespread dysregulation of LRRK2 mRNA expression may contribute to the pathogenesis of IPD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqArcjWRuByHrVg90H21EOLACvtfcHk0liuezhzK2geOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1KjsbnM&md5=f5be255aaff70f27329ee13ea6747d5e</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2990.2011.01187.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2990.2011.01187.x%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DBandopadhyay%26aufirst%3DR.%26aulast%3DLashley%26aufirst%3DT.%26aulast%3DRenton%26aufirst%3DA.%2BE.%2BM.%26aulast%3DKingsbury%26aufirst%3DA.%2BE.%26aulast%3DKumaran%26aufirst%3DR.%26aulast%3DKallis%26aufirst%3DC.%26aulast%3DVilari%25C3%25B1o-G%25C3%25BCell%26aufirst%3DC.%26aulast%3DO%25E2%2580%2599Sullivan%26aufirst%3DS.%2BS.%26aulast%3DLees%26aufirst%3DA.%2BJ.%26aulast%3DRevesz%26aufirst%3DT.%26aulast%3DWood%26aufirst%3DN.%2BW.%26aulast%3DHolton%26aufirst%3DJ.%2BL.%26atitle%3DLRRK2%2520expression%2520in%2520idiopathic%2520and%2520G2019S%2520positive%2520Parkinson%25E2%2580%2599s%2520disease%2520subjects%253A%2520a%2520morphological%2520and%2520quantitative%2520study%26jtitle%3DNeuropathol.%2520Appl.%2520Neurobiol.%26date%3D2011%26volume%3D37%26spage%3D777%26epage%3D790" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Mills, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulhern, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Culvenor, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H. C.</span><span> </span><span class="NLM_article-title">Prediction of the repeat domain structures and impact of parkinsonism-associated variations on structure and function of all functional domains of leucine-rich repeat kinase 2 (LRRK2)</span> <span class="citation_source-journal">Hum. Mutat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">395</span><span class="NLM_x">–</span> <span class="NLM_lpage">412</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1002%2Fhumu.22515" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=24470158" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC2cXktlKmurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=395-412&author=R.+D.+Millsauthor=T.+D.+Mulhernauthor=F.+Liuauthor=J.+G.+Culvenorauthor=H.+C.+Cheng&title=Prediction+of+the+repeat+domain+structures+and+impact+of+parkinsonism-associated+variations+on+structure+and+function+of+all+functional+domains+of+leucine-rich+repeat+kinase+2+%28LRRK2%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Prediction of the Repeat Domain Structures and Impact of Parkinsonism-Associated Variations on Structure and Function of all Functional Domains of Leucine-Rich Repeat Kinase 2 (LRRK2)</span></div><div class="casAuthors">Mills, Ryan D.; Mulhern, Terrence D.; Liu, Fei; Culvenor, Janetta G.; Cheng, Heung-Chin</div><div class="citationInfo"><span class="NLM_cas:title">Human Mutation</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">395-412</span>CODEN:
                <span class="NLM_cas:coden">HUMUE3</span>;
        ISSN:<span class="NLM_cas:issn">1059-7794</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  Genetic variations of leucine-rich repeat kinase 2 (LRRK2) are the major cause of dominantly inherited Parkinson disease (PD).  LRRK2 protein contains seven predicted domains: a tandem Ras-like GTPase (ROC) domain and C-terminal of Roc (COR) domain, a protein kinase domain, and four repeat domains.  PD-causative variations arise in all domains, suggesting that aberrant functioning of any domain can contribute to neurotoxic mechanisms of LRRK2.  Detn. of the three-dimensional structure of LRRK2 is one of the best avenues to decipher its neurotoxic mechanism.  However, with the exception of the Roc domain, the three-dimensional structures of the functional domains of LRRK2 have yet to be detd.  Based on the known three-dimensional structures of repeat domains of other proteins, the tandem Roc-COR domains of the Chlorobium tepidum Rab family protein, and the kinase domain of the Dictyostelium discoideum Roco4 protein, we predicted (1) the motifs essential for protein-protein interactions in all domains, (2) the motifs crit. for catalysis and substrate recognition in the tandem Roc-COR and kinase domains, and (3) the effects of some PD-assocd. missense variations on the neurotoxic action of LRRK2.  Results of our anal. provide a conceptual framework for future investigation into the regulation and the neurotoxic mechanism of LRRK2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCQyitGjwuJ7Vg90H21EOLACvtfcHk0liuezhzK2geOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXktlKmurg%253D&md5=71fb35dc3def1fa847bad36b1b38f035</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2Fhumu.22515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhumu.22515%26sid%3Dliteratum%253Aachs%26aulast%3DMills%26aufirst%3DR.%2BD.%26aulast%3DMulhern%26aufirst%3DT.%2BD.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DCulvenor%26aufirst%3DJ.%2BG.%26aulast%3DCheng%26aufirst%3DH.%2BC.%26atitle%3DPrediction%2520of%2520the%2520repeat%2520domain%2520structures%2520and%2520impact%2520of%2520parkinsonism-associated%2520variations%2520on%2520structure%2520and%2520function%2520of%2520all%2520functional%2520domains%2520of%2520leucine-rich%2520repeat%2520kinase%25202%2520%2528LRRK2%2529%26jtitle%3DHum.%2520Mutat.%26date%3D2014%26volume%3D35%26spage%3D395%26epage%3D412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Anand, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braithwaite, S. P.</span><span> </span><span class="NLM_article-title">LRRK2 in Parkinson’s disease: biochemical functions</span> <span class="citation_source-journal">FEBS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">6428</span><span class="NLM_x">–</span> <span class="NLM_lpage">6435</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2009&pages=6428-6435&author=V.+S.+Anandauthor=S.+P.+Braithwaite&title=LRRK2+in+Parkinson%E2%80%99s+disease%3A+biochemical+functions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAnand%26aufirst%3DV.%2BS.%26aulast%3DBraithwaite%26aufirst%3DS.%2BP.%26atitle%3DLRRK2%2520in%2520Parkinson%25E2%2580%2599s%2520disease%253A%2520biochemical%2520functions%26jtitle%3DFEBS%2520J.%26date%3D2009%26volume%3D276%26spage%3D6428%26epage%3D6435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Drolet, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanders, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kern, J. T.</span><span> </span><span class="NLM_article-title">Leucine-rich repeat kinase 2 (LRRK2) cellular biology: a review of recent advances in identifying physiological substrates and cellular functions</span> <span class="citation_source-journal">J. Neurogenet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">140</span><span class="NLM_x">–</span> <span class="NLM_lpage">151</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.3109%2F01677063.2011.627072" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=22077787" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsV2hs7bL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=140-151&author=R.+E.+Droletauthor=J.+M.+Sandersauthor=J.+T.+Kern&title=Leucine-rich+repeat+kinase+2+%28LRRK2%29+cellular+biology%3A+a+review+of+recent+advances+in+identifying+physiological+substrates+and+cellular+functions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Leucine-Rich Repeat Kinase 2 (LRRK2) Cellular Biology: A Review of Recent Advances in Identifying Physiological Substrates and Cellular Functions</span></div><div class="casAuthors">Drolet, Robert E.; Sanders, John M.; Kern, Jonathan T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurogenetics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">140-151</span>CODEN:
                <span class="NLM_cas:coden">JLNEDK</span>;
        ISSN:<span class="NLM_cas:issn">0167-7063</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are the most common forms of inheritable Parkinson's disease and likely play a role in sporadic disease as well.  LRRK2 is a large multidomain protein contg. two key groups, a Ras-like GTP binding domain and a serine, threonine kinase domain.  Mutations in the LRRK2 gene that assoc. with Parkinson's disease reside primarily within the two functional domains of the protein, suggesting that LRRK2 function is crit. to the pathogenesis of the disease.  The most common LRRK2 mutation increases kinase activity, making LRRK2 kinase inhibition an attractive target for small mol. drug development.  However, the physiol. function of LRRK2 kinase as well as its endogenous protein substrates remains poorly understood and has hindered drug development efforts.  Recent advances in LRRK2 biol. have revealed several potential cellular roles, interacting proteins, and putative physiol. substrates.  Together, a picture emerges of a complex multifunctional protein that exists in multiple cellular compartments.  Through unclear mechanisms, LRRK2 kinase regulates cytoskeleton architecture through control of protein translation, phosphorylation of cytoskeletal proteins, and response to cellular stressors.  This article will briefly cover some interesting recent studies in LRRK2 cellular biol. and highlight emerging cellular models of LRRK2 kinase function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIaZnsxyLANrVg90H21EOLACvtfcHk0lhDlptynBSgCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsV2hs7bL&md5=b4b40ac3ccfa45091410f59e1401587c</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.3109%2F01677063.2011.627072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F01677063.2011.627072%26sid%3Dliteratum%253Aachs%26aulast%3DDrolet%26aufirst%3DR.%2BE.%26aulast%3DSanders%26aufirst%3DJ.%2BM.%26aulast%3DKern%26aufirst%3DJ.%2BT.%26atitle%3DLeucine-rich%2520repeat%2520kinase%25202%2520%2528LRRK2%2529%2520cellular%2520biology%253A%2520a%2520review%2520of%2520recent%2520advances%2520in%2520identifying%2520physiological%2520substrates%2520and%2520cellular%2520functions%26jtitle%3DJ.%2520Neurogenet.%26date%3D2011%26volume%3D25%26spage%3D140%26epage%3D151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Gilsbach, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, F. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vetter, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Haastert, P. J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittinghofer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kortholt, A.</span><span> </span><span class="NLM_article-title">Roco kinase structures give insights into the mechanism of Parkinson disease-related leucine-rich-repeat kinase 2 mutations</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">10322</span><span class="NLM_x">–</span> <span class="NLM_lpage">10327</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=10322-10327&author=B.+K.+Gilsbachauthor=F.+Y.+Hoauthor=I.+R.+Vetterauthor=P.+J.+M.+van+Haastertauthor=A.+Wittinghoferauthor=A.+Kortholt&title=Roco+kinase+structures+give+insights+into+the+mechanism+of+Parkinson+disease-related+leucine-rich-repeat+kinase+2+mutations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGilsbach%26aufirst%3DB.%2BK.%26aulast%3DHo%26aufirst%3DF.%2BY.%26aulast%3DVetter%26aufirst%3DI.%2BR.%26aulast%3Dvan%2BHaastert%26aufirst%3DP.%2BJ.%2BM.%26aulast%3DWittinghofer%26aufirst%3DA.%26aulast%3DKortholt%26aufirst%3DA.%26atitle%3DRoco%2520kinase%2520structures%2520give%2520insights%2520into%2520the%2520mechanism%2520of%2520Parkinson%2520disease-related%2520leucine-rich-repeat%2520kinase%25202%2520mutations%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2012%26volume%3D109%26spage%3D10322%26epage%3D10327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Liu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bender, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuny, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherman, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glicksman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, S. S.</span><span> </span><span class="NLM_article-title">Type II kinase inhibitors show an unexpected inhibition mode against Parkinson’s disease-linked LRRK2 mutant G2019S</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1725</span><span class="NLM_x">–</span> <span class="NLM_lpage">1736</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi3012077" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=1725-1736&author=M.+Liuauthor=S.+A.+Benderauthor=G.+D.+Cunyauthor=W.+Shermanauthor=M.+Glicksmanauthor=S.+S.+Ray&title=Type+II+kinase+inhibitors+show+an+unexpected+inhibition+mode+against+Parkinson%E2%80%99s+disease-linked+LRRK2+mutant+G2019S"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fbi3012077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi3012077%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DBender%26aufirst%3DS.%2BA.%26aulast%3DCuny%26aufirst%3DG.%2BD.%26aulast%3DSherman%26aufirst%3DW.%26aulast%3DGlicksman%26aufirst%3DM.%26aulast%3DRay%26aufirst%3DS.%2BS.%26atitle%3DType%2520II%2520kinase%2520inhibitors%2520show%2520an%2520unexpected%2520inhibition%2520mode%2520against%2520Parkinson%25E2%2580%2599s%2520disease-linked%2520LRRK2%2520mutant%2520G2019S%26jtitle%3DBiochemistry%26date%3D2013%26volume%3D52%26spage%3D1725%26epage%3D1736" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Gilsbach, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kortholt, A.</span><span> </span><span class="NLM_article-title">Structural biology of the LRRK2 GTPase and kinase domains: implications for regulation</span> <span class="citation_source-journal">Front. Mol. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">32</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.3389%2Ffnmol.2014.00032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=24847205" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVChsLbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2014&pages=32&author=B.+K.+Gilsbachauthor=A.+Kortholt&title=Structural+biology+of+the+LRRK2+GTPase+and+kinase+domains%3A+implications+for+regulation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Structural biology of the LRRK2 GTPase and kinase domains: implications for regulation</span></div><div class="casAuthors">Gilsbach, Bernd K.; Kortholt, Arjan</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Molecular Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">32/1-32/9, 9 pp.</span>CODEN:
                <span class="NLM_cas:coden">FMNRAJ</span>;
        ISSN:<span class="NLM_cas:issn">1662-5099</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Human leucine rich repeat kinase 2 (LRRK2) belongs to the Roco family of proteins, which are characterized by the presence of a Ras-like G-domain (Roc), a C-terminal of Roc domain (COR), and a kinase domain.  Mutations in LRRK2 have been found to be thus far the most frequent cause of late-onset Parkinson's disease (PD).  Several of the pathogenic mutations in LRRK2 result in decreased GTPase activity and enhanced kinase activity, suggesting a possible PD-related gain of abnormal function.  Important progress in the structural understanding of LRRK2 has come from our work with related Roco proteins from lower organisms.  Atomic structures of Roco proteins from prokaryotes revealed that Roco proteins belong to the GAD class of mol. switches (G proteins activated by nucleotide dependent dimerization).  As in LRRK2, PD-analogous mutations in Roco proteins from bacteria decrease the GTPase reaction.  Studies with Roco proteins from the model organism Dictyostelium discoideum revealed that PD mutants have different effects and most importantly they explained the G2019S-related increased LRRK2 kinase activity.  Furthermore, the structure of Dictyostelium Roco4 kinase in complex with the LRRK2 inhibitor H1152 showed that Roco4 and other Roco family proteins can be important for the optimization of the current, and identification of new, LRRK2 kinase inhibitors.  In this review we highlight the recent progress in structural and biochem. characterization of Roco proteins and discuss its implication for the understanding of the complex regulatory mechanism of LRRK2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnWPIGCCasqLVg90H21EOLACvtfcHk0lhDlptynBSgCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVChsLbN&md5=de1cef27dd0b8e5b5b242a4a1607192f</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.3389%2Ffnmol.2014.00032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnmol.2014.00032%26sid%3Dliteratum%253Aachs%26aulast%3DGilsbach%26aufirst%3DB.%2BK.%26aulast%3DKortholt%26aufirst%3DA.%26atitle%3DStructural%2520biology%2520of%2520the%2520LRRK2%2520GTPase%2520and%2520kinase%2520domains%253A%2520implications%2520for%2520regulation%26jtitle%3DFront.%2520Mol.%2520Neurosci.%26date%3D2014%26volume%3D7%26spage%3D32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Sen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webber, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, A. B.</span><span> </span><span class="NLM_article-title">Dependence of leucine-rich repeat kinase 2 (LRRK2) kinase activity on dimerization</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x">, </span> <span class="NLM_fpage">36346</span><span class="NLM_x">–</span> <span class="NLM_lpage">36356</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=36346-36356&author=S.+Senauthor=P.+J.+Webberauthor=A.+B.+West&title=Dependence+of+leucine-rich+repeat+kinase+2+%28LRRK2%29+kinase+activity+on+dimerization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSen%26aufirst%3DS.%26aulast%3DWebber%26aufirst%3DP.%2BJ.%26aulast%3DWest%26aufirst%3DA.%2BB.%26atitle%3DDependence%2520of%2520leucine-rich%2520repeat%2520kinase%25202%2520%2528LRRK2%2529%2520kinase%2520activity%2520on%2520dimerization%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D36346%26epage%3D36356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Ito, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujino, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichijo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katada, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwatsubo, T.</span><span> </span><span class="NLM_article-title">GTP binding is essential to the protein kinase activity of LRRK2, a causative gene product for familial Parkinson’s disease</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">1380</span><span class="NLM_x">–</span> <span class="NLM_lpage">1388</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi061960m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=1380-1388&author=G.+Itoauthor=T.+Okaiauthor=G.+Fujinoauthor=K.+Takedaauthor=H.+Ichijoauthor=T.+Katadaauthor=T.+Iwatsubo&title=GTP+binding+is+essential+to+the+protein+kinase+activity+of+LRRK2%2C+a+causative+gene+product+for+familial+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fbi061960m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi061960m%26sid%3Dliteratum%253Aachs%26aulast%3DIto%26aufirst%3DG.%26aulast%3DOkai%26aufirst%3DT.%26aulast%3DFujino%26aufirst%3DG.%26aulast%3DTakeda%26aufirst%3DK.%26aulast%3DIchijo%26aufirst%3DH.%26aulast%3DKatada%26aufirst%3DT.%26aulast%3DIwatsubo%26aufirst%3DT.%26atitle%3DGTP%2520binding%2520is%2520essential%2520to%2520the%2520protein%2520kinase%2520activity%2520of%2520LRRK2%252C%2520a%2520causative%2520gene%2520product%2520for%2520familial%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DBiochemistry%26date%3D2007%26volume%3D46%26spage%3D1380%26epage%3D1388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Sheng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bustos, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleinheinz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Pichon, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominguez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solanoy, H. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drummond, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yue, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Brug, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burdick, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunzner-Toste, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estrada, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweeney, Z. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scearce-Levie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moffat, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirkpatrick, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.</span><span> </span><span class="NLM_article-title">Ser<sup>1292</sup> autophosphorylation is an indicator of LRRK2 kinase activity and contributes to the cellular effects of PD mutations</span> <span class="citation_source-journal">Sci. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">164ra161</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1126%2Fscitranslmed.3004485" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=23241745" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=164ra161&author=Z.+Shengauthor=S.+Zhangauthor=D.+Bustosauthor=T.+Kleinheinzauthor=C.+E.+Le+Pichonauthor=S.+Dominguezauthor=H.+O.+Solanoyauthor=J.+Drummondauthor=X.+Zhangauthor=X.+Dingauthor=F.+Caiauthor=Q.+Songauthor=X.+Liauthor=Z.+Yueauthor=M.+P.+van+der+Brugauthor=D.+J.+Burdickauthor=J.+Gunzner-Tosteauthor=H.+Chenauthor=X.+Liuauthor=A.+A.+Estradaauthor=Z.+K.+Sweeneyauthor=K.+Scearce-Levieauthor=J.+G.+Moffatauthor=D.+S.+Kirkpatrickauthor=H.+Zhu&title=Ser1292+autophosphorylation+is+an+indicator+of+LRRK2+kinase+activity+and+contributes+to+the+cellular+effects+of+PD+mutations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3004485&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3004485%26sid%3Dliteratum%253Aachs%26aulast%3DSheng%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DBustos%26aufirst%3DD.%26aulast%3DKleinheinz%26aufirst%3DT.%26aulast%3DLe%2BPichon%26aufirst%3DC.%2BE.%26aulast%3DDominguez%26aufirst%3DS.%26aulast%3DSolanoy%26aufirst%3DH.%2BO.%26aulast%3DDrummond%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DDing%26aufirst%3DX.%26aulast%3DCai%26aufirst%3DF.%26aulast%3DSong%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DYue%26aufirst%3DZ.%26aulast%3Dvan%2Bder%2BBrug%26aufirst%3DM.%2BP.%26aulast%3DBurdick%26aufirst%3DD.%2BJ.%26aulast%3DGunzner-Toste%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DEstrada%26aufirst%3DA.%2BA.%26aulast%3DSweeney%26aufirst%3DZ.%2BK.%26aulast%3DScearce-Levie%26aufirst%3DK.%26aulast%3DMoffat%26aufirst%3DJ.%2BG.%26aulast%3DKirkpatrick%26aufirst%3DD.%2BS.%26aulast%3DZhu%26aufirst%3DH.%26atitle%3DSer1292%2520autophosphorylation%2520is%2520an%2520indicator%2520of%2520LRRK2%2520kinase%2520activity%2520and%2520contributes%2520to%2520the%2520cellular%2520effects%2520of%2520PD%2520mutations%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2012%26volume%3D4%26spage%3D164ra161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">West, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biskup, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bugayenko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, T. M.</span><span> </span><span class="NLM_article-title">Parkinson’s disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">16842</span><span class="NLM_x">–</span> <span class="NLM_lpage">16847</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=16842-16847&author=A.+B.+Westauthor=D.+J.+Mooreauthor=S.+Biskupauthor=A.+Bugayenkoauthor=W.+W.+Smithauthor=C.+A.+Rossauthor=V.+L.+Dawsonauthor=T.+M.+Dawson&title=Parkinson%E2%80%99s+disease-associated+mutations+in+leucine-rich+repeat+kinase+2+augment+kinase+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWest%26aufirst%3DA.%2BB.%26aulast%3DMoore%26aufirst%3DD.%2BJ.%26aulast%3DBiskup%26aufirst%3DS.%26aulast%3DBugayenko%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DW.%2BW.%26aulast%3DRoss%26aufirst%3DC.%2BA.%26aulast%3DDawson%26aufirst%3DV.%2BL.%26aulast%3DDawson%26aufirst%3DT.%2BM.%26atitle%3DParkinson%25E2%2580%2599s%2520disease-associated%2520mutations%2520in%2520leucine-rich%2520repeat%2520kinase%25202%2520augment%2520kinase%2520activity%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2005%26volume%3D102%26spage%3D16842%26epage%3D16847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">West, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrabi, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dikeman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biskup, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, T. M.</span><span> </span><span class="NLM_article-title">Parkinson’s disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity</span> <span class="citation_source-journal">Hum. Mol. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">223</span><span class="NLM_x">–</span> <span class="NLM_lpage">232</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1093%2Fhmg%2Fddl471" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=17200152" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVKkt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2007&pages=223-232&author=A.+B.+Westauthor=D.+J.+Mooreauthor=C.+Choiauthor=S.+A.+Andrabiauthor=X.+Liauthor=D.+Dikemanauthor=S.+Biskupauthor=Z.+Zhangauthor=K.+L.+Limauthor=V.+L.+Dawsonauthor=T.+M.+Dawson&title=Parkinson%E2%80%99s+disease-associated+mutations+in+LRRK2+link+enhanced+GTP-binding+and+kinase+activities+to+neuronal+toxicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity</span></div><div class="casAuthors">West, Andrew B.; Moore, Darren J.; Choi, Catherine; Andrabi, Shaida A.; Li, Xiaojie; Dikeman, Dustin; Biskup, Saskia; Zhang, Zhenshui; Lim, Kah-Leong; Dawson, Valina L.; Dawson, Ted M.</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">223-232</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Mutations in the leucine-rich repeat kinase 2 gene (LRRK2) cause late-onset Parkinson's disease indistinguishable from idiopathic disease.  The mechanisms whereby missense alterations in the LRRK2 gene initiate neurodegeneration remain unknown.  Here, we demonstrate that seven of 10 suspected familial-linked mutations result in increased kinase activity.  Functional and disease-assocd. mutations in conserved residues reveal the crit. link between intrinsic guanosine triphosphatase (GTPase) activity and downstream kinase activity.  LRRK2 kinase activity requires GTPase activity, whereas GTPase activity functions independently of kinase activity.  Both LRRK2 kinase and GTPase activity are required for neurotoxicity and potentiate peroxide-induced cell death, although LRRK2 does not function as a canonical MAP-kinase-kinase-kinase.  These results suggest a link between LRRK2 kinase activity and pathogenic mechanisms relating to neurodegeneration, further supporting a gain-of-function role for LRRK2 mutations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrt9g3fmGyJFLVg90H21EOLACvtfcHk0lhHXknhI63eMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVKkt70%253D&md5=b98933d068e9443ae10181b3343a471f</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddl471&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddl471%26sid%3Dliteratum%253Aachs%26aulast%3DWest%26aufirst%3DA.%2BB.%26aulast%3DMoore%26aufirst%3DD.%2BJ.%26aulast%3DChoi%26aufirst%3DC.%26aulast%3DAndrabi%26aufirst%3DS.%2BA.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DDikeman%26aufirst%3DD.%26aulast%3DBiskup%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DLim%26aufirst%3DK.%2BL.%26aulast%3DDawson%26aufirst%3DV.%2BL.%26aulast%3DDawson%26aufirst%3DT.%2BM.%26atitle%3DParkinson%25E2%2580%2599s%2520disease-associated%2520mutations%2520in%2520LRRK2%2520link%2520enhanced%2520GTP-binding%2520and%2520kinase%2520activities%2520to%2520neuronal%2520toxicity%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2007%26volume%3D16%26spage%3D223%26epage%3D232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Jaleel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillardon, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knebel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span> </span><span class="NLM_article-title">LRRK2 phosphorylates moesin at threonine-558: characterization of how Parkinson’s disease mutants affect kinase activity</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">405</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">317</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=405&publication_year=2007&pages=307-317&author=M.+Jaleelauthor=R.+J.+Nicholsauthor=M.+Deakauthor=D.+G.+Campbellauthor=F.+Gillardonauthor=A.+Knebelauthor=D.+R.+Alessi&title=LRRK2+phosphorylates+moesin+at+threonine-558%3A+characterization+of+how+Parkinson%E2%80%99s+disease+mutants+affect+kinase+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJaleel%26aufirst%3DM.%26aulast%3DNichols%26aufirst%3DR.%2BJ.%26aulast%3DDeak%26aufirst%3DM.%26aulast%3DCampbell%26aufirst%3DD.%2BG.%26aulast%3DGillardon%26aufirst%3DF.%26aulast%3DKnebel%26aufirst%3DA.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26atitle%3DLRRK2%2520phosphorylates%2520moesin%2520at%2520threonine-558%253A%2520characterization%2520of%2520how%2520Parkinson%25E2%2580%2599s%2520disease%2520mutants%2520affect%2520kinase%2520activity%26jtitle%3DBiochem.%2520J.%26date%3D2007%26volume%3D405%26spage%3D307%26epage%3D317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Silva, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geoghegan, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aulabaugh, A.</span><span> </span><span class="NLM_article-title">A continuous and direct assay to monitor leucine-rich repeat kinase 2 activity</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">450</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">–</span> <span class="NLM_lpage">69</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=450&publication_year=2014&pages=63-69&author=R.+G.+Silvaauthor=K.+F.+Geogheganauthor=X.+Qiuauthor=A.+Aulabaugh&title=A+continuous+and+direct+assay+to+monitor+leucine-rich+repeat+kinase+2+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSilva%26aufirst%3DR.%2BG.%26aulast%3DGeoghegan%26aufirst%3DK.%2BF.%26aulast%3DQiu%26aufirst%3DX.%26aulast%3DAulabaugh%26aufirst%3DA.%26atitle%3DA%2520continuous%2520and%2520direct%2520assay%2520to%2520monitor%2520leucine-rich%2520repeat%2520kinase%25202%2520activity%26jtitle%3DAnal.%2520Biochem.%26date%3D2014%26volume%3D450%26spage%3D63%26epage%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Kachergus, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mata, I. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hulihan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lincoln, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aasly, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, O. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payami, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nutt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maraganore, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czyzewski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Styczynska, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wszolek, Z. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrer, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toft, M.</span><span> </span><span class="NLM_article-title">Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations</span> <span class="citation_source-journal">Am. J. Hum. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x">, </span> <span class="NLM_fpage">672</span><span class="NLM_x">–</span> <span class="NLM_lpage">680</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1086%2F429256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=15726496" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisleisLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2005&pages=672-680&author=J.+Kachergusauthor=I.+F.+Mataauthor=M.+Hulihanauthor=J.+P.+Taylorauthor=S.+Lincolnauthor=J.+Aaslyauthor=J.+M.+Gibsonauthor=O.+W.+Rossauthor=T.+Lynchauthor=J.+Wileyauthor=H.+Payamiauthor=J.+Nuttauthor=D.+M.+Maraganoreauthor=K.+Czyzewskiauthor=M.+Styczynskaauthor=Z.+K.+Wszolekauthor=M.+J.+Farrerauthor=M.+Toft&title=Identification+of+a+novel+LRRK2+mutation+linked+to+autosomal+dominant+parkinsonism%3A+evidence+of+a+common+founder+across+European+populations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations</span></div><div class="casAuthors">Kachergus, Jennifer; Mata, Ignacio F.; Hulihan, Mary; Taylor, Julie P.; Lincoln, Sarah; Aasly, Jan; Gibson, J. Mark; Ross, Owen A.; Lynch, Timothy; Wiley, Joseph; Payami, Haydeh; Nutt, John; Maraganore, Demetrius M.; Czyzewski, Krzysztof; Styczynska, Maria; Wszolek, Zbigniew K.; Farrer, Matthew J.; Toft, Mathias</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Human Genetics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">672-680</span>CODEN:
                <span class="NLM_cas:coden">AJHGAG</span>;
        ISSN:<span class="NLM_cas:issn">0002-9297</span>.
    
            (<span class="NLM_cas:orgname">University of Chicago Press</span>)
        </div><div class="casAbstract">Autosomal dominant parkinsonism has been attributed to pathogenic amino acid substitutions in leucine-rich repeat kinase 2 (LRRK2).  By sequencing multiplex families consistent with a PARK8 assignment, the authors identified a novel heterozygous LRRK2 mutation.  A referral sample of 248 affected probands from families with autosomal dominant parkinsonism was subsequently assessed; 7 (2.8%) were found to carry a heterozygous LRRK2 6055G→A transition (G2019S).  These seven patients originate from the United States, Norway, Ireland, and Poland.  In samples of patients with idiopathic Parkinson disease (PD) from the same populations, further screening identified six more patients with LRRK2 G2019S; no mutations were found in matched control individuals.  Subsequently, 42 family members of the 13 probands were examd.; 22 have an LRRK2 G2019S substitution, 7 with a diagnosis of PD.  Of note, all patients share an ancestral haplotype indicative of a common founder, and, within families, LRRK2 G2019S segregates with disease (multipoint LOD score 2.41).  Penetrance is age dependent, increasing from 17% at age 50 years to 85% at age 70 years.  In summary, the authors' study demonstrates that LRRK2 G2019S accounts for parkinsonism in several families within Europe and North America.  The authors' work highlights the fact that a proportion of clin. typical, late-onset PD cases have a genetic basis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnPfJFU1UPybVg90H21EOLACvtfcHk0ljQo6Y973Pn2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisleisLY%253D&md5=a3ffc5c6ee4170a12bd11437a95aca35</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1086%2F429256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F429256%26sid%3Dliteratum%253Aachs%26aulast%3DKachergus%26aufirst%3DJ.%26aulast%3DMata%26aufirst%3DI.%2BF.%26aulast%3DHulihan%26aufirst%3DM.%26aulast%3DTaylor%26aufirst%3DJ.%2BP.%26aulast%3DLincoln%26aufirst%3DS.%26aulast%3DAasly%26aufirst%3DJ.%26aulast%3DGibson%26aufirst%3DJ.%2BM.%26aulast%3DRoss%26aufirst%3DO.%2BW.%26aulast%3DLynch%26aufirst%3DT.%26aulast%3DWiley%26aufirst%3DJ.%26aulast%3DPayami%26aufirst%3DH.%26aulast%3DNutt%26aufirst%3DJ.%26aulast%3DMaraganore%26aufirst%3DD.%2BM.%26aulast%3DCzyzewski%26aufirst%3DK.%26aulast%3DStyczynska%26aufirst%3DM.%26aulast%3DWszolek%26aufirst%3DZ.%2BK.%26aulast%3DFarrer%26aufirst%3DM.%2BJ.%26aulast%3DToft%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520a%2520novel%2520LRRK2%2520mutation%2520linked%2520to%2520autosomal%2520dominant%2520parkinsonism%253A%2520evidence%2520of%2520a%2520common%2520founder%2520across%2520European%2520populations%26jtitle%3DAm.%2520J.%2520Hum.%2520Genet.%26date%3D2005%26volume%3D76%26spage%3D672%26epage%3D680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Smith, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pei, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, C. A.</span><span> </span><span class="NLM_article-title">Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">18676</span><span class="NLM_x">–</span> <span class="NLM_lpage">18681</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=18676-18681&author=W.+W.+Smithauthor=Z.+Peiauthor=H.+Jiangauthor=D.+J.+Mooreauthor=Y.+Liangauthor=A.+B.+Westauthor=V.+L.+Dawsonauthor=T.+M.+Dawsonauthor=C.+A.+Ross&title=Leucine-rich+repeat+kinase+2+%28LRRK2%29+interacts+with+parkin%2C+and+mutant+LRRK2+induces+neuronal+degeneration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DW.%2BW.%26aulast%3DPei%26aufirst%3DZ.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DMoore%26aufirst%3DD.%2BJ.%26aulast%3DLiang%26aufirst%3DY.%26aulast%3DWest%26aufirst%3DA.%2BB.%26aulast%3DDawson%26aufirst%3DV.%2BL.%26aulast%3DDawson%26aufirst%3DT.%2BM.%26aulast%3DRoss%26aufirst%3DC.%2BA.%26atitle%3DLeucine-rich%2520repeat%2520kinase%25202%2520%2528LRRK2%2529%2520interacts%2520with%2520parkin%252C%2520and%2520mutant%2520LRRK2%2520induces%2520neuronal%2520degeneration%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2005%26volume%3D102%26spage%3D18676%26epage%3D18681" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Gloeckner, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinkl, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schumacher, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braun, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meitinger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolch, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prokisch, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueffing, M.</span><span> </span><span class="NLM_article-title">The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity</span> <span class="citation_source-journal">Hum. Mol. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">223</span><span class="NLM_x">–</span> <span class="NLM_lpage">232</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1093%2Fhmg%2Fddi439" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=16321986" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BD28XktF2gtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2006&pages=223-232&author=C.+J.+Gloecknerauthor=N.+Kinklauthor=A.+Schumacherauthor=R.+J.+Braunauthor=E.+O%E2%80%99Neillauthor=T.+Meitingerauthor=W.+Kolchauthor=H.+Prokischauthor=M.+Ueffing&title=The+Parkinson+disease+causing+LRRK2+mutation+I2020T+is+associated+with+increased+kinase+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity</span></div><div class="casAuthors">Gloeckner, Christian Johannes; Kinkl, Norbert; Schumacher, Annette; Braun, Ralf J.; O'Neill, Eric; Meitinger, Thomas; Kolch, Walter; Prokisch, Holger; Ueffing, Marius</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">223-232</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Mutations in the leucine-rich repeat kinase 2 gene (LRRK2) have been recently identified in families with autosomal dominant late-onset Parkinson disease (PD).  The LRRK2 protein consists of multiple domains and belongs to the Roco family, a novel group of the Ras/GTPase superfamily.  Besides the GTPase (Roc) domain, it contains a predicted kinase domain, with homol. to MAP kinase kinase kinases.  Using cell fractionation and immunofluorescence microscopy, we show that LRRK2 is localized in the cytoplasm and is assocd. with cellular membrane structures.  The purified LRRK2 protein demonstrates autokinase activity.  The disease-assocd. I2020T mutant shows a significant increase in autophosphorylation of ∼40% in comparison to wild-type protein in vitro.  This suggests that the pathol. of PD caused by the I2020T mutation is assocd. with an increase rather than a loss in LRRK2 kinase activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqm5pHX4t5L17Vg90H21EOLACvtfcHk0ljQo6Y973Pn2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XktF2gtQ%253D%253D&md5=191962d8ff4cdf80546e916d74d57f3a</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddi439&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddi439%26sid%3Dliteratum%253Aachs%26aulast%3DGloeckner%26aufirst%3DC.%2BJ.%26aulast%3DKinkl%26aufirst%3DN.%26aulast%3DSchumacher%26aufirst%3DA.%26aulast%3DBraun%26aufirst%3DR.%2BJ.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DE.%26aulast%3DMeitinger%26aufirst%3DT.%26aulast%3DKolch%26aufirst%3DW.%26aulast%3DProkisch%26aufirst%3DH.%26aulast%3DUeffing%26aufirst%3DM.%26atitle%3DThe%2520Parkinson%2520disease%2520causing%2520LRRK2%2520mutation%2520I2020T%2520is%2520associated%2520with%2520increased%2520kinase%2520activity%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2006%26volume%3D15%26spage%3D223%26epage%3D232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Deng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buhrlage, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Leucine-rich repeat kinase 2 inhibitors: a patent review (2006–2011)</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1415</span><span class="NLM_x">–</span> <span class="NLM_lpage">1426</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1517%2F13543776.2012.729041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=23126385" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs12itLfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=1415-1426&author=X.+Dengauthor=H.+G.+Choiauthor=S.+J.+Buhrlageauthor=N.+S.+Gray&title=Leucine-rich+repeat+kinase+2+inhibitors%3A+a+patent+review+%282006%E2%80%932011%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Leucine-rich repeat kinase 2 inhibitors: a patent review (2006 - 2011)</span></div><div class="casAuthors">Deng, Xianming; Choi, Hwan Geun; Buhrlage, Sara J.; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1415-1426</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Leucine-rich repeat kinase 2 (LRRK2) has received considerable attention since the discovery of LRRK2 mutations in families with dominantly inherited Parkinson's disease (PD) in 2004.  The missense mutation G2019S is the most common LRRK2 mutation and has been identified in both familial and sporadic PD cases.  The G2019S mutation enhances kinase activity suggesting that LRRK2 could be an attractive therapeutic target for PD and small-mol. ATP-competitive LRRK2 kinase inhibitors are one way to investigate this possibility.Areas covered: Currently, LRRK2 kinase inhibitors are being actively pursued by industry and academia.  Herein, patents detailing the discovery of LRRK2 kinase inhibitors from 2006 through 2011 and the corresponding publications from 2006 through July of 2012 are summarized.Expert opinion: Wild-type and mutant forms of LRRK2 are currently being actively pursued as therapeutic targets for the potential treatment of PD.  The increasing no. of patent applications being filed for inhibitors of LRRK2 is a testament to this activity.  Numerous distinct chemo-types have been reported as LRRK2 inhibitors with some demonstrating exceptional potency and selectivity for LRRK2 relative to other kinases.  These compds. are being used as pharmacol. tools' to elucidate the physiol. and pathophysiol. function of LRRK2 and it appears likely that some will be investigated for their potential therapeutic effects for the treatment of PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqXrD7fzsqS7Vg90H21EOLACvtfcHk0lj9QJbUAk0pFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs12itLfI&md5=35f36ce3bdb3b40162263b9be0f85243</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1517%2F13543776.2012.729041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2012.729041%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DChoi%26aufirst%3DH.%2BG.%26aulast%3DBuhrlage%26aufirst%3DS.%2BJ.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DLeucine-rich%2520repeat%2520kinase%25202%2520inhibitors%253A%2520a%2520patent%2520review%2520%25282006%25E2%2580%25932011%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2012%26volume%3D22%26spage%3D1415%26epage%3D1426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Smith, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pei, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, C. A.</span><span> </span><span class="NLM_article-title">Kinase activity of mutant LRRK2 mediates neuronal toxicity</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1231</span><span class="NLM_x">–</span> <span class="NLM_lpage">1233</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1038%2Fnn1776" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=16980962" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVSgu7fJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=1231-1233&author=W.+W.+Smithauthor=Z.+Peiauthor=H.+Jiangauthor=V.+L.+Dawsonauthor=T.+M.+Dawsonauthor=C.+A.+Ross&title=Kinase+activity+of+mutant+LRRK2+mediates+neuronal+toxicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32aR"><div class="casContent"><span class="casTitleNuber">32a</span><div class="casTitle"><span class="NLM_cas:atitle">Kinase activity of mutant LRRK2 mediates neuronal toxicity</span></div><div class="casAuthors">Smith, Wanli W.; Pei, Zhong; Jiang, Haibing; Dawson, Valina L.; Dawson, Ted M.; Ross, Christopher A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1231-1233</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Mutations in the leucine-rich repeat kinase-2 (LRRK2) gene cause autosomal-dominant Parkinson disease and some cases of sporadic Parkinson disease.  Here we found that LRRK2 kinase activity was regulated by GTP via the intrinsic GTPase Roc domain, and alterations of LRRK2 protein that reduced kinase activity of mutant LRRK2 correspondingly reduced neuronal toxicity.  These data elucidate the pathogenesis of LRRK2-linked Parkinson disease, potentially illuminate mechanisms of sporadic Parkinson disease and suggest therapeutic targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqS61-FFqaSfLVg90H21EOLACvtfcHk0lj9QJbUAk0pFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVSgu7fJ&md5=353c92fdf5be0efb00e23b6d0b8141d6</span></div><a href="/servlet/linkout?suffix=cit32a&amp;dbid=16384&amp;doi=10.1038%2Fnn1776&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn1776%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DW.%2BW.%26aulast%3DPei%26aufirst%3DZ.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DDawson%26aufirst%3DV.%2BL.%26aulast%3DDawson%26aufirst%3DT.%2BM.%26aulast%3DRoss%26aufirst%3DC.%2BA.%26atitle%3DKinase%2520activity%2520of%2520mutant%2520LRRK2%2520mediates%2520neuronal%2520toxicity%26jtitle%3DNat.%2520Neurosci.%26date%3D2006%26volume%3D9%26spage%3D1231%26epage%3D1233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit32b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Greggio, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kingsbury, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bandopadhyay, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaganovich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Brug, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beilina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackinton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmad, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kesavapany, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singleton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lees, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cookson, M. R.</span><span> </span><span class="NLM_article-title">Kinase activity is required for the toxic effects of mutant LRRK2/dardarin</span> <span class="citation_source-journal">Neurobiol. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">341</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1016%2Fj.nbd.2006.04.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2006&pages=329-341&author=E.+Greggioauthor=S.+Jainauthor=A.+Kingsburyauthor=R.+Bandopadhyayauthor=P.+Lewisauthor=A.+Kaganovichauthor=M.+P.+van+der+Brugauthor=A.+Beilinaauthor=J.+Blackintonauthor=K.+J.+Thomasauthor=R.+Ahmadauthor=D.+W.+Millerauthor=S.+Kesavapanyauthor=A.+Singletonauthor=A.+Leesauthor=R.+J.+Harveyauthor=K.+Harveyauthor=M.+R.+Cookson&title=Kinase+activity+is+required+for+the+toxic+effects+of+mutant+LRRK2%2Fdardarin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32b&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2006.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2006.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DGreggio%26aufirst%3DE.%26aulast%3DJain%26aufirst%3DS.%26aulast%3DKingsbury%26aufirst%3DA.%26aulast%3DBandopadhyay%26aufirst%3DR.%26aulast%3DLewis%26aufirst%3DP.%26aulast%3DKaganovich%26aufirst%3DA.%26aulast%3Dvan%2Bder%2BBrug%26aufirst%3DM.%2BP.%26aulast%3DBeilina%26aufirst%3DA.%26aulast%3DBlackinton%26aufirst%3DJ.%26aulast%3DThomas%26aufirst%3DK.%2BJ.%26aulast%3DAhmad%26aufirst%3DR.%26aulast%3DMiller%26aufirst%3DD.%2BW.%26aulast%3DKesavapany%26aufirst%3DS.%26aulast%3DSingleton%26aufirst%3DA.%26aulast%3DLees%26aufirst%3DA.%26aulast%3DHarvey%26aufirst%3DR.%2BJ.%26aulast%3DHarvey%26aufirst%3DK.%26aulast%3DCookson%26aufirst%3DM.%2BR.%26atitle%3DKinase%2520activity%2520is%2520required%2520for%2520the%2520toxic%2520effects%2520of%2520mutant%2520LRRK2%252Fdardarin%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2006%26volume%3D2%26spage%3D329%26epage%3D341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit32c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">MacLeod, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammond, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leete, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abeliovich, A.</span><span> </span><span class="NLM_article-title">The familial parkinsonism gene LRRK2 regulates neurite process morphology</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">587</span><span class="NLM_x">–</span> <span class="NLM_lpage">593</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2006&pages=587-593&author=D.+MacLeodauthor=J.+Dowmanauthor=R.+Hammondauthor=T.+Leeteauthor=K.+Inoueauthor=A.+Abeliovich&title=The+familial+parkinsonism+gene+LRRK2+regulates+neurite+process+morphology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMacLeod%26aufirst%3DD.%26aulast%3DDowman%26aufirst%3DJ.%26aulast%3DHammond%26aufirst%3DR.%26aulast%3DLeete%26aufirst%3DT.%26aulast%3DInoue%26aufirst%3DK.%26aulast%3DAbeliovich%26aufirst%3DA.%26atitle%3DThe%2520familial%2520parkinsonism%2520gene%2520LRRK2%2520regulates%2520neurite%2520process%2520morphology%26jtitle%3DNeuron%26date%3D2006%26volume%3D52%26spage%3D587%26epage%3D593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Pchelina, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emelyanov, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Usenko, T. S.</span><span> </span><span class="NLM_article-title">Molecular basis of Parkinsons’s disease linked to LRRK2 mutations</span> <span class="citation_source-journal">Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">10</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1134%2FS0026893314010117" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtlWhsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2014&pages=1-10&author=S.+N.+Pchelinaauthor=A.+K.+Emelyanovauthor=T.+S.+Usenko&title=Molecular+basis+of+Parkinsons%E2%80%99s+disease+linked+to+LRRK2+mutations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular basis of Parkinsons's disease linked to LRRK2 mutations</span></div><div class="casAuthors">Pchelina, S. N.; Emelyanov, A. K.; Usenko, T. S.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Biology (Moscow, Russian Federation, English Edition)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-10</span>CODEN:
                <span class="NLM_cas:coden">MOLBBJ</span>;
        ISSN:<span class="NLM_cas:issn">0026-8933</span>.
    
            (<span class="NLM_cas:orgname">SP MAIK Nauka/Interperiodica</span>)
        </div><div class="casAbstract">A review.  Parkinson's disease (PD) is a common neurodegenerative disorder whose symptoms are consistent with death of dopaminergic neurons in the substantia nigra of the brain.  The pathogenesis of PD involves several factors, such as α-synuclein aggregation, oxidative stress, mitochondrial dysfunction, and activation of apoptosis, but the exact mol. mechanism of neurodegeneration remains obscure.  PD is usually sporadic, while rare monogenic forms have been identified and described in the past 15 years.  Familial Parkinson's disease is most commonly assocd. with mutations of the leucine repeat-rich kinase 2 gene (LRRK2).  The mechanism of the disease due to LRRK2 mutations is unknown.  The signaling cascades regulated by LRRK2 are difficult to study because the physiol. substrates of the enzyme are unidentified.  The G2019S substitution has been found to be the most common LRRK2 mutation, facilitating a search for patients with LRRK2-assocd. PD in various populations.  The review considers the effects of LRRK2 mutations on protein and, in particular, α-synuclein aggregation, cytoskeletal dynamics, the inflammatory response, and the induction of apoptosis as revealed in both in vitro expts. and studies in PD patients.  Investigation of rare hereditary PD forms with known etiol. provides for a better understanding of the mechanism of neurodegeneration in more common sporadic PD forms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWCLUFIR7w9bVg90H21EOLACvtfcHk0lgr1bQjBXIFTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtlWhsro%253D&md5=5f13c7249aa8dffd85d2bb696a7ce461</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1134%2FS0026893314010117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1134%252FS0026893314010117%26sid%3Dliteratum%253Aachs%26aulast%3DPchelina%26aufirst%3DS.%2BN.%26aulast%3DEmelyanov%26aufirst%3DA.%2BK.%26aulast%3DUsenko%26aufirst%3DT.%2BS.%26atitle%3DMolecular%2520basis%2520of%2520Parkinsons%25E2%2580%2599s%2520disease%2520linked%2520to%2520LRRK2%2520mutations%26jtitle%3DMol.%2520Biol.%26date%3D2014%26volume%3D48%26spage%3D1%26epage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Zhu, H.; Chen, H.; Cho, W.; Estrada, A. A.; Sweeney, Z. K.</span><span> </span><span class="NLM_article-title">From human genetics to drug candidates: An industrial perspective on LRRK2 inhibition as a treatment for Parkinson’s disease</span>. In  <span class="citation_source-book">Medicinal Chemistry Approaches to Personalized Medicine</span>; <span class="NLM_contrib-group">Lackey, K.; Roth, B. D.</span>, Eds.; <span class="NLM_publisher-name">Wiley-VCH Verlag GmbH & Co. KGaA</span>: <span class="NLM_publisher-loc">Weinheim, Germany</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">227</span><span class="NLM_x">–</span> <span class="NLM_lpage">254</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1002%2F9783527677252.ch10" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=227-254&author=H.+Zhu&author=H.+Chen&author=W.+Cho&author=A.+A.+Estrada&author=Z.+K.+Sweeneyauthor=K.+Lackey&author=B.+D.+Roth&title=Medicinal+Chemistry+Approaches+to+Personalized+Medicine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34a&amp;dbid=16384&amp;doi=10.1002%2F9783527677252.ch10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9783527677252.ch10%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DH.%26atitle%3DFrom%2520human%2520genetics%2520to%2520drug%2520candidates%253A%2520An%2520industrial%2520perspective%2520on%2520LRRK2%2520inhibition%2520as%2520a%2520treatment%2520for%2520Parkinson%25E2%2580%2599s%2520disease%26btitle%3DMedicinal%2520Chemistry%2520Approaches%2520to%2520Personalized%2520Medicine%26aulast%3DLackey%26aufirst%3DK.%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26date%3D2013%26spage%3D227%26epage%3D254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit34b"><span><span class="NLM_label">(b) </span><div class="note"><p class="first last">For a recent proposed LRRK2 substrate see the following: </p></div><span class="NLM_contrib-group">Martin, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stankowski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrabi, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickson, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wszolek, Z. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, V. L.</span><span> </span><span class="NLM_article-title">Ribosomal protein s15 phosphorylation mediates LRRK2 neurodegeneration in Parkinson’s disease</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">157</span><span class="NLM_x">, </span> <span class="NLM_fpage">472</span><span class="NLM_x">–</span> <span class="NLM_lpage">485</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=2014&pages=472-485&author=I.+Martinauthor=J.+W.+Kimauthor=B.+D.+Leeauthor=H.+C.+Kangauthor=J.+C.+Xuauthor=H.+Jiaauthor=J.+Stankowskiauthor=M.+S.+Kimauthor=J.+Zhongauthor=M.+Kumarauthor=S.+A.+Andrabiauthor=Y.+Xiongauthor=D.+W.+Dicksonauthor=Z.+K.+Wszolekauthor=A.+Pandeyauthor=T.+M.+Dawsonauthor=V.+L.+Dawson&title=Ribosomal+protein+s15+phosphorylation+mediates+LRRK2+neurodegeneration+in+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DI.%26aulast%3DKim%26aufirst%3DJ.%2BW.%26aulast%3DLee%26aufirst%3DB.%2BD.%26aulast%3DKang%26aufirst%3DH.%2BC.%26aulast%3DXu%26aufirst%3DJ.%2BC.%26aulast%3DJia%26aufirst%3DH.%26aulast%3DStankowski%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DM.%2BS.%26aulast%3DZhong%26aufirst%3DJ.%26aulast%3DKumar%26aufirst%3DM.%26aulast%3DAndrabi%26aufirst%3DS.%2BA.%26aulast%3DXiong%26aufirst%3DY.%26aulast%3DDickson%26aufirst%3DD.%2BW.%26aulast%3DWszolek%26aufirst%3DZ.%2BK.%26aulast%3DPandey%26aufirst%3DA.%26aulast%3DDawson%26aufirst%3DT.%2BM.%26aulast%3DDawson%26aufirst%3DV.%2BL.%26atitle%3DRibosomal%2520protein%2520s15%2520phosphorylation%2520mediates%2520LRRK2%2520neurodegeneration%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DCell%26date%3D2014%26volume%3D157%26spage%3D472%26epage%3D485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Russo, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bubacco, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greggio, E.</span><span> </span><span class="NLM_article-title">LRRK2 and neuroinflammation: partners in crime in Parkinson’s disease?</span> <span class="citation_source-journal">J. Neuroinflammation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">52</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1186%2F1742-2094-11-52" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=24655756" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs12hu7%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2014&pages=52&author=I.+Russoauthor=L.+Bubaccoauthor=E.+Greggio&title=LRRK2+and+neuroinflammation%3A+partners+in+crime+in+Parkinson%E2%80%99s+disease%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">LRRK2 and neuroinflammation: partners in crime in Parkinson's disease?</span></div><div class="casAuthors">Russo, Isabella; Bubacco, Luigi; Greggio, Elisa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroinflammation</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">52/1-52/9, 9</span>CODEN:
                <span class="NLM_cas:coden">JNOEB3</span>;
        ISSN:<span class="NLM_cas:issn">1742-2094</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  It is now well established that chronic inflammation is a prominent feature of several neurodegenerative disorders including Parkinson's disease (PD).  Growing evidence indicates that neuroinflammation can contribute greatly to dopaminergic neuron degeneration and progression of the disease.  Recent literature highlights that leucine-rich repeat kinase 2 (LRRK2), a kinase mutated in both autosomal-dominantly inherited and sporadic PD cases, modulates inflammation in response to different pathol. stimuli.  In this review, we outline the state of the art of LRRK2 functions in microglia cells and in neuroinflammation.  Furthermore, we discuss the potential role of LRRK2 in cytoskeleton remodeling and vesicle trafficking in microglia cells under physiol. and pathol. conditions.  We also hypothesize that LRRK2 mutations might sensitize microglia cells toward a pro-inflammatory state, which in turn results in exacerbated inflammation with consequent neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjNPc_MEt2tLVg90H21EOLACvtfcHk0ljOCfJ3dysJjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs12hu7%252FJ&md5=1d8b2a0eb7291a89ac461234ef0a4a54</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1186%2F1742-2094-11-52&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1742-2094-11-52%26sid%3Dliteratum%253Aachs%26aulast%3DRusso%26aufirst%3DI.%26aulast%3DBubacco%26aufirst%3DL.%26aulast%3DGreggio%26aufirst%3DE.%26atitle%3DLRRK2%2520and%2520neuroinflammation%253A%2520partners%2520in%2520crime%2520in%2520Parkinson%25E2%2580%2599s%2520disease%253F%26jtitle%3DJ.%2520Neuroinflammation%26date%3D2014%26volume%3D11%26spage%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Moehle, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webber, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tse, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sukar, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Standaert, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeSilva, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowell, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, A. B.</span><span> </span><span class="NLM_article-title">LRRK2 inhibition attenuates microglial inflammatory responses</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">1602</span><span class="NLM_x">–</span> <span class="NLM_lpage">1611</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1523%2FJNEUROSCI.5601-11.2012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=22302802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC38XitFOls7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=1602-1611&author=M.+S.+Moehleauthor=P.+J.+Webberauthor=T.+Tseauthor=N.+Sukarauthor=D.+G.+Standaertauthor=T.+M.+DeSilvaauthor=R.+M.+Cowellauthor=A.+B.+West&title=LRRK2+inhibition+attenuates+microglial+inflammatory+responses"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">LRRK2 inhibition attenuates microglial inflammatory responses</span></div><div class="casAuthors">Moehle, Mark S.; Webber, Philip J.; Tse, Tonia; Sukar, Nour; Standaert, David G.; De Silva, Tara M.; Cowell, Rita M.; West, Andrew B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1602-1611</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Missense mutations in leucine-rich repeat kinase 2 (LRRK2) cause late-onset Parkinson's disease (PD), and common genetic variation in LRRK2 modifies susceptibility to Crohn's disease and leprosy.  High levels of LRRK2 expression in peripheral monocytes and macrophages suggest a role for LRRK2 in these cells, yet little is known about LRRK2 expression and function in immune cells of the brain.  Here, we demonstrate a role for LRRK2 in mediating microglial proinflammatory responses and morphol.  In a murine model of neuroinflammation, we observe robust induction of LRRK2 in microglia.  Expts. with toll-like receptor 4 (TLR4)-stimulated rat primary microglia show that inflammation increases LRRK2 activity and expression, while inhibition of LRRK2 kinase activity or knockdown of protein attenuates TNFα secretion and nitric oxide synthase (iNOS) induction.  LRRK2 inhibition blocks TLR4 stimulated microglial process outgrowth and impairs ADP stimulated microglial chemotaxis.  However, actin inhibitors that phenocopy inhibition of process outgrowth and chemotaxis fail to modify TLR4 stimulation of TNFα secretion and inducible iNOS induction, suggesting that LRRK2 acts upstream of cytoskeleton control as a stress-responsive kinase.  These data demonstrate LRRK2 in regulating responses in immune cells of the brain and further implicate microglial involvement in late-onset PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruQzN_xrHcLLVg90H21EOLACvtfcHk0lh3XgXqUihfjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XitFOls7g%253D&md5=75dc1c0d0b2277c0fb20b857b5654f53</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.5601-11.2012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.5601-11.2012%26sid%3Dliteratum%253Aachs%26aulast%3DMoehle%26aufirst%3DM.%2BS.%26aulast%3DWebber%26aufirst%3DP.%2BJ.%26aulast%3DTse%26aufirst%3DT.%26aulast%3DSukar%26aufirst%3DN.%26aulast%3DStandaert%26aufirst%3DD.%2BG.%26aulast%3DDeSilva%26aufirst%3DT.%2BM.%26aulast%3DCowell%26aufirst%3DR.%2BM.%26aulast%3DWest%26aufirst%3DA.%2BB.%26atitle%3DLRRK2%2520inhibition%2520attenuates%2520microglial%2520inflammatory%2520responses%26jtitle%3DJ.%2520Neurosci.%26date%3D2012%26volume%3D32%26spage%3D1602%26epage%3D1611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Reynolds, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doggett, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riddle, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebakken, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, R. J.</span><span> </span><span class="NLM_article-title">LRRK2 kinase activity and biology are not uniformly predicted by its autophosphorylation and cellular phosphorylation site status</span> <span class="citation_source-journal">Front. Mol. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">54</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.3389%2Ffnmol.2014.00054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=25009464" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVaqsLzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2014&pages=54&author=A.+Reynoldsauthor=E.+A.+Doggettauthor=S.+M.+Riddleauthor=C.+S.+Lebakkenauthor=R.+J.+Nichols&title=LRRK2+kinase+activity+and+biology+are+not+uniformly+predicted+by+its+autophosphorylation+and+cellular+phosphorylation+site+status"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">LRRK2 kinase activity and biology are not uniformly predicted by its autophosphorylation and cellular phosphorylation site status</span></div><div class="casAuthors">Reynolds, April; Doggett, Elizabeth A.; Riddle, Steve M.; Lebakken, Connie S.; Nichols, R. Jeremy</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Molecular Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">54/1-54/14, 14 pp.</span>CODEN:
                <span class="NLM_cas:coden">FMNRAJ</span>;
        ISSN:<span class="NLM_cas:issn">1662-5099</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Missense mutations in the Leucine-Rich Repeat protein Kinase 2 (LRRK2) gene are the most common genetic predisposition to develop Parkinson's disease (PD).  LRRK2 is a large multi-domain phosphoprotein with a GTPase domain and a serine/threonine protein kinase domain whose activity is implicated in neuronal toxicity; however the precise mechanism is unknown.  LRRK2 autophosphorylates on several serine/threonine residues across the enzyme and is found constitutively phosphorylated on Ser910, Ser935, Ser955, and Ser973, which are proposed to be regulated by upstream kinases.  Here we investigate the phosphoregulation at these sites by analyzing the effects of disease-assocd. mutations Arg1441Cys, Arg1441Gly, Ala1442Pro, Tyr1699Cys, Ile2012Thr, Gly2019Ser, and Ile2020Thr.  We also studied alanine substitutions of phosphosite serines 910, 935, 955, and 973 and specific LRRK2 inhibition on autophosphorylation of LRRK2 Ser1292, Thr1491, Thr2483 and phosphorylation at the cellular sites.  We found that mutants in the Roc-COR domains, including Arg1441Cys, Arg1441His, Ala1442Pro, and Tyr1699Cys, can pos. enhance LRRK2 kinase activity, while concomitantly inducing the dephosphorylation of the cellular sites.  Mutation of the cellular sites individually did not affect LRRK2 intrinsic kinase activity; however, Ser910/935/955/973Ala mutations trended toward increased kinase activity of LRRK2.  Increased cAMP levels did not lead to increased LRRK2 cellular site phosphorylation, 14-3-3 binding or kinase activity.  In cells, inhibition of LRRK2 kinase activity leads to dephosphorylation of Ser1292 by Calyculin A and Okadaic acid sensitive phosphatases, while the cellular sites are dephosphorylated by Calyculin A sensitive phosphatases.  These findings indicate that comparative anal. of both Ser1292 and Ser910/935/955/973 phosphorylation sites will provide important and distinct measures of LRRK2 kinase and biol. activity in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6oWoQ9m-jtrVg90H21EOLACvtfcHk0lh3XgXqUihfjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVaqsLzE&md5=f737969c3defba76566a36330ffb64d2</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.3389%2Ffnmol.2014.00054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnmol.2014.00054%26sid%3Dliteratum%253Aachs%26aulast%3DReynolds%26aufirst%3DA.%26aulast%3DDoggett%26aufirst%3DE.%2BA.%26aulast%3DRiddle%26aufirst%3DS.%2BM.%26aulast%3DLebakken%26aufirst%3DC.%2BS.%26aulast%3DNichols%26aufirst%3DR.%2BJ.%26atitle%3DLRRK2%2520kinase%2520activity%2520and%2520biology%2520are%2520not%2520uniformly%2520predicted%2520by%2520its%2520autophosphorylation%2520and%2520cellular%2520phosphorylation%2520site%2520status%26jtitle%3DFront.%2520Mol.%2520Neurosci.%26date%3D2014%26volume%3D7%26spage%3D54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Vancraenenbroeck, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Raeymaecker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lobbestael, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Maeyer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voet, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baekelandt, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taymans, J. M.</span><span> </span><span class="NLM_article-title">In silico, in vitro and cellular analysis with a kinome-wide inhibitor panel correlates cellular LRRK2 dephosphorylation to inhibitor activity on LRRK2</span> <span class="citation_source-journal">Front. Mol. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">51</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.3389%2Ffnmol.2014.00051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=24917786" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVChsb%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2014&pages=51&author=R.+Vancraenenbroeckauthor=J.+De+Raeymaeckerauthor=E.+Lobbestaelauthor=F.+Gaoauthor=M.+De+Maeyerauthor=A.+Voetauthor=V.+Baekelandtauthor=J.+M.+Taymans&title=In+silico%2C+in+vitro+and+cellular+analysis+with+a+kinome-wide+inhibitor+panel+correlates+cellular+LRRK2+dephosphorylation+to+inhibitor+activity+on+LRRK2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">In silico, in vitro and cellular analysis with a kinome-wide inhibitor panel correlates cellular LRRK2 dephosphorylation to inhibitor activity on LRRK2</span></div><div class="casAuthors">Vancraenenbroeck, Renee; De Raeymaecker, Joren; Lobbestael, Evy; Gao, Fangye; De Maeyer, Marc; Voet, Arnout; Baekelandt, Veerle; Taymans, Jean-Marc</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Molecular Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">51/1-51/19, 19 pp.</span>CODEN:
                <span class="NLM_cas:coden">FMNRAJ</span>;
        ISSN:<span class="NLM_cas:issn">1662-5099</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">A review.  Leucine-rich repeat kinase 2 (LRRK2) is a complex, multidomain protein which is considered a valuable target for potential disease-modifying therapeutic strategies for Parkinson's disease (PD).  In mammalian cells and brain, LRRK2 is phosphorylated and treatment of cells with inhibitors of LRRK2 kinase activity can induce LRRK2 dephosphorylation at a cluster of serines including Ser910/935/955/973.  It has been suggested that phosphorylation levels at these sites reflect LRRK2 kinase activity, however kinase-dead variants of LRRK2 or kinase activating variants do not display altered Ser935 phosphorylation levels compared to wild type.  Furthermore, Ser910/935/955/973 are not autophosphorylation sites, therefore, it is unclear if inhibitor induced dephosphorylation depends on the activity of compds. on LRRK2 or on yet to be identified upstream kinases.  Here we used a panel of 160 ATP competitive and cell permeable kinase inhibitors directed against all branches of the kinome and tested their activity on LRRK2 in vitro using a peptide-substrate-based kinase assay.  In neuronal SH-SY5Y cells overexpressing LRRK2 we used compd.-induced dephosphorylation of Ser935 as readout.  In silico docking of selected compds. was performed using a modeled LRRK2 kinase structure.  Receiver operating characteristic plots demonstrated that the obtained docking scores to the LRRK2 ATP binding site correlated with in vitro and cellular compd. activity.  We also found that in vitro potency showed a high degree of correlation to cellular compd. induced LRRK2 dephosphorylation activity across multiple compd. classes.  Therefore, acute LRRK2 dephosphorylation at Ser935 in inhibitor treated cells involves a strong component of inhibitor activity on LRRK2 itself, without excluding a role for upstream kinases.  Understanding the regulation of LRRK2 phosphorylation by kinase inhibitors aids our understanding of LRRK2 signaling and may lead to development of new classes of LRRK2 kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOkDJX9D3umrVg90H21EOLACvtfcHk0lgGCPu_pxFp-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVChsb%252FK&md5=e489943d1d2337897ddb460ff21f9cb7</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.3389%2Ffnmol.2014.00051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnmol.2014.00051%26sid%3Dliteratum%253Aachs%26aulast%3DVancraenenbroeck%26aufirst%3DR.%26aulast%3DDe%2BRaeymaecker%26aufirst%3DJ.%26aulast%3DLobbestael%26aufirst%3DE.%26aulast%3DGao%26aufirst%3DF.%26aulast%3DDe%2BMaeyer%26aufirst%3DM.%26aulast%3DVoet%26aufirst%3DA.%26aulast%3DBaekelandt%26aufirst%3DV.%26aulast%3DTaymans%26aufirst%3DJ.%2BM.%26atitle%3DIn%2520silico%252C%2520in%2520vitro%2520and%2520cellular%2520analysis%2520with%2520a%2520kinome-wide%2520inhibitor%2520panel%2520correlates%2520cellular%2520LRRK2%2520dephosphorylation%2520to%2520inhibitor%2520activity%2520on%2520LRRK2%26jtitle%3DFront.%2520Mol.%2520Neurosci.%26date%3D2014%26volume%3D7%26spage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Tieu, K.</span><span> </span><span class="NLM_article-title">A guide to neurotoxic animal models of Parkinson’s disease</span> <span class="citation_source-journal">Cold Spring Harbor Perspect. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">a009316</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2011&pages=a009316&author=K.+Tieu&title=A+guide+to+neurotoxic+animal+models+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTieu%26aufirst%3DK.%26atitle%3DA%2520guide%2520to%2520neurotoxic%2520animal%2520models%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspect.%2520Med.%26date%3D2011%26volume%3D1%26spage%3Da009316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Sweeney, Z. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewcock, J. W.</span><span> </span><span class="NLM_article-title">ACS chemical neuroscience spotlight on CEP-1347</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">4</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn1000793" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFWiurzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=3-4&author=Z.+K.+Sweeneyauthor=J.+W.+Lewcock&title=ACS+chemical+neuroscience+spotlight+on+CEP-1347"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">ACS Chemical Neuroscience Spotlight on CEP-1347</span></div><div class="casAuthors">Sweeney, Zachary K.; Lewcock, Joseph W.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-4</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6ot-9NHLazbVg90H21EOLACvtfcHk0lgGCPu_pxFp-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFWiurzE&md5=f2364649af4f96ac72753fbba21557f7</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fcn1000793&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn1000793%26sid%3Dliteratum%253Aachs%26aulast%3DSweeney%26aufirst%3DZ.%2BK.%26aulast%3DLewcock%26aufirst%3DJ.%2BW.%26atitle%3DACS%2520chemical%2520neuroscience%2520spotlight%2520on%2520CEP-1347%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2011%26volume%3D2%26spage%3D3%26epage%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Olanow, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schapira, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeWitt, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kieburtz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sauer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivieri, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pohlmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubble, J.</span><span> </span><span class="NLM_article-title">TCH346 as a neuroprotective drug in Parkinson’s disease: a double-blind, randomised, controlled trial</span> <span class="citation_source-journal">Lancet Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1013</span><span class="NLM_x">–</span> <span class="NLM_lpage">1020</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1016%2FS1474-4422%2806%2970602-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=17110281" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlCju77J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=1013-1020&author=C.+W.+Olanowauthor=A.+H.+Schapiraauthor=P.+A.+LeWittauthor=K.+Kieburtzauthor=D.+Sauerauthor=G.+Olivieriauthor=H.+Pohlmannauthor=J.+Hubble&title=TCH346+as+a+neuroprotective+drug+in+Parkinson%E2%80%99s+disease%3A+a+double-blind%2C+randomised%2C+controlled+trial"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">TCH346 as a nueroprotective drug in Parkinson's disease: a double-blind, randomised, controlled trial</span></div><div class="casAuthors">Olanow, C. Warren; Schapira, Anthony H. V.; LeWitt, Peter A.; Kieburtz, Karl; Sauer, Dirk; Olivieri, Gianfranco; Pohlmann, Harald; Hubble, Jean</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1013-1020</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Lancet Neurology</span>)
        </div><div class="casAbstract">Background There is an important unmet medical need in Parkinson's disease for a neuroprotective treatment that slows or stops disease progression.  TCH346 is a potent anti-apoptotic drug that protects against loss of dopaminergic neurons in lab. models.  Our aim was to assess TCH346 as a neuroprotective drug in patients with Parkinson's disease.  Methods Patients presenting at 45 international movement disorder clinics with early untreated Parkinson's disease were assessed as part of this parallel-group, double-blind, randomized controlled trial.  301 Eligible patients were randomly assigned 12-18 mo' treatment with TCH346 at a daily dose of 0.5 mg (n=78), 2.5 mg (n=79), or 10 mg (n=73), or placebo (n=71), followed by a 4 wk washout period.  The primary outcome measure was time to development of a disability requiring dopaminergic treatment.  Secondary outcome measures were the annual rate of change in the unified Parkinson's disease rating scale (UPDRS) and the PDQ-39, a measure of quality of life.  Analyses were by intention-to-treat.  This study is pending registration with ClinicalTrials.gov.  Findings 255 patients completed the study.  TCH346 did not differ from placebo for any of the study outcomes.  Treatment was needed in 26 (34%) patients in the TCH346 0.5 mg group, 30 (38%) in the TCH346 2.5 mg group, 24 (33%) in the TCH346 10 mg group, and 23 (32%) in the placebo group.  There were no significant differences between groups.  There were no differences between groups in the annual change in the UPDRS or PDQ-39 either.  Few patients withdrew because of adverse events and none was judged to be related to the study intervention.  Interpretation TCH346 did not show evidence of a neuroprotective effect.  The discrepancy between the preclin. promise of TCH346 and the clin. outcome could have arisen because of the use of lab. models that do not accurately reflect the pathogenesis of Parkinson's disease, the doses of study drug used, insensitive clin. endpoints, and the patient population selected for study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZisnEZsBV07Vg90H21EOLACvtfcHk0ljWWStZO-zuPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlCju77J&md5=25b2cfd9942f21e1cf851fe52f8b861d</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2806%2970602-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252806%252970602-0%26sid%3Dliteratum%253Aachs%26aulast%3DOlanow%26aufirst%3DC.%2BW.%26aulast%3DSchapira%26aufirst%3DA.%2BH.%26aulast%3DLeWitt%26aufirst%3DP.%2BA.%26aulast%3DKieburtz%26aufirst%3DK.%26aulast%3DSauer%26aufirst%3DD.%26aulast%3DOlivieri%26aufirst%3DG.%26aulast%3DPohlmann%26aufirst%3DH.%26aulast%3DHubble%26aufirst%3DJ.%26atitle%3DTCH346%2520as%2520a%2520neuroprotective%2520drug%2520in%2520Parkinson%25E2%2580%2599s%2520disease%253A%2520a%2520double-blind%252C%2520randomised%252C%2520controlled%2520trial%26jtitle%3DLancet%2520Neurol.%26date%3D2006%26volume%3D5%26spage%3D1013%26epage%3D1020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Baptista, M. A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dave, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheth, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Silva, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aziz, Y. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiske, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherer, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frasier, M. A.</span><span> </span><span class="NLM_article-title">A strategy for the generation, characterization and distribution of animal models by The Michael J. Fox Foundation for Parkinson’s research</span> <span class="citation_source-journal">Dis. Models Mech.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1316</span><span class="NLM_x">–</span> <span class="NLM_lpage">1324</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1242%2Fdmm.011940" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=24046356" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1Shu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2013&pages=1316-1324&author=M.+A.+S.+Baptistaauthor=K.+D.+Daveauthor=N.+P.+Shethauthor=S.+N.+De+Silvaauthor=K.+M.+Carlsonauthor=Y.+N.+Azizauthor=B.+K.+Fiskeauthor=T.+M.+Shererauthor=M.+A.+Frasier&title=A+strategy+for+the+generation%2C+characterization+and+distribution+of+animal+models+by+The+Michael+J.+Fox+Foundation+for+Parkinson%E2%80%99s+research"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">A strategy for the generation, characterization and distribution of animal models by The Michael J. Fox Foundation for Parkinson's Research</span></div><div class="casAuthors">Baptista, Marco A. S.; Dave, Kuldip D.; Sheth, Niketa P.; De Silva, Shehan N.; Carlson, Kirsten M.; Aziz, Yasmin N.; Fiske, Brian K.; Sherer, Todd B.; Frasier, Mark A.</div><div class="citationInfo"><span class="NLM_cas:title">Disease Models & Mechanisms</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1316-1324</span>CODEN:
                <span class="NLM_cas:coden">DMMIAX</span>;
        ISSN:<span class="NLM_cas:issn">1754-8403</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">A review.  Progress in Parkinson's disease (PD) research and therapeutic development is hindered by many challenges, including a need for robust preclin. animal models.  Limited availability of these tools is due to tech. hurdles, patent issues, licensing restrictions and the high costs assocd. with generating and distributing these animal models.  Furthermore, the lack of standardization of phenotypic characterization and use of varying methodologies has made it difficult to compare outcome measures across labs.  In response, The Michael J. Fox Foundation for Parkinson's Research (MJFF) is directly sponsoring the generation, characterization and distribution of preclin. rodent models, enabling increased access to these crucial tools in order to accelerate PD research.  To date, MJFF has initiated and funded the generation of 30 different models, which include transgenic or knockout models of PD-relevant genes such as Park 1 (also known as Park4 and SNCA), Park8 (LRRK2), Park7 (DJ-1), Park6 (PINK1), Park2 (Parkin), VPS35, EiF4G1 and GBA.  The phenotypic characterization of these animals is performed in a uniform and streamlined manner at independent contract research organizations.  Finally, MJFF created a central repository at The Jackson Lab. (JAX) that houses both non-MJFF and MJFF-generated preclin. animal models.  Funding from MJFF, which subsidizes the costs involved in transfer, rederivation and colony expansion, has directly resulted in over 2500 rodents being distributed to the PD community for research use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoU8ctHnC1w47Vg90H21EOLACvtfcHk0ljWWStZO-zuPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1Shu7s%253D&md5=f1cfb71533cc2741da93c7afe9c1efb1</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1242%2Fdmm.011940&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fdmm.011940%26sid%3Dliteratum%253Aachs%26aulast%3DBaptista%26aufirst%3DM.%2BA.%2BS.%26aulast%3DDave%26aufirst%3DK.%2BD.%26aulast%3DSheth%26aufirst%3DN.%2BP.%26aulast%3DDe%2BSilva%26aufirst%3DS.%2BN.%26aulast%3DCarlson%26aufirst%3DK.%2BM.%26aulast%3DAziz%26aufirst%3DY.%2BN.%26aulast%3DFiske%26aufirst%3DB.%2BK.%26aulast%3DSherer%26aufirst%3DT.%2BM.%26aulast%3DFrasier%26aufirst%3DM.%2BA.%26atitle%3DA%2520strategy%2520for%2520the%2520generation%252C%2520characterization%2520and%2520distribution%2520of%2520animal%2520models%2520by%2520The%2520Michael%2520J.%2520Fox%2520Foundation%2520for%2520Parkinson%25E2%2580%2599s%2520research%26jtitle%3DDis.%2520Models%2520Mech.%26date%3D2013%26volume%3D6%26spage%3D1316%26epage%3D1324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Xu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shenoy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span> </span><span class="NLM_article-title">Mouse models for LRRK2 Parkinson’s disease</span> <span class="citation_source-journal">Parkinsonism Relat. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">S186</span><span class="NLM_x">–</span> <span class="NLM_lpage">S189</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=S186-S189&issue=Suppl.+1&author=Q.+Xuauthor=S.+Shenoyauthor=C.+Li&title=Mouse+models+for+LRRK2+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DShenoy%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DC.%26atitle%3DMouse%2520models%2520for%2520LRRK2%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DParkinsonism%2520Relat.%2520Disord.%26date%3D2012%26volume%3D18%26issue%3DSuppl.%25201%26spage%3DS186%26epage%3DS189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit43b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lee, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">VanKampen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrucelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ko, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, Y. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maguire-Zeiss, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowers, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Federoff, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, T. M.</span><span> </span><span class="NLM_article-title">Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson’s disease</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">998</span><span class="NLM_x">–</span> <span class="NLM_lpage">1000</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1038%2Fnm.2199" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=20729864" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVGgtLbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=998-1000&author=B.+D.+Leeauthor=J.+H.+Shinauthor=J.+VanKampenauthor=L.+Petrucelliauthor=A.+B.+Westauthor=H.+S.+Koauthor=Y.+I.+Leeauthor=K.+A.+Maguire-Zeissauthor=W.+J.+Bowersauthor=H.+J.+Federoffauthor=V.+L.+Dawsonauthor=T.+M.+Dawson&title=Inhibitors+of+leucine-rich+repeat+kinase-2+protect+against+models+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43bR"><div class="casContent"><span class="casTitleNuber">43b</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease</span></div><div class="casAuthors">Lee, Byoung Dae; Shin, Joo-Ho; Van Kampen, Jackalina; Petrucelli, Leonard; West, Andrew B.; Ko, Han Seok; Lee, Yun-Il; Maguire-Zeiss, Kathleen A.; Bowers, William J.; Federoff, Howard J.; Dawson, Valina L.; Dawson, Ted M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">998-1000</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Leucine-rich repeat kinase-2 (LRRK2) mutations are a common cause of Parkinson's disease.  Here we identify inhibitors of LRRK2 kinase that are protective in in vitro and in vivo models of LRRK2-induced neurodegeneration.  These results establish that LRRK2-induced degeneration of neurons in vivo is kinase dependent and that LRRK2 kinase inhibition provides a potential new neuroprotective paradigm for the treatment of Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpn78Hm84uiebVg90H21EOLACvtfcHk0ljzTUqu6JK7Rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVGgtLbE&md5=d6c5df67511a2f154b21a523af408f65</span></div><a href="/servlet/linkout?suffix=cit43b&amp;dbid=16384&amp;doi=10.1038%2Fnm.2199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.2199%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DB.%2BD.%26aulast%3DShin%26aufirst%3DJ.%2BH.%26aulast%3DVanKampen%26aufirst%3DJ.%26aulast%3DPetrucelli%26aufirst%3DL.%26aulast%3DWest%26aufirst%3DA.%2BB.%26aulast%3DKo%26aufirst%3DH.%2BS.%26aulast%3DLee%26aufirst%3DY.%2BI.%26aulast%3DMaguire-Zeiss%26aufirst%3DK.%2BA.%26aulast%3DBowers%26aufirst%3DW.%2BJ.%26aulast%3DFederoff%26aufirst%3DH.%2BJ.%26aulast%3DDawson%26aufirst%3DV.%2BL.%26aulast%3DDawson%26aufirst%3DT.%2BM.%26atitle%3DInhibitors%2520of%2520leucine-rich%2520repeat%2520kinase-2%2520protect%2520against%2520models%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DNat.%2520Med.%26date%3D2010%26volume%3D16%26spage%3D998%26epage%3D1000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Yue, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lachenmayer, M. L.</span><span> </span><span class="NLM_article-title">Genetic LRRK2 models of Parkinson’s disease: dissecting the pathogenic pathway and exploring clinical applications</span> <span class="citation_source-journal">Mov. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">1386</span><span class="NLM_x">–</span> <span class="NLM_lpage">1397</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2011&pages=1386-1397&author=Z.+Yueauthor=M.+L.+Lachenmayer&title=Genetic+LRRK2+models+of+Parkinson%E2%80%99s+disease%3A+dissecting+the+pathogenic+pathway+and+exploring+clinical+applications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYue%26aufirst%3DZ.%26aulast%3DLachenmayer%26aufirst%3DM.%2BL.%26atitle%3DGenetic%2520LRRK2%2520models%2520of%2520Parkinson%25E2%2580%2599s%2520disease%253A%2520dissecting%2520the%2520pathogenic%2520pathway%2520and%2520exploring%2520clinical%2520applications%26jtitle%3DMov.%2520Disord.%26date%3D2011%26volume%3D26%26spage%3D1386%26epage%3D1397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Longo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russo, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimshek, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greggio, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morari, M.</span><span> </span><span class="NLM_article-title">Genetic and pharmacological evidence that G2019S LRRK2 confers a hyperkinetic phenotype, resistant to motor decline associated with aging</span> <span class="citation_source-journal">Neurobiol. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">62</span><span class="NLM_x">–</span> <span class="NLM_lpage">73</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1016%2Fj.nbd.2014.07.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=25107341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlCjt77N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2014&pages=62-73&author=F.+Longoauthor=I.+Russoauthor=D.+R.+Shimshekauthor=E.+Greggioauthor=M.+Morari&title=Genetic+and+pharmacological+evidence+that+G2019S+LRRK2+confers+a+hyperkinetic+phenotype%2C+resistant+to+motor+decline+associated+with+aging"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Genetic and pharmacological evidence that G2019S LRRK2 confers a hyperkinetic phenotype, resistant to motor decline associated with aging</span></div><div class="casAuthors">Longo, Francesco; Russo, Isabella; Shimshek, Derya R.; Greggio, Elisa; Morari, Michele</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">62-73</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">The leucine-rich repeat kinase 2 mutation G2019S in the kinase-domain is the most common genetic cause of Parkinson's disease.  To investigate the impact of the G2019S mutation on motor activity in vivo, a longitudinal phenotyping approach was developed in knock-in (KI) mice bearing this kinase-enhancing mutation.  Two cohorts of G2019S KI mice and wild-type littermates (WT) were subjected to behavioral tests, specific for akinesia, bradykinesia and overall gait ability, at different ages (3, 6, 10, 15 and 19 mo).  The motor performance of G2019S KI mice remained stable up to the age of 19 mo and did not show the typical age-related decline in immobility time and stepping activity of WT.  Several lines of evidence suggest that enhanced LRRK2 kinase activity is the main contributor to the obsd. hyperkinetic phenotype of G2019S KI mice: i) KI mice carrying a LRRK2 kinase-dead mutation (D1994S KD) showed a similar progressive motor decline as WT; ii) two LRRK2 kinase inhibitors, H-1152 and Nov-LRRK2-11, acutely reversed the hyperkinetic phenotype of G2019S KI mice, while being ineffective in WT or D1994S KD animals.  LRRK2 target engagement in vivo was further substantiated by redn. of LRRK2 phosphorylation at Ser935 in the striatum and cortex at efficacious doses of Nov-LRRK2-11, and in the striatum at efficacious doses of H-1152.  In summary, expression of the G2019S mutation in the mouse LRRK2 gene confers a hyperkinetic phenotype that is resistant to age-related motor decline, likely via enhancement of LRRK2 kinase activity.  This study provides an in vivo model to investigate the effects of LRRK2 inhibitors on motor function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGFbgFG6slMbVg90H21EOLACvtfcHk0ljfrhdAvK6e5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlCjt77N&md5=d1ded3a5d247904ac1f6f42c02b744d8</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2014.07.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2014.07.013%26sid%3Dliteratum%253Aachs%26aulast%3DLongo%26aufirst%3DF.%26aulast%3DRusso%26aufirst%3DI.%26aulast%3DShimshek%26aufirst%3DD.%2BR.%26aulast%3DGreggio%26aufirst%3DE.%26aulast%3DMorari%26aufirst%3DM.%26atitle%3DGenetic%2520and%2520pharmacological%2520evidence%2520that%2520G2019S%2520LRRK2%2520confers%2520a%2520hyperkinetic%2520phenotype%252C%2520resistant%2520to%2520motor%2520decline%2520associated%2520with%2520aging%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2014%26volume%3D71%26spage%3D62%26epage%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Fuji, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flagella, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baca, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baptista, M. A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodbeck, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiske, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honigberg, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jubb, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katavolos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewin-Koh, S.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyssikatos, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Mahony, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reichelt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roose-Girma, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherer, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweeney, Z. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarrant, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urkowitz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warming, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yaylaoglu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estrada, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watts, R. J.</span><span> </span><span class="NLM_article-title">Effect of selective LRRK2 kinase inhibition on nonhuman primate lung</span> <span class="citation_source-journal">Sci. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">273ra15</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1126%2Fscitranslmed.aaa3634" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=25653221" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=273ra15&author=R.+Fujiauthor=M.+Flagellaauthor=M.+Bacaauthor=M.+A.+S.+Baptistaauthor=J.+Brodbeckauthor=B.+K.+Chanauthor=B.+K.+Fiskeauthor=L.+Honigbergauthor=A.+M.+Jubbauthor=P.+Katavolosauthor=D.+W.+Leeauthor=S.-C.+Lewin-Kohauthor=T.+Linauthor=X.+Liuauthor=S.+Liuauthor=J.+P.+Lyssikatosauthor=J.+O%E2%80%99Mahonyauthor=M.+Reicheltauthor=M.+Roose-Girmaauthor=Z.+Shengauthor=T.+B.+Shererauthor=A.+Smithauthor=M.+Solonauthor=Z.+K.+Sweeneyauthor=J.+Tarrantauthor=A.+Urkowitzauthor=S.+Warmingauthor=M.+Yaylaogluauthor=S.+Zhangauthor=H.+Zhuauthor=A.+A.+Estradaauthor=R.+J.+Watts&title=Effect+of+selective+LRRK2+kinase+inhibition+on+nonhuman+primate+lung"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.aaa3634&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.aaa3634%26sid%3Dliteratum%253Aachs%26aulast%3DFuji%26aufirst%3DR.%26aulast%3DFlagella%26aufirst%3DM.%26aulast%3DBaca%26aufirst%3DM.%26aulast%3DBaptista%26aufirst%3DM.%2BA.%2BS.%26aulast%3DBrodbeck%26aufirst%3DJ.%26aulast%3DChan%26aufirst%3DB.%2BK.%26aulast%3DFiske%26aufirst%3DB.%2BK.%26aulast%3DHonigberg%26aufirst%3DL.%26aulast%3DJubb%26aufirst%3DA.%2BM.%26aulast%3DKatavolos%26aufirst%3DP.%26aulast%3DLee%26aufirst%3DD.%2BW.%26aulast%3DLewin-Koh%26aufirst%3DS.-C.%26aulast%3DLin%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DLyssikatos%26aufirst%3DJ.%2BP.%26aulast%3DO%25E2%2580%2599Mahony%26aufirst%3DJ.%26aulast%3DReichelt%26aufirst%3DM.%26aulast%3DRoose-Girma%26aufirst%3DM.%26aulast%3DSheng%26aufirst%3DZ.%26aulast%3DSherer%26aufirst%3DT.%2BB.%26aulast%3DSmith%26aufirst%3DA.%26aulast%3DSolon%26aufirst%3DM.%26aulast%3DSweeney%26aufirst%3DZ.%2BK.%26aulast%3DTarrant%26aufirst%3DJ.%26aulast%3DUrkowitz%26aufirst%3DA.%26aulast%3DWarming%26aufirst%3DS.%26aulast%3DYaylaoglu%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DEstrada%26aufirst%3DA.%2BA.%26aulast%3DWatts%26aufirst%3DR.%2BJ.%26atitle%3DEffect%2520of%2520selective%2520LRRK2%2520kinase%2520inhibition%2520on%2520nonhuman%2520primate%2520lung%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2015%26volume%3D7%26spage%3D273ra15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Tong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giaime, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelleher, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, J.</span><span> </span><span class="NLM_article-title">Loss of leucine-rich repeat kinase 2 causes impairment of protein degradation pathways, accumulation of alpha-synuclein, and apoptotic cell death in aged mice</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">9879</span><span class="NLM_x">–</span> <span class="NLM_lpage">9884</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1073%2Fpnas.1004676107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=20457918" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntFWltrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=9879-9884&author=Y.+Tongauthor=H.+Yamaguchiauthor=E.+Giaimeauthor=S.+Boyleauthor=R.+Kopanauthor=R.+J.+Kelleherauthor=J.+Shen&title=Loss+of+leucine-rich+repeat+kinase+2+causes+impairment+of+protein+degradation+pathways%2C+accumulation+of+alpha-synuclein%2C+and+apoptotic+cell+death+in+aged+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Loss of leucine-rich repeat kinase 2 causes impairment of protein degradation pathways, accumulation of α-synuclein, and apoptotic cell death in aged mice</span></div><div class="casAuthors">Tong, Youren; Yamaguchi, Hiroo; Giaime, Emilie; Boyle, Scott; Kopan, Raphael; Kelleher, Raymond J., III; Shen, Jie</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9879-9884, S9879/1-S9879/4</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common genetic cause of Parkinson's disease.  LRRK2 is a large protein contg. a small GTPase domain and a kinase domain, but its physiol. role is unknown.  To identify the normal function of LRRK2 in vivo, we generated two independent lines of germ-line deletion mice.  The dopaminergic system of LRRK2-/- mice appears normal, and nos. of dopaminergic neurons and levels of striatal dopamine are unchanged.  However, LRRK2-/- kidneys, which suffer the greatest loss of LRRK compared with other organs, develop striking accumulation and aggregation of α-synuclein and ubiquitinated proteins at 20 mo of age.  The autophagy-lysosomal pathway is also impaired in the absence of LRRK2, as indicated by accumulation of lipofuscin granules as well as altered levels of LC3-II and p62.  Furthermore, loss of LRRK2 dramatically increases apoptotic cell death, inflammatory responses, and oxidative damage.  Collectively, our findings show that LRRK2 plays an essential and unexpected role in the regulation of protein homeostasis during aging, and suggest that LRRK2 mutations may cause Parkinson's disease and cell death via impairment of protein degrdn. pathways, leading to α-synuclein accumulation and aggregation over time.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwJUmT5o1nLLVg90H21EOLACvtfcHk0lixTZmcDPvloA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntFWltrc%253D&md5=09474f2cb0fa155bb88311a5af0afbe1</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1004676107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1004676107%26sid%3Dliteratum%253Aachs%26aulast%3DTong%26aufirst%3DY.%26aulast%3DYamaguchi%26aufirst%3DH.%26aulast%3DGiaime%26aufirst%3DE.%26aulast%3DBoyle%26aufirst%3DS.%26aulast%3DKopan%26aufirst%3DR.%26aulast%3DKelleher%26aufirst%3DR.%2BJ.%26aulast%3DShen%26aufirst%3DJ.%26atitle%3DLoss%2520of%2520leucine-rich%2520repeat%2520kinase%25202%2520causes%2520impairment%2520of%2520protein%2520degradation%2520pathways%252C%2520accumulation%2520of%2520alpha-synuclein%252C%2520and%2520apoptotic%2520cell%2520death%2520in%2520aged%2520mice%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2010%26volume%3D107%26spage%3D9879%26epage%3D9884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Tong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giaime, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichimura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Si, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonventre, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, J.</span><span> </span><span class="NLM_article-title">Loss of leucine-rich repeat kinase 2 causes age-dependent bi-phasic alterations of the autophagy pathway</span> <span class="citation_source-journal">Mol. Neurodegener.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">2</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1186%2F1750-1326-7-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=22230652" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvVOqu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=2&author=Y.+Tongauthor=E.+Giaimeauthor=H.+Yamaguchiauthor=T.+Ichimuraauthor=Y.+Liuauthor=H.+Siauthor=H.+Caiauthor=J.+V.+Bonventreauthor=J.+Shen&title=Loss+of+leucine-rich+repeat+kinase+2+causes+age-dependent+bi-phasic+alterations+of+the+autophagy+pathway"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Loss of leucine-rich repeat kinase 2 causes age-dependent bi-phasic alterations of the autophagy pathway</span></div><div class="casAuthors">Tong, Youren; Giaime, Emilie; Yamaguchi, Hiroo; Ichimura, Takaharu; Liu, Yumin; Si, Huiqing; Cai, Huaibin; Bonventre, Joseph V.; Shen, Jie</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neurodegeneration</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2</span>CODEN:
                <span class="NLM_cas:coden">MNOEAZ</span>;
        ISSN:<span class="NLM_cas:issn">1750-1326</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Dominantly inherited missense mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common genetic cause of Parkinson's disease, but its normal physiol. function remains unclear.  We previously reported that loss of LRRK2 causes impairment of protein degrdn. pathways as well as increases of apoptotic cell death and inflammatory responses in the kidney of aged mice.  Results: Our anal. of LRRK2-/- kidneys at multiple ages, such as 1, 4, 7, and 20 mo, revealed unique age-dependent development of a variety of mol., cellular, and ultrastructural changes.  Gross morphol. abnormalities of the kidney, including altered size, wt., texture, and color, are evident in LRRK2-/- mice at 3-4 mo of age, along with increased accumulation of autofluorescent granules in proximal renal tubules.  The ratio of kidney/body wt. in LRRK2-/- mice is increased at 1, 4, and 7 mo of age (∼10% at 1 mo, and ∼20% at 4 and 7 mo), whereas the ratio is drastically decreased at 20 mo of age (∼50%).  While kidney filtration function evaluated by levels of blood urea nitrogen and serum creatinine is not significantly affected in LRRK2-/- mice at 12-14 mo of age, expression of kidney injury mol.-1, a sensitive and specific biomarker for epithelial cell injury of proximal renal tubules, is up-regulated (∼10-fold).  Surprisingly, loss of LRRK2 causes age-dependent bi-phasic alterations of the autophagic activity in LRRK2-/- kidneys, which is unchanged at 1 mo of age, enhanced at 7 mo but reduced at 20 mo, as evidenced by corresponding changes in the levels of LC3-I/II, a reliable autophagy marker, and p62, an autophagy substrate.  Levels of α-synuclein and protein carbonyls, a general oxidative damage marker, are also decreased in LRRK2-/- kidneys at 7 mo of age but increased at 20 mo.  Interestingly, the age-dependent bi-phasic alterations in autophagic activity in LRRK2-/- kidneys is accompanied by increased levels of lysosomal proteins and proteases at 1, 7, and 20 mo of age as well as progressive accumulation of autolysosomes and lipofuscin granules at 4, 7-10, and 20 mo of age.  Conclusions: LRRK2 is important for the dynamic regulation of autophagy function in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1NQ2pq6njq7Vg90H21EOLACvtfcHk0lixTZmcDPvloA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvVOqu7w%253D&md5=d725f523a486c397369b182034df8323</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1186%2F1750-1326-7-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1750-1326-7-2%26sid%3Dliteratum%253Aachs%26aulast%3DTong%26aufirst%3DY.%26aulast%3DGiaime%26aufirst%3DE.%26aulast%3DYamaguchi%26aufirst%3DH.%26aulast%3DIchimura%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DSi%26aufirst%3DH.%26aulast%3DCai%26aufirst%3DH.%26aulast%3DBonventre%26aufirst%3DJ.%2BV.%26aulast%3DShen%26aufirst%3DJ.%26atitle%3DLoss%2520of%2520leucine-rich%2520repeat%2520kinase%25202%2520causes%2520age-dependent%2520bi-phasic%2520alterations%2520of%2520the%2520autophagy%2520pathway%26jtitle%3DMol.%2520Neurodegener.%26date%3D2012%26volume%3D7%26spage%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Herzig, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolly, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Persohn, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theil, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schweizer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hafner, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stemmelen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troxler, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmid, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnell, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinzel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grevot, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognani, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stirn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaupmann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Putten, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rovelli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimshek, D. R.</span><span> </span><span class="NLM_article-title">LRRK2 protein levels are determined by kinase function and are crucial for kidney and lung homeostasis in mice</span> <span class="citation_source-journal">Hum. Mol. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">4209</span><span class="NLM_x">–</span> <span class="NLM_lpage">4223</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1093%2Fhmg%2Fddr348" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=21828077" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1yltrnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2011&pages=4209-4223&author=M.+C.+Herzigauthor=C.+Kollyauthor=E.+Persohnauthor=D.+Theilauthor=T.+Schweizerauthor=T.+Hafnerauthor=C.+Stemmelenauthor=T.+J.+Troxlerauthor=P.+Schmidauthor=S.+Dannerauthor=C.+R.+Schnellauthor=M.+Muellerauthor=B.+Kinzelauthor=A.+Grevotauthor=F.+Bolognaniauthor=M.+Stirnauthor=R.+R.+Kuhnauthor=K.+Kaupmannauthor=P.+H.+van+der+Puttenauthor=G.+Rovelliauthor=D.+R.+Shimshek&title=LRRK2+protein+levels+are+determined+by+kinase+function+and+are+crucial+for+kidney+and+lung+homeostasis+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">LRRK2 protein levels are determined by kinase function and are crucial for kidney and lung homeostasis in mice</span></div><div class="casAuthors">Herzig, Martin C.; Kolly, Carine; Persohn, Elke; Theil, Diethilde; Schweizer, Tatjana; Hafner, Thomas; Stemmelen, Christine; Troxler, Thomas J.; Schmid, Peter; Danner, Simone; Schnell, Christian R.; Mueller, Matthias; Kinzel, Bernd; Grevot, Armelle; Bolognani, Federico; Stirn, Martina; Kuhn, Rainer R.; Kaupmann, Klemens; van der Putten, P. Herman; Rovelli, Giorgio; Shimshek, Derya R.</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">4209-4223</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Mutations in leucine-rich repeat kinase 2 (LRRK2) cause late-onset Parkinson's disease (PD), but the underlying pathophysiol. mechanisms and the normal function of this large multidomain protein remain speculative.  To address the role of this protein in vivo, we generated three different LRRK2 mutant mouse lines.  Mice completely lacking the LRRK2 protein (knock-out, KO) showed an early-onset (age 6 wk) marked increase in no. and size of secondary lysosomes in kidney proximal tubule cells and lamellar bodies in lung type II cells.  Mice expressing a LRRK2 kinase-dead (KD) mutant from the endogenous locus displayed similar early-onset pathophysiol. changes in kidney but not lung.  KD mutants had dramatically reduced full-length LRRK2 protein levels in the kidney and this genetic effect was mimicked pharmacol. in wild-type mice treated with a LRRK2-selective kinase inhibitor.  Knock-in (KI) mice expressing the G2019S PD-assocd. mutation that increases LRRK2 kinase activity showed none of the LRRK2 protein level and histopathol. changes obsd. in KD and KO mice.  The autophagy marker LC3 remained unchanged but kidney mTOR and TCS2 protein levels decreased in KD and increased in KO and KI mice.  Unexpectedly, KO and KI mice suffered from diastolic hypertension opposed to normal blood pressure in KD mice.  Our findings demonstrate a role for LRRK2 in kidney and lung physiol. and further show that LRRK2 kinase function affects LRRK2 protein steady-state levels thereby altering putative scaffold/GTPase activity.  These novel aspects of peripheral LRRK2 biol. critically impact ongoing attempts to develop LRRK2 selective kinase inhibitors as therapeutics for PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGol714w-ZIM5rVg90H21EOLACvtfcHk0lhZHQBRn94ogw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1yltrnI&md5=9c7935965c8f21e13b42bdc9e794cde0</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddr348&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddr348%26sid%3Dliteratum%253Aachs%26aulast%3DHerzig%26aufirst%3DM.%2BC.%26aulast%3DKolly%26aufirst%3DC.%26aulast%3DPersohn%26aufirst%3DE.%26aulast%3DTheil%26aufirst%3DD.%26aulast%3DSchweizer%26aufirst%3DT.%26aulast%3DHafner%26aufirst%3DT.%26aulast%3DStemmelen%26aufirst%3DC.%26aulast%3DTroxler%26aufirst%3DT.%2BJ.%26aulast%3DSchmid%26aufirst%3DP.%26aulast%3DDanner%26aufirst%3DS.%26aulast%3DSchnell%26aufirst%3DC.%2BR.%26aulast%3DMueller%26aufirst%3DM.%26aulast%3DKinzel%26aufirst%3DB.%26aulast%3DGrevot%26aufirst%3DA.%26aulast%3DBolognani%26aufirst%3DF.%26aulast%3DStirn%26aufirst%3DM.%26aulast%3DKuhn%26aufirst%3DR.%2BR.%26aulast%3DKaupmann%26aufirst%3DK.%26aulast%3Dvan%2Bder%2BPutten%26aufirst%3DP.%2BH.%26aulast%3DRovelli%26aufirst%3DG.%26aulast%3DShimshek%26aufirst%3DD.%2BR.%26atitle%3DLRRK2%2520protein%2520levels%2520are%2520determined%2520by%2520kinase%2520function%2520and%2520are%2520crucial%2520for%2520kidney%2520and%2520lung%2520homeostasis%2520in%2520mice%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2011%26volume%3D20%26spage%3D4209%26epage%3D4223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Hinkle, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behrouz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dächsel, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lincoln, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowles, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beevers, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dugger, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prots, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kent, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishioka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickson, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janus, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrer, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melrose, H. L.</span><span> </span><span class="NLM_article-title">LRRK2 knockout mice have an intact dopaminergic system but display alterations in exploratory and motor co-ordination behaviors</span> <span class="citation_source-journal">Mol. Neurodegener.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">25</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1186%2F1750-1326-7-25" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=22647713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVSiurnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=25&author=K.+M.+Hinkleauthor=M.+Yueauthor=B.+Behrouzauthor=J.+C.+D%C3%A4chselauthor=S.+J.+Lincolnauthor=E.+E.+Bowlesauthor=J.+E.+Beeversauthor=B.+Duggerauthor=B.+Winnerauthor=I.+Protsauthor=C.+B.+Kentauthor=K.+Nishiokaauthor=W.+L.+Linauthor=D.+W.+Dicksonauthor=C.+J.+Janusauthor=M.+J.+Farrerauthor=H.+L.+Melrose&title=LRRK2+knockout+mice+have+an+intact+dopaminergic+system+but+display+alterations+in+exploratory+and+motor+co-ordination+behaviors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">LRRK2 knockout mice have an intact dopaminergic system but display alterations in exploratory and motor co-ordination behaviors</span></div><div class="casAuthors">Hinkle, Kelly M.; Yue, Mei; Behrouz, Bahareh; Dachsel, Justus C.; Lincoln, Sarah J.; Bowles, Erin E.; Beevers, Joel E.; Dugger, Brittany; Winner, Beate; Prots, Iryna; Kent, Caroline B.; Nishioka, Kenya; Lin, Wen-Lang; Dickson, Dennis W.; Janus, Christopher J.; Farrer, Matthew J.; Melrose, Heather L.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neurodegeneration</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">25</span>CODEN:
                <span class="NLM_cas:coden">MNOEAZ</span>;
        ISSN:<span class="NLM_cas:issn">1750-1326</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Mutations in the LRRK2 gene are the most common cause of genetic Parkinson's disease.  Although the mechanisms behind the pathogenic effects of LRRK2 mutations are still not clear, data emerging from in vitro and in vivo models suggests roles in regulating neuronal polarity, neurotransmission, membrane and cytoskeletal dynamics and protein degrdn.  We created mice lacking exon 41 that encodes the activation hinge of the kinase domain of LRRK2.  We have performed a comprehensive anal. of these mice up to 20 mo of age, including evaluation of dopamine storage, release, uptake and synthesis, behavioral testing, dendritic spine and proliferation/neurogenesis anal.  Our results show that the dopaminergic system was not functionally comprised in LRRK2 knockout mice.  However, LRRK2 knockout mice displayed abnormal exploratory activity in the open-field test.  Moreover, LRRK2 knockout mice stayed longer than their wild type littermates on the accelerated rod during rotarod testing.  Finally, we confirm that loss of LRRK2 caused degeneration in the kidney, accompanied by a progressive enhancement of autophagic activity and accumulation of autofluorescent material, but without evidence of biphasic changes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3jk_BNWhPU7Vg90H21EOLACvtfcHk0lhZHQBRn94ogw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVSiurnM&md5=d877c7237d22675e464a905af797679c</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1186%2F1750-1326-7-25&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1750-1326-7-25%26sid%3Dliteratum%253Aachs%26aulast%3DHinkle%26aufirst%3DK.%2BM.%26aulast%3DYue%26aufirst%3DM.%26aulast%3DBehrouz%26aufirst%3DB.%26aulast%3DD%25C3%25A4chsel%26aufirst%3DJ.%2BC.%26aulast%3DLincoln%26aufirst%3DS.%2BJ.%26aulast%3DBowles%26aufirst%3DE.%2BE.%26aulast%3DBeevers%26aufirst%3DJ.%2BE.%26aulast%3DDugger%26aufirst%3DB.%26aulast%3DWinner%26aufirst%3DB.%26aulast%3DProts%26aufirst%3DI.%26aulast%3DKent%26aufirst%3DC.%2BB.%26aulast%3DNishioka%26aufirst%3DK.%26aulast%3DLin%26aufirst%3DW.%2BL.%26aulast%3DDickson%26aufirst%3DD.%2BW.%26aulast%3DJanus%26aufirst%3DC.%2BJ.%26aulast%3DFarrer%26aufirst%3DM.%2BJ.%26aulast%3DMelrose%26aufirst%3DH.%2BL.%26atitle%3DLRRK2%2520knockout%2520mice%2520have%2520an%2520intact%2520dopaminergic%2520system%2520but%2520display%2520alterations%2520in%2520exploratory%2520and%2520motor%2520co-ordination%2520behaviors%26jtitle%3DMol.%2520Neurodegener.%26date%3D2012%26volume%3D7%26spage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Baptista, M. A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dave, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frasier, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherer, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greeley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varsho, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Churchill, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meshul, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiske, B. K.</span><span> </span><span class="NLM_article-title">Loss of leucine-rich repeat kinase 2 (LRRK2) in rats leads to progressive abnormal phenotypes in peripheral organs</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e80705</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e80705&author=M.+A.+S.+Baptistaauthor=K.+D.+Daveauthor=M.+A.+Frasierauthor=T.+B.+Shererauthor=M.+Greeleyauthor=M.+J.+Beckauthor=J.+S.+Varshoauthor=G.+A.+Parkerauthor=C.+Mooreauthor=M.+J.+Churchillauthor=C.+K.+Meshulauthor=B.+K.+Fiske&title=Loss+of+leucine-rich+repeat+kinase+2+%28LRRK2%29+in+rats+leads+to+progressive+abnormal+phenotypes+in+peripheral+organs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBaptista%26aufirst%3DM.%2BA.%2BS.%26aulast%3DDave%26aufirst%3DK.%2BD.%26aulast%3DFrasier%26aufirst%3DM.%2BA.%26aulast%3DSherer%26aufirst%3DT.%2BB.%26aulast%3DGreeley%26aufirst%3DM.%26aulast%3DBeck%26aufirst%3DM.%2BJ.%26aulast%3DVarsho%26aufirst%3DJ.%2BS.%26aulast%3DParker%26aufirst%3DG.%2BA.%26aulast%3DMoore%26aufirst%3DC.%26aulast%3DChurchill%26aufirst%3DM.%2BJ.%26aulast%3DMeshul%26aufirst%3DC.%2BK.%26aulast%3DFiske%26aufirst%3DB.%2BK.%26atitle%3DLoss%2520of%2520leucine-rich%2520repeat%2520kinase%25202%2520%2528LRRK2%2529%2520in%2520rats%2520leads%2520to%2520progressive%2520abnormal%2520phenotypes%2520in%2520peripheral%2520organs%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De80705" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Miklavc, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehinger, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hobi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimshek, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frick, M.</span><span> </span><span class="NLM_article-title">Surfactant secretion in LRRK2 knock-out rats: changes in lamellar body morphology and rate of exocytosis</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">e84926</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e84926&author=P.+Miklavcauthor=K.+Ehingerauthor=K.+E.+Thompsonauthor=N.+Hobiauthor=D.+R.+Shimshekauthor=M.+Frick&title=Surfactant+secretion+in+LRRK2+knock-out+rats%3A+changes+in+lamellar+body+morphology+and+rate+of+exocytosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMiklavc%26aufirst%3DP.%26aulast%3DEhinger%26aufirst%3DK.%26aulast%3DThompson%26aufirst%3DK.%2BE.%26aulast%3DHobi%26aufirst%3DN.%26aulast%3DShimshek%26aufirst%3DD.%2BR.%26aulast%3DFrick%26aufirst%3DM.%26atitle%3DSurfactant%2520secretion%2520in%2520LRRK2%2520knock-out%2520rats%253A%2520changes%2520in%2520lamellar%2520body%2520morphology%2520and%2520rate%2520of%2520exocytosis%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De84926" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Kramer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo Monte, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Göring, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amombo, G. M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, B.</span><span> </span><span class="NLM_article-title">Small molecule kinase inhibitors for LRRK2 and their application to Parkinson’s disease models</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">151</span><span class="NLM_x">–</span> <span class="NLM_lpage">160</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn200117j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC38XosFentA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=151-160&author=T.+Kramerauthor=F.+Lo+Monteauthor=S.+G%C3%B6ringauthor=G.+M.+O.+Amomboauthor=B.+Schmidt&title=Small+molecule+kinase+inhibitors+for+LRRK2+and+their+application+to+Parkinson%E2%80%99s+disease+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Small Molecule Kinase Inhibitors for LRRK2 and Their Application to Parkinson's Disease Models</span></div><div class="casAuthors">Kramer, Thomas; Lo Monte, Fabio; Goering, Stefan; Okala Amombo, Ghislaine Marlyse; Schmidt, Boris</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">151-160</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Parkinson's disease (PD) is the second most common neurodegenerative disorder.  Several single gene mutations have been linked to this disease.  Mutations in the gene encoding leucine-rich repeat kinase 2 (LRRK2) indicate LRRK2 as promising therapeutic target for the treatment of PD.  LRRK2 mutations were obsd. in sporadic as well as familial PD patients and have been investigated intensively.  LRRK2 is a large and complex protein, with multiple enzymic and protein-interaction domains, each of which is effected by mutations.  The most common mutation in PD patients is G2019S.  Several LRRK2 inhibitors have been reported already, although the crystal structure of LRRK2 has not yet been detd.  This review provides a summary of known LRRK2 inhibitors and will discuss recent in vitro and in vivo results of these inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqUiu7gx3NxLVg90H21EOLACvtfcHk0lgZ4WkTFWaWVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XosFentA%253D%253D&md5=bda078bde5e0b515ca9d6f183d8b06f8</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fcn200117j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn200117j%26sid%3Dliteratum%253Aachs%26aulast%3DKramer%26aufirst%3DT.%26aulast%3DLo%2BMonte%26aufirst%3DF.%26aulast%3DG%25C3%25B6ring%26aufirst%3DS.%26aulast%3DAmombo%26aufirst%3DG.%2BM.%2BO.%26aulast%3DSchmidt%26aufirst%3DB.%26atitle%3DSmall%2520molecule%2520kinase%2520inhibitors%2520for%2520LRRK2%2520and%2520their%2520application%2520to%2520Parkinson%25E2%2580%2599s%2520disease%2520models%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2012%26volume%3D3%26spage%3D151%26epage%3D160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Kavanagh, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doddareddy, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassiou, M.</span><span> </span><span class="NLM_article-title">The development of CNS-active LRRK2 inhibitors using property-directed optimisation</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3690</span><span class="NLM_x">–</span> <span class="NLM_lpage">3696</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=3690-3696&author=M.+E.+Kavanaghauthor=M.+R.+Doddareddyauthor=M.+Kassiou&title=The+development+of+CNS-active+LRRK2+inhibitors+using+property-directed+optimisation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKavanagh%26aufirst%3DM.%2BE.%26aulast%3DDoddareddy%26aufirst%3DM.%2BR.%26aulast%3DKassiou%26aufirst%3DM.%26atitle%3DThe%2520development%2520of%2520CNS-active%2520LRRK2%2520inhibitors%2520using%2520property-directed%2520optimisation%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D3690%26epage%3D3696" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Dzamko, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halliday, G. M.</span><span> </span><span class="NLM_article-title">Unlocking the secrets of LRRK2 function with selective kinase inhibitors</span> <span class="citation_source-journal">Future Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">347</span><span class="NLM_x">–</span> <span class="NLM_lpage">357</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.2217%2Ffnl.13.9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmvFOjurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=347-357&author=N.+Dzamkoauthor=G.+M.+Halliday&title=Unlocking+the+secrets+of+LRRK2+function+with+selective+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Unlocking the secrets of LRRK2 function with selective kinase inhibitors</span></div><div class="casAuthors">Dzamko, Nicolas; Halliday, Glenda M.</div><div class="citationInfo"><span class="NLM_cas:title">Future Neurology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">347-357</span>CODEN:
                <span class="NLM_cas:coden">FNUEAM</span>;
        ISSN:<span class="NLM_cas:issn">1479-6708</span>.
    
            (<span class="NLM_cas:orgname">Future Medicine Ltd.</span>)
        </div><div class="casAbstract">A review.  LRRK2 is currently considered to be a potential therapeutic target for the treatment of Parkinson's disease.  A no. of pathol. mutations, the majority of which lie in the dual catalytic domains of LRRK2, segregate with Parkinson's disease in an autosomal-dominant fashion.  The most common mutation, G2019S, results in an increase in the kinase activity of LRRK2 and much work has, therefore, gone into the development of potent and specific inhibitors of LRRK2 kinase activity.  A no. of LRRK2 kinase inhibitors have now been employed in the search for the physiol. function of LRRK2 and the targets of LRRK2 kinase activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6NRBdq_2uUbVg90H21EOLACvtfcHk0lhoJ0yedppTnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmvFOjurk%253D&md5=e0eb24e6bcc30784715dcbda9832d586</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.2217%2Ffnl.13.9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252Ffnl.13.9%26sid%3Dliteratum%253Aachs%26aulast%3DDzamko%26aufirst%3DN.%26aulast%3DHalliday%26aufirst%3DG.%2BM.%26atitle%3DUnlocking%2520the%2520secrets%2520of%2520LRRK2%2520function%2520with%2520selective%2520kinase%2520inhibitors%26jtitle%3DFuture%2520Neurol.%26date%3D2013%26volume%3D8%26spage%3D347%26epage%3D357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Schulz, S.; Goring, S.; Schmidt, B.; Hopf, C.</span><span> </span><span class="NLM_article-title">LRRK2 kinase inhibitors as new drugs for Parkinson’s disease?</span> In  <span class="citation_source-book">Emerging Drugs and Targets for Parkinson’s Disease</span>; <span class="NLM_contrib-group">Martinez, A.; Gil, C.</span>, Eds.; RSC Drug Discovery Series No. 34; <span class="NLM_publisher-name">The Royal Society of Chemistry</span>: <span class="NLM_publisher-loc">London</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">266</span><span class="NLM_x">–</span> <span class="NLM_lpage">293</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1039%2F9781849737357-00266" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=266-293&author=S.+Schulz&author=S.+Goring&author=B.+Schmidt&author=C.+Hopfauthor=A.+Martinez&author=C.+Gil&title=Emerging+Drugs+and+Targets+for+Parkinson%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1039%2F9781849737357-00266&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1039%252F9781849737357-00266%26sid%3Dliteratum%253Aachs%26aulast%3DSchulz%26aufirst%3DS.%26atitle%3DLRRK2%2520kinase%2520inhibitors%2520as%2520new%2520drugs%2520for%2520Parkinson%25E2%2580%2599s%2520disease%253F%26btitle%3DEmerging%2520Drugs%2520and%2520Targets%2520for%2520Parkinson%25E2%2580%2599s%2520Disease%26aulast%3DMartinez%26aufirst%3DA.%26pub%3DThe%2520Royal%2520Society%2520of%2520Chemistry%26date%3D2013%26spage%3D266%26epage%3D293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Galatsis, P.; Henderson, J. L.; Kormos, B. L.; Hirst, W. D.</span><span> </span><span class="NLM_article-title">Leucine-rich repeat kinase 2 (LRRK2) inhibitors</span>. In  <span class="citation_source-book">Topics in Medicinal Chemistry</span>; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Berlin</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">; </span>DOI: <span class="refDoi"> DOI: 10.1007/7355_2014_69</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1007%2F7355_2014_69" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=P.+Galatsis&author=J.+L.+Henderson&author=B.+L.+Kormos&author=W.+D.+Hirst&title=Topics+in+Medicinal+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1007%2F7355_2014_69&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F7355_2014_69%26sid%3Dliteratum%253Aachs%26aulast%3DGalatsis%26aufirst%3DP.%26atitle%3DLeucine-rich%2520repeat%2520kinase%25202%2520%2528LRRK2%2529%2520inhibitors%26btitle%3DTopics%2520in%2520Medicinal%2520Chemistry%26pub%3DSpringer%26date%3D2014%26doi%3D10.1007%2F7355_2014_69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Burdick, D. J.</span><span> </span><span class="NLM_article-title">Response to Deng et al.’s LRRK2 patent review</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">279</span><span class="NLM_x">–</span> <span class="NLM_lpage">279</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1517%2F13543776.2013.757594" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=23268730" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpt1Glsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=279-279&author=D.+J.+Burdick&title=Response+to+Deng+et+al.%E2%80%99s+LRRK2+patent+review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Response to Deng et al.'s LRRK2 patent review</span></div><div class="casAuthors">Burdick, Daniel Jon</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">279</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">In response to a recent article entitled "Leucine-rich repeat kinase 2 inhibitors: a patent review (2006-2011).  The authors appear to claim that they were the first to discover compd. 11 and that Genentech/Roche discovered 11 in a parallel effort, however, the patent and non-patent literature clearly shows that Genentech/Roche was the first to discover compd. 11 and that the Gray group found it later.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMsbAAgdiBdLVg90H21EOLACvtfcHk0lixqdukK6NSXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpt1Glsg%253D%253D&md5=273a70f208da6933a24df1c914e18849</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1517%2F13543776.2013.757594&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2013.757594%26sid%3Dliteratum%253Aachs%26aulast%3DBurdick%26aufirst%3DD.%2BJ.%26atitle%3DResponse%2520to%2520Deng%2520et%2520al.%25E2%2580%2599s%2520LRRK2%2520patent%2520review%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2013%26volume%3D23%26spage%3D279%26epage%3D279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Kethiri, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakthavatchalam, R.</span><span> </span><span class="NLM_article-title">Leucine-rich repeat kinase 2 inhibitors: a review of recent patents (2011–2013)</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">745</span><span class="NLM_x">–</span> <span class="NLM_lpage">757</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1517%2F13543776.2014.907275" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2013&pages=745-757&author=R.+R.+Kethiriauthor=R.+Bakthavatchalam&title=Leucine-rich+repeat+kinase+2+inhibitors%3A+a+review+of+recent+patents+%282011%E2%80%932013%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1517%2F13543776.2014.907275&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2014.907275%26sid%3Dliteratum%253Aachs%26aulast%3DKethiri%26aufirst%3DR.%2BR.%26aulast%3DBakthavatchalam%26aufirst%3DR.%26atitle%3DLeucine-rich%2520repeat%2520kinase%25202%2520inhibitors%253A%2520a%2520review%2520of%2520recent%2520patents%2520%25282011%25E2%2580%25932013%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2013%26volume%3D24%26spage%3D745%26epage%3D757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Ramsden, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zinn, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bova, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewes, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bantscheff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bard, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopf, C.</span><span> </span><span class="NLM_article-title">Chemoproteomics-based design of potent LRRK2-selective lead compounds that attenuate Parkinson’s disease-related toxicity in human neurons</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1021</span><span class="NLM_x">–</span> <span class="NLM_lpage">1028</span></span><div class="citationLinks">[<a href="/doi/10.1021/cb2002413" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=1021-1028&author=N.+Ramsdenauthor=J.+Perrinauthor=Z.+Renauthor=B.+D.+Leeauthor=N.+Zinnauthor=V.+L.+Dawsonauthor=D.+Tamauthor=M.+Bovaauthor=M.+Langauthor=G.+Drewesauthor=M.+Bantscheffauthor=F.+Bardauthor=T.+M.+Dawsonauthor=C.+Hopf&title=Chemoproteomics-based+design+of+potent+LRRK2-selective+lead+compounds+that+attenuate+Parkinson%E2%80%99s+disease-related+toxicity+in+human+neurons"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1021%2Fcb2002413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb2002413%26sid%3Dliteratum%253Aachs%26aulast%3DRamsden%26aufirst%3DN.%26aulast%3DPerrin%26aufirst%3DJ.%26aulast%3DRen%26aufirst%3DZ.%26aulast%3DLee%26aufirst%3DB.%2BD.%26aulast%3DZinn%26aufirst%3DN.%26aulast%3DDawson%26aufirst%3DV.%2BL.%26aulast%3DTam%26aufirst%3DD.%26aulast%3DBova%26aufirst%3DM.%26aulast%3DLang%26aufirst%3DM.%26aulast%3DDrewes%26aufirst%3DG.%26aulast%3DBantscheff%26aufirst%3DM.%26aulast%3DBard%26aufirst%3DF.%26aulast%3DDawson%26aufirst%3DT.%2BM.%26aulast%3DHopf%26aufirst%3DC.%26atitle%3DChemoproteomics-based%2520design%2520of%2520potent%2520LRRK2-selective%2520lead%2520compounds%2520that%2520attenuate%2520Parkinson%25E2%2580%2599s%2520disease-related%2520toxicity%2520in%2520human%2520neurons%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2011%26volume%3D6%26spage%3D1021%26epage%3D1028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Deng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dzamko, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prescott, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.-D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patricelli, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomanbhoy, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Characterization of a selective inhibitor of the Parkinson’s disease kinase LRRK2</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">–</span> <span class="NLM_lpage">205</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1038%2Fnchembio.538" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=21378983" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkvVKqsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=203-205&author=X.+Dengauthor=N.+Dzamkoauthor=A.+Prescottauthor=P.+Daviesauthor=Q.+Liuauthor=Q.+Yangauthor=J.-D.+Leeauthor=M.+P.+Patricelliauthor=T.+K.+Nomanbhoyauthor=D.+R.+Alessiauthor=N.+S.+Gray&title=Characterization+of+a+selective+inhibitor+of+the+Parkinson%E2%80%99s+disease+kinase+LRRK2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2</span></div><div class="casAuthors">Deng, Xianming; Dzamko, Nicolas; Prescott, Alan; Davies, Paul; Liu, Qingsong; Yang, Qingkai; Lee, Jiing-Dwan; Patricelli, Matthew P.; Nomanbhoy, Tyzoon K.; Alessi, Dario R.; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">203-205</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Mutations in leucine-rich repeat kinase 2 (LRRK2) are strongly assocd. with late-onset autosomal dominant Parkinson's disease.  We employed a new, parallel, compd.-centric approach to identify a potent and selective LRRK2 inhibitor, LRRK2-IN-1, and demonstrated that inhibition of LRRK2 induces dephosphorylation of Ser910 and Ser935 and accumulation of LRRK2 within aggregate structures.  LRRK2-IN-1 will serve as a versatile tool to pharmacol. interrogate LRRK2 biol. and study its role in Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwLpGURHqDULVg90H21EOLACvtfcHk0li4XNJDarOI6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkvVKqsL0%253D&md5=9f48f74cad9988e3ea8bb7af280473c1</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.538&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.538%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DDzamko%26aufirst%3DN.%26aulast%3DPrescott%26aufirst%3DA.%26aulast%3DDavies%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DQ.%26aulast%3DLee%26aufirst%3DJ.-D.%26aulast%3DPatricelli%26aufirst%3DM.%2BP.%26aulast%3DNomanbhoy%26aufirst%3DT.%2BK.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DCharacterization%2520of%2520a%2520selective%2520inhibitor%2520of%2520the%2520Parkinson%25E2%2580%2599s%2520disease%2520kinase%2520LRRK2%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2011%26volume%3D7%26spage%3D203%26epage%3D205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Parisiadou, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sgobio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, X.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowley, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovinger, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, H.</span><span> </span><span class="NLM_article-title">LRRK2 regulates synaptogenesis and dopamine receptor activation through modulation of PKA activity</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">367</span><span class="NLM_x">–</span> <span class="NLM_lpage">376</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1038%2Fnn.3636" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=24464040" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1yju7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2014&pages=367-376&author=L.+Parisiadouauthor=J.+Yuauthor=C.+Sgobioauthor=C.+Xieauthor=G.+Liuauthor=L.+Sunauthor=X.-L.+Guauthor=X.+Linauthor=N.+A.+Crowleyauthor=D.+M.+Lovingerauthor=H.+Cai&title=LRRK2+regulates+synaptogenesis+and+dopamine+receptor+activation+through+modulation+of+PKA+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">LRRK2 regulates synaptogenesis and dopamine receptor activation through modulation of PKA activity</span></div><div class="casAuthors">Parisiadou, Loukia; Yu, Jia; Sgobio, Carmelo; Xie, Chengsong; Liu, Guoxiang; Sun, Lixin; Gu, Xing-Long; Lin, Xian; Crowley, Nicole A.; Lovinger, David M.; Cai, Huaibin</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">367-376</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Leucine-rich repeat kinase 2 (LRRK2) is enriched in the striatal projection neurons (SPNs).  We found that LRRK2 neg. regulates protein kinase A (PKA) activity in the SPNs during synaptogenesis and in response to dopamine receptor Drd1 activation.  LRRK2 interacted with PKA regulatory subunit IIβ (PKARIIβ).  A lack of LRRK2 promoted the synaptic translocation of PKA and increased PKA-mediated phosphorylation of actin-disassembling enzyme cofilin and glutamate receptor GluR1, resulting in abnormal synaptogenesis and transmission in the developing SPNs.  Furthermore, PKA-dependent phosphorylation of GluR1 was also aberrantly enhanced in the striatum of young and aged Lrrk2-/- mice after treatment with a Drd1 agonist.  Notably, a Parkinson's disease-related Lrrk2 R1441C missense mutation that impaired the interaction of LRRK2 with PKARIIβ also induced excessive PKA activity in the SPNs.  Our findings reveal a previously unknown regulatory role for LRRK2 in PKA signaling and suggest a pathogenic mechanism of SPN dysfunction in Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBNKCM4t2-prVg90H21EOLACvtfcHk0li4XNJDarOI6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1yju7c%253D&md5=a36b3bc5f61a78bbaf3e97885b67f85b</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1038%2Fnn.3636&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn.3636%26sid%3Dliteratum%253Aachs%26aulast%3DParisiadou%26aufirst%3DL.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DSgobio%26aufirst%3DC.%26aulast%3DXie%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DGu%26aufirst%3DX.-L.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DCrowley%26aufirst%3DN.%2BA.%26aulast%3DLovinger%26aufirst%3DD.%2BM.%26aulast%3DCai%26aufirst%3DH.%26atitle%3DLRRK2%2520regulates%2520synaptogenesis%2520and%2520dopamine%2520receptor%2520activation%2520through%2520modulation%2520of%2520PKA%2520activity%26jtitle%3DNat.%2520Neurosci.%26date%3D2014%26volume%3D17%26spage%3D367%26epage%3D376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Kuss, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adamopoulou, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahle, P. J.</span><span> </span><span class="NLM_article-title">Interferon-γ induces leucine-rich repeat kinase LRRK2 via extracellular signal-regulated kinase ERK5 in macrophages</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">129</span><span class="NLM_x">, </span> <span class="NLM_fpage">980</span><span class="NLM_x">–</span> <span class="NLM_lpage">987</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1111%2Fjnc.12668" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=24479685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpsVKrsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2014&pages=980-987&author=M.+Kussauthor=E.+Adamopoulouauthor=P.+J.+Kahle&title=Interferon-%CE%B3+induces+leucine-rich+repeat+kinase+LRRK2+via+extracellular+signal-regulated+kinase+ERK5+in+macrophages"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Interferon-γ induces leucine-rich repeat kinase LRRK2 via extracellular signal-regulated kinase ERK5 in macrophages</span></div><div class="casAuthors">Kuss, Martin; Adamopoulou, Eleni; Kahle, Philipp J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">980-987</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The gene encoding leucine-rich repeat kinase 2 (LRRK2) comprises a major risk factor for Parkinson's disease.  Recently, it has emerged that LRRK2 plays important roles in the immune system.  LRRK2 is induced by interferon-γ (IFN-γ) in monocytes, but the signaling pathway is not known.  Here, we show that IFN-γ-mediated induction of LRRK2 was suppressed by pharmacol. inhibition and RNA interference of the extracellular signal-regulated kinase 5 (ERK5).  This was confirmed by LRRK2 immunostaining, which also revealed that the morphol. responses to IFN-γ were suppressed by ERK5 inhibitor treatment.  Both human acute monocytic leukemia THP-1 cells and human peripheral blood monocytes stimulated the ERK5-LRRK2 pathway after differentiation into macrophages.  Thus, LRRK2 is induced via a novel, ERK5-dependent IFN-γ signal transduction pathway, pointing to new functions of ERK5 and LRRK2 in human macrophages.  Leucine-rich repeat kinase 2 (LRRK2) is a major risk factor for the development of Parkinson's disease (PD).  However, the role of LRRK2 in the affected neurons remains enigmatic.  Recently, LRRK2 has been reported to be strongly expressed in the immune system.  Here, we demonstrate that LRRK2 is induced by interferon gamma via extracellular signal-regulated kinase 5 (ERK5) in macrophages, thus providing new insights in LRRK2 and ERK5 biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLdgRFksIqCbVg90H21EOLACvtfcHk0lh8Wmvh0xKTQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpsVKrsL0%253D&md5=7b0bdb62727ea3d1aebb1a789ec244c2</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1111%2Fjnc.12668&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjnc.12668%26sid%3Dliteratum%253Aachs%26aulast%3DKuss%26aufirst%3DM.%26aulast%3DAdamopoulou%26aufirst%3DE.%26aulast%3DKahle%26aufirst%3DP.%2BJ.%26atitle%3DInterferon-%25CE%25B3%2520induces%2520leucine-rich%2520repeat%2520kinase%2520LRRK2%2520via%2520extracellular%2520signal-regulated%2520kinase%2520ERK5%2520in%2520macrophages%26jtitle%3DJ.%2520Neurochem.%26date%3D2014%26volume%3D129%26spage%3D980%26epage%3D987" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Elkins, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pattison, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arthur, J. S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erazo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lizcano, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span> </span><span class="NLM_article-title">X-ray crystal structure of ERK5 (MAPK7) in complex with a specific inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">4413</span><span class="NLM_x">–</span> <span class="NLM_lpage">4421</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm4000837" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4413-4421&author=J.+M.+Elkinsauthor=J.+Wangauthor=X.+Dengauthor=M.+J.+Pattisonauthor=J.+S.+C.+Arthurauthor=T.+Erazoauthor=N.+Gomezauthor=J.+M.+Lizcanoauthor=N.+S.+Grayauthor=S.+Knapp&title=X-ray+crystal+structure+of+ERK5+%28MAPK7%29+in+complex+with+a+specific+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Fjm4000837&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4000837%26sid%3Dliteratum%253Aachs%26aulast%3DElkins%26aufirst%3DJ.%2BM.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DPattison%26aufirst%3DM.%2BJ.%26aulast%3DArthur%26aufirst%3DJ.%2BS.%2BC.%26aulast%3DErazo%26aufirst%3DT.%26aulast%3DGomez%26aufirst%3DN.%26aulast%3DLizcano%26aufirst%3DJ.%2BM.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DKnapp%26aufirst%3DS.%26atitle%3DX-ray%2520crystal%2520structure%2520of%2520ERK5%2520%2528MAPK7%2529%2520in%2520complex%2520with%2520a%2520specific%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4413%26epage%3D4421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Weygant, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">May, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandrakesan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sureban, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janknecht, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houchen, C. W.</span><span> </span><span class="NLM_article-title">Small molecule kinase inhibitor LRRK2-IN-1 demonstrates potent activity against colorectal and pancreatic cancer through inhibition of doublecortin-like kinase 1</span> <span class="citation_source-journal">Mol. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">103</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1186%2F1476-4598-13-103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=24885928" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC2MXivFWns7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=103&author=N.+Weygantauthor=D.+Quauthor=W.+L.+Berryauthor=R.+Mayauthor=P.+Chandrakesanauthor=D.+B.+Owenauthor=S.+M.+Surebanauthor=N.+Aliauthor=R.+Janknechtauthor=C.+W.+Houchen&title=Small+molecule+kinase+inhibitor+LRRK2-IN-1+demonstrates+potent+activity+against+colorectal+and+pancreatic+cancer+through+inhibition+of+doublecortin-like+kinase+1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule kinase inhibitor LRRK2-IN-1 demonstrates potent activity against colorectal and pancreatic cancer through inhibition of doublecortin-like kinase 1</span></div><div class="casAuthors">Weygant, Nathaniel; Qu, Dongfeng; Berry, William L.; May, Randal; Chandrakesan, Parthasarathy; Owen, Daniel B.; Sureban, Sripathi M.; Ali, Naushad; Janknecht, Ralf; Houchen, Courtney W.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">103/1-103/14, 14 pp.</span>CODEN:
                <span class="NLM_cas:coden">MCOACG</span>;
        ISSN:<span class="NLM_cas:issn">1476-4598</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Doublecortin-like kinase 1 (DCLK1) is emerging as a tumor specific stem cell marker in colorectal and pancreatic cancer.  Previous in vitro and in vivo studies have demonstrated the therapeutic effects of inhibiting DCLK1 with small interfering RNA (siRNA) as well as genetically targeting the DCLK1+ cell for deletion.  However, the effects of inhibiting DCLK1 kinase activity have not been studied directly.  Therefore, we assessed the effects of inhibiting DCLK1 kinase activity using the novel small mol. kinase inhibitor, LRRK2-IN-1, which demonstrates significant affinity for DCLK1.  Results: Here we report that LRRK2-IN-1 demonstrates potent anti-cancer activity including inhibition of cancer cell proliferation, migration, and invasion as well as induction of apoptosis and cell cycle arrest.  Addnl. we found that it regulates stemness, epithelial-mesenchymal transition, and oncogenic targets on the mol. level.  Moreover, we show that LRRK2-IN-1 suppresses DCLK1 kinase activity and downstream DCLK1 effector c-MYC, and demonstrate that DCLK1 kinase activity is a significant factor in resistance to LRRK2-IN-1.  Conclusions: Given DCLK1's tumor stem cell marker status, a strong understanding of its biol. role and interactions in gastrointestinal tumors may lead to discoveries that improve patient outcomes.  The results of this study suggest that small mol. inhibitors of DCLK1 kinase should be further investigated as they may hold promise as anti-tumor stem cell drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2e_YpWjFtarVg90H21EOLACvtfcHk0lizyod74z3e4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXivFWns7w%253D&md5=922f240a73513dbdad1e5df5eba20b83</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1186%2F1476-4598-13-103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1476-4598-13-103%26sid%3Dliteratum%253Aachs%26aulast%3DWeygant%26aufirst%3DN.%26aulast%3DQu%26aufirst%3DD.%26aulast%3DBerry%26aufirst%3DW.%2BL.%26aulast%3DMay%26aufirst%3DR.%26aulast%3DChandrakesan%26aufirst%3DP.%26aulast%3DOwen%26aufirst%3DD.%2BB.%26aulast%3DSureban%26aufirst%3DS.%2BM.%26aulast%3DAli%26aufirst%3DN.%26aulast%3DJanknecht%26aufirst%3DR.%26aulast%3DHouchen%26aufirst%3DC.%2BW.%26atitle%3DSmall%2520molecule%2520kinase%2520inhibitor%2520LRRK2-IN-1%2520demonstrates%2520potent%2520activity%2520against%2520colorectal%2520and%2520pancreatic%2520cancer%2520through%2520inhibition%2520of%2520doublecortin-like%2520kinase%25201%26jtitle%3DMol.%2520Cancer%26date%3D2014%26volume%3D13%26spage%3D103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Luerman, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samaroo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurtado-Lorenzo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Needle, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noell, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galatsis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunlop, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geoghegan, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirst, W. D.</span><span> </span><span class="NLM_article-title">Phosphoproteomic evaluation of pharmacological inhibition of leucine-rich repeat kinase 2 reveals significant off-target effects of LRRK-2-IN-1</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">128</span><span class="NLM_x">, </span> <span class="NLM_fpage">561</span><span class="NLM_x">–</span> <span class="NLM_lpage">576</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1111%2Fjnc.12483" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=24117733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFWktL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2014&pages=561-576&author=G.+C.+Luermanauthor=C.+Nguyenauthor=H.+Samarooauthor=P.+Loosauthor=H.+Xiauthor=A.+Hurtado-Lorenzoauthor=E.+Needleauthor=G.+S.+Noellauthor=P.+Galatsisauthor=J.+Dunlopauthor=K.+F.+Geogheganauthor=W.+D.+Hirst&title=Phosphoproteomic+evaluation+of+pharmacological+inhibition+of+leucine-rich+repeat+kinase+2+reveals+significant+off-target+effects+of+LRRK-2-IN-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphoproteomic evaluation of pharmacological inhibition of leucine-rich repeat kinase 2 reveals significant off-target effects of LRRK-2-IN-1</span></div><div class="casAuthors">Luerman, Gregory C.; Nguyen, Chuong; Samaroo, Harry; Loos, Paula; Xi, Hualin; Hurtado-Lorenzo, Andres; Needle, Elie; Stephen Noell, G.; Galatsis, Paul; Dunlop, John; Geoghegan, Kieran F.; Hirst, Warren D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">561-576</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Genetic mutations in leucine-rich repeat kinase 2 (LRRK2) have been linked to autosomal dominant Parkinson's disease.  The most prevalent mutation, G2019S, results in enhanced LRRK2 kinase activity that potentially contributes to the etiol. of Parkinson's disease.  Consequently, disease progression is potentially mediated by poorly characterized phosphorylation-dependent LRRK2 substrate pathways.  To address this gap in knowledge, we transduced SH-SY5Y neuroblastoma cells with LRRK2 G2019S via adenovirus, then detd. quant. changes in the phosphoproteome upon LRRK2 kinase inhibition (LRRK2-IN-1 treatment) using stable isotope labeling of amino acids in culture combined with phosphopeptide enrichment and LC-MS/MS anal.  We identified 776 phosphorylation sites that were increased or decreased at least 50% in response to LRRK2-IN-1 treatment, including sites on proteins previously known to assoc. with LRRK2.  Bioinformatic anal. of those phosphoproteins suggested a potential role for LRRK2 kinase activity in regulating pro-inflammatory responses and neurite morphol., among other pathways.  In follow-up expts., LRRK2-IN-1 inhibited lipopolysaccharide-induced tumor necrosis factor alpha (TNFα) and C-X-C motif chemokine 10 (CXCL10) levels in astrocytes and also enhanced multiple neurite characteristics in primary neuronal cultures.  However, LRRK2-IN-1 had almost identical effects in primary glial and neuronal cultures from LRRK2 knockout mice.  These data suggest LRRK2-IN-1 may inhibit pathways of perceived LRRK2 pathophysiol. function independently of LRRK2 highlighting the need to use multiple pharmacol. tools and genetic approaches in studies detg. LRRK2 function.  Genetic mutations in leucine-rich repeat kinase 2 (LRRK2) have been linked to Parkinson's disease, potentially contributing to the pathogenesis through increased kinase activity acting via phosphorylation-dependent LRRK2 substrate pathways.  To det. the potential pathways, we performed SILAC combined with phosphopeptide enrichment and LC-MS/MS anal. +/- LRRK2 inhibitor.  Bioinformatic anal. of those phosphoproteins suggested a potential role for LRRK2 kinase activity in regulating pro-inflammatory responses and neurite morphol., among other pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnRsstKaXLjrVg90H21EOLACvtfcHk0lizyod74z3e4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFWktL8%253D&md5=b2da1a4134ae04f9aa5e00672ef4e058</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1111%2Fjnc.12483&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjnc.12483%26sid%3Dliteratum%253Aachs%26aulast%3DLuerman%26aufirst%3DG.%2BC.%26aulast%3DNguyen%26aufirst%3DC.%26aulast%3DSamaroo%26aufirst%3DH.%26aulast%3DLoos%26aufirst%3DP.%26aulast%3DXi%26aufirst%3DH.%26aulast%3DHurtado-Lorenzo%26aufirst%3DA.%26aulast%3DNeedle%26aufirst%3DE.%26aulast%3DNoell%26aufirst%3DG.%2BS.%26aulast%3DGalatsis%26aufirst%3DP.%26aulast%3DDunlop%26aufirst%3DJ.%26aulast%3DGeoghegan%26aufirst%3DK.%2BF.%26aulast%3DHirst%26aufirst%3DW.%2BD.%26atitle%3DPhosphoproteomic%2520evaluation%2520of%2520pharmacological%2520inhibition%2520of%2520leucine-rich%2520repeat%2520kinase%25202%2520reveals%2520significant%2520off-target%2520effects%2520of%2520LRRK-2-IN-1%26jtitle%3DJ.%2520Neurochem.%26date%3D2014%26volume%3D128%26spage%3D561%26epage%3D576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Characterization of TAE684 as a potent LRRK2 kinase inhibitor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1864</span><span class="NLM_x">–</span> <span class="NLM_lpage">1869</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=1864-1869&author=J.+Zhangauthor=X.+Dengauthor=H.+G.+Choiauthor=D.+R.+Alessiauthor=N.+S.+Gray&title=Characterization+of+TAE684+as+a+potent+LRRK2+kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DChoi%26aufirst%3DH.%2BG.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DCharacterization%2520of%2520TAE684%2520as%2520a%2520potent%2520LRRK2%2520kinase%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D1864%26epage%3D1869" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Galkin, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melnick, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hood, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steensma, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopiuk, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warmuth, M.</span><span> </span><span class="NLM_article-title">Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALK</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">270</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=270-275&author=A.+V.+Galkinauthor=J.+S.+Melnickauthor=S.+Kimauthor=T.+L.+Hoodauthor=N.+Liauthor=L.+Liauthor=G.+Xiaauthor=R.+Steensmaauthor=G.+Chopiukauthor=J.+Jiangauthor=Y.+Wanauthor=P.+Dingauthor=Y.+Liuauthor=F.+Sunauthor=P.+G.+Schultzauthor=N.+S.+Grayauthor=M.+Warmuth&title=Identification+of+NVP-TAE684%2C+a+potent%2C+selective%2C+and+efficacious+inhibitor+of+NPM-ALK"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGalkin%26aufirst%3DA.%2BV.%26aulast%3DMelnick%26aufirst%3DJ.%2BS.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DHood%26aufirst%3DT.%2BL.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DXia%26aufirst%3DG.%26aulast%3DSteensma%26aufirst%3DR.%26aulast%3DChopiuk%26aufirst%3DG.%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DWan%26aufirst%3DY.%26aulast%3DDing%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DF.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DWarmuth%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520NVP-TAE684%252C%2520a%2520potent%252C%2520selective%252C%2520and%2520efficacious%2520inhibitor%2520of%2520NPM-ALK%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2007%26volume%3D104%26spage%3D270%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Davis, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrgard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciceri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wodicka, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallares, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hocker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinkar, P. P.</span><span> </span><span class="NLM_article-title">Comprehensive analysis of kinase inhibitor selectivity</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1046</span><span class="NLM_x">–</span> <span class="NLM_lpage">1051</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1038%2Fnbt.1990" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=22037378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlyisrrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=1046-1051&author=M.+I.+Davisauthor=J.+P.+Huntauthor=S.+Herrgardauthor=P.+Ciceriauthor=L.+M.+Wodickaauthor=G.+Pallaresauthor=M.+Hockerauthor=D.+K.+Treiberauthor=P.+P.+Zarrinkar&title=Comprehensive+analysis+of+kinase+inhibitor+selectivity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Comprehensive analysis of kinase inhibitor selectivity</span></div><div class="casAuthors">Davis, Mindy I.; Hunt, Jeremy P.; Herrgard, Sanna; Ciceri, Pietro; Wodicka, Lisa M.; Pallares, Gabriel; Hocker, Michael; Treiber, Daniel K.; Zarrinkar, Patrick P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1046-1051</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We tested the interaction of 72 kinase inhibitors with 442 kinases covering >80% of the human catalytic protein kinome.  Our data show that, as a class, type II inhibitors are more selective than type I inhibitors, but that there are important exceptions to this trend.  The data further illustrate that selective inhibitors have been developed against the majority of kinases targeted by the compds. tested.  Anal. of the interaction patterns reveals a class of 'group-selective' inhibitors broadly active against a single subfamily of kinases, but selective outside that subfamily.  The data set suggests compds. to use as tools to study kinases for which no dedicated inhibitors exist.  It also provides a foundation for further exploring kinase inhibitor biol. and toxicity, as well as for studying the structural basis of the obsd. interaction patterns.  Our findings will help to realize the direct enabling potential of genomics for drug development and basic research about cellular signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEZnKVs6Xt5rVg90H21EOLACvtfcHk0lgOsben5R-3Uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlyisrrK&md5=67639f702cb48ffb2c60e9a250f0df5e</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1038%2Fnbt.1990&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.1990%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DM.%2BI.%26aulast%3DHunt%26aufirst%3DJ.%2BP.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DPallares%26aufirst%3DG.%26aulast%3DHocker%26aufirst%3DM.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26atitle%3DComprehensive%2520analysis%2520of%2520kinase%2520inhibitor%2520selectivity%26jtitle%3DNat.%2520Biotechnol.%26date%3D2011%26volume%3D29%26spage%3D1046%26epage%3D1051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Galatsis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henderson, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kormos, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurumbail, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noell, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Needle, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steyn, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houle, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirst, W. D.</span><span> </span><span class="NLM_article-title">Kinase domain inhibition of leucine rich repeat kinase 2 (LRRK2) using a [1,2,4]triazolo[4,3-<i>b</i>]pyridazine scaffold</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">4132</span><span class="NLM_x">–</span> <span class="NLM_lpage">4140</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=4132-4140&author=P.+Galatsisauthor=J.+L.+Hendersonauthor=B.+L.+Kormosauthor=S.+Hanauthor=R.+G.+Kurumbailauthor=T.+T.+Wagerauthor=P.+R.+Verhoestauthor=G.+S.+Noellauthor=Y.+Chenauthor=E.+Needleauthor=Z.+Bergerauthor=S.+J.+Steynauthor=C.+Houleauthor=W.+D.+Hirst&title=Kinase+domain+inhibition+of+leucine+rich+repeat+kinase+2+%28LRRK2%29+using+a+%5B1%2C2%2C4%5Dtriazolo%5B4%2C3-b%5Dpyridazine+scaffold"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGalatsis%26aufirst%3DP.%26aulast%3DHenderson%26aufirst%3DJ.%2BL.%26aulast%3DKormos%26aufirst%3DB.%2BL.%26aulast%3DHan%26aufirst%3DS.%26aulast%3DKurumbail%26aufirst%3DR.%2BG.%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DNoell%26aufirst%3DG.%2BS.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DNeedle%26aufirst%3DE.%26aulast%3DBerger%26aufirst%3DZ.%26aulast%3DSteyn%26aufirst%3DS.%2BJ.%26aulast%3DHoule%26aufirst%3DC.%26aulast%3DHirst%26aufirst%3DW.%2BD.%26atitle%3DKinase%2520domain%2520inhibition%2520of%2520leucine%2520rich%2520repeat%2520kinase%25202%2520%2528LRRK2%2529%2520using%2520a%2520%255B1%252C2%252C4%255Dtriazolo%255B4%252C3-b%255Dpyridazine%2520scaffold%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D4132%26epage%3D4140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Franzini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, X. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aubele, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garofalo, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauby, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldbach, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Probst, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santiago, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sham, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truong, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, Z.</span><span> </span><span class="NLM_article-title">Triazolopyridazine LRRK2 kinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1967</span><span class="NLM_x">–</span> <span class="NLM_lpage">1973</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=1967-1973&author=M.+Franziniauthor=X.+M.+Yeauthor=M.+Adlerauthor=D.+L.+Aubeleauthor=A.+W.+Garofaloauthor=S.+Gaubyauthor=E.+Goldbachauthor=G.+D.+Probstauthor=K.+P.+Quinnauthor=P.+Santiagoauthor=H.+L.+Shamauthor=D.+Tamauthor=A.+Truongauthor=Z.+Ren&title=Triazolopyridazine+LRRK2+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFranzini%26aufirst%3DM.%26aulast%3DYe%26aufirst%3DX.%2BM.%26aulast%3DAdler%26aufirst%3DM.%26aulast%3DAubele%26aufirst%3DD.%2BL.%26aulast%3DGarofalo%26aufirst%3DA.%2BW.%26aulast%3DGauby%26aufirst%3DS.%26aulast%3DGoldbach%26aufirst%3DE.%26aulast%3DProbst%26aufirst%3DG.%2BD.%26aulast%3DQuinn%26aufirst%3DK.%2BP.%26aulast%3DSantiago%26aufirst%3DP.%26aulast%3DSham%26aufirst%3DH.%2BL.%26aulast%3DTam%26aufirst%3DD.%26aulast%3DTruong%26aufirst%3DA.%26aulast%3DRen%26aufirst%3DZ.%26atitle%3DTriazolopyridazine%2520LRRK2%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D1967%26epage%3D1973" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Rankovic, Z.</span><span> </span><span class="NLM_article-title">CNS drug design: balancing physicochemical properties for optimal brain exposure</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">2584</span><span class="NLM_x">–</span> <span class="NLM_lpage">2608</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm501535r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVyhsrrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2584-2608&author=Z.+Rankovic&title=CNS+drug+design%3A+balancing+physicochemical+properties+for+optimal+brain+exposure"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">CNS Drug Design: Balancing Physicochemical Properties for Optimal Brain Exposure</span></div><div class="casAuthors">Rankovic, Zoran</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2584-2608</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The human brain is a uniquely complex organ, which has evolved a sophisticated protection system to prevent injury from external insults and toxins.  Designing mols. that can overcome this protection system and achieve optimal concn. at the desired therapeutic target in the brain is a specific and major challenge for medicinal chemists working in CNS drug discovery.  Analogous to the now widely accepted rule of 5 in the design of oral drugs, the physicochem. properties required for optimal brain exposure have been extensively studied in an attempt to similarly define the attributes of successful CNS drugs and drug candidates.  This body of work is systematically reviewed here, with a particular emphasis on the interplay between the most crit. physicochem. and pharmacokinetic parameters of CNS drugs as well as their impact on medicinal chem. strategies toward mols. with optimal brain exposure.  A summary of modern CNS pharmacokinetic concepts and methods is also provided.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8V0N1j49uuLVg90H21EOLACvtfcHk0li7WFfV7DmYuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVyhsrrP&md5=f01e3f2dc4e2eff7b0618124277a5cf8</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1021%2Fjm501535r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501535r%26sid%3Dliteratum%253Aachs%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DCNS%2520drug%2520design%253A%2520balancing%2520physicochemical%2520properties%2520for%2520optimal%2520brain%2520exposure%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2584%26epage%3D2608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span> </span><span class="NLM_article-title">Moving beyond the rules: The development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn100008c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=435-449&author=T.+T.+Wagerauthor=X.+Houauthor=P.+R.+Verhoestauthor=A.+Villalobos&title=Moving+beyond+the+rules%3A+The+development+of+a+central+nervous+system+multiparameter+optimization+%28CNS+MPO%29+approach+to+enable+alignment+of+druglike+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span></div><div class="casAuthors">Wager, Travis T.; Hou, Xinjun; Verhoest, Patrick R.; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">435-449</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The interplay among commonly used physicochem. properties in drug design was examd. and utilized to create a prospective design tool focused on the alignment of key druglike attributes.  Using a set of six physicochem. parameters ((a) lipophilicity, calcd. partition coeff. (ClogP); (b) calcd. distribution coeff. at pH = 7.4 (ClogD); (c) mol. wt. (MW); (d) topol. polar surface area (TPSA); (e) no. of hydrogen bond donors (HBD); (f) most basic center (pKa)), a druglikeness central nervous system multiparameter optimization (CNS MPO) algorithm was built and applied to a set of marketed CNS drugs (N = 119) and Pfizer CNS candidates (N = 108), as well as to a large diversity set of Pfizer proprietary compds. (N = 11 303).  The novel CNS MPO algorithm showed that 74% of marketed CNS drugs displayed a high CNS MPO score (MPO desirability score ≥ 4, using a scale of 0-6), in comparison to 60% of the Pfizer CNS candidates.  This anal. suggests that this algorithm could potentially be used to identify compds. with a higher probability of successfully testing hypotheses in the clinic.  In addn., a relationship between an increasing CNS MPO score and alignment of key in vitro attributes of drug discovery (favorable permeability, P-glycoprotein (P-gp) efflux, metabolic stability, and safety) was seen in the marketed CNS drug set, the Pfizer candidate set, and the Pfizer proprietary diversity set.  The CNS MPO scoring function offers advantages over hard cutoffs or utilization of single parameters to optimize structure-activity relationships (SAR) by expanding medicinal chem. design space through a holistic assessment approach.  Based on six physicochem. properties commonly used by medicinal chemists, the CNS MPO function may be used prospectively at the design stage to accelerate the identification of compds. with increased probability of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB3Mvkgm_X5bVg90H21EOLACvtfcHk0li7WFfV7DmYuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D&md5=e94998f65a420be6ee4dec4a987cb983</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1021%2Fcn100008c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100008c%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DMoving%2520beyond%2520the%2520rules%253A%2520The%2520development%2520of%2520a%2520central%2520nervous%2520system%2520multiparameter%2520optimization%2520%2528CNS%2520MPO%2529%2520approach%2520to%2520enable%2520alignment%2520of%2520druglike%2520properties%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D435%26epage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span> </span><span class="NLM_article-title">Structural modifications that alter the P-glycoprotein efflux properties of a compound</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">4877</span><span class="NLM_x">–</span> <span class="NLM_lpage">4895</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201136z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4877-4895&author=S.+A.+Hitchcock&title=Structural+modifications+that+alter+the+P-glycoprotein+efflux+properties+of+a+compound"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1021%2Fjm201136z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201136z%26sid%3Dliteratum%253Aachs%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26atitle%3DStructural%2520modifications%2520that%2520alter%2520the%2520P-glycoprotein%2520efflux%2520properties%2520of%2520a%2520compound%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4877%26epage%3D4895" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennington, L. D.</span><span> </span><span class="NLM_article-title">Structure–brain exposure relationships</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7559</span><span class="NLM_x">–</span> <span class="NLM_lpage">7583</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060642i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7559-7583&author=S.+A.+Hitchcockauthor=L.+D.+Pennington&title=Structure%E2%80%93brain+exposure+relationships"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1021%2Fjm060642i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060642i%26sid%3Dliteratum%253Aachs%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DPennington%26aufirst%3DL.%2BD.%26atitle%3DStructure%25E2%2580%2593brain%2520exposure%2520relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7559%26epage%3D7583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">Pajouhesh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, G. R.</span><span> </span><span class="NLM_article-title">Medicinal chemical properties of succesful central nervous system drugs</span> <span class="citation_source-journal">NeuroRx</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">541</span><span class="NLM_x">–</span> <span class="NLM_lpage">553</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=541-553&author=H.+Pajouheshauthor=G.+R.+Lenz&title=Medicinal+chemical+properties+of+succesful+central+nervous+system+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPajouhesh%26aufirst%3DH.%26aulast%3DLenz%26aufirst%3DG.%2BR.%26atitle%3DMedicinal%2520chemical%2520properties%2520of%2520succesful%2520central%2520nervous%2520system%2520drugs%26jtitle%3DNeuroRx%26date%3D2005%26volume%3D2%26spage%3D541%26epage%3D553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group">Ghose, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herbertz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudkins, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorsey, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallamo, J. P.</span><span> </span><span class="NLM_article-title">Knowledge-based, central nervous system (CNS) lead selection and lead optimization for CNS drug discovery</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">50</span><span class="NLM_x">–</span> <span class="NLM_lpage">68</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn200100h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=50-68&author=A.+K.+Ghoseauthor=T.+Herbertzauthor=R.+L.+Hudkinsauthor=B.+D.+Dorseyauthor=J.+P.+Mallamo&title=Knowledge-based%2C+central+nervous+system+%28CNS%29+lead+selection+and+lead+optimization+for+CNS+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1021%2Fcn200100h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn200100h%26sid%3Dliteratum%253Aachs%26aulast%3DGhose%26aufirst%3DA.%2BK.%26aulast%3DHerbertz%26aufirst%3DT.%26aulast%3DHudkins%26aufirst%3DR.%2BL.%26aulast%3DDorsey%26aufirst%3DB.%2BD.%26aulast%3DMallamo%26aufirst%3DJ.%2BP.%26atitle%3DKnowledge-based%252C%2520central%2520nervous%2520system%2520%2528CNS%2529%2520lead%2520selection%2520and%2520lead%2520optimization%2520for%2520CNS%2520drug%2520discovery%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2012%26volume%3D18%26spage%3D50%26epage%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hop, C. E. C. A.</span><span> </span><span class="NLM_article-title">Rational use of plasma protein and tissue binding data in drug design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">8238</span><span class="NLM_x">–</span> <span class="NLM_lpage">8248</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm5007935" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1Git77M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8238-8248&author=X.+Liuauthor=M.+Wrightauthor=C.+E.+C.+A.+Hop&title=Rational+use+of+plasma+protein+and+tissue+binding+data+in+drug+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Use of Plasma Protein and Tissue Binding Data in Drug Design</span></div><div class="casAuthors">Liu, Xingrong; Wright, Matthew; Hop, Cornelis E. C. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8238-8248</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  It is a commonly accepted assumption that only unbound drug mols. are available to interact with their targets.  Therefore, one of the objectives in drug design is to optimize the compd. structure to increase in vivo unbound drug concn.  In this review, theor. analyses and exptl. observations are presented to illustrate that low plasma protein binding does not necessarily lead to high in vivo unbound plasma concn.  Similarly, low brain tissue binding does not lead to high in vivo unbound brain tissue concn.  Instead, low intrinsic clearance leads to high in vivo unbound plasma concn., and low efflux transport activity at the blood-brain barrier leads to high unbound brain concn.  Plasma protein and brain tissue binding are very important parameters in understanding pharmacokinetics, pharmacodynamics, and toxicities of drugs, but these parameters should not be targeted for optimization in drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKiYUz9ljIDrVg90H21EOLACvtfcHk0likJW7gakWeJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1Git77M&md5=53ffbdb88ddf500a90a0eee14b0e641f</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1021%2Fjm5007935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5007935%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DWright%26aufirst%3DM.%26aulast%3DHop%26aufirst%3DC.%2BE.%2BC.%2BA.%26atitle%3DRational%2520use%2520of%2520plasma%2520protein%2520and%2520tissue%2520binding%2520data%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D8238%26epage%3D8248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drummond, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estrada, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunzner-Toste, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moffat, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shore, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweeney, Z. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burdick, D. J.</span><span> </span><span class="NLM_article-title">Discovery of selective LRRK2 inhibitors guided by computational analysis and molecular modeling</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">5536</span><span class="NLM_x">–</span> <span class="NLM_lpage">5545</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300452p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC38XntVOlu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=5536-5545&author=H.+Chenauthor=B.+K.+Chanauthor=J.+Drummondauthor=A.+A.+Estradaauthor=J.+Gunzner-Tosteauthor=X.+Liuauthor=Y.+Liuauthor=J.+G.+Moffatauthor=D.+Shoreauthor=Z.+K.+Sweeneyauthor=T.+Tranauthor=S.+Wangauthor=G.+Zhaoauthor=H.+Zhuauthor=D.+J.+Burdick&title=Discovery+of+selective+LRRK2+inhibitors+guided+by+computational+analysis+and+molecular+modeling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Selective LRRK2 Inhibitors Guided by Computational Analysis and Molecular Modeling</span></div><div class="casAuthors">Chen, Huifen; Chan, Bryan K.; Drummond, Jason; Estrada, Anthony A.; Gunzner-Toste, Janet; Liu, Xingrong; Liu, Yichin; Moffat, John; Shore, Daniel; Sweeney, Zachary K.; Tran, Thuy; Wang, Shumei; Zhao, Guiling; Zhu, Haitao; Burdick, Daniel J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5536-5545</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mutations in the genetic sequence of leucine-rich repeat kinase 2 (LRRK2) have been linked to increased LRRK2 activity and risk for the development of Parkinson's disease (PD).  Potent and selective small mols. capable of inhibiting the kinase activity of LRRK2 will be important tools for establishing a link between the kinase activity of LRRK2 and PD.  In the absence of LRRK2 kinase domain crystal structures, a LRRK2 homol. model was developed that provided robust guidance in the hit-to-lead optimization of small mol. LRRK2 inhibitors.  Through a combination of mol. modeling, sequence anal., and matched mol. pair (MMP) activity cliff anal., a potent and selective lead inhibitor was discovered.  The selectivity of this compd. could be understood using the LRRK2 homol. model, and application of this learning to a series of 2,4-diaminopyrimidine inhibitors in a scaffold hopping exercise led to the identification of highly potent and selective LRRK2 inhibitors that were also brain penetrable.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1YrcBmeoRILVg90H21EOLACvtfcHk0ljzUMnoBGFNEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XntVOlu7Y%253D&md5=fe4d3a709a35f94e3c092b73bdb09936</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1021%2Fjm300452p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300452p%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DH.%26aulast%3DChan%26aufirst%3DB.%2BK.%26aulast%3DDrummond%26aufirst%3DJ.%26aulast%3DEstrada%26aufirst%3DA.%2BA.%26aulast%3DGunzner-Toste%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DMoffat%26aufirst%3DJ.%2BG.%26aulast%3DShore%26aufirst%3DD.%26aulast%3DSweeney%26aufirst%3DZ.%2BK.%26aulast%3DTran%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DG.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DBurdick%26aufirst%3DD.%2BJ.%26atitle%3DDiscovery%2520of%2520selective%2520LRRK2%2520inhibitors%2520guided%2520by%2520computational%2520analysis%2520and%2520molecular%2520modeling%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D5536%26epage%3D5545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group">Choi, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatcher, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patricelli, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Brain penetrant LRRK2 inhibitor</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">658</span><span class="NLM_x">–</span> <span class="NLM_lpage">662</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml300123a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=658-662&author=H.+G.+Choiauthor=J.+Zhangauthor=X.+Dengauthor=J.+M.+Hatcherauthor=M.+P.+Patricelliauthor=Z.+Zhaoauthor=D.+R.+Alessiauthor=N.+S.+Gray&title=Brain+penetrant+LRRK2+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1021%2Fml300123a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300123a%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DH.%2BG.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DHatcher%26aufirst%3DJ.%2BM.%26aulast%3DPatricelli%26aufirst%3DM.%2BP.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DBrain%2520penetrant%2520LRRK2%2520inhibitor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D658%26epage%3D662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group">Estrada, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker-Glenn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beresford, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burdick, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiPasquale, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominguez, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dotson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drummond, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flagella, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuji, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gill, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunzner-Toste, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heffron, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleinheinz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Pichon, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyssikatos, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medhurst, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moffat, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukund, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nash, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scearce-Levie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shore, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trivedi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweeney, Z. K.</span><span> </span><span class="NLM_article-title">Discovery of highly potent, selective and brain-penetrable leucine-rich repeat kinase 2 (LRRK2) small molecule inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9416</span><span class="NLM_x">–</span> <span class="NLM_lpage">9433</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301020q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9416-9433&author=A.+A.+Estradaauthor=X.+Liuauthor=C.+Baker-Glennauthor=A.+Beresfordauthor=D.+J.+Burdickauthor=M.+Chambersauthor=B.+K.+Chanauthor=H.+Chenauthor=X.+Dingauthor=A.+G.+DiPasqualeauthor=S.+L.+Dominguezauthor=J.+Dotsonauthor=J.+Drummondauthor=M.+Flagellaauthor=S.+Flynnauthor=R.+Fujiauthor=A.+Gillauthor=J.+Gunzner-Tosteauthor=S.+F.+Harrisauthor=T.+P.+Heffronauthor=T.+Kleinheinzauthor=D.+W.+Leeauthor=C.+E.+Le+Pichonauthor=J.+P.+Lyssikatosauthor=A.+D.+Medhurstauthor=J.+G.+Moffatauthor=S.+Mukundauthor=K.+Nashauthor=K.+Scearce-Levieauthor=Z.+Shengauthor=D.+G.+Shoreauthor=T.+Tranauthor=N.+Trivediauthor=S.+Wangauthor=S.+Zhangauthor=X.+Zhangauthor=G.+Zhaoauthor=H.+Zhuauthor=Z.+K.+Sweeney&title=Discovery+of+highly+potent%2C+selective+and+brain-penetrable+leucine-rich+repeat+kinase+2+%28LRRK2%29+small+molecule+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1021%2Fjm301020q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301020q%26sid%3Dliteratum%253Aachs%26aulast%3DEstrada%26aufirst%3DA.%2BA.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DBaker-Glenn%26aufirst%3DC.%26aulast%3DBeresford%26aufirst%3DA.%26aulast%3DBurdick%26aufirst%3DD.%2BJ.%26aulast%3DChambers%26aufirst%3DM.%26aulast%3DChan%26aufirst%3DB.%2BK.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DDing%26aufirst%3DX.%26aulast%3DDiPasquale%26aufirst%3DA.%2BG.%26aulast%3DDominguez%26aufirst%3DS.%2BL.%26aulast%3DDotson%26aufirst%3DJ.%26aulast%3DDrummond%26aufirst%3DJ.%26aulast%3DFlagella%26aufirst%3DM.%26aulast%3DFlynn%26aufirst%3DS.%26aulast%3DFuji%26aufirst%3DR.%26aulast%3DGill%26aufirst%3DA.%26aulast%3DGunzner-Toste%26aufirst%3DJ.%26aulast%3DHarris%26aufirst%3DS.%2BF.%26aulast%3DHeffron%26aufirst%3DT.%2BP.%26aulast%3DKleinheinz%26aufirst%3DT.%26aulast%3DLee%26aufirst%3DD.%2BW.%26aulast%3DLe%2BPichon%26aufirst%3DC.%2BE.%26aulast%3DLyssikatos%26aufirst%3DJ.%2BP.%26aulast%3DMedhurst%26aufirst%3DA.%2BD.%26aulast%3DMoffat%26aufirst%3DJ.%2BG.%26aulast%3DMukund%26aufirst%3DS.%26aulast%3DNash%26aufirst%3DK.%26aulast%3DScearce-Levie%26aufirst%3DK.%26aulast%3DSheng%26aufirst%3DZ.%26aulast%3DShore%26aufirst%3DD.%2BG.%26aulast%3DTran%26aufirst%3DT.%26aulast%3DTrivedi%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DG.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DSweeney%26aufirst%3DZ.%2BK.%26atitle%3DDiscovery%2520of%2520highly%2520potent%252C%2520selective%2520and%2520brain-penetrable%2520leucine-rich%2520repeat%2520kinase%25202%2520%2528LRRK2%2529%2520small%2520molecule%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9416%26epage%3D9433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group">Leeson, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springthorpe, B.</span><span> </span><span class="NLM_article-title">The influence of drug-like concepts on decision-making in medicinal chemistry</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">890</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1038%2Fnrd2445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=17971784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=881-890&author=P.+D.+Leesonauthor=B.+Springthorpe&title=The+influence+of+drug-like+concepts+on+decision-making+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of drug-like concepts on decision-making in medicinal chemistry</span></div><div class="casAuthors">Leeson, Paul D.; Springthorpe, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">881-890</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite the wide acceptance of drug-like principles such as the 'rule of five', this anal. of mols. currently being synthesized in leading pharmaceutical companies reveals that their phys. properties differ significantly from those of recently discovered oral drugs.  The marked increase in lipophilicity in particular could increase the likelihood of attrition in drug development.  The application of guidelines linked to the concept of drug-likeness, such as the 'rule of five', has gained wide acceptance as an approach to reduce attrition in drug discovery and development.  However, despite this acceptance, anal. of recent trends reveals that the phys. properties of mols. that are currently being synthesized in leading drug discovery companies differ significantly from those of recently discovered oral drugs and compds. in clin. development.  The consequences of the marked increase in lipophilicity - the most important drug-like phys. property - include a greater likelihood of lack of selectivity and attrition in drug development.  Tackling the threat of compd.-related toxicol. attrition needs to move to the mainstream of medicinal chem. decision-making.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTUeonLD6iebVg90H21EOLACvtfcHk0liYZheWnvvGvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL&md5=5665a9e2dc266a1ee096e20625757ef7</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1038%2Fnrd2445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2445%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DSpringthorpe%26aufirst%3DB.%26atitle%3DThe%2520influence%2520of%2520drug-like%2520concepts%2520on%2520decision-making%2520in%2520medicinal%2520chemistry%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D881%26epage%3D890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group">Estrada, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker-Glenn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beresford, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burdick, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominguez, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dotson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drummond, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flagella, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuji, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gill, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halladay, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heffron, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleinheinz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Pichon, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyssikatos, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medhurst, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moffat, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nash, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scearce-Levie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shore, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweeney, Z. K.</span><span> </span><span class="NLM_article-title">Discovery of highly potent, selective, and brain-penetrant aminopyrazole leucine-rich repeat kinase 2 (LRRK2) small molecule inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">921</span><span class="NLM_x">–</span> <span class="NLM_lpage">936</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm401654j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=921-936&author=A.+A.+Estradaauthor=B.+K.+Chanauthor=C.+Baker-Glennauthor=A.+Beresfordauthor=D.+J.+Burdickauthor=M.+Chambersauthor=H.+Chenauthor=S.+L.+Dominguezauthor=J.+Dotsonauthor=J.+Drummondauthor=M.+Flagellaauthor=R.+Fujiauthor=A.+Gillauthor=J.+Halladayauthor=S.+F.+Harrisauthor=T.+P.+Heffronauthor=T.+Kleinheinzauthor=D.+W.+Leeauthor=C.+E.+Le+Pichonauthor=X.+Liuauthor=J.+P.+Lyssikatosauthor=A.+D.+Medhurstauthor=J.+G.+Moffatauthor=K.+Nashauthor=K.+Scearce-Levieauthor=Z.+Shengauthor=D.+G.+Shoreauthor=S.+Wongauthor=S.+Zhangauthor=X.+Zhangauthor=H.+Zhuauthor=Z.+K.+Sweeney&title=Discovery+of+highly+potent%2C+selective%2C+and+brain-penetrant+aminopyrazole+leucine-rich+repeat+kinase+2+%28LRRK2%29+small+molecule+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1021%2Fjm401654j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401654j%26sid%3Dliteratum%253Aachs%26aulast%3DEstrada%26aufirst%3DA.%2BA.%26aulast%3DChan%26aufirst%3DB.%2BK.%26aulast%3DBaker-Glenn%26aufirst%3DC.%26aulast%3DBeresford%26aufirst%3DA.%26aulast%3DBurdick%26aufirst%3DD.%2BJ.%26aulast%3DChambers%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DDominguez%26aufirst%3DS.%2BL.%26aulast%3DDotson%26aufirst%3DJ.%26aulast%3DDrummond%26aufirst%3DJ.%26aulast%3DFlagella%26aufirst%3DM.%26aulast%3DFuji%26aufirst%3DR.%26aulast%3DGill%26aufirst%3DA.%26aulast%3DHalladay%26aufirst%3DJ.%26aulast%3DHarris%26aufirst%3DS.%2BF.%26aulast%3DHeffron%26aufirst%3DT.%2BP.%26aulast%3DKleinheinz%26aufirst%3DT.%26aulast%3DLee%26aufirst%3DD.%2BW.%26aulast%3DLe%2BPichon%26aufirst%3DC.%2BE.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLyssikatos%26aufirst%3DJ.%2BP.%26aulast%3DMedhurst%26aufirst%3DA.%2BD.%26aulast%3DMoffat%26aufirst%3DJ.%2BG.%26aulast%3DNash%26aufirst%3DK.%26aulast%3DScearce-Levie%26aufirst%3DK.%26aulast%3DSheng%26aufirst%3DZ.%26aulast%3DShore%26aufirst%3DD.%2BG.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DSweeney%26aufirst%3DZ.%2BK.%26atitle%3DDiscovery%2520of%2520highly%2520potent%252C%2520selective%252C%2520and%2520brain-penetrant%2520aminopyrazole%2520leucine-rich%2520repeat%2520kinase%25202%2520%2528LRRK2%2529%2520small%2520molecule%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D921%26epage%3D936" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callegari, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cianfronga, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doran, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doran, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbs, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosea, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szewc, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Deusen, J.</span><span> </span><span class="NLM_article-title">Evaluation of cerebrospinal fluid concentration and plasma free concentration as a surrogate measurement for brain free concentration</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1443</span><span class="NLM_x">–</span> <span class="NLM_lpage">1447</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1124%2Fdmd.105.008201" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=16760229" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BD28Xpt1Sksrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2006&pages=1443-1447&author=X.+Liuauthor=B.+J.+Smithauthor=C.+Chenauthor=E.+Callegariauthor=S.+L.+Beckerauthor=X.+Chenauthor=J.+Cianfrongaauthor=A.+C.+Doranauthor=S.+D.+Doranauthor=J.+P.+Gibbsauthor=N.+Hoseaauthor=J.+Liuauthor=F.+R.+Nelsonauthor=M.+A.+Szewcauthor=J.+Van+Deusen&title=Evaluation+of+cerebrospinal+fluid+concentration+and+plasma+free+concentration+as+a+surrogate+measurement+for+brain+free+concentration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of cerebrospinal fluid concentration and plasma free concentration as a surrogate measurement for brain free concentration</span></div><div class="casAuthors">Liu, Xingrong; Smith, Bill J.; Chen, Cuiping; Callegari, Ernesto; Becker, Stacey L.; Chen, Xi; Cianfrogna, Julie; Doran, Angela C.; Doran, Shawn D.; Gibbs, John P.; Hosea, Natilie; Liu, Jianhua; Nelson, Frederick R.; Szewc, Mark A.; Van Deusen, Jeffrey</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1443-1447</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">This study was designed to evaluate the use of cerebrospinal fluid (CSF) drug concn. and plasma unbound concn. (Cu,plasma) to predict brain unbound concn. (Cu,brain).  The concn.-time profiles in CSF, plasma, and brain of seven model compds. were detd. after s.c. administration in rats.  The Cu,brain was estd. from the product of total brain concns. and unbound fractions, which were detd. using brain tissue slice and brain homogenate methods.  For theobromine, theophylline, caffeine, fluoxetine, and propranolol, which represent rapid brain penetration compds. with a simple diffusion mechanism, the ratios of the area under the curve of Cu,brain/CCSF and Cu,brain/Cu,plasma were 0.27 to 1.5 and 0.29 to 2.1, resp., using the brain slice method, and were 0.27 to 2.9 and 0.36 to 3.9, resp., using the brain homogenate method.  A P-glycoprotein substrate, CP-141938 (methoxy-3-[(2-phenyl-piperidinyl-3-amino)-methyl]-phenyl-N-methyl-methane-sulfonamide), had Cu,brain/CCSF and Cu,brain/Cu,plasma ratios of 0.57 and 0.066, using the brain slice method, and 1.1 and 0.13, using the brain homogenate method, resp.  The slow brain-penetrating compd., N[3-(4'-fluorophenyl)-3-(4'-phenylphenoxy)propyl]sarcosine, had Cu,brain/CCSF and Cu,brain/Cu,plasma ratios of 0.94 and 0.12 using the brain slice method and 0.15 and 0.018 using the brain homogenate method, resp.  Therefore, for quick brain penetration with simple diffusion mechanism compds., CCSF and Cu,plasma represent Cu,brain equally well; for efflux substrates or slow brain penetration compds., CCSF appears to be equiv. to or more accurate than Cu,plasma to represent Cu,brain.  Thus, we hypothesize that CCSF is equiv. to or better than Cu,plasma to predict Cu,brain.  This hypothesis is supported by the literature data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpw43dRkq9lx7Vg90H21EOLACvtfcHk0lgtQBv_od-_sA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xpt1Sksrc%253D&md5=cef079e1a667dbddf9d5a2f7d01889e8</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1124%2Fdmd.105.008201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.105.008201%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DSmith%26aufirst%3DB.%2BJ.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DCallegari%26aufirst%3DE.%26aulast%3DBecker%26aufirst%3DS.%2BL.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DCianfronga%26aufirst%3DJ.%26aulast%3DDoran%26aufirst%3DA.%2BC.%26aulast%3DDoran%26aufirst%3DS.%2BD.%26aulast%3DGibbs%26aufirst%3DJ.%2BP.%26aulast%3DHosea%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DNelson%26aufirst%3DF.%2BR.%26aulast%3DSzewc%26aufirst%3DM.%2BA.%26aulast%3DVan%2BDeusen%26aufirst%3DJ.%26atitle%3DEvaluation%2520of%2520cerebrospinal%2520fluid%2520concentration%2520and%2520plasma%2520free%2520concentration%2520as%2520a%2520surrogate%2520measurement%2520for%2520brain%2520free%2520concentration%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2006%26volume%3D34%26spage%3D1443%26epage%3D1447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group">Lin, J. H.</span><span> </span><span class="NLM_article-title">CSF as a surrogate for assessing CNS exposure: An industrial perspective</span> <span class="citation_source-journal">Curr. Drug Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">46</span><span class="NLM_x">–</span> <span class="NLM_lpage">59</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.2174%2F138920008783331077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=18220571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFSitbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=46-59&author=J.+H.+Lin&title=CSF+as+a+surrogate+for+assessing+CNS+exposure%3A+An+industrial+perspective"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">CSF as a surrogate for assessing CNS exposure: an industrial perspective</span></div><div class="casAuthors">Lin, Jiunn H.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">46-59</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  For drugs that directly act on targets in the central nervous system (CNS), sufficient drug delivery into the brain is a prerequisite for drug action.  Systemically administered drugs can reach CNS by passage across the endothelium of capillary vasculatures, the so-called blood-brain barrier (BBB).  Literature data suggest that most marketed CNS drugs have good membrane permeability and relatively high plasma unbound fraction, but are not good P-glycoprotein (P-gp) substrates.  Therefore, it is important to use the in vitro parameters of P-gp function activity, membrane permeability and plasma unbound fraction as key criteria for lead optimization during the early stage of drug discovery.  Evidence from preclin. and clin. studies suggests that drug concn. in cerebrospinal fluid (CSF) appears to be reasonably accurate in predicting unbound drug concn. in the brain.  Therefore, CSF can be used as a useful surrogate for in vivo assessment of CNS exposure and provides an important basis for the selection of drug candidates for entry into development.  However, it is important to point out that CSF drug concn. is not always an accurate surrogate for predicting unbound drug concn. in the brain.  Depending on the physicochem. properties of drugs and the site/timing of CSF sampling, the unbound drug concn. at the biophase within the brain could differ significantly from the corresponding CSF drug concn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrft1JtBu-LmrVg90H21EOLACvtfcHk0lhpVSMdCM_qvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFSitbo%253D&md5=cfea50f80a3bcf592477e8ecb8825084</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.2174%2F138920008783331077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920008783331077%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DJ.%2BH.%26atitle%3DCSF%2520as%2520a%2520surrogate%2520for%2520assessing%2520CNS%2520exposure%253A%2520An%2520industrial%2520perspective%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2008%26volume%3D9%26spage%3D46%26epage%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group">Reith, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamborough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jandu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreotti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mensah, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dossang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">GSK2578215A; a potent and highly selective 2-arylmethyloxy-5-substituent-N-arylbenzamide LRRK2 kinase inhibitor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">5625</span><span class="NLM_x">–</span> <span class="NLM_lpage">5629</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=5625-5629&author=A.+D.+Reithauthor=P.+Bamboroughauthor=K.+Janduauthor=D.+Andreottiauthor=L.+Mensahauthor=P.+Dossangauthor=H.+G.+Choiauthor=X.+Dengauthor=J.+Zhangauthor=D.+R.+Alessiauthor=N.+S.+Gray&title=GSK2578215A%3B+a+potent+and+highly+selective+2-arylmethyloxy-5-substituent-N-arylbenzamide+LRRK2+kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReith%26aufirst%3DA.%2BD.%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DJandu%26aufirst%3DK.%26aulast%3DAndreotti%26aufirst%3DD.%26aulast%3DMensah%26aufirst%3DL.%26aulast%3DDossang%26aufirst%3DP.%26aulast%3DChoi%26aufirst%3DH.%2BG.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DGSK2578215A%253B%2520a%2520potent%2520and%2520highly%2520selective%25202-arylmethyloxy-5-substituent-N-arylbenzamide%2520LRRK2%2520kinase%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D5625%26epage%3D5629" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group">Cirnaru, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marte, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belluzzi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russo, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabrielli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Longo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arcuri, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murru, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bubacco, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matteoli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedele, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sala, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Passafaro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morari, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greggio, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onofri, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piccoli, G.</span><span> </span><span class="NLM_article-title">LRRK2 kinase activity regulates synaptic vesicle trafficking and neurotransmitter release through modulation of LRRK2 macro-molecular complex</span> <span class="citation_source-journal">Front. Mol. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">49</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.3389%2Ffnmol.2014.00049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=24904275" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVaqsLzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2014&pages=49&author=M.+D.+Cirnaruauthor=A.+Marteauthor=E.+Belluzziauthor=I.+Russoauthor=M.+Gabrielliauthor=F.+Longoauthor=L.+Arcuriauthor=L.+Murruauthor=L.+Bubaccoauthor=M.+Matteoliauthor=E.+Fedeleauthor=C.+Salaauthor=M.+Passafaroauthor=M.+Morariauthor=E.+Greggioauthor=F.+Onofriauthor=G.+Piccoli&title=LRRK2+kinase+activity+regulates+synaptic+vesicle+trafficking+and+neurotransmitter+release+through+modulation+of+LRRK2+macro-molecular+complex"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">LRRK2 kinase activity regulates synaptic vesicle trafficking and neurotransmitter release through modulation of LRRK2 macro-molecular complex</span></div><div class="casAuthors">Cirnaru, Maria D.; Marte, Antonella; Belluzzi, Elisa; Russo, Isabella; Gabrielli, Martina; Longo, Francesco; Arcuri, Ludovico; Murru, Luca; Bubacco, Luigi; Matteoli, Michela; Fedele, Ernesto; Sala, Carlo; Passafaro, Maria; Morari, Michele; Greggio, Elisa; Onofri, Franco; Piccoli, Giovanni</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Molecular Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">49/1-49/12, 12 pp.</span>CODEN:
                <span class="NLM_cas:coden">FMNRAJ</span>;
        ISSN:<span class="NLM_cas:issn">1662-5099</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Mutations in Leucine-rich repeat kinase 2 gene (LRRK2) are assocd. with familial and sporadic Parkinson's disease (PD).  LRRK2 is a complex protein that consists of multiple domains executing several functions, including GTP hydrolysis, kinase activity, and protein binding.  Robust evidence suggests that LRRK2 acts at the synaptic site as a mol. hub connecting synaptic vesicles to cytoskeletal elements via a complex panel of protein-protein interactions.  Here we investigated the impact of pharmacol. inhibition of LRRK2 kinase activity on synaptic function.  Acute treatment with LRRK2 inhibitors reduced the frequency of spontaneous currents, the rate of synaptic vesicle trafficking and the release of neurotransmitter from isolated synaptosomes.  The investigation of complementary models lacking LRRK2 expression allowed us to exclude potential off-side effects of kinase inhibitors on synaptic functions.  Next we studied whether kinase inhibition affects LRRK2 heterologous interactions.  We found that the binding among LRRK2, presynaptic proteins and synaptic vesicles is affected by kinase inhibition.  Our results suggest that LRRK2 kinase activity influences synaptic vesicle release via modulation of LRRK2 macro-mol. complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiZWGhHzhQ5rVg90H21EOLACvtfcHk0ljbkbHLeKY-iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVaqsLzK&md5=06ff91fbc02b7a90a3c01ac241801643</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.3389%2Ffnmol.2014.00049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnmol.2014.00049%26sid%3Dliteratum%253Aachs%26aulast%3DCirnaru%26aufirst%3DM.%2BD.%26aulast%3DMarte%26aufirst%3DA.%26aulast%3DBelluzzi%26aufirst%3DE.%26aulast%3DRusso%26aufirst%3DI.%26aulast%3DGabrielli%26aufirst%3DM.%26aulast%3DLongo%26aufirst%3DF.%26aulast%3DArcuri%26aufirst%3DL.%26aulast%3DMurru%26aufirst%3DL.%26aulast%3DBubacco%26aufirst%3DL.%26aulast%3DMatteoli%26aufirst%3DM.%26aulast%3DFedele%26aufirst%3DE.%26aulast%3DSala%26aufirst%3DC.%26aulast%3DPassafaro%26aufirst%3DM.%26aulast%3DMorari%26aufirst%3DM.%26aulast%3DGreggio%26aufirst%3DE.%26aulast%3DOnofri%26aufirst%3DF.%26aulast%3DPiccoli%26aufirst%3DG.%26atitle%3DLRRK2%2520kinase%2520activity%2520regulates%2520synaptic%2520vesicle%2520trafficking%2520and%2520neurotransmitter%2520release%2520through%2520modulation%2520of%2520LRRK2%2520macro-molecular%2520complex%26jtitle%3DFront.%2520Mol.%2520Neurosci.%26date%3D2014%26volume%3D7%26spage%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group">Nichols, P. L.; Eatherton, A. J.; Bamborough, P.; Jandu, K. S.; Philps, O. J.; Andreotti, D.</span><span> </span><span class="NLM_article-title">Novel compounds</span>. WO 2011/038572 A1,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=P.+L.+Nichols&author=A.+J.+Eatherton&author=P.+Bamborough&author=K.+S.+Jandu&author=O.+J.+Philps&author=D.+Andreotti&title=Novel+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DNichols%26aufirst%3DP.%2BL.%26atitle%3DNovel%2520compounds%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group">Afsari, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hentzer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nippe, O. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, C. J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wade, A. R.</span><span> </span><span class="NLM_article-title">Abnormal visual gain control in a Parkinson’s disease model</span> <span class="citation_source-journal">Hum. Mol. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4465</span><span class="NLM_x">–</span> <span class="NLM_lpage">4478</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1093%2Fhmg%2Fddu159" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=24718285" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1OrsbzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2014&pages=4465-4478&author=F.+Afsariauthor=K.+V.+Christensenauthor=G.+P.+Smithauthor=M.+Hentzerauthor=O.+M.+Nippeauthor=C.+J.+H.+Elliottauthor=A.+R.+Wade&title=Abnormal+visual+gain+control+in+a+Parkinson%E2%80%99s+disease+model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Abnormal visual gain control in a Parkinson's disease model</span></div><div class="casAuthors">Afsari, Farinaz; Christensen, Kenneth V.; Smith, Garrick Paul; Hentzer, Morten; Nippe, Olivia M.; Elliott, Christopher J. H.; Wade, Alex R.</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4465-4478</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Our understanding of Parkinson's disease (PD) has been revolutionized by the discovery of disease-causing genetic mutations.  The most common of these is the G2019S mutation in the LRRK2 kinase gene, which leads to increased kinase activity.  However, the link between increased kinase activity and PD is unclear.  Previously, we showed that dopaminergic expression of the human LRRK2-G2019S transgene in flies led to an activity-dependent loss of vision in older animals and we hypothesized that this may have been preceded by a failure to regulate neuronal activity correctly in younger animals.  To test this hypothesis, we used a sensitive measure of visual function based on frequency-tagged steady-state visually evoked potentials.  Spectral anal. allowed us to identify signals from multiple levels of the fly visual system and wild-type visual response curves were qual. similar to those from human cortex.  Dopaminergic expression of hLRRK2-G2019S increased contrast sensitivity throughout the retinal network.  To test whether this was due to increased kinase activity, we fed Drosophila with kinase inhibitors targeted at LRRK2.  Contrast sensitivity in both day 1 and day 14 flies was normalized by a novel LRRK2 kinase inhibitor 'BMPPB-32'.  Biochem. and cellular assays suggested that BMPPB-32 would be a more specific kinase inhibitor than LRRK2-IN-1.  We confirmed this in vivo, finding that dLRRK- null flies show large off-target effects with LRRK2-IN-1 but not BMPPB-32.  Our data link the increased Kinase activity of the G2019S-LRRK2 mutation to neuronal dysfunction and demonstrate the power of the Drosophila visual system in assaying the neurol. effects of genetic diseases and therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpa_glJRmFOqrVg90H21EOLACvtfcHk0ljbkbHLeKY-iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1OrsbzF&md5=8804121c354a2d548151649497b52bdb</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddu159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddu159%26sid%3Dliteratum%253Aachs%26aulast%3DAfsari%26aufirst%3DF.%26aulast%3DChristensen%26aufirst%3DK.%2BV.%26aulast%3DSmith%26aufirst%3DG.%2BP.%26aulast%3DHentzer%26aufirst%3DM.%26aulast%3DNippe%26aufirst%3DO.%2BM.%26aulast%3DElliott%26aufirst%3DC.%2BJ.%2BH.%26aulast%3DWade%26aufirst%3DA.%2BR.%26atitle%3DAbnormal%2520visual%2520gain%2520control%2520in%2520a%2520Parkinson%25E2%2580%2599s%2520disease%2520model%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2014%26volume%3D23%26spage%3D4465%26epage%3D4478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group">Garofalo, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aubele, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brigham, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chian, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franzini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldbach, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwong, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Motter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Probst, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruslim, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sham, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truong, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, X. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, Z.</span><span> </span><span class="NLM_article-title">Discovery of 4-alkylamino-7-aryl-3-cyanoquinoline LRRK2 kinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1974</span><span class="NLM_x">–</span> <span class="NLM_lpage">1977</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=1974-1977&author=A.+W.+Garofaloauthor=M.+Adlerauthor=D.+L.+Aubeleauthor=E.+F.+Brighamauthor=D.+Chianauthor=M.+Franziniauthor=E.+Goldbachauthor=G.+T.+Kwongauthor=R.+Motterauthor=G.+D.+Probstauthor=K.+P.+Quinnauthor=L.+Ruslimauthor=H.+L.+Shamauthor=D.+Tamauthor=P.+Tanakaauthor=A.+P.+Truongauthor=X.+M.+Yeauthor=Z.+Ren&title=Discovery+of+4-alkylamino-7-aryl-3-cyanoquinoline+LRRK2+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGarofalo%26aufirst%3DA.%2BW.%26aulast%3DAdler%26aufirst%3DM.%26aulast%3DAubele%26aufirst%3DD.%2BL.%26aulast%3DBrigham%26aufirst%3DE.%2BF.%26aulast%3DChian%26aufirst%3DD.%26aulast%3DFranzini%26aufirst%3DM.%26aulast%3DGoldbach%26aufirst%3DE.%26aulast%3DKwong%26aufirst%3DG.%2BT.%26aulast%3DMotter%26aufirst%3DR.%26aulast%3DProbst%26aufirst%3DG.%2BD.%26aulast%3DQuinn%26aufirst%3DK.%2BP.%26aulast%3DRuslim%26aufirst%3DL.%26aulast%3DSham%26aufirst%3DH.%2BL.%26aulast%3DTam%26aufirst%3DD.%26aulast%3DTanaka%26aufirst%3DP.%26aulast%3DTruong%26aufirst%3DA.%2BP.%26aulast%3DYe%26aufirst%3DX.%2BM.%26aulast%3DRen%26aufirst%3DZ.%26atitle%3DDiscovery%2520of%25204-alkylamino-7-aryl-3-cyanoquinoline%2520LRRK2%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D1974%26epage%3D1977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group">Troxler, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenidge, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmermann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desrayaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Druckes, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schweizer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rovelli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimshek, D. R.</span><span> </span><span class="NLM_article-title">Discovery of novel indolinone-based, potent, selective and brain penetrant inhibitors of LRRK2</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4085</span><span class="NLM_x">–</span> <span class="NLM_lpage">4090</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4085-4090&author=T.+Troxlerauthor=P.+Greenidgeauthor=K.+Zimmermannauthor=S.+Desrayaudauthor=P.+Druckesauthor=T.+Schweizerauthor=D.+Staufferauthor=G.+Rovelliauthor=D.+R.+Shimshek&title=Discovery+of+novel+indolinone-based%2C+potent%2C+selective+and+brain+penetrant+inhibitors+of+LRRK2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTroxler%26aufirst%3DT.%26aulast%3DGreenidge%26aufirst%3DP.%26aulast%3DZimmermann%26aufirst%3DK.%26aulast%3DDesrayaud%26aufirst%3DS.%26aulast%3DDruckes%26aufirst%3DP.%26aulast%3DSchweizer%26aufirst%3DT.%26aulast%3DStauffer%26aufirst%3DD.%26aulast%3DRovelli%26aufirst%3DG.%26aulast%3DShimshek%26aufirst%3DD.%2BR.%26atitle%3DDiscovery%2520of%2520novel%2520indolinone-based%252C%2520potent%252C%2520selective%2520and%2520brain%2520penetrant%2520inhibitors%2520of%2520LRRK2%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D4085%26epage%3D4090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group">Nichols, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dzamko, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutti, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantley, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moran, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamborough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span> </span><span class="NLM_article-title">Substrate specificity and inhibitors of LRRK2, a protein kinase mutated in Parkinson’s disease</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">424</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">60</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=424&publication_year=2009&pages=47-60&author=R.+J.+Nicholsauthor=N.+Dzamkoauthor=J.+E.+Huttiauthor=L.+C.+Cantleyauthor=M.+Deakauthor=J.+Moranauthor=P.+Bamboroughauthor=A.+D.+Reithauthor=D.+R.+Alessi&title=Substrate+specificity+and+inhibitors+of+LRRK2%2C+a+protein+kinase+mutated+in+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNichols%26aufirst%3DR.%2BJ.%26aulast%3DDzamko%26aufirst%3DN.%26aulast%3DHutti%26aufirst%3DJ.%2BE.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26aulast%3DDeak%26aufirst%3DM.%26aulast%3DMoran%26aufirst%3DJ.%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DReith%26aufirst%3DA.%2BD.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26atitle%3DSubstrate%2520specificity%2520and%2520inhibitors%2520of%2520LRRK2%252C%2520a%2520protein%2520kinase%2520mutated%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DBiochem.%2520J.%26date%3D2009%26volume%3D424%26spage%3D47%26epage%3D60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group">Dzamko, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hentati, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prescott, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, R. J.</span><span> </span><span class="NLM_article-title">Inhibition of LRRK2 kinase activity leads to dephosphorylation of Ser(910)/Ser(935), disruption of 14-3-3 binding and altered cytoplasmic localization</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">430</span><span class="NLM_x">, </span> <span class="NLM_fpage">405</span><span class="NLM_x">–</span> <span class="NLM_lpage">413</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=430&publication_year=2010&pages=405-413&author=N.+Dzamkoauthor=M.+Deakauthor=F.+Hentatiauthor=A.+D.+Reithauthor=A.+R.+Prescottauthor=D.+R.+Alessiauthor=R.+J.+Nichols&title=Inhibition+of+LRRK2+kinase+activity+leads+to+dephosphorylation+of+Ser%28910%29%2FSer%28935%29%2C+disruption+of+14-3-3+binding+and+altered+cytoplasmic+localization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDzamko%26aufirst%3DN.%26aulast%3DDeak%26aufirst%3DM.%26aulast%3DHentati%26aufirst%3DF.%26aulast%3DReith%26aufirst%3DA.%2BD.%26aulast%3DPrescott%26aufirst%3DA.%2BR.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DNichols%26aufirst%3DR.%2BJ.%26atitle%3DInhibition%2520of%2520LRRK2%2520kinase%2520activity%2520leads%2520to%2520dephosphorylation%2520of%2520Ser%2528910%2529%252FSer%2528935%2529%252C%2520disruption%2520of%252014-3-3%2520binding%2520and%2520altered%2520cytoplasmic%2520localization%26jtitle%3DBiochem.%2520J.%26date%3D2010%26volume%3D430%26spage%3D405%26epage%3D413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group">Chan, B. K.; Chen, H.; Estrada, A.; Shore, D.; Sweeney, Z.; McIver, E. G.</span><span> </span><span class="NLM_article-title">Compounds and their administration for treating a neurodegerative disease as well as a method for identifying a compound capable of inhibiting a kinase, such as LRRK2</span>. US 8569281 B2,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=B.+K.+Chan&author=H.+Chen&author=A.+Estrada&author=D.+Shore&author=Z.+Sweeney&author=E.+G.+McIver&title=Compounds+and+their+administration+for+treating+a+neurodegerative+disease+as+well+as+a+method+for+identifying+a+compound+capable+of+inhibiting+a+kinase%2C+such+as+LRRK2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DB.%2BK.%26atitle%3DCompounds%2520and%2520their%2520administration%2520for%2520treating%2520a%2520neurodegerative%2520disease%2520as%2520well%2520as%2520a%2520method%2520for%2520identifying%2520a%2520compound%2520capable%2520of%2520inhibiting%2520a%2520kinase%252C%2520such%2520as%2520LRRK2%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group">Chan, B.; Estrada, A.; Shore, D.; Sweeney, Z.</span><span> </span><span class="NLM_article-title">Pyrazolopyridines for treatment of Parkinson’s disease</span>. WO 2013/139882 A1,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=B.+Chan&author=A.+Estrada&author=D.+Shore&author=Z.+Sweeney&title=Pyrazolopyridines+for+treatment+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DB.%26atitle%3DPyrazolopyridines%2520for%2520treatment%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group">Vankayalapati, H.; Appalaneni, R. P.; Reddy, Y. V. K.</span><span> </span><span class="NLM_article-title">Substituted 5-(pyrazin-2-yl)-1H-pyrazolo[3,4-<i>B</i>]pyridine and pyrazolo[3,4-<i>B</i>]pyridine derivatives as protein kinase inhibitors</span>. WO 2012/135631 A1,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=H.+Vankayalapati&author=R.+P.+Appalaneni&author=Y.+V.+K.+Reddy&title=Substituted+5-%28pyrazin-2-yl%29-1H-pyrazolo%5B3%2C4-B%5Dpyridine+and+pyrazolo%5B3%2C4-B%5Dpyridine+derivatives+as+protein+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DVankayalapati%26aufirst%3DH.%26atitle%3DSubstituted%25205-%2528pyrazin-2-yl%2529-1H-pyrazolo%255B3%252C4-B%255Dpyridine%2520and%2520pyrazolo%255B3%252C4-B%255Dpyridine%2520derivatives%2520as%2520protein%2520kinase%2520inhibitors%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group">Almstetter, M.; Thormann, M.; Treml, A.; Koestler, R.; Yehia, N.</span><span> </span><span class="NLM_article-title">Heterocyclic compounds as kinase inhibitors</span>. WO 2012/143143 A1,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=M.+Almstetter&author=M.+Thormann&author=A.+Treml&author=R.+Koestler&author=N.+Yehia&title=Heterocyclic+compounds+as+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAlmstetter%26aufirst%3DM.%26atitle%3DHeterocyclic%2520compounds%2520as%2520kinase%2520inhibitors%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group">Almstetter, M.; Thormann, M.; Treml, A.; Traube, N.</span><span> </span><span class="NLM_article-title">Pyrazolo[4,3-D]pyrimidines useful as kinase inhibitors</span>. WO 2012/143144 A1,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=M.+Almstetter&author=M.+Thormann&author=A.+Treml&author=N.+Traube&title=Pyrazolo%5B4%2C3-D%5Dpyrimidines+useful+as+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAlmstetter%26aufirst%3DM.%26atitle%3DPyrazolo%255B4%252C3-D%255Dpyrimidines%2520useful%2520as%2520kinase%2520inhibitors%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group">Chan, B.; Estrada, A.; Sweeney, Z.; McIver, E. G.</span><span> </span><span class="NLM_article-title">Pyrazolopyridines as inhibitors of the kinase LRRK2</span>. WO 2011/141756 A1,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=B.+Chan&author=A.+Estrada&author=Z.+Sweeney&author=E.+G.+McIver&title=Pyrazolopyridines+as+inhibitors+of+the+kinase+LRRK2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DB.%26atitle%3DPyrazolopyridines%2520as%2520inhibitors%2520of%2520the%2520kinase%2520LRRK2%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group">McIver, E. G.; Smiljanic, E.; Harding, D. J.; Hough, J.</span><span> </span><span class="NLM_article-title">Compounds</span>. WO 2010/106333 A1,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=E.+G.+McIver&author=E.+Smiljanic&author=D.+J.+Harding&author=J.+Hough&title=Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMcIver%26aufirst%3DE.%2BG.%26atitle%3DCompounds%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group">Henderson, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kormos, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayward, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coffman, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jasti, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurumbail, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noell, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Needle, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steyn, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houle, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirst, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galatsis, P.</span><span> </span><span class="NLM_article-title">Discovery and preclinical profiling of 3-[4-(morpholin-4-yl)-7H-pyrrolo[2,3-<i>d</i>]pyrimidin-5-yl]benzonitrile (PF-06447475), a highly potent, selective, brain penetrant, and in vivo active LRRK2 kinase inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">419</span><span class="NLM_x">–</span> <span class="NLM_lpage">432</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm5014055" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=419-432&author=J.+L.+Hendersonauthor=B.+L.+Kormosauthor=M.+M.+Haywardauthor=K.+J.+Coffmanauthor=J.+Jastiauthor=R.+G.+Kurumbailauthor=T.+T.+Wagerauthor=P.+R.+Verhoestauthor=G.+S.+Noellauthor=Y.+Chenauthor=E.+Needleauthor=Z.+Bergerauthor=S.+J.+Steynauthor=C.+Houleauthor=W.+D.+Hirstauthor=P.+Galatsis&title=Discovery+and+preclinical+profiling+of+3-%5B4-%28morpholin-4-yl%29-7H-pyrrolo%5B2%2C3-d%5Dpyrimidin-5-yl%5Dbenzonitrile+%28PF-06447475%29%2C+a+highly+potent%2C+selective%2C+brain+penetrant%2C+and+in+vivo+active+LRRK2+kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1021%2Fjm5014055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5014055%26sid%3Dliteratum%253Aachs%26aulast%3DHenderson%26aufirst%3DJ.%2BL.%26aulast%3DKormos%26aufirst%3DB.%2BL.%26aulast%3DHayward%26aufirst%3DM.%2BM.%26aulast%3DCoffman%26aufirst%3DK.%2BJ.%26aulast%3DJasti%26aufirst%3DJ.%26aulast%3DKurumbail%26aufirst%3DR.%2BG.%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DNoell%26aufirst%3DG.%2BS.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DNeedle%26aufirst%3DE.%26aulast%3DBerger%26aufirst%3DZ.%26aulast%3DSteyn%26aufirst%3DS.%2BJ.%26aulast%3DHoule%26aufirst%3DC.%26aulast%3DHirst%26aufirst%3DW.%2BD.%26aulast%3DGalatsis%26aufirst%3DP.%26atitle%3DDiscovery%2520and%2520preclinical%2520profiling%2520of%25203-%255B4-%2528morpholin-4-yl%2529-7H-pyrrolo%255B2%252C3-d%255Dpyrimidin-5-yl%255Dbenzonitrile%2520%2528PF-06447475%2529%252C%2520a%2520highly%2520potent%252C%2520selective%252C%2520brain%2520penetrant%252C%2520and%2520in%2520vivo%2520active%2520LRRK2%2520kinase%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D419%26epage%3D432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group">Galatsis, P.; Hayward, M. M.; Kormos, B. L.; Wager, T. T.; Zhang, L.; Stepan, A. F.; Henderson, J. L.; Kurumbail, R. G.; Verhoest, P. R.</span><span> </span><span class="NLM_article-title">Novel 4-(substituted-amino)-7H-pyrrolo[2,3-d]pyrimidines as LRRK2 inhibitors</span>. WO 2014/001973 A1,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=P.+Galatsis&author=M.+M.+Hayward&author=B.+L.+Kormos&author=T.+T.+Wager&author=L.+Zhang&author=A.+F.+Stepan&author=J.+L.+Henderson&author=R.+G.+Kurumbail&author=P.+R.+Verhoest&title=Novel+4-%28substituted-amino%29-7H-pyrrolo%5B2%2C3-d%5Dpyrimidines+as+LRRK2+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGalatsis%26aufirst%3DP.%26atitle%3DNovel%25204-%2528substituted-amino%2529-7H-pyrrolo%255B2%252C3-d%255Dpyrimidines%2520as%2520LRRK2%2520inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group">Patricelli, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomanbhoy, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagannathan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aban, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okerberg, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herring, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nordin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weissig, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.-D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozarich, J. W.</span><span> </span><span class="NLM_article-title">In situ kinase profiling reveals functionally relevant properties of native kinases</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">699</span><span class="NLM_x">–</span> <span class="NLM_lpage">710</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1016%2Fj.chembiol.2011.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=21700206" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotVejtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=699-710&author=M.+P.+Patricelliauthor=T.+K.+Nomanbhoyauthor=J.+Wuauthor=H.+Brownauthor=D.+Zhouauthor=J.+Zhangauthor=S.+Jagannathanauthor=A.+Abanauthor=E.+Okerbergauthor=C.+Herringauthor=B.+Nordinauthor=H.+Weissigauthor=Q.+Yangauthor=J.-D.+Leeauthor=N.+S.+Grayauthor=J.+W.+Kozarich&title=In+situ+kinase+profiling+reveals+functionally+relevant+properties+of+native+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">In Situ Kinase Profiling Reveals Functionally Relevant Properties of Native Kinases</span></div><div class="casAuthors">Patricelli, Matthew P.; Nomanbhoy, Tyzoon K.; Wu, Jiangyue; Brown, Heidi; Zhou, David; Zhang, Jianming; Jagannathan, Subadhra; Aban, Arwin; Okerberg, Eric; Herring, Chris; Nordin, Brian; Weissig, Helge; Yang, Qingkai; Lee, Jiing-Dwan; Gray, Nathanael S.; Kozarich, John W.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">699-710</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Protein kinases are intensely studied mediators of cellular signaling, yet important questions remain regarding their regulation and in vivo properties.  Here, we use a probe-based chemoprotemics platform to profile several well studied kinase inhibitors against >200 kinases in native cell proteomes and reveal biol. targets for some of these inhibitors.  Several striking differences were identified between native and recombinant kinase inhibitory profiles, in particular, for the Raf kinases.  The native kinase binding profiles presented here closely mirror the cellular activity of these inhibitors, even when the inhibition profiles differ dramatically from recombinant assay results.  Addnl., Raf activation events could be detected on live cell treatment with inhibitors.  These studies highlight the complexities of protein kinase behavior in the cellular context and demonstrate that profiling with only recombinant/purified enzymes can be misleading.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopb21npuaC_rVg90H21EOLACvtfcHk0lh89gaeNuu6ZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotVejtbo%253D&md5=dda091b895850c95131f80c3aba9e8c7</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2011.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2011.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DPatricelli%26aufirst%3DM.%2BP.%26aulast%3DNomanbhoy%26aufirst%3DT.%2BK.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DBrown%26aufirst%3DH.%26aulast%3DZhou%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DJagannathan%26aufirst%3DS.%26aulast%3DAban%26aufirst%3DA.%26aulast%3DOkerberg%26aufirst%3DE.%26aulast%3DHerring%26aufirst%3DC.%26aulast%3DNordin%26aufirst%3DB.%26aulast%3DWeissig%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DQ.%26aulast%3DLee%26aufirst%3DJ.-D.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DKozarich%26aufirst%3DJ.%2BW.%26atitle%3DIn%2520situ%2520kinase%2520profiling%2520reveals%2520functionally%2520relevant%2520properties%2520of%2520native%2520kinases%26jtitle%3DChem.%2520Biol.%26date%3D2011%26volume%3D18%26spage%3D699%26epage%3D710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group">Deng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greggio, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sluch, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beilina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cookson, M. R.</span><span> </span><span class="NLM_article-title">Structure of the ROC domain from the Parkinson’s disease-associated leucine-rich repeat kinase 2 reveals a dimeric GTPase</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">1499</span><span class="NLM_x">–</span> <span class="NLM_lpage">1504</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=1499-1504&author=J.+Dengauthor=P.+A.+Lewisauthor=E.+Greggioauthor=E.+Sluchauthor=A.+Beilinaauthor=M.+R.+Cookson&title=Structure+of+the+ROC+domain+from+the+Parkinson%E2%80%99s+disease-associated+leucine-rich+repeat+kinase+2+reveals+a+dimeric+GTPase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DJ.%26aulast%3DLewis%26aufirst%3DP.%2BA.%26aulast%3DGreggio%26aufirst%3DE.%26aulast%3DSluch%26aufirst%3DE.%26aulast%3DBeilina%26aufirst%3DA.%26aulast%3DCookson%26aufirst%3DM.%2BR.%26atitle%3DStructure%2520of%2520the%2520ROC%2520domain%2520from%2520the%2520Parkinson%25E2%2580%2599s%2520disease-associated%2520leucine-rich%2520repeat%2520kinase%25202%2520reveals%2520a%2520dimeric%2520GTPase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2008%26volume%3D105%26spage%3D1499%26epage%3D1504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group">Li, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voulalas, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassan, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacKerell, A. D.,  Jr</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, W. W.</span><span> </span><span class="NLM_article-title">Novel LRRK2 GTP-binding inhibitors reduced degeneration in Parkinson’s disease cell and mouse models</span> <span class="citation_source-journal">Hum. Mol. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">6212</span><span class="NLM_x">–</span> <span class="NLM_lpage">6222</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=10.1093%2Fhmg%2Fddu341" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=24993787" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;key=1%3ACAS%3A280%3ADC%252BC2cfpsFWisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2014&pages=6212-6222&author=T.+Liauthor=D.+Yangauthor=S.+Zhongauthor=J.+M.+Thomasauthor=F.+Xueauthor=J.+Liuauthor=L.+Kongauthor=P.+Voulalasauthor=H.+E.+Hassanauthor=J.-S.+Parkauthor=A.+D.+MacKerellauthor=W.+W.+Smith&title=Novel+LRRK2+GTP-binding+inhibitors+reduced+degeneration+in+Parkinson%E2%80%99s+disease+cell+and+mouse+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Novel LRRK2 GTP-binding inhibitors reduced degeneration in Parkinson's disease cell and mouse models</span></div><div class="casAuthors">Li Tianxia; Yang Dejun; Zhong Shijun; Thomas Joseph M; Xue Fengtian; Liu Jingnan; Kong Lingbo; Voulalas Pamela; Hassan Hazem E; Park Jae-Sung; MacKerell Alexander D Jr; Smith Wanli W</div><div class="citationInfo"><span class="NLM_cas:title">Human molecular genetics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6212-22</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Mutations in the leucine-rich repeat kinase-2 (LRRK2) gene cause autosomal-dominant Parkinson's disease (PD) and contribute to sporadic PD.  LRRK2 contains Guanosine-5'-triphosphate (GTP) binding, GTPase and kinase activities that have been implicated in the neuronal degeneration of PD pathogenesis, making LRRK2, a potential drug target.  To date, there is no disease-modifying drug to slow the neuronal degeneration of PD and no published LRRK2 GTP domain inhibitor.  Here, the biological functions of two novel GTP-binding inhibitors of LRRK2 were examined in PD cell and mouse models.  Through a combination of computer-aided drug design (CADD) and LRRK2 bio-functional screens, two novel compounds, 68: and 70: , were shown to reduce LRRK2 GTP binding and to inhibit LRRK2 kinase activity in vitro and in cultured cell assays.  Moreover, these two compounds attenuated neuronal degeneration in human SH-SY5Y neuroblastoma cells and mouse primary neurons expressing mutant LRRK2 variants.  Although both compounds inhibited LRRK2 kinase activity and reduced neuronal degeneration, solubility problems with 70: prevented further testing in mice.  Thus, only 68: was tested in a LRRK2-based lipopolysaccharide (LPS)-induced pre-inflammatory mouse model. 68: reduced LRRK2 GTP-binding activity and kinase activity in brains of LRRK2 transgenic mice after intraperitoneal injection.  Moreover, LPS induced LRRK2 upregulation and microglia activation in mouse brains.  These findings suggest that disruption of GTP binding to LRRK2 represents a potential novel therapeutic approach for PD intervention and that these novel GTP-binding inhibitors provide both tools and lead compounds for future drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR8AnCN662wR90Q2ypr7jHkfW6udTcc2eYh_oC0f-jDPLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cfpsFWisA%253D%253D&md5=492b71c9c7d37fe2eaca4568076bb25c</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddu341&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddu341%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DT.%26aulast%3DYang%26aufirst%3DD.%26aulast%3DZhong%26aufirst%3DS.%26aulast%3DThomas%26aufirst%3DJ.%2BM.%26aulast%3DXue%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DKong%26aufirst%3DL.%26aulast%3DVoulalas%26aufirst%3DP.%26aulast%3DHassan%26aufirst%3DH.%2BE.%26aulast%3DPark%26aufirst%3DJ.-S.%26aulast%3DMacKerell%26aufirst%3DA.%2BD.%26aulast%3DSmith%26aufirst%3DW.%2BW.%26atitle%3DNovel%2520LRRK2%2520GTP-binding%2520inhibitors%2520reduced%2520degeneration%2520in%2520Parkinson%25E2%2580%2599s%2520disease%2520cell%2520and%2520mouse%2520models%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2014%26volume%3D23%26spage%3D6212%26epage%3D6222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group">Gardet, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benita, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sands, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballester, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korzenik, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rioux, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daly, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xavier, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podolsky, D. K.</span><span> </span><span class="NLM_article-title">LRRK2 is involved in the IFN-gamma response and host response to pathogens</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">185</span><span class="NLM_x">, </span> <span class="NLM_fpage">5577</span><span class="NLM_x">–</span> <span class="NLM_lpage">5585</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=185&publication_year=2010&pages=5577-5585&author=A.+Gardetauthor=Y.+Benitaauthor=C.+Liauthor=B.+E.+Sandsauthor=I.+Ballesterauthor=C.+Stevensauthor=J.+R.+Korzenikauthor=J.+D.+Riouxauthor=M.+J.+Dalyauthor=R.+J.+Xavierauthor=D.+K.+Podolsky&title=LRRK2+is+involved+in+the+IFN-gamma+response+and+host+response+to+pathogens"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGardet%26aufirst%3DA.%26aulast%3DBenita%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DSands%26aufirst%3DB.%2BE.%26aulast%3DBallester%26aufirst%3DI.%26aulast%3DStevens%26aufirst%3DC.%26aulast%3DKorzenik%26aufirst%3DJ.%2BR.%26aulast%3DRioux%26aufirst%3DJ.%2BD.%26aulast%3DDaly%26aufirst%3DM.%2BJ.%26aulast%3DXavier%26aufirst%3DR.%2BJ.%26aulast%3DPodolsky%26aufirst%3DD.%2BK.%26atitle%3DLRRK2%2520is%2520involved%2520in%2520the%2520IFN-gamma%2520response%2520and%2520host%2520response%2520to%2520pathogens%26jtitle%3DJ.%2520Immunol.%26date%3D2010%26volume%3D185%26spage%3D5577%26epage%3D5585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="note"><p class="first last">G7080 (<b>5</b>), GNE-7915 (<b>7</b>), GNE-0877 (<b>8</b>), and GNE-9605 (<b>9</b>) can be requested through the Genentech Research Contracts and Reagents Program. GSK2578215A (<b>10</b>, CAS = 1285515-21-0); PF-06447475 (<b>14</b>, CAS = 1527473-33-1).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2zej" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2zej','PDB','2zej'); return false;">PDB: 2zej</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.5b00261%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2015.58.issue-17%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.5b00261" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-b425991822a79ada59b3.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-fb88834b824b41b135ad.js"></script>

<script type="text/javascript" src="/wro/ke1q~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"667981ac1b9d23c8","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.6.0","si":10}'></script>
</body>
</html>
